data_2ksa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.843 HG12 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.974 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.98 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.92 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.012 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.888 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.706 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.006 HG23 HG23 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.102 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.954 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.939 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 1.006 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.832 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.012 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.087 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.79 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.888 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.853 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.79 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.954 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.811 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.82 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.827 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.119 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.119 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.777 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.827 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.826 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.785 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.815 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.981 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.815 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.929 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.929 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.895 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.774 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.866 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.751 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 279' ' ' LEU . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.862 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.917 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.122 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.122 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.058 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.058 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.998 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.102 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.991 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.991 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.521 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.888 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.525 ' N ' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.07 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.703 1.602 . . . . 1.0 111.856 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 127.36 92.1 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.276 -0.42 . . . . 1.0 109.876 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.5 Cg_endo -69.01 -20.03 38.89 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.458 2.106 . . . . 1.0 114.543 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.3 -38.67 77.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.702 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . 0.448 ' HG2' ' HG ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -71.34 -10.55 59.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 1.0 110.55 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 4.2 m-30 -58.57 -46.36 87.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.307 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.56 -49.06 78.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.55 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.098 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.368 -0.975 . . . . 97.08 108.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.63 155.41 22.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.072 0.939 . . . . 123.41 110.739 -172.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.931 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.52 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.51 1 N-CA-C 100.136 -4.024 . . . . 151.3 100.136 173.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.981 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.65 -38.6 58.39 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 115.981 -2.288 . . . . 169.25 106.145 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.981 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.27 168.51 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 122.273 0.617 . . . . 185.76 110.585 171.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.4 t -64.48 -25.9 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 C-N-CA 126.984 2.114 . . . . 145.47 110.336 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.714 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.4 21.51 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.088 -1.007 . . . . 102.76 109.453 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.58 154.17 25.13 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.014 -1.106 . . . . 106.25 108.014 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.87 51.87 0.74 Allowed 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.645 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.15 -45.9 91.5 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 103.619 -2.734 . . . . 150.2 103.619 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -86.98 164.7 35.38 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 103.711 -2.699 . . . . 183.52 103.711 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.79 6.87 3.85 Favored 'Trans proline' 0 C--N 1.281 -3.012 0 N-CA-C 109.948 -0.828 . . . . 235.61 109.948 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.7 t-20 -57.97 -41.19 82.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.813 1.245 . . . . 113.77 113.375 -170.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.931 HD13 HG11 ' A' ' 4' ' ' VAL . 33.5 pt -52.19 136.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 119.555 1.071 . . . . 150.85 110.947 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.48 156.24 46.4 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.624 -1.25 . . . . 100.42 107.624 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.04 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.974 0.892 . . . . 129.36 110.445 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.11 -25.45 68.36 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.278 1.831 . . . . 112.34 106.67 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.954 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.19 -40.11 62.73 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.565 -0.743 . . . . 131.73 111.75 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.48 -42.86 15.15 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.95 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.825 0 C-N-CA 118.155 -1.418 . . . . 98.98 111.21 -169.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.5 Cg_exo -61.82 -10.8 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.917 1 N-CA-C 128.862 6.447 . . . . 246.95 128.862 -170.05 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.673 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.67 17.56 8.77 Favored 'General case' 0 C--N 1.324 -0.523 1 CA-C-N 126.19 4.086 . . . . 269.62 114.183 175.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.25 67.12 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.785 -1.191 . . . . 86.8 107.785 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.4 p90 -66.87 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.126 -0.984 . . . . 85.91 110.517 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.886 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 123.663 0.785 . . . . 82.0 111.388 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.934 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.7 12.55 Favored Pre-proline 0 CA--C 1.489 -1.378 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.843 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.9 149.75 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.881 . . . . 87.86 109.913 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.821 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.99 89.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.851 -0.796 . . . . 36.46 108.851 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.842 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.8 -33.83 76.54 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.934 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.4 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.296 -0.877 . . . . 123.26 108.645 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.53 -47.16 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.42 -31.01 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 107.845 -1.169 . . . . 112.19 107.845 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.842 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.12 84.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.899 -0.72 . . . . 60.87 109.622 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.705 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -65.99 -35.65 81.14 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 119.953 -0.699 . . . . 157.57 110.388 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.786 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.614 -0.884 . . . . 47.06 108.614 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.74 -41.32 98.05 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.743 -0.598 . . . . 43.94 109.573 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.81 -43.35 99.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.717 -0.846 . . . . 42.61 108.717 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.34 -41.28 94.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.616 -0.266 . . . . 140.66 111.002 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.76 -43.97 97.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 118.596 -1.241 . . . . 116.04 110.236 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.75 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 N-CA-C 108.728 -0.842 . . . . 97.16 108.728 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.913 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -39.97 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 108.952 -0.759 . . . . 54.85 108.952 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.0 HG23 HG23 ' A' ' 86' ' ' THR . 92.8 t -57.74 -42.36 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.835 -0.802 . . . . 45.39 108.835 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.1 t -63.54 -50.94 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 118.826 -1.15 . . . . 48.64 110.166 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.789 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.25 -47.07 78.04 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.14 -0.624 . . . . 116.65 111.703 -174.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.64 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.96 -43.92 97.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.683 -0.488 . . . . 51.16 109.683 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.58 -48.92 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 C-N-CA 119.85 -0.74 . . . . 44.3 110.834 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.9 t -64.78 -46.91 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 120.239 -0.585 . . . . 48.82 111.034 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.76 -44.14 95.23 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.474 -0.87 . . . . 58.7 112.016 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.64 -34.18 67.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 122.136 -0.626 . . . . 101.4 111.056 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.816 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.97 -38.64 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.45 -43.06 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.972 -0.751 . . . . 61.89 108.972 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.98 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 109.463 -0.569 . . . . 70.01 109.463 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.716 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.37 98.97 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.128 -0.693 . . . . 132.1 109.128 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.67 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.65 82.95 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.706 -0.225 . . . . 104.5 110.435 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.61 -49.91 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 120.233 -0.587 . . . . 142.96 111.303 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.036 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.68 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.926 -1.91 . . . . 158.32 110.893 -175.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.73 -41.39 98.05 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 117.71 -1.596 . . . . 137.11 109.496 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.55 91.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 122.089 -0.382 . . . . 54.66 110.997 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.953 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.44 117.17 29.45 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.646 0.736 . . . . 127.18 109.559 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.89 -36.74 80.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 124.039 0.935 . . . . 87.93 110.859 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.067 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.43 -34.62 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.65 -0.656 . . . . 131.12 111.482 -175.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.007 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.67 69.47 7.19 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 115.271 -2.571 . . . . 246.56 109.6 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.24 91.49 3.49 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 105.453 -2.055 . . . . 339.35 105.453 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.854 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.24 17.93 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 102.97 -2.974 . . . . 114.66 102.97 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.956 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.11 -39.5 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 106.754 -1.573 . . . . 143.28 106.754 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 1.001 HG21 HD13 ' A' ' 71' ' ' LEU . 95.7 m -59.67 -38.03 80.38 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.697 -0.853 . . . . 160.22 108.697 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.854 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.35 -31.75 72.44 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.893 -0.78 . . . . 120.54 108.893 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.66 -43.74 95.85 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.482 -0.562 . . . . 67.22 109.482 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.54 -39.77 88.75 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.537 -0.727 . . . . 138.6 109.683 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 1.001 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.59 -35.9 82.03 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.449 0.3 . . . . 151.46 110.644 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.036 HG13 HD12 ' A' ' 57' ' ' ILE . 24.0 m -62.51 -38.02 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.719 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.1 -45.97 91.16 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.889 -1.152 . . . . 56.82 107.889 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.91 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.94 98.01 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.917 -0.771 . . . . 145.3 108.917 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.34 95.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.574 -0.898 . . . . 45.71 108.574 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.36 -42.04 99.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.387 -0.597 . . . . 105.61 109.387 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.47 92.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.668 -0.864 . . . . 47.89 108.668 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.34 84.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.976 -0.379 . . . . 124.53 109.976 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.19 99.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.944 -0.473 . . . . 35.89 109.807 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.26 -37.3 84.95 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.966 -1.494 . . . . 88.97 106.966 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.21 -49.11 77.06 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.809 -0.756 . . . . 239.91 109.064 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.36 90.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.522 -0.736 . . . . 146.1 110.611 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.4 1.97 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.764 1.765 . . . . 197.45 115.764 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.996 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.26 55.63 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 117.891 -1.524 . . . . 242.6 114.039 -170.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 1.0 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.37 -36.57 84.39 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.862 -1.135 . . . . 215.61 109.886 -172.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.25 -46.92 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 120.361 -0.536 . . . . 87.19 110.493 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.88 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 109.754 -0.461 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.958 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.1 75.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.349 -0.982 . . . . 364.98 108.349 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.23 -44.69 75.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.559 -0.713 . . . . 181.63 111.236 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.898 HG21 ' HD2' ' A' ' 95' ' ' HIS . 58.1 m -60.91 -45.76 93.33 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 107.409 -1.33 . . . . 269.02 107.409 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.069 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.78 -45.01 93.62 Favored 'General case' 0 CA--C 1.469 -2.146 0 C-N-CA 118.625 -1.23 . . . . 562.66 109.983 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.28 95.34 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.685 -1.206 . . . . 446.75 108.066 -167.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.786 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.48 -26.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.859 -2.336 . . . . 370.05 112.195 -178.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.898 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.49 60.04 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.552 -0.717 . . . . 354.91 112.478 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.882 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.3 m-20 82.76 4.45 1.01 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 125.048 1.339 . . . . 462.44 111.934 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.3 178.06 2.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.971 0.891 . . . . 652.37 111.168 171.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.7 86.35 2.16 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 128.473 2.709 . . . . 905.99 107.947 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -67.97 -36.36 79.93 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.203 -1.036 . . . . 570.43 108.203 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.37 82.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.345 1.458 . . . . 453.22 111.146 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.954 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.57 178.68 33.86 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.716 -1.707 . . . . 445.63 109.875 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.778 HD21 ' CE1' ' B' ' 371' ' ' PHE . 89.1 mt -56.45 -41.23 76.13 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.208 1.403 . . . . 457.72 112.374 -170.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.57 -47.02 85.66 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.69 -1.204 . . . . 340.58 109.266 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.68 -32.14 71.76 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.802 -1.159 . . . . 453.6 111.59 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.36 73.37 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.15 75.99 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.949 0.781 . . . . 466.68 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.75 -47.09 86.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.296 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.16 -36.76 82.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 112.365 0.506 . . . . 537.87 112.365 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.39 -42.68 74.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 116.882 -1.927 . . . . 422.12 111.604 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.8 t80 -59.04 -50.09 75.4 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 121.34 -0.85 . . . . 340.17 111.84 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.3 m-85 -65.34 -46.48 70.82 Favored Pre-proline 0 N--CA 1.443 -0.776 0 C-N-CA 119.085 -1.046 . . . . 258.06 111.705 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.996 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.55 -31.57 87.43 Favored 'Trans proline' 0 N--CA 1.435 -1.954 0 N-CA-C 115.324 1.24 . . . . 305.71 115.324 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.702 -0.851 . . . . 252.7 108.702 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.66 93.93 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.776 -1.194 . . . . 149.27 107.776 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.85 95.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.661 -0.416 . . . . 138.08 111.509 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.749 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.92 -42.35 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 121.587 -0.696 . . . . 132.89 110.996 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.947 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.81 -44.66 92.63 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.84 -0.8 . . . . 193.61 108.84 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.69 84.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.846 0.458 . . . . 63.83 110.063 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -64.04 -52.41 59.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 122.068 -0.395 . . . . 76.4 111.228 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.96 -41.63 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.188 -1.041 . . . . 171.13 108.188 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.074 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.58 91.63 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.82 -0.55 . . . . 78.3 110.599 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.74 80.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 118.886 -1.126 . . . . 92.36 109.217 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.08 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.45 -34.26 76.45 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.199 -1.037 . . . . 93.73 108.199 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.48 -41.61 84.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.193 -1.003 . . . . 132.74 109.34 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.05 94.65 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.194 -1.41 . . . . 43.39 107.194 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.5 -41.97 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.593 -0.891 . . . . 59.34 108.593 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.43 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 121.781 -0.574 . . . . 69.68 110.491 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.48 -42.79 91.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.287 -1.005 . . . . 106.98 108.287 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.659 -0.817 . . . . 147.63 108.917 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.761 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.17 -41.54 99.25 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.549 -0.908 . . . . 190.06 108.549 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.962 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.32 -44.08 97.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.306 -0.998 . . . . 118.85 108.306 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.124 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.3 -42.76 99.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.99 -0.374 . . . . 102.5 109.99 -177.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.61 95.34 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 121.875 -0.516 . . . . 89.98 109.853 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.52 -50.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 C-N-CA 118.151 -1.419 . . . . 106.09 111.003 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.32 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.847 -174.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.83 100.09 51.01 Favored Pre-proline 0 CA--C 1.486 -1.511 0 C-N-CA 116.261 -2.176 . . . . 262.55 110.047 -175.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.1 Cg_endo -69.65 -10.33 28.38 Favored 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 121.606 1.537 . . . . 210.25 111.332 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.521 -1.659 . . . . 270.58 106.521 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.893 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.8 -39.52 24.18 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-N 115.377 -0.829 . . . . 129.84 112.312 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.5 Cg_exo -61.36 -26.65 81.85 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 116.296 1.614 . . . . 330.71 116.296 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -80.99 77.16 7.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 114.502 -2.879 . . . . 204.51 107.3 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.88 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.35 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.431 -1.322 . . . . 387.41 107.431 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.88 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.65 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 118.761 -1.176 . . . . 166.22 109.461 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.821 -1.177 . . . . 44.23 107.821 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.28 -39.13 85.77 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.206 -1.035 . . . . 28.8 108.206 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.83 92.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.074 -0.714 . . . . 30.29 109.074 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.956 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.4 m -59.56 -43.06 93.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.016 -0.735 . . . . 46.11 109.016 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.47 -42.1 99.25 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.683 -1.229 . . . . 87.33 107.683 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.5 t -61.68 -42.1 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.883 -1.155 . . . . 23.69 107.883 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.23 -44.31 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 109.649 -0.5 . . . . 43.86 109.649 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.937 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.59 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.352 -0.981 . . . . 91.13 108.352 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.3 t -62.53 -37.97 88.15 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.768 -0.827 . . . . 65.88 108.768 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.07 -41.96 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.536 -0.542 . . . . 33.86 109.536 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.34 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.595 -1.261 . . . . 146.52 107.595 -176.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.33 90.5 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.512 -0.875 . . . . 75.44 108.849 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.58 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 O-C-N 121.031 -1.043 . . . . 43.64 109.725 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.81 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.73 -37.95 89.26 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 109.027 -0.731 . . . . 102.57 109.027 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.09 87.01 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.383 -1.34 . . . . 58.16 107.383 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.817 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.03 -32.52 73.91 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.043 -0.725 . . . . 121.11 109.043 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.99 -42.37 84.97 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 118.586 -1.245 . . . . 153.15 109.895 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.993 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.1 -43.73 19.02 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 113.051 -3.46 . . . . 133.67 113.488 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.9 96.07 Favored 'General case' 0 CA--C 1.489 -1.402 0 O-C-N 120.893 -1.13 . . . . 157.42 112.226 -171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.09 2.44 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 115.037 1.495 . . . . 250.91 115.037 -173.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.6 Cg_exo -59.51 -25.47 78.82 Favored 'Trans proline' 0 CA--C 1.488 -1.816 0 N-CA-C 118.018 2.276 . . . . 207.34 118.018 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.028 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.15 -34.21 74.65 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.978 -1.49 . . . . 192.46 106.978 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.55 -40.99 98.07 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 107.938 -2.065 . . . . 261.0 107.938 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.83 159.09 26.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 101.554 -3.499 . . . . 491.4 101.554 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 116.287 -2.165 . . . . 386.1 109.797 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.028 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 103.54 -2.763 . . . . 289.8 103.54 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.118 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.41 0.86 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.725 -1.131 . . . . 402.06 109.556 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.78 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 71.9 p -165.29 177.48 7.56 Favored 'General case' 0 CA--C 1.587 2.373 0 C-N-CA 127.323 2.249 . . . . 690.53 114.902 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.35 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.698 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.792 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.84 22.09 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 127.399 2.28 . . . . 617.99 110.916 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.99 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.246 3.419 . . . . 434.98 113.455 -175.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 122.397 3.96 . . . . 365.88 122.397 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.89 1.7 Allowed 'General case' 0 CA--C 1.467 -2.235 0 N-CA-C 104.83 -2.285 . . . . 635.81 104.83 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.776 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.33 152.21 18.83 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.975 7.768 . . . . 999.99 131.975 -135.735 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.069 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.909 36.9 t -131.85 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.73 1 CA-C-N 103.311 -6.313 . . . . 594.32 113.588 149.175 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.18 144.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.792 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.55 45.91 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.05 -1.86 . . . . 999.99 109.374 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.7 mmm -147.22 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.009 0.909 . . . . 431.86 110.038 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.14 148.64 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 124.351 1.06 . . . . 457.18 108.8 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.829 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.29 85.51 3.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.109 0.963 . . . . 458.77 113.486 -174.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.54 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.928 1.291 . . . . 999.99 112.479 168.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.943 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.76 5.65 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 N-CA-C 120.865 3.371 . . . . 999.99 120.865 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.59 171.69 8.19 Favored 'General case' 0 CA--C 1.472 -2.032 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.274 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.84 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.518 -2.473 . . . . 999.99 108.767 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.051 ' HB2' HD11 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.55 101.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.167 1 C-N-CA 126.015 4.477 . . . . 999.99 105.716 -170.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.18 -44.02 97.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 126.786 2.034 . . . . 967.72 112.092 -165.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.3 -36.57 78.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.711 -1.589 . . . . 934.3 106.711 -175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.26 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.212 3.005 . . . . 565.15 113.898 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.51 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 118.468 0.576 . . . . 755.61 109.863 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.118 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.28 67.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.557 1.143 . . . . 325.89 113.274 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.98 78.37 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 123.55 0.74 . . . . 250.21 111.64 -169.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.544 0.688 . . . . 142.46 110.38 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.14 -41.5 96.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.942 0.897 . . . . 247.69 108.832 -173.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.893 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.48 -51.35 69.85 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.467 1.507 . . . . 199.61 113.103 -175.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.36 -44.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 107.694 -1.225 . . . . 106.73 107.694 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.787 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.13 -48.48 81.46 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.88 -0.6 . . . . 115.01 110.251 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.993 HG13 HD12 ' A' ' 161' ' ' LEU . 85.8 t -65.28 -49.17 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 C-N-CA 119.433 -0.907 . . . . 129.42 111.801 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.817 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.9 -53.16 59.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 118.23 -1.388 . . . . 172.48 109.933 -172.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.83 -54.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 123.471 0.482 . . . . 55.86 110.982 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.95 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 118.551 -1.259 . . . . 184.68 111.509 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.975 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.41 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 116.67 -2.012 . . . . 291.81 114.715 -174.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.431 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.06 -55.05 4.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.817 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.54 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.485 1.291 . . . . 80.16 114.485 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.933 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.48 83.22 Favored Pre-proline 0 N--CA 1.435 -1.198 0 C-N-CA 119.963 -0.695 . . . . 136.02 109.48 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.933 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.8 -27.11 59.7 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.707 0.574 . . . . 92.17 110.62 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.35 76.63 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.486 -1.302 . . . . 135.6 107.486 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.14 -44.72 91.33 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.603 -0.517 . . . . 52.1 109.603 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.68 -43.51 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.111 -0.7 . . . . 95.89 109.111 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.33 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.725 -1.583 . . . . 43.41 106.725 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.33 99.14 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.907 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.37 75.71 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 122.195 -0.591 . . . . 54.41 110.476 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.42 -34.1 74.82 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.976 -1.49 . . . . 53.88 106.976 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.85 93.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.469 -0.937 . . . . 68.29 108.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.907 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.84 -39.01 92.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.672 -0.811 . . . . 107.59 110.604 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -62.95 -38.41 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.553 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.5 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.87 99.43 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.088 -0.805 . . . . 40.71 111.088 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.08 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.399 -0.963 . . . . 95.86 108.399 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.4 p -76.93 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.401 -0.962 . . . . 144.37 108.401 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.57 -1.27 . . . . 326.72 107.57 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.29 -168.03 1.5 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.072 -1.825 . . . . 158.38 106.072 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.96 98.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.659 -0.496 . . . . 36.78 109.659 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.12 125.84 25.2 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.17 -1.012 . . . . 85.46 109.808 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.772 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.47 8.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.53 -2.026 . . . . 127.78 105.53 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.96 139.87 34.96 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 106.023 -1.843 . . . . 164.84 106.023 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.6 Cg_exo -56.77 -39.97 87.57 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.935 0.706 . . . . 222.35 113.935 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.12 166.97 44.94 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 106.445 -2.662 . . . . 45.22 106.445 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.923 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.73 93.49 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.035 -1.839 . . . . 107.57 106.035 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.735 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.78 141.83 58.18 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.9 -1.12 . . . . 167.96 109.168 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.87 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.52 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 126.734 2.014 . . . . 280.68 109.706 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.777 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.04 11.23 0.7 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.443 1.097 . . . . 218.25 110.698 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.934 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.36 137.64 54.79 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.241 -2.133 . . . . 343.57 105.241 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.579 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.93 1.54 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.839 -1.541 . . . . 263.29 106.839 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.658 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.26 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 126.568 1.947 . . . . 261.92 108.522 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.19 -38.1 89.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.893 -1.151 . . . . 106.81 107.893 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.35 -1.34 . . . . 112.2 107.594 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.24 -39.87 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 N-CA-C 109.259 -0.645 . . . . 45.41 109.259 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.868 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.9 p -70.88 -32.05 68.91 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.313 -0.255 . . . . 97.62 110.313 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.62 81.66 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.684 0.794 . . . . 59.29 110.992 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.55 84.01 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.656 1.182 . . . . 106.49 110.683 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.934 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.63 69.2 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.32 -0.993 . . . . 106.62 108.32 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.02 -41.02 91.51 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.809 -0.557 . . . . 75.97 110.079 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.57 -40.8 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 122.908 0.483 . . . . 65.27 109.788 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.837 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.06 -41.56 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.154 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.58 -40.76 97.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 121.712 -0.618 . . . . 87.98 110.27 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.66 -40.4 96.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 118.815 -1.154 . . . . 65.5 108.367 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.66 -36.41 80.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.162 -1.051 . . . . 85.05 108.162 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.6 mt -63.47 -45.77 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 109.053 -0.721 . . . . 42.25 109.053 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.26 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 119.542 -0.863 . . . . 91.01 109.419 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 65.6 t -58.86 -41.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.99 -1.115 . . . . 66.09 107.99 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 250' ' ' MET . 94.6 t -66.07 -43.15 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 120.758 -0.377 . . . . 52.39 110.293 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.7 m -61.8 -46.73 88.28 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.907 -0.496 . . . . 46.42 109.866 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.13 88.29 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.26 -48.23 82.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.402 -0.592 . . . . 65.18 109.402 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.7 97.2 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 120.824 0.345 . . . . 51.33 110.407 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.34 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 C-N-CA 118.941 -1.103 . . . . 126.3 109.015 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.565 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.5 m -65.64 -49.31 69.12 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.539 -0.864 . . . . 133.94 112.456 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.87 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.74 -33.32 35.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 116.826 2.158 . . . . 134.84 116.826 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.43 -41.64 90.37 Favored Pre-proline 0 CA--C 1.493 -1.237 0 CA-C-N 118.632 0.651 . . . . 72.23 111.644 -167.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.819 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.67 -35.98 87.07 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 CA-C-N 119.83 0.975 . . . . 106.13 111.375 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.848 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.35 -44.73 82.45 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 119.752 -0.779 . . . . 128.35 110.051 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.693 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.43 -37.85 88.98 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.174 -0.306 . . . . 100.73 110.174 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.819 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.3 -44.55 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 C-N-CA 119.274 -0.971 . . . . 172.72 109.123 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.8 m-85 -66.57 -28.06 68.22 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.273 -1.01 . . . . 249.23 108.273 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.6 -55.11 35.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.644 -1.613 . . . . 259.78 106.644 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.893 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.11 -44.23 72.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.574 0.953 . . . . 233.11 113.574 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 279' ' ' LEU . 88.9 mt -61.38 -48.29 91.41 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 119.162 -1.015 . . . . 169.54 110.596 -171.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.683 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.4 Cg_exo -61.12 -24.56 79.51 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 C-N-CA 116.771 -1.686 . . . . 255.47 114.655 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.7 t80 -63.54 -44.23 94.8 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.213 0.915 . . . . 279.03 108.929 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.79 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.073 -0.343 . . . . 162.21 110.073 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.83 59.38 Favored Pre-proline 0 N--CA 1.431 -1.399 0 C-N-CA 118.802 -1.159 . . . . 128.13 108.09 -178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.02 11.28 Favored 'Trans proline' 0 C--N 1.295 -2.264 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.07 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 123.829 0.705 . . . . 312.91 109.37 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.75 -170.64 2.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.534 -1.654 . . . . 353.54 106.534 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.024 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.9 p90 -115.7 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.854 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -77.01 -118.69 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.5 -45.0 96.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.837 -3.764 . . . . 99.07 100.837 172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.17 9.17 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.463 -2.791 . . . . 243.21 103.463 171.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.024 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.94 25.08 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 116.051 -2.259 . . . . 201.04 105.262 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.741 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.91 173.76 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 C-N-CA 115.954 -2.298 . . . . 201.36 108.781 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.06 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.281 0.6 OUTLIER -59.49 -41.45 89.84 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.248 -1.796 . . . . 203.82 107.905 174.44 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.912 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.21 -1.396 . . . . 215.06 112.562 -171.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.635 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.5 t -65.7 -46.4 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 118.529 -1.268 . . . . 125.28 112.928 -171.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.85 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.74 -37.07 86.36 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.191 -1.411 . . . . 268.9 107.191 -171.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.874 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.18 -45.0 74.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 125.6 1.56 . . . . 280.88 108.817 -172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.49 86.0 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.91 -1.116 . . . . 184.47 109.043 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.848 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.7 mp -67.88 -42.13 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 119.284 -0.966 . . . . 167.92 112.785 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.661 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.77 -38.73 89.86 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 117.772 -1.571 . . . . 367.18 110.765 -175.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.17 -32.74 74.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 121.844 -0.535 . . . . 173.97 110.468 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.72 85.09 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.505 0.722 . . . . 119.66 109.78 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.87 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.95 74.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.686 -1.228 . . . . 112.3 107.686 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.711 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.08 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.263 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.75 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 124.7 1.2 . . . . 145.27 110.586 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.832 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.64 -35.36 70.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.095 -1.076 . . . . 170.15 108.095 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.32 -34.15 63.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 116.295 -0.411 . . . . 214.57 110.609 -171.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.789 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.19 -33.18 56.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.084 1.754 . . . . 168.29 115.566 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.832 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.49 -34.82 79.11 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.007 1.114 . . . . 167.15 114.007 -168.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.745 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.22 -38.26 32.86 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 115.512 -2.475 . . . . 165.13 113.937 -171.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.745 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.7 Cg_exo -62.55 -31.86 79.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.771 2.025 . . . . 123.92 111.236 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.787 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.75 -42.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 118.874 -1.131 . . . . 110.55 109.823 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.2 pt -61.15 -40.04 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.86 -0.793 . . . . 145.31 108.86 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.254 63.2 m-85 -58.16 -48.82 79.1 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.371 -0.932 . . . . 246.68 109.81 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.18 -47.45 84.43 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.542 -0.863 . . . . 64.43 109.621 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.84 -45.07 79.36 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 118.968 -1.093 . . . . 80.72 110.223 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.02 1.859 . . . . 140.44 116.02 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.623 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.25 34.37 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 112.699 -3.6 . . . . 178.87 113.03 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.1 86.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.394 -1.275 . . . . 110.22 110.09 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.847 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.71 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.268 0 O-C-N 121.744 -0.598 . . . . 174.78 109.757 -174.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.84 -41.69 95.52 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.273 -1.01 . . . . 161.84 108.273 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.34 -50.23 73.61 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.179 -0.675 . . . . 117.2 109.179 -173.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.53 -44.08 75.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.384 -0.527 . . . . 112.6 111.056 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.115 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.06 -37.41 94.54 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.647 -0.981 . . . . 101.46 110.647 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.15 -45.99 91.0 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 118.54 1.17 . . . . 151.49 109.505 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.15 -36.28 77.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.94 -1.504 . . . . 142.32 106.94 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.115 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.8 m80 -59.81 -41.81 92.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.885 -1.524 . . . . 109.09 106.885 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.4 85.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.35 -0.219 . . . . 76.11 111.066 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.44 -55.48 30.78 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.888 -0.725 . . . . 120.24 109.305 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.749 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.52 41.22 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 102.942 -2.984 . . . . 192.73 102.942 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.22 92.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.048 -1.061 . . . . 176.29 109.185 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.815 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.13 0.82 Allowed Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 106.296 -1.742 . . . . 69.68 106.296 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.97 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-O 118.711 -0.62 . . . . 191.05 112.604 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.815 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.51 43.89 16.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.62 0.575 . . . . 287.03 109.753 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.849 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.54 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.94 0 C-N-CA 112.964 -3.494 . . . . 292.29 109.847 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.78 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.21 -2.515 . . . . 184.57 104.21 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.7 4.98 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.042 0.756 . . . . 274.56 113.042 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.83 57.25 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 117.737 -2.173 . . . . 268.24 113.47 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.68 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.68 1.24 . . . . 200.06 110.778 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.847 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.92 -33.0 74.72 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.858 -1.164 . . . . 114.44 107.858 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.0 21.97 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.65 -1.241 . . . . 263.81 107.65 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.37 -137.28 3.56 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.55 10.24 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 114.942 -2.703 . . . . 117.3 106.014 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.06 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.92 Favored 'General case' 0 CA--C 1.468 -2.19 1 N-CA-C 98.016 -4.809 . . . . 231.58 98.016 167.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.067 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.66 -48.57 78.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 116.047 -2.261 . . . . 112.72 108.39 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.07 -63.61 1.24 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.124 -0.695 . . . . 83.22 109.124 -176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.5 m -156.29 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.791 -2.67 . . . . 174.36 103.791 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.06 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.88 160.98 8.75 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.025 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.93 149.02 52.56 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.1 -1.445 . . . . 180.62 107.1 176.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.946 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.5 -171.87 0.27 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 105.362 -2.088 . . . . 145.25 105.362 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.946 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.07 -43.11 88.36 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.192 -1.781 . . . . 66.05 106.192 174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.762 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.74 -152.17 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.482 -2.785 . . . . 266.49 103.482 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.36 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.024 -1.87 . . . . 219.2 107.757 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.005 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.98 -37.43 94.25 Favored Glycine 0 N--CA 1.426 -2.018 0 CA-C-N 114.52 -1.218 . . . . 94.78 112.885 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.2 100.45 9.11 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 112.321 -3.752 . . . . 121.41 109.41 -171.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.673 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.7 t -73.08 145.5 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.957 -0.757 . . . . 85.34 108.957 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.504 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.819 -1.178 . . . . 267.57 107.819 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.06 69.56 0.6 Allowed 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.524 -0.547 . . . . 226.1 109.524 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.045 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.98 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.6 m -61.31 161.93 8.42 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.626 0.727 . . . . 180.01 110.681 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.879 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.97 23.51 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.97 -1.492 . . . . 333.78 106.97 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.986 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.08 142.54 48.79 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.347 -1.353 . . . . 335.2 107.347 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.986 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.8 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.744 -0.836 . . . . 266.47 108.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.3 m -60.62 -46.94 88.38 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.64 -1.985 . . . . 59.34 105.64 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.84 12.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 104.442 -2.429 . . . . 201.26 104.442 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.784 HG21 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.93 106.71 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 C-N-CA 116.347 -2.141 . . . . 56.23 105.505 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 71.0 m -61.14 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.316 -0.624 . . . . 87.58 109.316 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.893 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.75 22.28 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.813 -1.18 . . . . 219.95 107.813 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 C-N-CA 116.372 -2.131 . . . . 121.79 105.423 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.4 t -154.13 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 105.835 -1.913 . . . . 53.85 105.835 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.623 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.034 -2.826 . . . . 196.55 106.034 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.677 0 N-CA-C 107.832 -1.173 . . . . 35.88 107.832 -178.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.62 ' NH2' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.945 ' HG2' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -67.09 144.06 67.92 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.663 1.575 . . . . 1.0 111.833 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' B' ' 367' ' ' LYS . 0.1 OUTLIER -70.4 127.36 92.18 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.22 -0.446 . . . . 1.0 109.905 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.664 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.8 Cg_endo -69.04 -20.02 38.77 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.428 2.085 . . . . 1.0 114.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.28 -38.68 77.48 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.725 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -71.36 -10.44 59.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 1.0 110.604 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.778 ' CE1' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -58.63 -46.28 87.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 1.0 110.323 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -61.65 -49.03 78.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.551 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.07 0 N-CA-C 109.819 -1.313 . . . . 1.0 109.819 179.821 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.38 -0.97 . . . . 97.08 108.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.6 155.4 22.41 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.085 0.945 . . . . 123.41 110.774 -172.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.928 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.57 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.461 1 N-CA-C 100.064 -4.051 . . . . 151.3 100.064 173.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.981 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.58 58.35 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 115.952 -2.299 . . . . 169.25 106.148 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.981 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.29 168.52 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 122.301 0.632 . . . . 185.76 110.568 171.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.851 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.5 t -64.44 -25.96 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 127.042 2.137 . . . . 145.47 110.342 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.44 21.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.058 -1.027 . . . . 102.76 109.445 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.68 154.16 25.0 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.937 -1.134 . . . . 106.25 107.937 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.924 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.83 51.84 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.754 -1.578 . . . . 157.81 107.663 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.15 -45.9 91.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.553 -2.758 . . . . 150.2 103.553 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.67 35.33 Favored Pre-proline 0 N--CA 1.422 -1.852 0 N-CA-C 103.669 -2.715 . . . . 183.52 103.669 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.71 6.87 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 N-CA-C 110.014 -0.802 . . . . 235.61 110.014 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.99 -41.16 82.44 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 124.749 1.22 . . . . 113.77 113.409 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.928 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.21 136.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 119.564 1.075 . . . . 150.85 110.973 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.441 ' HA ' HH12 ' B' ' 365' ' ' ARG . 47.7 t -140.5 156.28 46.38 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.59 -1.263 . . . . 100.42 107.59 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.041 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.93 0.871 . . . . 129.36 110.444 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.326 1.85 . . . . 112.34 106.663 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.955 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.2 m -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.618 -0.719 . . . . 131.73 111.739 177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.041 ' H ' HG21 ' A' ' 17' ' ' THR . 71.0 m -84.48 -42.85 15.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 116.984 2.216 . . . . 80.49 116.984 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -146.01 174.54 3.35 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 118.154 -1.418 . . . . 98.98 111.21 -169.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.8 Cg_exo -61.8 -10.74 18.09 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.953 6.482 . . . . 246.95 128.953 -170.103 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.66 17.49 8.7 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.112 4.051 . . . . 269.62 114.229 175.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.27 67.2 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.797 -1.186 . . . . 86.8 107.797 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.2 p90 -66.79 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.113 -0.992 . . . . 85.91 110.502 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.857 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.2 t -68.5 -40.23 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.718 0.807 . . . . 82.0 111.371 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.934 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.385 0 N-CA-C 108.522 -0.918 . . . . 120.73 108.522 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.843 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.03 149.75 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.882 . . . . 87.86 109.861 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.821 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.96 89.27 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.812 -0.81 . . . . 36.46 108.812 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.76 -33.87 76.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.87 -1.159 . . . . 150.6 107.87 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.934 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.2 -32.75 73.44 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 121.255 -0.903 . . . . 123.26 108.661 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.39 -47.21 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.95 -47.12 84.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.951 -0.7 . . . . 60.87 109.608 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.692 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.06 -35.63 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 120.004 -0.678 . . . . 157.57 110.361 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.67 -40.85 98.37 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.633 -0.877 . . . . 47.06 108.633 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.25 97.94 Favored 'General case' 0 CA--C 1.496 -1.12 0 O-C-N 121.721 -0.612 . . . . 43.94 109.544 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.85 -43.29 99.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.959 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.29 93.91 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 122.25 -0.281 . . . . 140.66 110.996 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.75 -44.02 97.72 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.605 -1.238 . . . . 116.04 110.22 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.38 -38.81 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.759 -0.83 . . . . 97.16 108.759 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.913 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -40.03 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.978 -0.749 . . . . 54.85 108.978 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.966 HG23 HG22 ' A' ' 86' ' ' THR . 93.2 t -57.65 -42.37 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.91 -0.774 . . . . 45.39 108.91 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.4 t -63.48 -50.99 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 C-N-CA 118.819 -1.152 . . . . 48.64 110.203 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.792 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.7 t -65.25 -47.03 78.17 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.167 -0.613 . . . . 116.65 111.73 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.95 -43.96 97.74 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.701 -0.481 . . . . 51.16 109.701 -174.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.58 -48.9 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 119.829 -0.748 . . . . 44.3 110.854 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 94.0 t -64.74 -46.97 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 120.299 -0.561 . . . . 48.82 111.027 -174.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.2 95.18 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.561 -0.828 . . . . 58.7 111.994 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.61 -34.26 67.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.018 -0.695 . . . . 101.4 111.039 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.89 -38.72 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 107.757 -1.201 . . . . 103.57 107.757 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.45 -43.01 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.977 -0.749 . . . . 61.89 108.977 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.641 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.7 t -63.43 -50.93 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.303 -0.559 . . . . 70.01 109.525 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.43 98.81 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.108 -0.701 . . . . 132.1 109.108 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.62 83.08 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.649 -0.251 . . . . 104.5 110.443 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 C-N-CA 120.213 -0.595 . . . . 142.96 111.253 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.043 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.7 pt -64.82 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.957 -1.897 . . . . 158.32 110.838 -175.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.71 -41.4 98.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 117.698 -1.601 . . . . 137.11 109.5 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.52 91.14 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.156 -0.34 . . . . 54.66 111.015 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.95 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.612 0.72 . . . . 127.18 109.577 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.79 -36.86 80.08 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.102 0.961 . . . . 87.93 110.859 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.067 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.69 78.75 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.69 -0.631 . . . . 131.12 111.514 -175.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.52 7.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.294 -2.562 . . . . 246.56 109.598 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 105.475 -2.046 . . . . 339.35 105.475 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.14 165.3 17.79 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.961 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.19 -39.4 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.766 -1.568 . . . . 143.28 106.766 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.999 HG21 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.72 -38.04 80.56 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.67 -0.863 . . . . 160.22 108.67 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.2 m-20 -62.4 -31.78 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.823 -0.806 . . . . 120.54 108.823 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.57 -43.8 95.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.466 -0.568 . . . . 67.22 109.466 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.59 -39.78 88.59 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.505 -0.747 . . . . 138.6 109.623 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.999 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.53 -35.89 81.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.468 0.307 . . . . 151.46 110.679 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.043 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.6 -37.89 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.724 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.96 91.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.855 -1.165 . . . . 56.82 107.855 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.912 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.937 -0.764 . . . . 145.3 108.937 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.38 95.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.495 -0.928 . . . . 45.71 108.495 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.37 -42.04 99.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.364 -0.606 . . . . 105.61 109.364 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 -39.54 92.78 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.611 -0.885 . . . . 47.89 108.611 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.37 84.84 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.953 -0.388 . . . . 124.53 109.953 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.24 99.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.968 -0.458 . . . . 35.89 109.838 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.29 -37.28 84.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.022 -1.473 . . . . 88.97 107.022 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.16 76.96 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.086 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.4 -43.41 90.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.511 -0.743 . . . . 146.1 110.591 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 117.423 -1.711 . . . . 91.74 113.829 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.47 1.95 Allowed 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 115.719 1.748 . . . . 197.45 115.719 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.23 -42.2 55.88 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 117.866 -1.534 . . . . 242.6 114.073 -170.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.966 HG22 HG23 ' A' ' 43' ' ' VAL . 4.7 t -65.48 -36.5 84.04 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.919 -1.113 . . . . 215.61 109.797 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' HG23 ' A' ' 86' ' ' THR . 73.0 t -60.36 -46.95 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 O-C-N 121.782 -0.574 . . . . 87.19 110.399 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.89 -41.84 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 O-C-N 121.942 -0.474 . . . . 231.82 109.776 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.959 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.39 -34.12 76.09 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.306 -0.998 . . . . 364.98 108.306 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.2 -44.74 75.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.533 -0.729 . . . . 181.63 111.228 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.866 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.3 m -60.8 -45.81 92.95 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 107.468 -1.308 . . . . 269.02 107.468 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.068 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.07 93.25 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 118.679 -1.209 . . . . 562.66 110.004 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.856 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.22 95.59 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 118.634 -1.226 . . . . 446.75 108.103 -167.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.46 -26.35 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.875 -2.33 . . . . 370.05 112.197 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.866 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.51 60.06 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.565 -0.71 . . . . 354.91 112.491 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.88 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.49 0.98 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.047 1.339 . . . . 462.44 111.868 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.9 mm-40 -172.35 178.09 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.009 0.909 . . . . 652.37 111.129 171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.78 86.31 2.2 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 128.492 2.717 . . . . 905.99 107.906 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.83 -36.45 80.38 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.261 -1.014 . . . . 570.43 108.261 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.842 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.34 82.36 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 125.331 1.453 . . . . 453.22 111.129 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.955 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.48 178.65 33.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.939 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.924 HD21 ' NZ ' ' B' ' 367' ' ' LYS . 89.0 mt -56.4 -41.21 75.92 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 125.274 1.43 . . . . 457.72 112.38 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.02 Favored 'General case' 0 CA--C 1.484 -1.569 0 C-N-CA 118.678 -1.209 . . . . 340.58 109.335 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.842 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.66 -32.23 71.92 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 118.819 -1.152 . . . . 453.6 111.544 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.3 73.26 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.013 -1.847 . . . . 541.48 106.013 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.21 75.83 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 123.972 0.795 . . . . 466.68 110.86 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.72 -47.09 86.85 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 117.527 -1.669 . . . . 427.34 107.306 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.82 82.77 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 112.402 0.519 . . . . 537.87 112.402 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.33 -42.73 74.93 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 116.845 -1.942 . . . . 422.12 111.576 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.914 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.15 75.18 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.314 -0.866 . . . . 340.17 111.84 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.8 m-85 -65.27 -46.49 71.52 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.084 -1.047 . . . . 258.06 111.75 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.53 -31.56 87.52 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 N-CA-C 115.323 1.24 . . . . 305.71 115.323 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.941 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.712 -0.848 . . . . 252.7 108.712 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.56 93.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.8 -1.185 . . . . 149.27 107.8 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.05 -44.78 95.95 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 120.632 -0.427 . . . . 138.08 111.506 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.75 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.93 -42.42 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.523 -0.735 . . . . 132.89 110.966 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.948 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.71 -44.68 92.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.749 -0.78 . . . . 193.61 108.925 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.7 84.55 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 122.838 0.455 . . . . 63.83 110.079 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.98 -52.4 59.81 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.057 -0.402 . . . . 76.4 111.233 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.99 -41.68 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.166 -1.05 . . . . 171.13 108.166 -174.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.078 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.82 -38.52 91.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 121.889 -0.507 . . . . 78.3 110.612 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.13 -35.71 80.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.897 -1.121 . . . . 92.36 109.231 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.083 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.31 76.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.131 -1.062 . . . . 93.73 108.131 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.39 -41.65 84.63 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.248 -0.981 . . . . 132.74 109.346 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.1 94.86 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.17 -1.419 . . . . 43.39 107.17 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.864 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.9 t -58.43 -42.03 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.59 -0.893 . . . . 59.34 108.59 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.4 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.04 95.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 121.838 -0.539 . . . . 69.68 110.523 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.46 -42.77 91.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.333 -0.988 . . . . 106.98 108.333 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.864 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.58 81.36 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 119.712 -0.795 . . . . 147.63 108.928 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.761 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.56 99.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.514 -0.921 . . . . 190.06 108.514 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.962 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.3 t80 -61.32 -44.04 97.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.313 -0.995 . . . . 118.85 108.313 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.126 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.68 98.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.64 95.28 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 121.827 -0.546 . . . . 89.98 109.86 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.887 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.72 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 C-N-CA 118.098 -1.441 . . . . 106.09 111.035 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.802 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.29 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.062 -1.855 . . . . 227.74 111.799 -174.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.89 100.06 50.94 Favored Pre-proline 0 CA--C 1.486 -1.515 0 C-N-CA 116.237 -2.185 . . . . 262.55 110.05 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.57 -10.42 28.66 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.678 1.586 . . . . 210.25 111.341 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.03 1.0 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 106.556 -1.646 . . . . 270.58 106.556 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.894 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.49 23.54 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 115.382 -0.826 . . . . 129.84 112.325 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.38 -26.59 81.68 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 N-CA-C 116.31 1.619 . . . . 330.71 116.31 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 114.467 -2.893 . . . . 204.51 107.289 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.881 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.415 -1.328 . . . . 387.41 107.415 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.881 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.5 t -143.73 147.04 33.64 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 118.729 -1.188 . . . . 166.22 109.446 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.73 87.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.841 -1.17 . . . . 44.23 107.841 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.0 m -60.29 -39.11 85.76 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.2 -1.037 . . . . 28.8 108.2 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.646 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.86 -38.73 92.0 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.103 -0.702 . . . . 30.29 109.103 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.961 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.65 -42.99 94.03 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.981 -0.748 . . . . 46.11 108.981 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.5 -42.11 99.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.671 -1.233 . . . . 87.33 107.671 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.4 t -61.67 -42.07 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.916 -1.142 . . . . 23.69 107.916 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.21 -44.31 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.625 -0.509 . . . . 43.86 109.625 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.934 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.55 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.263 -1.014 . . . . 91.13 108.263 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.503 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.58 -37.98 88.32 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.72 -0.844 . . . . 65.88 108.72 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.86 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.52 -0.548 . . . . 33.86 109.52 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.078 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.35 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.556 -1.275 . . . . 146.52 107.556 -176.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.781 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.0 m95 -62.84 -38.35 90.41 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.475 -0.89 . . . . 75.44 108.878 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.4 t -60.58 -48.4 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.063 -1.023 . . . . 43.64 109.72 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.812 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -37.95 89.29 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.096 -0.705 . . . . 102.57 109.096 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.08 86.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.403 -1.332 . . . . 58.16 107.403 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.865 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.53 73.93 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.989 -0.745 . . . . 121.11 108.989 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.03 -42.26 84.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 C-N-CA 118.55 -1.26 . . . . 153.15 109.948 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.99 HD12 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.05 -43.76 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 113.09 -3.444 . . . . 133.67 113.533 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.899 -1.126 . . . . 157.42 112.167 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.12 2.45 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 115.011 1.485 . . . . 250.91 115.011 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.5 Cg_exo -59.54 -25.42 78.7 Favored 'Trans proline' 0 CA--C 1.488 -1.81 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.19 -34.21 74.71 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.915 -1.513 . . . . 192.46 106.915 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.02 98.1 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 108.033 -2.027 . . . . 261.0 108.033 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.77 159.13 25.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.529 -3.508 . . . . 491.4 101.529 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 116.278 -2.169 . . . . 386.1 109.819 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.08 -166.61 2.41 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 103.511 -2.774 . . . . 289.8 103.511 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.115 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 117.745 -1.121 . . . . 402.06 109.534 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.781 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.5 p -165.3 177.54 7.51 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.314 2.246 . . . . 690.53 114.94 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.181 4.511 . . . . 633.62 123.181 162.742 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.58 153.79 22.17 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.415 2.286 . . . . 617.99 110.918 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.125 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.67 174.39 6.01 Favored Pre-proline 0 C--N 1.364 1.222 0 C-N-CA 130.255 3.422 . . . . 434.98 113.417 -175.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.125 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.5 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 N-CA-C 122.408 3.965 . . . . 365.88 122.408 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.7 m -84.88 20.92 1.7 Allowed 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.791 -2.3 . . . . 635.81 104.791 178.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.774 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.36 152.27 18.77 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.934 7.753 . . . . 999.99 131.934 -135.746 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.068 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.85 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.747 1 CA-C-N 103.264 -6.335 . . . . 594.32 113.573 149.195 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.821 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.21 144.07 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 1 N-CA-C 98.337 -4.69 . . . . 811.91 98.337 162.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.47 144.55 45.92 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.074 -1.851 . . . . 999.99 109.419 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.24 -175.65 4.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.007 0.908 . . . . 431.86 110.018 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.06 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.12 148.68 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 124.384 1.074 . . . . 457.18 108.758 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.83 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.35 85.49 3.77 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 124.071 0.948 . . . . 458.77 113.506 -174.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.38 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.9 1.28 . . . . 999.99 112.424 168.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.78 5.63 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 120.84 3.362 . . . . 999.99 120.84 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.164 -1.814 . . . . 81.18 107.248 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.12 45.12 0.19 Allowed Pre-proline 0 N--CA 1.423 -1.817 0 CA-C-O 114.866 -2.492 . . . . 999.99 108.748 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.059 ' HB2' HD11 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.52 101.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.141 1 C-N-CA 126.051 4.501 . . . . 999.99 105.7 -170.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.03 97.47 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 126.748 2.019 . . . . 967.72 112.045 -165.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.28 -36.5 77.99 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.779 -1.563 . . . . 934.3 106.779 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.059 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.27 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 129.196 2.998 . . . . 565.15 113.938 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.55 55.4 2.79 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 118.423 0.556 . . . . 755.61 109.849 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.115 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.48 -49.35 66.9 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.59 1.156 . . . . 325.89 113.203 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.94 78.32 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 123.557 0.743 . . . . 250.21 111.61 -169.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.81 -43.28 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.552 0.691 . . . . 142.46 110.375 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.06 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.7 t80 -61.1 -41.56 96.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 123.983 0.913 . . . . 247.69 108.806 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.5 -51.34 69.85 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.453 1.501 . . . . 199.61 113.086 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.35 -44.45 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.754 -1.202 . . . . 106.73 107.754 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.592 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.14 -48.53 81.28 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.832 -0.622 . . . . 115.01 110.241 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.99 HG13 HD12 ' A' ' 161' ' ' LEU . 85.8 t -65.25 -49.2 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.431 -0.908 . . . . 129.42 111.811 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.816 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.3 m -61.79 -53.18 59.38 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.223 -1.391 . . . . 172.48 109.969 -172.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.6 t -63.9 -54.19 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 120.489 -0.484 . . . . 55.86 110.987 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.62 -51.52 58.98 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.513 -1.275 . . . . 184.68 111.501 -174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.979 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.64 -52.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.635 -2.026 . . . . 291.81 114.695 -174.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.431 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.7 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 115.153 1.538 . . . . 130.66 115.153 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.816 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.9 -48.46 68.66 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.493 1.294 . . . . 80.16 114.493 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.53 83.3 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.483 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.4 Cg_exo -64.79 -27.11 59.75 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.617 -0.57 . . . . 92.17 110.617 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.36 76.62 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.478 -1.304 . . . . 135.6 107.478 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.63 91.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.61 -0.515 . . . . 52.1 109.61 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.72 -43.51 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.056 -0.72 . . . . 95.89 109.056 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.31 -42.33 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.655 -1.609 . . . . 43.41 106.655 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.22 99.06 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.338 -1.505 . . . . 27.69 109.338 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.905 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.76 -47.35 75.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 117.411 0.605 . . . . 54.41 110.423 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 107.005 -1.479 . . . . 53.88 107.005 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.71 -40.83 93.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.517 -0.92 . . . . 68.29 108.517 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.905 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -39.04 92.94 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 119.71 -0.796 . . . . 107.59 110.634 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.41 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.514 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.887 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.3 -22.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.414 -0.958 . . . . 85.26 108.414 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.91 99.43 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.089 -0.804 . . . . 40.71 111.089 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.7 -44.12 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 108.386 -0.968 . . . . 95.86 108.386 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.89 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.445 -0.946 . . . . 144.37 108.445 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.38 132.15 47.48 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.025 -1.843 . . . . 158.38 106.025 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.85 98.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.676 -0.49 . . . . 36.78 109.676 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.14 125.8 25.05 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.15 -1.02 . . . . 85.46 109.812 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.539 -2.023 . . . . 127.78 105.539 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.89 34.77 Favored Pre-proline 0 CA--C 1.493 -1.233 0 N-CA-C 105.929 -1.878 . . . . 164.84 105.929 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.7 Cg_exo -56.82 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.189 0 N-CA-C 113.926 0.702 . . . . 222.35 113.926 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.807 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.1 166.95 44.94 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 106.435 -2.666 . . . . 45.22 106.435 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.923 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.9 -45.81 93.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.058 -1.83 . . . . 107.57 106.058 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.735 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.4 m -65.73 141.77 58.23 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 118.924 -1.11 . . . . 167.96 109.151 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.56 106.71 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.67 1.988 . . . . 280.68 109.71 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.98 11.31 0.7 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.455 1.102 . . . . 218.25 110.694 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.934 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.58 54.78 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.234 -2.135 . . . . 343.57 105.234 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.89 1.53 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.868 -1.53 . . . . 263.29 106.868 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.35 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 126.565 1.946 . . . . 261.92 108.484 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.1 89.83 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.891 -1.151 . . . . 106.81 107.891 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.391 -1.324 . . . . 112.2 107.531 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.751 HG13 ' NH1' ' A' ' 244' ' ' ARG . 76.0 t -64.36 -39.77 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 109.247 -0.649 . . . . 45.41 109.247 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.865 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.07 68.91 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.28 -0.267 . . . . 97.62 110.28 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.6 81.71 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.691 0.796 . . . . 59.29 110.976 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.26 -36.49 83.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.624 1.17 . . . . 106.49 110.668 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.934 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.68 69.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.302 -0.999 . . . . 106.62 108.302 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.08 91.62 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 121.87 -0.518 . . . . 75.97 110.039 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.52 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 C-N-CA 122.909 0.484 . . . . 65.27 109.802 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.838 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.95 -41.64 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 C-N-CA 120.391 -0.524 . . . . 107.94 110.174 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.49 -40.82 98.09 Favored 'General case' 0 N--CA 1.434 -1.235 0 O-C-N 121.649 -0.657 . . . . 87.98 110.3 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.62 -40.4 96.81 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.794 -1.162 . . . . 65.5 108.378 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.127 -1.064 . . . . 85.05 108.127 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.5 -45.72 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 109.076 -0.712 . . . . 42.25 109.076 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.31 -38.3 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.55 -0.86 . . . . 91.01 109.378 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 66.0 t -58.89 -41.54 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.96 -1.126 . . . . 66.09 107.96 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.23 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 O-C-N 122.108 -0.37 . . . . 52.39 110.324 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.77 88.2 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 121.883 -0.511 . . . . 46.42 109.856 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.4 t -62.35 -38.12 88.28 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.311 -0.996 . . . . 116.51 108.311 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.26 -48.22 82.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.384 -0.599 . . . . 65.18 109.384 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.67 97.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 122.118 -0.364 . . . . 51.33 110.432 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.32 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 C-N-CA 118.91 -1.116 . . . . 126.3 109.016 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.31 69.25 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.476 -0.889 . . . . 133.94 112.491 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.67 -33.43 35.54 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.853 2.168 . . . . 134.84 116.853 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.802 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.41 -41.61 90.22 Favored Pre-proline 0 CA--C 1.493 -1.236 0 O-C-N 121.671 -0.643 . . . . 72.23 111.647 -167.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.82 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.2 Cg_exo -60.66 -35.98 87.15 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 CA-C-N 119.887 0.995 . . . . 106.13 111.334 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.905 ' N ' HG22 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.7 82.21 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.728 -0.789 . . . . 128.35 110.027 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.693 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.8 88.79 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.24 -0.281 . . . . 100.73 110.24 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.82 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.55 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 119.285 -0.966 . . . . 172.72 109.137 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.749 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.59 -28.07 68.22 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.195 -1.039 . . . . 249.23 108.195 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.58 -55.1 35.96 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.667 -1.605 . . . . 259.78 106.667 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.2 -44.15 72.7 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.568 0.951 . . . . 233.11 113.568 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.29 91.35 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 119.182 -1.007 . . . . 169.54 110.588 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.07 -24.59 79.72 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.707 -1.728 . . . . 255.47 114.708 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.57 -44.22 94.72 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 119.189 0.904 . . . . 279.03 108.899 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.29 -44.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.87 59.36 Favored Pre-proline 0 N--CA 1.431 -1.394 0 C-N-CA 118.712 -1.195 . . . . 128.13 108.028 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.28 164.04 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.274 0 N-CA-C 107.443 -1.791 . . . . 278.35 107.443 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.862 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.12 15.03 9.93 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 123.756 0.66 . . . . 312.91 109.343 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.7 -170.65 2.48 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.506 -1.664 . . . . 353.54 106.506 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.28 46.95 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.829 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.069 -3.308 . . . . 175.26 102.069 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.775 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.96 96.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 100.894 -3.743 . . . . 99.07 100.894 172.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.775 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.46 124.16 9.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.455 -2.794 . . . . 243.21 103.455 171.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.99 112.97 25.11 Favored 'General case' 0 CA--C 1.473 -2.0 0 C-N-CA 115.992 -2.283 . . . . 201.04 105.316 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.765 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.92 173.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 C-N-CA 116.02 -2.272 . . . . 201.36 108.82 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.065 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.52 -41.44 89.98 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.834 174.516 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.912 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.77 86.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 118.213 -1.395 . . . . 215.06 112.538 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.635 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.61 -46.47 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.607 -1.237 . . . . 125.28 112.917 -171.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.852 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -36.94 85.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.229 -1.397 . . . . 268.9 107.229 -171.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.29 -44.97 74.32 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.617 1.567 . . . . 280.88 108.792 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.48 86.06 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.004 -1.078 . . . . 184.47 108.958 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.905 HG22 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.99 -42.09 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 119.285 -0.966 . . . . 167.92 112.709 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.66 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.73 -38.81 90.18 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 117.792 -1.563 . . . . 367.18 110.734 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.2 -32.7 73.95 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.824 -0.547 . . . . 173.97 110.402 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.52 -36.73 85.14 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.559 0.744 . . . . 119.66 109.797 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.21 -34.0 74.39 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.703 -1.221 . . . . 112.3 107.703 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.08 73.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.228 -0.442 . . . . 174.17 110.235 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.6 m -64.7 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 124.685 1.194 . . . . 145.27 110.627 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.831 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.62 -35.4 70.41 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.093 -1.077 . . . . 170.15 108.093 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.26 -34.17 63.81 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 122.721 0.408 . . . . 214.57 110.63 -171.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.792 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.21 -33.2 56.29 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.022 1.729 . . . . 168.29 115.548 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.831 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.35 -34.9 79.22 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 114.096 1.147 . . . . 167.15 114.096 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.745 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.18 -38.32 33.67 Favored Pre-proline 0 N--CA 1.434 -1.234 0 C-N-CA 115.485 -2.486 . . . . 165.13 113.931 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.745 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.57 -31.81 79.82 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 CA-C-N 122.809 2.039 . . . . 123.92 111.231 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.788 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.77 -42.54 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.845 -1.142 . . . . 110.55 109.807 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.0 pt -61.16 -39.99 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.849 -0.797 . . . . 145.31 108.849 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.08 -48.88 78.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.447 -0.901 . . . . 246.68 109.789 -177.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.18 -47.48 84.29 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.524 -0.87 . . . . 64.43 109.565 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.06 79.34 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.2 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.72 75.91 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 116.022 1.86 . . . . 140.44 116.022 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.79 132.24 34.45 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 112.71 -3.596 . . . . 178.87 113.031 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.35 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.358 -1.292 . . . . 110.22 110.112 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.71 -50.61 72.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 121.74 -0.6 . . . . 174.78 109.756 -174.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.95 -41.63 95.32 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.478 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.31 -50.23 73.59 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.011 -0.676 . . . . 117.2 109.214 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.84 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.08 75.54 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.375 -0.53 . . . . 112.6 111.113 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.12 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.11 -37.44 94.57 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.596 -1.002 . . . . 101.46 110.596 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.13 -45.98 91.05 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 118.485 1.143 . . . . 151.49 109.541 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.13 -36.31 77.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.931 -1.507 . . . . 142.32 106.931 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.12 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.72 -41.9 91.9 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.46 85.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 122.309 -0.244 . . . . 76.11 111.019 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -55.51 30.77 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.374 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.29 131.5 41.23 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.94 -2.985 . . . . 192.73 102.94 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.18 92.14 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.192 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.8 m -79.4 -177.1 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.464 0 N-CA-C 106.332 -1.729 . . . . 69.68 106.332 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -58.97 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 118.368 -0.621 . . . . 191.05 112.583 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.54 43.87 16.43 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 123.562 0.539 . . . . 287.03 109.756 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.849 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.5 78.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 112.977 -3.489 . . . . 292.29 109.847 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.41 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 104.195 -2.52 . . . . 184.57 104.195 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.69 4.94 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 113.038 0.755 . . . . 274.56 113.038 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.92 57.3 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 117.69 -2.195 . . . . 268.24 113.487 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.722 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.5 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.641 1.221 . . . . 200.06 110.788 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.1 21.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.593 -1.262 . . . . 263.81 107.593 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.37 3.61 Favored Glycine 0 CA--C 1.479 -2.206 1 N-CA-C 102.518 -4.233 . . . . 103.79 102.518 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.993 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.29 95.64 10.26 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 114.914 -2.715 . . . . 117.3 106.016 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.067 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.93 -39.82 90.84 Favored 'General case' 0 CA--C 1.468 -2.179 1 N-CA-C 97.989 -4.819 . . . . 231.58 97.989 167.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.067 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.45 29.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.097 -3.297 . . . . 303.24 102.097 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.993 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.62 78.64 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 116.022 -2.271 . . . . 112.72 108.391 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -60.99 -63.71 1.2 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.095 -0.706 . . . . 83.22 109.095 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.7 m -156.24 -126.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.86 -2.644 . . . . 174.36 103.86 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.067 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.9 160.97 8.81 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.787 -1.931 . . . . 202.73 105.787 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.92 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.093 -1.447 . . . . 180.62 107.093 176.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.52 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 105.356 -2.09 . . . . 145.25 105.356 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.948 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.05 -43.17 88.27 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.171 -1.789 . . . . 66.05 106.171 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.69 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.536 -2.764 . . . . 266.49 103.536 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.61 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.31 -124.96 0.28 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.793 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.005 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.38 94.15 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.552 -1.204 . . . . 94.78 112.877 -176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.19 100.41 9.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.324 -3.751 . . . . 121.41 109.469 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.01 145.49 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 108.948 -0.76 . . . . 85.34 108.948 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.506 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.47 41.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.518 -0.549 . . . . 226.1 109.518 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.6 p -50.93 156.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.997 -1.483 . . . . 154.84 106.997 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.505 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.7 m -61.36 161.94 8.53 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.627 0.727 . . . . 180.01 110.679 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.881 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.44 156.91 23.66 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.964 -1.495 . . . . 333.78 106.964 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.985 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.48 48.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.985 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.4 mm-40 82.85 158.84 0.13 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.739 -0.838 . . . . 266.47 108.739 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.53 -46.93 88.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.674 -1.972 . . . . 59.34 105.674 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.6 173.83 11.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.415 -2.439 . . . . 201.26 104.415 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.0 mt -95.87 106.68 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 116.322 -2.151 . . . . 56.23 105.562 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.518 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.11 -59.46 5.3 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.309 -0.626 . . . . 87.58 109.309 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.894 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.53 153.74 22.24 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 107.841 -1.17 . . . . 219.95 107.841 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.04 83.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.435 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.625 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 105.86 -1.904 . . . . 53.85 105.86 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.625 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.24 16.58 77.09 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 106.067 -2.813 . . . . 196.55 106.067 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.683 0 N-CA-C 107.848 -1.167 . . . . 35.88 107.848 -178.866 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.441 HH12 ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.04 144.09 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.67 1.58 . . . . 1.0 111.831 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.924 ' NZ ' HD21 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -70.52 127.39 92.07 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.248 -0.433 . . . . 1.0 109.864 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.835 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.4 Cg_endo -69.09 -19.96 38.61 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.496 2.13 . . . . 1.0 114.504 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.549 ' HB3' ' HD2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -58.31 -38.66 77.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.789 -178.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -71.28 -10.48 59.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.812 0.339 . . . . 1.0 110.578 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.835 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.66 -46.34 87.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.28 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -49.03 78.29 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.596 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.113 0 N-CA-C 109.764 -1.334 . . . . 1.0 109.764 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.365 -0.976 . . . . 97.08 108.365 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.425 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.088 0.946 . . . . 123.41 110.766 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.934 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.62 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.513 1 N-CA-C 100.056 -4.053 . . . . 151.3 100.056 173.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.979 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.57 58.05 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.939 -2.305 . . . . 169.25 106.139 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.979 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.27 0.616 . . . . 185.76 110.53 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.854 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.5 -25.86 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.988 2.115 . . . . 145.47 110.383 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.717 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.38 21.48 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.099 -1.0 . . . . 102.76 109.427 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.58 154.2 25.1 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.994 -1.113 . . . . 106.25 107.994 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.9 51.9 0.74 Allowed 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 117.807 -1.557 . . . . 157.81 107.616 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.24 -45.87 91.75 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.585 -2.746 . . . . 150.2 103.585 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.01 164.71 35.26 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 103.652 -2.721 . . . . 183.52 103.652 172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -76.82 6.92 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.982 0 N-CA-C 109.973 -0.818 . . . . 235.61 109.973 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.95 -41.24 82.44 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 124.781 1.233 . . . . 113.77 113.377 -170.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.934 HD13 HG11 ' A' ' 4' ' ' VAL . 33.3 pt -52.21 136.2 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 119.605 1.093 . . . . 150.85 110.989 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.595 -1.261 . . . . 100.42 107.595 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.022 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.967 0.889 . . . . 129.36 110.389 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.43 68.36 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 126.241 1.816 . . . . 112.34 106.702 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.95 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.4 m -74.1 -40.2 62.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.545 -0.752 . . . . 131.73 111.766 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.022 ' H ' HG23 ' A' ' 17' ' ' THR . 71.6 m -84.42 -42.85 15.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 117.036 2.236 . . . . 80.49 117.036 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -146.0 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 118.151 -1.42 . . . . 98.98 111.198 -169.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.0 Cg_exo -61.81 -10.8 18.29 Favored 'Trans proline' 0 C--N 1.321 -0.898 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.09 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.58 8.75 Favored 'General case' 0 C--N 1.324 -0.542 1 CA-C-N 126.152 4.069 . . . . 269.62 114.209 175.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.12 -27.33 67.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.816 -1.179 . . . . 86.8 107.816 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.119 -0.988 . . . . 85.91 110.493 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.57 -40.18 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.728 0.811 . . . . 82.0 111.339 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.73 12.49 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.518 -0.919 . . . . 120.73 108.518 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.841 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.97 149.76 89.85 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 120.578 0.852 . . . . 87.86 109.937 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.05 -37.92 89.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.884 -0.784 . . . . 36.46 108.884 -176.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.843 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.91 76.73 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.16 -32.74 73.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 121.301 -0.874 . . . . 123.26 108.645 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.49 -47.15 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.4 -31.02 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.918 -1.141 . . . . 112.19 107.918 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.843 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.4 tp -63.02 -47.09 84.55 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.924 -0.71 . . . . 60.87 109.576 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.707 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.07 -35.6 80.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.933 -0.707 . . . . 157.57 110.392 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.818 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.61 -40.92 98.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.622 -0.881 . . . . 47.06 108.622 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.19 97.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.745 -0.597 . . . . 43.94 109.526 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.88 -43.29 99.14 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.688 -0.856 . . . . 42.61 108.688 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.956 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.22 93.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.625 -0.261 . . . . 140.66 111.024 -178.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.81 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.566 -1.254 . . . . 116.04 110.211 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.43 -38.72 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.747 -0.835 . . . . 97.16 108.747 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.911 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.34 -39.94 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.99 -0.744 . . . . 54.85 108.99 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 86' ' ' THR . 93.0 t -57.72 -42.39 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 108.877 -0.786 . . . . 45.39 108.877 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.6 t -63.49 -50.94 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.217 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.793 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.26 -47.07 78.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.196 -0.601 . . . . 116.65 111.693 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.64 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -62.0 -43.93 97.81 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.705 -0.48 . . . . 51.16 109.705 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.7 t -65.5 -48.93 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.878 -0.729 . . . . 44.3 110.878 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.5 t -64.8 -46.94 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 120.308 -0.557 . . . . 48.82 110.995 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.2 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.505 -0.855 . . . . 58.7 111.987 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.66 -34.17 67.07 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 122.118 -0.637 . . . . 101.4 111.032 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 107.748 -1.204 . . . . 103.57 107.748 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.4 -43.06 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 108.965 -0.754 . . . . 61.89 108.965 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.641 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.9 t -63.45 -50.93 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 109.453 -0.573 . . . . 70.01 109.453 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.716 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.41 98.87 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.165 -0.68 . . . . 132.1 109.165 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.16 -46.64 83.14 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.623 -0.262 . . . . 104.5 110.472 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.89 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.91 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.026 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.9 pt -64.77 -41.67 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 116.96 -1.896 . . . . 158.32 110.859 -175.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.34 98.04 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.459 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.53 90.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.173 -0.329 . . . . 54.66 110.994 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.956 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.17 29.45 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.651 0.739 . . . . 127.18 109.575 -174.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.099 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.88 80.3 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.067 0.947 . . . . 87.93 110.813 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.065 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.63 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.655 -0.653 . . . . 131.12 111.481 -175.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.009 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.43 7.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 115.319 -2.553 . . . . 246.56 109.607 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.48 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.471 -2.048 . . . . 339.35 105.471 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.85 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.6 p -124.22 165.26 17.92 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 102.989 -2.967 . . . . 114.66 102.989 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.946 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.13 -39.46 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.783 -1.562 . . . . 143.28 106.783 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.999 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.67 -38.05 80.44 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.673 -0.862 . . . . 160.22 108.673 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.85 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.37 -31.75 72.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.88 -0.785 . . . . 120.54 108.88 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.94 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.56 -43.86 95.8 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.507 -0.553 . . . . 67.22 109.507 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.94 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.49 -39.8 88.92 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.504 -0.747 . . . . 138.6 109.654 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.999 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.54 -35.94 82.14 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 122.529 0.332 . . . . 151.46 110.631 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.026 HG13 HD12 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 C-N-CA 117.397 -1.721 . . . . 117.93 106.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.0 -46.01 90.88 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.928 -1.138 . . . . 56.82 107.928 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.91 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.4 -43.94 98.01 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.911 -0.774 . . . . 145.3 108.911 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.38 95.47 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.523 -0.917 . . . . 45.71 108.523 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.35 -42.06 99.09 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.384 -0.599 . . . . 105.61 109.384 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.5 92.67 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.608 -0.886 . . . . 47.89 108.608 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.703 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.942 -0.392 . . . . 124.53 109.942 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.23 99.28 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 121.979 -0.45 . . . . 35.89 109.851 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.19 -37.31 84.8 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 107.038 -1.467 . . . . 88.97 107.038 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.839 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.23 -49.2 76.69 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.978 -0.749 . . . . 239.91 108.978 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.36 -43.38 91.02 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.594 -0.691 . . . . 146.1 110.635 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 117.422 -1.711 . . . . 91.74 113.86 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.6 -61.31 2.0 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.74 1.755 . . . . 197.45 115.74 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 1.003 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.32 -42.2 55.01 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.872 -1.531 . . . . 242.6 114.042 -170.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.971 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.921 -1.112 . . . . 215.61 109.813 -172.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.454 ' N ' HG23 ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 O-C-N 121.843 -0.535 . . . . 87.19 110.462 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.8 t -65.96 -41.83 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.956 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.15 76.07 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.655 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.1 t80 -68.13 -44.8 75.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.568 -0.708 . . . . 181.63 111.29 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.1 m -60.81 -45.78 93.07 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.471 -1.307 . . . . 269.02 107.471 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.071 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.75 -45.0 93.56 Favored 'General case' 0 N--CA 1.415 -2.183 0 C-N-CA 118.646 -1.222 . . . . 562.66 110.03 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.26 95.42 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 118.725 -1.19 . . . . 446.75 108.076 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.818 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.47 -26.37 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 C-N-CA 115.842 -2.343 . . . . 370.05 112.22 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.901 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.1 m-70 -74.45 -26.5 60.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.555 -0.716 . . . . 354.91 112.507 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.77 4.59 0.99 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.09 1.356 . . . . 462.44 111.891 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.8 mm-40 -172.36 178.04 2.91 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.989 0.9 . . . . 652.37 111.107 171.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.835 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.31 2.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.477 2.711 . . . . 905.99 107.905 -174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.95 -36.37 79.99 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.2 -1.037 . . . . 570.43 108.2 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.34 82.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 125.303 1.441 . . . . 453.22 111.171 -174.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.54 178.67 33.91 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 118.799 -1.667 . . . . 445.63 109.925 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.21 75.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 125.274 1.429 . . . . 457.72 112.358 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.6 -46.99 85.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.701 -1.2 . . . . 340.58 109.262 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 87.8 m-85 -68.71 -32.17 71.78 Favored 'General case' 0 N--CA 1.424 -1.747 0 C-N-CA 118.755 -1.178 . . . . 453.6 111.552 -176.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.4 t -56.03 -40.32 73.27 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.86 -47.18 75.8 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 123.976 0.798 . . . . 466.68 110.803 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.07 86.92 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.457 -1.697 . . . . 427.34 107.287 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.12 -36.78 82.64 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.398 0.518 . . . . 537.87 112.398 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.42 -42.67 74.73 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.852 -1.939 . . . . 422.12 111.585 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.912 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.08 -50.09 75.41 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 121.336 -0.853 . . . . 340.17 111.818 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.8 m-85 -65.24 -46.58 71.95 Favored Pre-proline 0 N--CA 1.443 -0.821 0 C-N-CA 119.097 -1.041 . . . . 258.06 111.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.7 Cg_exo -61.53 -31.54 87.56 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 N-CA-C 115.37 1.258 . . . . 305.71 115.37 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.683 -0.858 . . . . 252.7 108.683 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.65 93.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.785 -1.191 . . . . 149.27 107.785 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.77 95.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.621 -0.432 . . . . 138.08 111.485 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.749 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 64.7 t -66.91 -42.41 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 O-C-N 121.588 -0.695 . . . . 132.89 110.998 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.948 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.69 -44.75 92.74 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.875 -0.787 . . . . 193.61 108.875 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.46 -37.68 84.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 122.773 0.429 . . . . 63.83 110.057 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.97 -52.45 59.61 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.092 -0.38 . . . . 76.4 111.231 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.805 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.99 -41.65 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.203 -1.036 . . . . 171.13 108.203 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.063 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.4 m-85 -63.69 -38.68 92.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.845 -0.534 . . . . 78.3 110.649 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.02 -35.78 80.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.925 -1.11 . . . . 92.36 109.249 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.076 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.48 -34.3 76.57 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.188 -1.042 . . . . 93.73 108.188 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.68 84.55 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.194 -1.002 . . . . 132.74 109.341 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.05 94.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.217 -1.401 . . . . 43.39 107.217 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.867 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.6 t -58.48 -41.97 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.08 95.48 Favored 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 121.765 -0.584 . . . . 69.68 110.553 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.74 91.78 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.339 -0.985 . . . . 106.98 108.339 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.867 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.64 81.54 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.69 -0.804 . . . . 147.63 108.956 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.763 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.18 -41.49 99.22 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.957 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.2 t80 -61.36 -44.03 97.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.298 -1.001 . . . . 118.85 108.298 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.39 -42.63 98.82 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 110.022 -0.362 . . . . 102.5 110.022 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.64 95.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.808 -0.558 . . . . 89.98 109.818 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.891 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.76 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 118.201 -1.4 . . . . 106.09 110.985 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.31 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 C-N-CA 117.119 -1.832 . . . . 227.74 111.81 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.12 50.94 Favored Pre-proline 0 CA--C 1.486 -1.494 0 C-N-CA 116.18 -2.208 . . . . 262.55 110.057 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.42 28.62 Favored 'Trans proline' 0 C--N 1.289 -2.581 0 C-N-CA 121.616 1.544 . . . . 210.25 111.326 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.95 0.98 Allowed 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.533 -1.655 . . . . 270.58 106.533 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.373 -0.831 . . . . 129.84 112.382 -176.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.4 -26.56 81.53 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 N-CA-C 116.27 1.604 . . . . 330.71 116.27 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.2 7.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.51 -2.876 . . . . 204.51 107.275 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.71 147.41 0.09 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.419 -1.326 . . . . 387.41 107.419 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.879 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.69 147.07 33.72 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 118.781 -1.168 . . . . 166.22 109.466 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.91 -40.69 87.75 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.851 -1.166 . . . . 44.23 107.851 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.3 -39.13 85.88 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.195 -1.039 . . . . 28.8 108.195 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.87 -38.76 92.14 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.079 -0.712 . . . . 30.29 109.079 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.946 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.7 m -59.63 -42.99 93.95 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.988 -0.745 . . . . 46.11 108.988 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.47 -42.18 99.3 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.644 -1.243 . . . . 87.33 107.644 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.788 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.8 t -61.64 -42.09 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.953 -1.129 . . . . 23.69 107.953 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.17 -44.32 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 109.703 -0.48 . . . . 43.86 109.703 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.94 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.22 -42.59 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.303 -0.999 . . . . 91.13 108.303 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.1 t -62.6 -37.94 88.2 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.727 -0.842 . . . . 65.88 108.727 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.13 -41.84 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 109.521 -0.548 . . . . 33.86 109.521 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.063 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.43 -40.31 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.264 . . . . 146.52 107.586 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.779 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.28 90.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.469 -0.892 . . . . 75.44 108.929 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.42 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 O-C-N 121.056 -1.028 . . . . 43.64 109.726 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.804 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -38.02 89.52 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.042 -0.725 . . . . 102.57 109.042 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.07 86.76 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.428 -1.323 . . . . 58.16 107.428 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.82 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.56 73.96 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.999 -0.741 . . . . 121.11 108.999 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.96 -42.32 84.73 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 118.56 -1.256 . . . . 153.15 109.98 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.08 -43.73 19.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.518 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 120.91 -1.119 . . . . 157.42 112.187 -171.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.516 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.43 -36.06 2.44 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 115.038 1.496 . . . . 250.91 115.038 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.1 Cg_exo -59.58 -25.46 78.92 Favored 'Trans proline' 0 CA--C 1.488 -1.805 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.029 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.2 -34.17 74.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.93 -1.508 . . . . 192.46 106.93 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.05 98.09 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.959 -2.056 . . . . 261.0 107.959 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.76 159.15 25.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 101.512 -3.514 . . . . 491.4 101.512 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -60.02 106.86 0.55 Allowed 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 116.25 -2.18 . . . . 386.1 109.799 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.029 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.2 m -154.02 -166.63 2.42 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 103.563 -2.755 . . . . 289.8 103.563 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.118 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.93 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 117.757 -1.116 . . . . 402.06 109.567 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.78 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.22 177.52 7.58 Favored 'General case' 0 CA--C 1.586 2.34 0 C-N-CA 127.302 2.241 . . . . 690.53 114.922 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.62 0.0 OUTLIER 'General case' 1 C--N 1.429 4.046 1 N-CA-C 123.203 4.52 . . . . 633.62 123.203 162.672 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.792 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.69 153.84 22.06 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.354 2.262 . . . . 617.99 110.917 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.98 Favored Pre-proline 0 C--N 1.364 1.22 0 C-N-CA 130.291 3.436 . . . . 434.98 113.381 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.3 Cg_endo -44.25 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 122.428 3.972 . . . . 365.88 122.428 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.79 ' OG ' HD13 ' A' ' 288' ' ' LEU 0.306 70.5 m -84.89 20.96 1.69 Allowed 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 104.774 -2.306 . . . . 635.81 104.774 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.782 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.41 152.24 18.77 Favored 'General case' 1 CA--C 1.419 -4.087 3 N-CA-C 132.002 7.779 . . . . 999.99 132.002 -135.767 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.071 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.84 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.774 1 CA-C-N 103.337 -6.301 . . . . 594.32 113.615 149.237 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.818 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.14 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 1 N-CA-C 98.277 -4.712 . . . . 811.91 98.277 162.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.792 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.48 45.98 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.424 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' N ' ' HE2' ' A' ' 174' ' ' MET . 70.7 mmm -147.15 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.003 0.906 . . . . 431.86 110.05 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.063 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.13 148.65 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 124.39 1.076 . . . . 457.18 108.766 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.823 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.48 3.74 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.106 0.962 . . . . 458.77 113.535 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.016 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.975 1.31 . . . . 999.99 112.401 168.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.1 Cg_exo -65.95 -45.84 5.56 Favored 'Trans proline' 0 N--CA 1.438 -1.794 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.556 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.037 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.283 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.866 0 CA-C-O 114.908 -2.472 . . . . 999.99 108.743 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.041 ' HB2' HD11 ' A' ' 191' ' ' ILE . 88.1 Cg_endo -41.63 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.144 1 C-N-CA 126.045 4.497 . . . . 999.99 105.692 -170.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.31 -44.01 97.51 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 126.721 2.008 . . . . 967.72 112.04 -165.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.27 -36.52 78.0 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.75 -1.574 . . . . 934.3 106.75 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.041 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.61 -30.21 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 129.18 2.992 . . . . 565.15 113.92 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.52 55.43 2.8 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 118.451 0.568 . . . . 755.61 109.846 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.118 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.29 66.99 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.554 1.142 . . . . 325.89 113.254 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.98 78.31 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 123.582 0.753 . . . . 250.21 111.602 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.77 -43.28 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.575 0.702 . . . . 142.46 110.399 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.063 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.6 t80 -61.09 -41.55 96.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.953 0.901 . . . . 247.69 108.83 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.894 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.9 t60 -60.51 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.429 1.491 . . . . 199.61 113.122 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.37 -44.52 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 107.673 -1.232 . . . . 106.73 107.673 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.786 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.12 -48.57 81.14 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 115.875 -0.602 . . . . 115.01 110.217 -173.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.21 -49.1 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 119.393 -0.923 . . . . 129.42 111.875 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.817 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.88 -53.18 59.28 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 118.209 -1.396 . . . . 172.48 109.919 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.2 t -63.82 -54.3 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 120.53 -0.468 . . . . 55.86 110.942 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.56 58.97 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 118.546 -1.262 . . . . 184.68 111.525 -174.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.972 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 116.641 -2.023 . . . . 291.81 114.74 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.7 t80 -82.02 -55.02 4.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 115.172 1.545 . . . . 130.66 115.172 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.817 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.92 -48.48 68.52 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.459 1.281 . . . . 80.16 114.459 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.936 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.53 -45.49 83.33 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.503 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.83 -27.12 59.46 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.627 -0.566 . . . . 92.17 110.627 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.35 -41.37 76.67 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.475 -1.305 . . . . 135.6 107.475 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.15 -44.73 91.22 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.67 -43.46 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.147 -0.686 . . . . 95.89 109.147 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.683 -1.599 . . . . 43.41 106.683 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.29 99.11 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.363 -1.495 . . . . 27.69 109.363 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.908 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.65 -47.4 75.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 122.177 -0.602 . . . . 54.41 110.47 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.894 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.8 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.984 -1.488 . . . . 53.88 106.984 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.8 -40.81 94.02 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.466 -0.938 . . . . 68.29 108.466 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.908 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.02 92.91 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 119.679 -0.808 . . . . 107.59 110.625 -175.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 119.64 -0.824 . . . . 111.61 109.549 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.891 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.29 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.393 -0.965 . . . . 85.26 108.393 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.42 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.072 -0.811 . . . . 40.71 111.072 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.73 -44.11 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.384 -0.969 . . . . 95.86 108.384 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.2 p -76.91 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.926 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.34 132.13 47.31 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.589 -1.263 . . . . 326.72 107.589 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.449 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.02 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.991 -1.855 . . . . 158.38 105.991 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.91 98.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.662 -0.496 . . . . 36.78 109.662 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.09 125.87 25.29 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.148 -1.021 . . . . 85.46 109.816 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.56 8.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.498 -2.038 . . . . 127.78 105.498 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.91 34.81 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.981 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.8 Cg_exo -56.78 -39.92 87.94 Favored 'Trans proline' 0 N--CA 1.431 -2.174 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.14 167.0 44.92 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.922 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.92 -45.76 93.37 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.057 -1.831 . . . . 107.57 106.057 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.84 58.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 118.842 -1.143 . . . . 167.96 109.177 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.867 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.47 106.75 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 126.754 2.022 . . . . 280.68 109.732 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.78 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 56.02 11.24 0.7 Allowed 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.503 1.121 . . . . 218.25 110.695 174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.934 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.61 54.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.251 -2.129 . . . . 343.57 105.251 177.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.88 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.844 -1.539 . . . . 263.29 106.844 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.656 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.33 147.01 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 126.503 1.921 . . . . 261.92 108.475 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.15 90.04 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.887 -1.153 . . . . 106.81 107.887 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.44 -39.95 95.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.392 -1.323 . . . . 112.2 107.526 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.747 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.24 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.288 -0.634 . . . . 45.41 109.288 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.871 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.3 p -70.92 -32.01 68.8 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.57 81.52 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.634 0.774 . . . . 59.29 111.014 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.649 1.18 . . . . 106.49 110.673 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.934 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.61 69.18 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.331 -0.989 . . . . 106.62 108.331 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.02 91.27 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.848 -0.532 . . . . 75.97 110.058 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.88 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 C-N-CA 122.89 0.476 . . . . 65.27 109.817 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.837 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 120.357 -0.537 . . . . 107.94 110.147 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.51 -40.82 98.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.652 -0.655 . . . . 87.98 110.293 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.057 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.68 -40.33 96.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 118.834 -1.147 . . . . 65.5 108.382 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.72 -36.35 80.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.173 -1.047 . . . . 85.05 108.173 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.54 -45.68 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.067 -0.716 . . . . 42.25 109.067 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.33 -38.32 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 119.544 -0.862 . . . . 91.01 109.344 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.58 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.978 -1.119 . . . . 66.09 107.978 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.1 -43.12 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 120.731 -0.388 . . . . 52.39 110.312 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.2 m -61.81 -46.73 88.23 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 121.869 -0.52 . . . . 46.42 109.834 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.36 -38.17 88.51 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.286 -1.005 . . . . 116.51 108.286 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.542 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.19 -48.22 82.64 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.437 -0.579 . . . . 65.18 109.437 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.93 -42.73 97.27 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 122.13 -0.356 . . . . 51.33 110.437 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.816 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.39 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 118.898 -1.121 . . . . 126.3 109.013 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.508 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.7 -33.36 35.44 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.8 tp -58.44 -41.64 90.35 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.686 -0.633 . . . . 72.23 111.618 -167.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.4 Cg_exo -60.61 -36.02 87.27 Favored 'Trans proline' 0 N--CA 1.429 -2.272 0 CA-C-N 119.88 0.993 . . . . 106.13 111.343 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.848 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.68 82.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.723 -0.791 . . . . 128.35 110.021 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.83 88.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 110.207 -0.294 . . . . 100.73 110.207 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.35 -44.43 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 C-N-CA 119.268 -0.973 . . . . 172.72 109.144 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.753 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.7 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.192 -1.04 . . . . 249.23 108.192 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.61 -55.05 36.62 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.615 -1.624 . . . . 259.78 106.615 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.894 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.24 -44.13 72.62 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.856 HD12 HD21 ' A' ' 279' ' ' LEU . 88.7 mt -61.38 -48.28 91.45 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 119.153 -1.019 . . . . 169.54 110.592 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.686 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.5 Cg_exo -61.18 -24.52 79.28 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 116.72 -1.72 . . . . 255.47 114.629 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.58 -44.21 94.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 119.255 0.934 . . . . 279.03 108.886 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.79 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.078 -0.342 . . . . 162.21 110.078 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.778 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.9 59.25 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.75 -1.18 . . . . 128.13 108.083 -178.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.29 164.03 11.2 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 N-CA-C 107.395 -1.81 . . . . 278.35 107.395 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.86 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.01 9.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.813 0.695 . . . . 312.91 109.335 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.86 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.69 -170.7 2.49 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.56 -1.645 . . . . 353.54 106.56 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.026 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 43.0 p90 -115.66 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.856 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.95 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 102.092 -3.299 . . . . 175.26 102.092 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.53 -44.97 96.09 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 100.88 -3.748 . . . . 99.07 100.88 172.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.41 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.52 -2.77 . . . . 243.21 103.52 171.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.026 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.93 112.91 25.04 Favored 'General case' 0 CA--C 1.473 -1.995 0 C-N-CA 116.109 -2.237 . . . . 201.04 105.293 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.742 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 C-N-CA 116.033 -2.267 . . . . 201.36 108.831 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.051 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.02 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.278 -1.783 . . . . 203.82 107.85 174.481 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.915 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.196 -1.401 . . . . 215.06 112.56 -171.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.633 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.4 t -65.7 -46.37 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 C-N-CA 118.567 -1.253 . . . . 125.28 112.937 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.85 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.8 -36.99 86.12 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.177 -1.416 . . . . 268.9 107.177 -171.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.876 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.21 -45.02 74.49 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 125.65 1.58 . . . . 280.88 108.815 -172.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.54 85.79 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 118.957 -1.097 . . . . 184.47 108.971 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.848 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.07 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 119.27 -0.972 . . . . 167.92 112.772 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.665 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.79 -38.77 89.91 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 117.796 -1.562 . . . . 367.18 110.77 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.573 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.74 74.05 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.877 -0.514 . . . . 173.97 110.439 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.44 -36.79 85.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.495 0.718 . . . . 119.66 109.788 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.19 -34.0 74.36 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.725 -1.213 . . . . 112.3 107.725 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.708 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.239 -0.437 . . . . 174.17 110.246 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 124.685 1.194 . . . . 145.27 110.616 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.833 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.58 -35.36 70.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.113 -1.069 . . . . 170.15 108.113 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.839 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.17 63.97 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.3 -0.409 . . . . 214.57 110.621 -171.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.793 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.19 56.51 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.063 1.745 . . . . 168.29 115.562 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.833 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.88 79.22 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.008 1.114 . . . . 167.15 114.008 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.745 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.2 -38.28 33.18 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 115.521 -2.472 . . . . 165.13 113.942 -171.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.745 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.53 -31.88 80.08 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.751 2.018 . . . . 123.92 111.21 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.74 -42.57 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 118.879 -1.128 . . . . 110.55 109.802 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.2 pt -61.07 -40.08 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 108.846 -0.798 . . . . 145.31 108.846 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.057 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.3 m-85 -58.05 -48.85 78.85 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.408 -0.917 . . . . 246.68 109.84 -177.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.22 -47.52 84.09 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 119.557 -0.857 . . . . 64.43 109.555 -173.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.75 -45.13 79.53 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.04 -1.064 . . . . 80.72 110.204 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.754 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 115.989 1.848 . . . . 140.44 115.989 -173.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.089 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.36 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.35 -1.295 . . . . 110.22 110.094 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.846 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.54 72.9 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.731 -0.606 . . . . 174.78 109.739 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.95 -41.71 95.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.248 -1.019 . . . . 161.84 108.248 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.481 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.24 -50.27 73.42 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.029 -0.668 . . . . 117.2 109.25 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.13 75.46 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.374 -0.53 . . . . 112.6 111.063 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.109 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.01 -37.43 94.59 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.626 -0.99 . . . . 101.46 110.626 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.15 -46.01 90.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 118.458 1.129 . . . . 151.49 109.52 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.08 -36.31 77.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.962 -1.496 . . . . 142.32 106.962 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.109 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.8 m80 -59.8 -41.8 92.0 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.41 85.67 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 122.358 -0.213 . . . . 76.11 111.02 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.49 30.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.879 -0.728 . . . . 120.24 109.318 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.749 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.54 41.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 102.912 -2.996 . . . . 192.73 102.912 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.22 -44.17 92.31 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 118.994 -1.082 . . . . 176.29 109.163 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.816 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.0 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.46 0 N-CA-C 106.303 -1.739 . . . . 69.68 106.303 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.97 -75.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 118.364 -0.624 . . . . 191.05 112.605 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.816 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.47 43.88 16.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 O-C-N 123.578 0.549 . . . . 287.03 109.778 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.848 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.945 0 C-N-CA 112.956 -3.498 . . . . 292.29 109.818 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.213 -2.514 . . . . 184.57 104.213 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.71 4.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.026 0.75 . . . . 274.56 113.026 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.24 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.748 -2.167 . . . . 268.24 113.453 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.6 m-20 51.56 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 118.685 1.242 . . . . 200.06 110.764 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.846 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.98 74.7 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.885 -1.154 . . . . 114.44 107.885 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.29 46.04 21.87 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.611 -1.255 . . . . 263.81 107.611 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.195 1 N-CA-C 102.563 -4.215 . . . . 103.79 102.563 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.99 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.3 95.6 10.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 114.943 -2.703 . . . . 117.3 106.016 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.045 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.76 90.77 Favored 'General case' 0 CA--C 1.468 -2.187 1 N-CA-C 98.041 -4.8 . . . . 231.58 98.041 167.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.065 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.97 163.44 29.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 102.063 -3.31 . . . . 303.24 102.063 168.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.99 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.55 78.9 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.024 -2.271 . . . . 112.72 108.424 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.413 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.8 t -61.06 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.072 -0.714 . . . . 83.22 109.072 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.3 m -156.28 -126.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.829 -2.656 . . . . 174.36 103.829 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.045 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.81 160.94 8.71 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 105.768 -1.938 . . . . 202.73 105.768 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.023 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.051 -1.463 . . . . 180.62 107.051 176.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.943 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.51 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.943 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.13 -43.11 88.06 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.492 -2.781 . . . . 266.49 103.492 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.606 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.93 0.28 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 117.055 -1.858 . . . . 219.2 107.753 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.0 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.08 -37.36 94.08 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 114.542 -1.208 . . . . 94.78 112.881 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.099 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.21 100.41 9.1 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.34 -3.744 . . . . 121.41 109.452 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.673 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.4 t -73.08 145.54 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.517 -0.765 . . . . 85.34 108.949 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.502 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.8 143.45 42.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.832 -1.174 . . . . 267.57 107.832 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.63 0.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.502 -0.555 . . . . 226.1 109.502 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.043 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.989 -1.485 . . . . 154.84 106.989 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.93 8.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.622 0.725 . . . . 180.01 110.696 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.875 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.91 23.63 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.989 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.5 48.77 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.399 -1.334 . . . . 335.2 107.399 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.989 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.63 -46.81 88.87 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.698 -1.964 . . . . 59.34 105.698 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.62 173.81 11.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.422 -2.436 . . . . 201.26 104.422 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.786 HG21 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.89 106.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.525 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.4 5.37 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.337 -0.616 . . . . 87.58 109.337 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.52 153.71 22.26 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.847 -1.168 . . . . 219.95 107.847 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 C-N-CA 116.348 -2.141 . . . . 121.79 105.434 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.9 t -154.14 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.816 -1.92 . . . . 53.85 105.816 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.618 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.26 16.56 77.11 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.886 -1.153 . . . . 35.88 107.886 -178.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' B' ' 365' ' ' ARG . 1.7 tpp180 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.02 68.13 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.665 1.577 . . . . 1.0 111.877 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.507 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 1.2 mtpt -70.5 127.38 92.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.267 -0.424 . . . . 1.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.84 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -69.01 -19.97 38.99 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.397 2.065 . . . . 1.0 114.601 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' B' ' 369' ' ' GLN . 0.0 OUTLIER -58.39 -38.63 77.72 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.71 -178.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -71.29 -10.53 59.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.355 . . . . 1.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.84 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.61 -46.34 87.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.332 -178.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . 0.494 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -61.51 -49.11 78.05 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.587 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 -0.068 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 108.361 -0.977 . . . . 97.08 108.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.59 155.46 22.32 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.161 0.981 . . . . 123.41 110.745 -172.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.928 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.63 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.469 1 N-CA-C 100.106 -4.035 . . . . 151.3 100.106 173.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 1.022 HD22 ' HG3' ' B' ' 366' ' ' PRO . 5.2 mp -60.66 -38.61 58.5 Favored Pre-proline 0 N--CA 1.439 -1.01 0 C-N-CA 115.98 -2.288 . . . . 169.25 106.101 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.98 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_exo -81.29 168.54 16.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 122.265 0.613 . . . . 185.76 110.508 171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.851 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.2 t -64.51 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.051 2.141 . . . . 145.47 110.324 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.35 157.42 21.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.064 -1.023 . . . . 102.76 109.446 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.61 154.18 25.07 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.994 -1.114 . . . . 106.25 107.994 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.92 51.91 0.74 Allowed 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 117.757 -1.577 . . . . 157.81 107.658 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.19 -45.9 91.56 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.541 -2.763 . . . . 150.2 103.541 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.7 m -87.01 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.874 0 N-CA-C 103.68 -2.711 . . . . 183.52 103.68 172.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -76.77 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 N-CA-C 109.995 -0.81 . . . . 235.61 109.995 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.99 -41.22 82.56 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.847 1.259 . . . . 113.77 113.354 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.928 HD13 HG11 ' A' ' 4' ' ' VAL . 33.5 pt -52.17 136.24 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 119.616 1.098 . . . . 150.85 110.965 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.52 156.29 46.37 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 107.594 -1.262 . . . . 100.42 107.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.041 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.63 58.33 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.955 0.883 . . . . 129.36 110.436 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.288 1.835 . . . . 112.34 106.693 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.006 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.7 m -74.11 -40.16 62.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.553 -0.749 . . . . 131.73 111.777 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.041 ' H ' HG21 ' A' ' 17' ' ' THR . 71.2 m -84.4 -42.9 15.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 117.018 2.229 . . . . 80.49 117.018 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.53 3.35 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.196 -1.402 . . . . 98.98 111.252 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.84 -10.7 18.09 Favored 'Trans proline' 0 C--N 1.32 -0.921 1 N-CA-C 128.937 6.476 . . . . 246.95 128.937 -170.061 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.62 17.55 8.71 Favored 'General case' 0 C--N 1.325 -0.484 1 CA-C-N 126.12 4.055 . . . . 269.62 114.236 175.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.15 -27.3 67.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.793 -1.188 . . . . 86.8 107.793 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.83 -29.28 69.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.088 -1.007 . . . . 85.91 110.498 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 123.65 0.78 . . . . 82.0 111.364 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.934 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.76 12.43 Favored Pre-proline 0 CA--C 1.488 -1.417 0 N-CA-C 108.555 -0.906 . . . . 120.73 108.555 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.844 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 C-N-CA 120.659 0.906 . . . . 87.86 109.935 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.814 -0.81 . . . . 36.46 108.814 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.1 p-90 -63.8 -33.89 76.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.934 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.18 -32.7 73.37 Favored 'General case' 0 CA--C 1.491 -1.322 0 O-C-N 121.301 -0.874 . . . . 123.26 108.685 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.822 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.14 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 109.196 -0.668 . . . . 120.14 109.196 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.43 -31.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.91 -47.21 84.24 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.633 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.692 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.65 81.16 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 119.977 -0.689 . . . . 157.57 110.362 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.58 -40.9 98.36 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.682 -0.858 . . . . 47.06 108.682 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.02 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 121.751 -0.593 . . . . 43.94 109.569 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.83 -43.29 99.15 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.705 -0.85 . . . . 42.61 108.705 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.35 -41.26 94.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.653 -0.249 . . . . 140.66 111.064 -178.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.79 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 118.613 -1.235 . . . . 116.04 110.221 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.44 -38.76 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.745 -0.835 . . . . 97.16 108.745 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.913 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.4 mt -61.32 -39.95 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.968 HG23 HG22 ' A' ' 86' ' ' THR . 93.1 t -57.7 -42.34 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 108.891 -0.781 . . . . 45.39 108.891 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 96.9 t -63.56 -50.97 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.837 -1.145 . . . . 48.64 110.156 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.7 t -65.21 -47.11 78.02 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.137 -0.625 . . . . 116.65 111.71 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.93 -43.93 97.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.695 -0.483 . . . . 51.16 109.695 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.96 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 119.864 -0.734 . . . . 44.3 110.828 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 94.1 t -64.71 -46.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 120.349 -0.54 . . . . 48.82 111.039 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.12 95.2 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.492 -0.861 . . . . 58.7 112.006 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.13 66.99 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 117.452 0.626 . . . . 101.4 111.006 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.77 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.727 -1.212 . . . . 103.57 107.727 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.41 -43.02 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.996 -0.742 . . . . 61.89 108.996 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.5 t -63.5 -50.94 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.45 -0.574 . . . . 70.01 109.45 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.91 -43.45 98.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.118 -0.697 . . . . 132.1 109.118 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.672 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.19 -46.63 83.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.652 -0.249 . . . . 104.5 110.458 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.64 -49.89 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.041 HD12 HG13 ' A' ' 72' ' ' VAL 0.28 25.0 pt -64.75 -41.76 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 C-N-CA 116.936 -1.906 . . . . 158.32 110.897 -175.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 117.692 -1.603 . . . . 137.11 109.516 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.155 -0.341 . . . . 54.66 111.02 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.39 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 121.615 0.721 . . . . 127.18 109.591 -174.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.78 -36.89 80.12 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.099 0.96 . . . . 87.93 110.884 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.067 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.618 -0.676 . . . . 131.12 111.526 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.007 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.46 7.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.25 -2.58 . . . . 246.56 109.613 -175.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.949 0 N-CA-C 105.489 -2.041 . . . . 339.35 105.489 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.857 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.4 p -124.12 165.23 17.89 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.033 -2.951 . . . . 114.66 103.033 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.96 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.42 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.799 -1.556 . . . . 143.28 106.799 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.999 HG21 HD13 ' A' ' 71' ' ' LEU . 95.5 m -59.66 -38.1 80.51 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.687 -0.857 . . . . 160.22 108.687 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.857 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.4 m-20 -62.3 -31.78 72.43 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.908 -0.775 . . . . 120.54 108.908 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.56 -43.8 96.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.508 -0.553 . . . . 67.22 109.508 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.935 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.54 -39.75 88.72 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.494 -0.754 . . . . 138.6 109.71 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.999 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.57 -35.94 82.15 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.451 0.301 . . . . 151.46 110.614 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.041 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.97 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 117.426 -1.71 . . . . 117.93 106.686 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.03 -46.01 90.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.891 -1.152 . . . . 56.82 107.891 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.41 -43.92 98.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.885 -0.783 . . . . 145.3 108.885 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.39 95.54 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.494 -0.928 . . . . 45.71 108.494 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.41 -42.03 99.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.357 -0.609 . . . . 105.61 109.357 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.617 -0.883 . . . . 47.89 108.617 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.35 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.935 -0.395 . . . . 124.53 109.935 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 121.966 -0.459 . . . . 35.89 109.831 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -37.29 84.83 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.999 -1.482 . . . . 88.97 106.999 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.18 76.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 119.859 -0.737 . . . . 239.91 109.075 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.45 -43.39 90.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.529 -0.732 . . . . 146.1 110.565 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.15 -58.2 3.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 117.358 -1.737 . . . . 91.74 113.874 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.6 -61.33 2.0 Allowed 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.991 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.26 -42.31 55.34 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.896 -1.521 . . . . 242.6 114.026 -170.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.968 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.61 84.55 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 118.957 -1.097 . . . . 215.61 109.831 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 86' ' ' THR . 72.0 t -60.26 -46.96 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.803 -0.561 . . . . 87.19 110.489 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 64.0 t -65.95 -41.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.754 -0.462 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.295 -1.002 . . . . 364.98 108.295 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.543 -0.723 . . . . 181.63 111.242 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.896 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.5 m -60.83 -45.83 92.91 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.423 -1.325 . . . . 269.02 107.423 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.07 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.67 -45.13 92.98 Favored 'General case' 0 CA--C 1.469 -2.15 0 C-N-CA 118.677 -1.209 . . . . 562.66 110.013 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.696 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -61.08 -45.21 95.67 Favored 'General case' 0 CA--C 1.479 -1.777 0 C-N-CA 118.713 -1.195 . . . . 446.75 108.108 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.0 m -70.52 -26.31 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 115.826 -2.35 . . . . 370.05 112.202 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.896 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.5 -26.48 60.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.598 -0.689 . . . . 354.91 112.53 175.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.83 4.55 0.98 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 125.057 1.343 . . . . 462.44 111.87 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.8 mm-40 -172.39 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.067 0.936 . . . . 652.37 111.085 171.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.829 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 128.508 2.723 . . . . 905.99 107.931 -174.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.88 -36.42 80.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.223 -1.028 . . . . 570.43 108.223 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.52 -36.37 82.35 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 125.31 1.444 . . . . 453.22 111.191 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.006 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.67 33.88 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 118.781 -1.676 . . . . 445.63 109.897 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.569 ' CD1' ' HB2' ' B' ' 368' ' ' PRO . 89.1 mt -56.39 -41.23 75.91 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.249 1.419 . . . . 457.72 112.378 -170.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.64 -46.93 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.688 -1.205 . . . . 340.58 109.299 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.74 -32.13 71.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.769 -1.172 . . . . 453.6 111.585 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.04 -40.33 73.32 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.9 -47.08 76.0 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 124.025 0.828 . . . . 466.68 110.888 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.06 86.86 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.491 -1.684 . . . . 427.34 107.263 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.12 -36.77 82.61 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 112.423 0.527 . . . . 537.87 112.423 -174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.66 74.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 116.86 -1.936 . . . . 422.12 111.617 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.7 t80 -59.05 -50.11 75.32 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.339 -0.85 . . . . 340.17 111.853 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.4 m-85 -65.35 -46.5 70.74 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.089 -1.045 . . . . 258.06 111.695 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.991 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.3 Cg_exo -61.47 -31.58 87.97 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.54 93.78 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.791 -1.188 . . . . 149.27 107.791 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.96 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.649 -0.42 . . . . 138.08 111.5 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.96 -42.41 88.72 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 O-C-N 121.556 -0.715 . . . . 132.89 110.936 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.947 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.75 -44.72 92.63 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.849 -0.797 . . . . 193.61 108.849 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.607 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.66 84.31 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 122.842 0.457 . . . . 63.83 110.128 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.4 59.68 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.75 -0.38 . . . . 76.4 111.214 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.0 -41.64 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.163 -1.051 . . . . 171.13 108.163 -174.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.077 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.84 -38.53 91.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.866 -0.521 . . . . 78.3 110.639 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.06 -35.78 80.59 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 118.9 -1.12 . . . . 92.36 109.236 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.083 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.45 -34.28 76.49 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.184 -1.043 . . . . 93.73 108.184 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.979 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.49 -41.59 84.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 119.205 -0.998 . . . . 132.74 109.323 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.13 94.72 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.188 -1.412 . . . . 43.39 107.188 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.47 -41.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 108.639 -0.875 . . . . 59.34 108.639 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.06 95.27 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.796 -0.565 . . . . 69.68 110.5 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.71 91.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.334 -0.987 . . . . 106.98 108.334 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.64 81.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.648 -0.821 . . . . 147.63 108.933 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.762 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.54 99.38 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.557 -0.905 . . . . 190.06 108.557 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.964 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.32 -44.13 97.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.273 -1.01 . . . . 118.85 108.273 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.125 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.65 98.97 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 110.008 -0.367 . . . . 102.5 110.008 -177.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.61 95.23 Favored 'General case' 0 CA--C 1.489 -1.375 0 O-C-N 121.866 -0.521 . . . . 89.98 109.812 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 C-N-CA 118.104 -1.438 . . . . 106.09 111.012 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.11 -48.26 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 C-N-CA 117.087 -1.845 . . . . 227.74 111.798 -174.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.08 50.94 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.238 -2.185 . . . . 262.55 110.052 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.47 28.81 Favored 'Trans proline' 0 C--N 1.289 -2.56 0 C-N-CA 121.685 1.59 . . . . 210.25 111.35 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.23 112.0 0.99 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 106.537 -1.653 . . . . 270.58 106.537 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.892 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.53 24.04 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-N 115.37 -0.832 . . . . 129.84 112.316 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 83.0 Cg_exo -61.36 -26.58 81.75 Favored 'Trans proline' 0 N--CA 1.432 -2.142 0 N-CA-C 116.321 1.623 . . . . 330.71 116.321 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.04 77.21 7.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 114.452 -2.899 . . . . 204.51 107.286 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.88 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.44 0.09 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.425 -1.324 . . . . 387.41 107.425 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.88 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.04 33.66 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 118.753 -1.179 . . . . 166.22 109.435 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.79 88.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.804 -1.184 . . . . 44.23 107.804 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.76 -38.83 92.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.085 -0.709 . . . . 30.29 109.085 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.96 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.04 93.88 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.962 -0.755 . . . . 46.11 108.962 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.47 -42.12 99.26 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.699 -1.223 . . . . 87.33 107.699 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.8 t -61.63 -42.13 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.954 -1.128 . . . . 23.69 107.954 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.22 -44.26 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.676 -0.49 . . . . 43.86 109.676 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.3 -42.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 108.351 -0.981 . . . . 91.13 108.351 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.4 t -62.56 -38.0 88.37 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.743 -0.836 . . . . 65.88 108.743 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.11 -41.81 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 109.58 -0.526 . . . . 33.86 109.58 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.077 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.41 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.173 0 N-CA-C 107.577 -1.268 . . . . 146.52 107.577 -176.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.84 -38.36 90.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.499 -0.88 . . . . 75.44 108.936 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.53 -48.39 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 O-C-N 121.04 -1.038 . . . . 43.64 109.733 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.812 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.48 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 109.045 -0.724 . . . . 102.57 109.045 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.1 86.87 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.398 -1.334 . . . . 58.16 107.398 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.815 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.5 73.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.993 -0.743 . . . . 121.11 108.993 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.3 84.93 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.565 -1.254 . . . . 153.15 109.938 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.992 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.11 -43.76 18.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 113.084 -3.446 . . . . 133.67 113.477 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.92 -39.93 96.07 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 120.918 -1.114 . . . . 157.42 112.193 -171.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.517 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 114.993 1.479 . . . . 250.91 114.993 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.3 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.488 -1.786 0 N-CA-C 117.984 2.263 . . . . 207.34 117.984 -174.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.027 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.2 -34.22 74.73 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.94 -1.504 . . . . 192.46 106.94 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.46 -41.06 98.16 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.01 -2.036 . . . . 261.0 108.01 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.71 159.11 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 101.519 -3.512 . . . . 491.4 101.519 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.437 0 C-N-CA 116.257 -2.177 . . . . 386.1 109.87 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.027 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.03 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 103.552 -2.758 . . . . 289.8 103.552 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.114 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 117.771 -1.109 . . . . 402.06 109.576 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.781 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.29 177.46 7.57 Favored 'General case' 0 CA--C 1.586 2.357 0 C-N-CA 127.32 2.248 . . . . 690.53 114.9 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.59 0.0 OUTLIER 'General case' 1 C--N 1.43 4.09 1 N-CA-C 123.178 4.511 . . . . 633.62 123.178 162.696 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.67 153.85 22.07 Favored 'General case' 0 C--N 1.389 2.305 0 C-N-CA 127.362 2.265 . . . . 617.99 110.889 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.42 5.96 Favored Pre-proline 0 C--N 1.364 1.227 0 C-N-CA 130.289 3.435 . . . . 434.98 113.382 -175.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.1 Cg_endo -44.21 -65.7 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 122.409 3.965 . . . . 365.88 122.409 -168.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.3 m -84.91 20.98 1.69 Allowed 'General case' 0 CA--C 1.467 -2.247 0 N-CA-C 104.832 -2.284 . . . . 635.81 104.832 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.35 152.19 18.83 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.959 7.762 . . . . 999.99 131.959 -135.764 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.07 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.913 37.2 t -131.79 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.773 1 CA-C-N 103.314 -6.312 . . . . 594.32 113.613 149.206 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.1 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.307 -4.701 . . . . 811.91 98.307 162.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.47 144.58 45.89 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 117.063 -1.855 . . . . 999.99 109.411 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.23 -175.63 4.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.036 0.922 . . . . 431.86 110.042 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.06 148.63 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 124.384 1.074 . . . . 457.18 108.823 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.829 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.29 85.45 3.72 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.134 0.973 . . . . 458.77 113.523 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.41 -31.56 0.97 Allowed Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.983 1.313 . . . . 999.99 112.38 168.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.73 5.68 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 N-CA-C 120.916 3.391 . . . . 999.99 120.916 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.57 171.76 8.13 Favored 'General case' 0 CA--C 1.472 -2.041 0 C-N-CA 117.133 -1.827 . . . . 81.18 107.235 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.14 45.12 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.881 0 C-N-CA 115.537 -2.465 . . . . 999.99 108.798 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.083 ' HB3' ' HD2' ' B' ' 365' ' ' ARG . 87.8 Cg_endo -41.61 101.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.126 1 C-N-CA 126.045 4.496 . . . . 999.99 105.677 -170.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.99 97.55 Favored 'General case' 0 CA--C 1.483 -1.621 0 C-N-CA 126.717 2.007 . . . . 967.72 112.043 -165.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.55 78.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.72 -1.585 . . . . 934.3 106.72 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.058 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.5 -30.29 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 129.188 2.995 . . . . 565.15 113.951 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.59 55.36 2.78 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 118.468 0.577 . . . . 755.61 109.854 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.114 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.25 67.21 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.559 1.144 . . . . 325.89 113.259 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -45.02 78.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.582 0.753 . . . . 250.21 111.639 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.66 -43.38 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-O 121.592 0.711 . . . . 142.46 110.379 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.953 0.901 . . . . 247.69 108.855 -173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.9 t60 -60.49 -51.32 69.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 125.444 1.498 . . . . 199.61 113.111 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.37 -44.49 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.701 -1.222 . . . . 106.73 107.701 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.786 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.59 81.03 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.853 -0.612 . . . . 115.01 110.232 -173.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.992 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.19 -49.13 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 119.411 -0.916 . . . . 129.42 111.857 -174.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.816 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.6 m -61.94 -53.09 60.5 Favored 'General case' 0 CA--C 1.482 -1.646 0 C-N-CA 118.178 -1.409 . . . . 172.48 109.943 -172.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.84 -54.32 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 120.51 -0.476 . . . . 55.86 110.973 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.5 -51.55 59.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.504 -1.278 . . . . 184.68 111.524 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.977 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.42 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.618 -2.033 . . . . 291.81 114.749 -174.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.98 4.86 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.181 1.548 . . . . 130.66 115.181 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.816 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.499 1.296 . . . . 80.16 114.499 -170.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.44 83.1 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.906 -0.717 . . . . 136.02 109.509 -174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.2 Cg_exo -64.83 -27.11 59.49 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.596 -0.579 . . . . 92.17 110.596 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.33 -41.44 76.68 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.441 -1.318 . . . . 135.6 107.441 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.11 -44.7 91.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.604 -0.517 . . . . 52.1 109.604 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.49 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 109.079 -0.711 . . . . 95.89 109.079 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.979 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.33 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.714 -1.587 . . . . 43.41 106.714 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.28 99.12 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.382 -1.487 . . . . 27.69 109.382 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.905 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.71 -47.38 75.57 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 117.32 0.56 . . . . 54.41 110.45 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.36 -34.19 74.88 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.957 -1.497 . . . . 53.88 106.957 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.84 93.85 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.503 -0.925 . . . . 68.29 108.503 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.905 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.04 92.96 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.682 -0.807 . . . . 107.59 110.626 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -63.0 -38.38 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.609 -0.837 . . . . 111.61 109.525 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.23 -22.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.45 -0.944 . . . . 85.26 108.45 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.92 99.42 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.074 -0.81 . . . . 40.71 111.074 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.71 -44.09 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.382 -0.97 . . . . 95.86 108.382 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.2 p -76.9 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.416 -0.957 . . . . 144.37 108.416 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.8 mt -55.34 132.12 47.29 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 107.606 -1.257 . . . . 326.72 107.606 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.446 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.1 1.52 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.015 -1.846 . . . . 158.38 106.015 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.28 -41.94 99.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.688 -0.486 . . . . 36.78 109.688 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.7 m -61.13 125.88 25.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.168 -1.013 . . . . 85.46 109.77 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.57 8.83 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 105.534 -2.024 . . . . 127.78 105.534 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.78 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 105.938 -1.875 . . . . 164.84 105.938 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.0 Cg_exo -56.77 -39.95 87.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 113.958 0.714 . . . . 222.35 113.958 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.806 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 106.403 -2.679 . . . . 45.22 106.403 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.77 93.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.017 -1.846 . . . . 107.57 106.017 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.735 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.83 141.82 58.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.897 -1.121 . . . . 167.96 109.142 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.71 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.686 1.994 . . . . 280.68 109.715 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.33 0.71 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.493 1.117 . . . . 218.25 110.686 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.212 -2.144 . . . . 343.57 105.212 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.04 81.93 1.54 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.875 -1.528 . . . . 263.29 106.875 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 126.57 1.948 . . . . 261.92 108.471 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.08 89.78 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 107.903 -1.147 . . . . 106.81 107.903 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.88 94.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 118.374 -1.33 . . . . 112.2 107.576 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.3 t -64.31 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.294 -0.632 . . . . 45.41 109.294 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.865 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.06 68.89 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.287 -0.264 . . . . 97.62 110.287 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.62 81.7 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.735 0.814 . . . . 59.29 111.025 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.27 -36.48 83.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.615 1.166 . . . . 106.49 110.687 -174.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.7 69.24 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.28 -1.007 . . . . 106.62 108.28 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.01 -41.03 91.53 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 121.836 -0.54 . . . . 75.97 110.028 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.7 t -65.56 -40.83 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 122.94 0.496 . . . . 65.27 109.754 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.838 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.6 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 C-N-CA 120.419 -0.512 . . . . 107.94 110.135 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.56 -40.78 97.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 121.68 -0.637 . . . . 87.98 110.275 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.63 -40.45 96.92 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.847 -1.141 . . . . 65.5 108.389 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.65 -36.37 80.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.157 -1.053 . . . . 85.05 108.157 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.5 -45.75 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 109.028 -0.73 . . . . 42.25 109.028 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.39 -38.17 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 C-N-CA 119.535 -0.866 . . . . 91.01 109.377 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 66.1 t -58.93 -41.55 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 107.973 -1.121 . . . . 66.09 107.973 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 120.726 -0.39 . . . . 52.39 110.331 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.3 m -61.75 -46.77 88.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.899 -0.501 . . . . 46.42 109.858 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.37 -38.05 88.09 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.337 -0.986 . . . . 116.51 108.337 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.35 -48.17 82.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.392 -0.595 . . . . 65.18 109.392 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.7 97.33 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 120.827 0.346 . . . . 51.33 110.472 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.61 -43.41 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 118.936 -1.106 . . . . 126.3 108.982 -176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.4 35.34 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 116.842 2.164 . . . . 134.84 116.842 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.802 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.36 -41.62 90.37 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.692 -0.63 . . . . 72.23 111.66 -167.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.819 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.5 Cg_exo -60.69 -35.98 86.94 Favored 'Trans proline' 0 N--CA 1.429 -2.286 0 CA-C-N 119.851 0.983 . . . . 106.13 111.341 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.848 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.69 82.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 119.754 -0.779 . . . . 128.35 110.068 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.87 89.04 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 110.218 -0.29 . . . . 100.73 110.218 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.819 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.27 -44.51 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.279 -0.969 . . . . 172.72 109.185 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.4 m-85 -66.62 -28.09 68.21 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.216 -1.031 . . . . 249.23 108.216 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.49 -55.17 34.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.701 -1.592 . . . . 259.78 106.701 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.16 -44.15 72.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.593 0.96 . . . . 233.11 113.593 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.852 HD12 HD21 ' A' ' 279' ' ' LEU . 88.6 mt -61.38 -48.33 91.31 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 119.22 -0.992 . . . . 169.54 110.544 -170.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.9 Favored 'Trans proline' 0 N--CA 1.429 -2.282 0 C-N-CA 116.784 -1.677 . . . . 255.47 114.66 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.57 -44.19 94.8 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 119.238 0.926 . . . . 279.03 108.893 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.055 -0.35 . . . . 162.21 110.055 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.4 84.9 59.27 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 118.779 -1.168 . . . . 128.13 108.052 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.25 164.0 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.289 0 N-CA-C 107.499 -1.769 . . . . 278.35 107.499 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.17 15.0 9.93 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 123.778 0.674 . . . . 312.91 109.325 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.73 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.54 -1.652 . . . . 353.54 106.54 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.26 46.97 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.852 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 102.06 -3.311 . . . . 175.26 102.06 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.97 96.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 100.857 -3.757 . . . . 99.07 100.857 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.14 9.16 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.496 -2.779 . . . . 243.21 103.496 171.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.97 112.93 25.07 Favored 'General case' 0 CA--C 1.474 -1.948 0 C-N-CA 116.047 -2.261 . . . . 201.04 105.293 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.789 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.064 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.44 -41.48 89.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.256 -1.793 . . . . 203.82 107.872 174.441 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.914 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.27 -45.69 86.94 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 118.181 -1.408 . . . . 215.06 112.552 -171.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.634 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.39 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.934 -171.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.851 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.84 -37.01 86.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.181 -1.414 . . . . 268.9 107.181 -171.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.19 -45.01 74.57 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 125.658 1.583 . . . . 280.88 108.809 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.52 85.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 118.981 -1.088 . . . . 184.47 108.982 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.848 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.7 mp -67.91 -42.13 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 119.262 -0.975 . . . . 167.92 112.769 -175.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.66 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.69 -38.87 90.44 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 117.787 -1.565 . . . . 367.18 110.783 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.57 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.73 74.06 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.819 -0.551 . . . . 173.97 110.471 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 123.541 0.736 . . . . 119.66 109.764 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.99 74.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.675 -1.231 . . . . 112.3 107.675 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.02 73.3 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.244 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 m -64.74 -22.74 67.05 Favored 'General case' 0 CA--C 1.485 -1.542 0 C-N-CA 124.656 1.182 . . . . 145.27 110.627 -175.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.831 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.36 70.42 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.066 -1.086 . . . . 170.15 108.066 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.37 -34.05 63.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 122.702 0.401 . . . . 214.57 110.639 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.27 -33.18 55.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.056 1.742 . . . . 168.29 115.514 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.831 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.91 79.29 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 114.024 1.12 . . . . 167.15 114.024 -168.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.746 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.8 p-10 -64.24 -38.23 32.49 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.472 -2.491 . . . . 165.13 113.932 -171.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.746 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.54 -31.82 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 122.846 2.052 . . . . 123.92 111.241 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.788 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.79 -42.53 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.769 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.22 -39.99 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.803 -0.814 . . . . 145.31 108.803 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.252 63.4 m-85 -58.11 -48.83 78.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 119.386 -0.926 . . . . 246.68 109.854 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.1 m -62.16 -47.51 84.19 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.608 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.1 79.52 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.005 -1.078 . . . . 80.72 110.222 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 115.98 1.844 . . . . 140.44 115.98 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.77 132.22 34.46 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 112.753 -3.579 . . . . 178.87 113.061 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -64.98 -37.12 86.61 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.4 -1.273 . . . . 110.22 110.125 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.62 72.62 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 121.772 -0.58 . . . . 174.78 109.708 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.67 95.52 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.274 -1.009 . . . . 161.84 108.274 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.478 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.35 -50.17 73.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 120.01 -0.676 . . . . 117.2 109.232 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.06 75.47 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.328 -0.549 . . . . 112.6 111.114 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.121 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.08 -37.36 94.47 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.671 -0.972 . . . . 101.46 110.671 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.21 -46.02 90.76 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 118.47 1.135 . . . . 151.49 109.511 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.0 -36.34 76.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.984 -1.487 . . . . 142.32 106.984 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.121 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.1 m80 -59.78 -41.85 92.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.41 85.93 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 122.287 -0.258 . . . . 76.11 111.047 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -61.48 -55.46 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.829 -0.748 . . . . 120.24 109.301 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.31 131.57 41.28 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 102.944 -2.984 . . . . 192.73 102.944 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.15 -44.22 92.07 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.017 -1.073 . . . . 176.29 109.22 -172.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.3 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.488 -1.431 0 N-CA-C 106.277 -1.749 . . . . 69.68 106.277 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.02 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.431 0 C-N-CA 118.381 -0.612 . . . . 191.05 112.595 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.48 43.92 16.23 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 123.504 0.502 . . . . 287.03 109.772 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.848 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.56 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.916 0 C-N-CA 112.948 -3.501 . . . . 292.29 109.795 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.51 -152.8 0.05 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.206 -2.516 . . . . 184.57 104.206 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.62 8.75 5.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.061 0.763 . . . . 274.56 113.061 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.85 57.28 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 117.72 -2.181 . . . . 268.24 113.451 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.58 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 118.694 1.247 . . . . 200.06 110.722 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.76 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.868 -1.16 . . . . 114.44 107.868 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.24 46.07 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.635 -1.246 . . . . 263.81 107.635 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.218 1 N-CA-C 102.475 -4.25 . . . . 103.79 102.475 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.992 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.27 95.66 10.26 Favored 'General case' 0 N--CA 1.419 -2.014 0 C-N-CA 114.933 -2.707 . . . . 117.3 106.0 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.065 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.82 90.81 Favored 'General case' 0 CA--C 1.468 -2.178 1 N-CA-C 97.986 -4.82 . . . . 231.58 97.986 167.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.067 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.061 -3.311 . . . . 303.24 102.061 169.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.992 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.62 78.61 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.051 -2.26 . . . . 112.72 108.402 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 48.0 t -61.07 -63.6 1.24 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.1 -0.704 . . . . 83.22 109.1 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.28 -126.23 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.81 -2.663 . . . . 174.36 103.81 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.065 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.85 160.96 8.73 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.91 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.085 -1.45 . . . . 180.62 107.085 176.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.947 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.406 -2.072 . . . . 145.25 105.406 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.947 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.12 -43.12 88.05 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.155 -1.795 . . . . 66.05 106.155 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.759 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.509 -2.775 . . . . 266.49 103.509 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.29 -124.9 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.029 -1.868 . . . . 219.2 107.788 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.004 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.14 -37.32 93.98 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 114.546 -1.207 . . . . 94.78 112.853 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.2 100.42 9.09 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 112.285 -3.766 . . . . 121.41 109.489 -171.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.8 t -73.02 145.5 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.947 -0.76 . . . . 85.34 108.947 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.39 42.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.843 -1.169 . . . . 267.57 107.843 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.11 69.6 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.472 -0.566 . . . . 226.1 109.472 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 107.02 -1.474 . . . . 154.84 107.02 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.505 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.7 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.585 0.707 . . . . 180.01 110.728 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.881 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.47 156.94 23.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.945 -1.502 . . . . 333.78 106.945 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.986 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.5 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.986 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.768 -0.827 . . . . 266.47 108.768 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.59 -46.93 88.41 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.633 -1.988 . . . . 59.34 105.633 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.59 173.85 11.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.428 -2.434 . . . . 201.26 104.428 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.91 106.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 116.298 -2.161 . . . . 56.23 105.509 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.26 -59.45 5.28 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.24 -0.652 . . . . 87.58 109.24 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.892 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.5 153.77 22.23 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.842 -1.17 . . . . 219.95 107.842 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 116.335 -2.146 . . . . 121.79 105.476 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.13 159.75 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 N-CA-C 105.797 -1.927 . . . . 53.85 105.797 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.623 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 106.021 -2.832 . . . . 196.55 106.021 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.661 0 N-CA-C 107.843 -1.169 . . . . 35.88 107.843 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 1.083 ' HD2' ' HB3' ' A' ' 188' ' ' PRO . 32.6 ttt180 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.841 -0.799 . . . . 1.0 108.841 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 1.022 ' HG3' HD22 ' A' ' 5' ' ' LEU . 50.1 Cg_endo -67.07 143.95 67.58 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.771 1.647 . . . . 1.0 111.815 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.521 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -70.33 127.28 92.28 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.941 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . 0.75 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -68.98 -20.02 39.08 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 122.386 2.057 . . . . 1.0 114.567 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -38.58 77.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.711 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' B' ' 367' ' ' LYS . 2.4 pt20 -71.33 -10.63 60.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.354 . . . . 1.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.75 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 3.1 m-85 -58.56 -46.34 87.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.277 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.66 -48.98 78.39 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.555 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.086 0 N-CA-C 109.878 -1.289 . . . . 1.0 109.878 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.843 HG12 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.974 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.98 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.92 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.012 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.888 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.706 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.006 HG23 HG23 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.102 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.954 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.939 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 1.006 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.832 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.012 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.087 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.79 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.888 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.853 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.79 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.954 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.811 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.82 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.827 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.119 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.119 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.777 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.827 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.826 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.785 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.815 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.981 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.815 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.929 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.929 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.895 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.774 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.866 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.751 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 279' ' ' LEU . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.862 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.917 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.122 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.122 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.058 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.058 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.998 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.102 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.991 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.991 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.521 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.888 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.525 ' N ' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.07 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.703 1.602 . . . . 1.0 111.856 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 127.36 92.1 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.276 -0.42 . . . . 1.0 109.876 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.5 Cg_endo -69.01 -20.03 38.89 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.458 2.106 . . . . 1.0 114.543 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.3 -38.67 77.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.702 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.448 ' HG2' ' HG ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -71.34 -10.55 59.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 1.0 110.55 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 4.2 m-30 -58.57 -46.36 87.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.307 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.56 -49.06 78.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.55 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.12 78.31 0.31 Allowed Glycine 0 CA--C 1.516 0.098 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -41.75 97.21 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.139 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.525 ' HA ' HG23 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.532 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.368 -0.975 . . . . 97.08 108.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.63 155.41 22.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.072 0.939 . . . . 123.41 110.739 -172.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.931 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.52 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.51 1 N-CA-C 100.136 -4.024 . . . . 151.3 100.136 173.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.981 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.65 -38.6 58.39 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 115.981 -2.288 . . . . 169.25 106.145 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.981 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.27 168.51 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 122.273 0.617 . . . . 185.76 110.585 171.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.852 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.4 t -64.48 -25.9 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 C-N-CA 126.984 2.114 . . . . 145.47 110.336 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.714 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.4 21.51 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.088 -1.007 . . . . 102.76 109.453 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.58 154.17 25.13 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.014 -1.106 . . . . 106.25 108.014 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.87 51.87 0.74 Allowed 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.645 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.15 -45.9 91.5 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 103.619 -2.734 . . . . 150.2 103.619 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -86.98 164.7 35.38 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 103.711 -2.699 . . . . 183.52 103.711 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.79 6.87 3.85 Favored 'Trans proline' 0 C--N 1.281 -3.012 0 N-CA-C 109.948 -0.828 . . . . 235.61 109.948 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.7 t-20 -57.97 -41.19 82.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.813 1.245 . . . . 113.77 113.375 -170.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.931 HD13 HG11 ' A' ' 4' ' ' VAL . 33.5 pt -52.19 136.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 119.555 1.071 . . . . 150.85 110.947 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.48 156.24 46.4 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.624 -1.25 . . . . 100.42 107.624 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.04 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.974 0.892 . . . . 129.36 110.445 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.11 -25.45 68.36 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.278 1.831 . . . . 112.34 106.67 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.954 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.19 -40.11 62.73 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.565 -0.743 . . . . 131.73 111.75 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.48 -42.86 15.15 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.95 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.825 0 C-N-CA 118.155 -1.418 . . . . 98.98 111.21 -169.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.5 Cg_exo -61.82 -10.8 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.917 1 N-CA-C 128.862 6.447 . . . . 246.95 128.862 -170.05 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.673 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.67 17.56 8.77 Favored 'General case' 0 C--N 1.324 -0.523 1 CA-C-N 126.19 4.086 . . . . 269.62 114.183 175.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.25 67.12 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.785 -1.191 . . . . 86.8 107.785 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.4 p90 -66.87 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.126 -0.984 . . . . 85.91 110.517 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.886 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 123.663 0.785 . . . . 82.0 111.388 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.934 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.7 12.55 Favored Pre-proline 0 CA--C 1.489 -1.378 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.843 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.9 149.75 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.881 . . . . 87.86 109.913 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.821 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.99 89.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.851 -0.796 . . . . 36.46 108.851 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.842 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.8 -33.83 76.54 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.934 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.4 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.296 -0.877 . . . . 123.26 108.645 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.53 -47.16 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.42 -31.01 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 107.845 -1.169 . . . . 112.19 107.845 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.842 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.12 84.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.899 -0.72 . . . . 60.87 109.622 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.705 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -65.99 -35.65 81.14 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 119.953 -0.699 . . . . 157.57 110.388 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.786 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.614 -0.884 . . . . 47.06 108.614 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.74 -41.32 98.05 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.743 -0.598 . . . . 43.94 109.573 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.81 -43.35 99.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.717 -0.846 . . . . 42.61 108.717 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.34 -41.28 94.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.616 -0.266 . . . . 140.66 111.002 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.76 -43.97 97.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 118.596 -1.241 . . . . 116.04 110.236 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.75 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 N-CA-C 108.728 -0.842 . . . . 97.16 108.728 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.913 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -39.97 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 108.952 -0.759 . . . . 54.85 108.952 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.0 HG23 HG23 ' A' ' 86' ' ' THR . 92.8 t -57.74 -42.36 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.835 -0.802 . . . . 45.39 108.835 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.1 t -63.54 -50.94 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 118.826 -1.15 . . . . 48.64 110.166 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.789 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.25 -47.07 78.04 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.14 -0.624 . . . . 116.65 111.703 -174.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.64 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.96 -43.92 97.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.683 -0.488 . . . . 51.16 109.683 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.58 -48.92 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 C-N-CA 119.85 -0.74 . . . . 44.3 110.834 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.9 t -64.78 -46.91 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 120.239 -0.585 . . . . 48.82 111.034 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.76 -44.14 95.23 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.474 -0.87 . . . . 58.7 112.016 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.64 -34.18 67.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 122.136 -0.626 . . . . 101.4 111.056 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.816 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.97 -38.64 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.45 -43.06 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.972 -0.751 . . . . 61.89 108.972 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.98 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 109.463 -0.569 . . . . 70.01 109.463 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.716 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.37 98.97 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.128 -0.693 . . . . 132.1 109.128 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.67 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.65 82.95 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.706 -0.225 . . . . 104.5 110.435 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.891 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.61 -49.91 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 120.233 -0.587 . . . . 142.96 111.303 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.036 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.68 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.926 -1.91 . . . . 158.32 110.893 -175.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.73 -41.39 98.05 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 117.71 -1.596 . . . . 137.11 109.496 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.55 91.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 122.089 -0.382 . . . . 54.66 110.997 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.953 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.44 117.17 29.45 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.646 0.736 . . . . 127.18 109.559 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.89 -36.74 80.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 124.039 0.935 . . . . 87.93 110.859 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.067 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.43 -34.62 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.65 -0.656 . . . . 131.12 111.482 -175.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.007 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.67 69.47 7.19 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 115.271 -2.571 . . . . 246.56 109.6 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.24 91.49 3.49 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 105.453 -2.055 . . . . 339.35 105.453 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.854 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.24 17.93 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 102.97 -2.974 . . . . 114.66 102.97 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.956 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.11 -39.5 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 106.754 -1.573 . . . . 143.28 106.754 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 1.001 HG21 HD13 ' A' ' 71' ' ' LEU . 95.7 m -59.67 -38.03 80.38 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.697 -0.853 . . . . 160.22 108.697 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.854 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.35 -31.75 72.44 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.893 -0.78 . . . . 120.54 108.893 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.66 -43.74 95.85 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.482 -0.562 . . . . 67.22 109.482 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.54 -39.77 88.75 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.537 -0.727 . . . . 138.6 109.683 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 1.001 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.59 -35.9 82.03 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.449 0.3 . . . . 151.46 110.644 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.036 HG13 HD12 ' A' ' 57' ' ' ILE . 24.0 m -62.51 -38.02 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.719 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.1 -45.97 91.16 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.889 -1.152 . . . . 56.82 107.889 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.91 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.94 98.01 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.917 -0.771 . . . . 145.3 108.917 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.34 95.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.574 -0.898 . . . . 45.71 108.574 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.36 -42.04 99.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.387 -0.597 . . . . 105.61 109.387 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.47 92.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.668 -0.864 . . . . 47.89 108.668 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.34 84.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.976 -0.379 . . . . 124.53 109.976 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.19 99.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.944 -0.473 . . . . 35.89 109.807 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.26 -37.3 84.95 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.966 -1.494 . . . . 88.97 106.966 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.21 -49.11 77.06 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.809 -0.756 . . . . 239.91 109.064 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.36 90.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.522 -0.736 . . . . 146.1 110.611 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.4 1.97 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.764 1.765 . . . . 197.45 115.764 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.996 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.26 55.63 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 117.891 -1.524 . . . . 242.6 114.039 -170.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 1.0 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.37 -36.57 84.39 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.862 -1.135 . . . . 215.61 109.886 -172.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.25 -46.92 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 120.361 -0.536 . . . . 87.19 110.493 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.88 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 109.754 -0.461 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.958 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.1 75.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.349 -0.982 . . . . 364.98 108.349 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.23 -44.69 75.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.559 -0.713 . . . . 181.63 111.236 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.898 HG21 ' HD2' ' A' ' 95' ' ' HIS . 58.1 m -60.91 -45.76 93.33 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 107.409 -1.33 . . . . 269.02 107.409 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.069 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.78 -45.01 93.62 Favored 'General case' 0 CA--C 1.469 -2.146 0 C-N-CA 118.625 -1.23 . . . . 562.66 109.983 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.28 95.34 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.685 -1.206 . . . . 446.75 108.066 -167.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.786 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.48 -26.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.859 -2.336 . . . . 370.05 112.195 -178.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.898 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.49 60.04 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.552 -0.717 . . . . 354.91 112.478 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.882 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.3 m-20 82.76 4.45 1.01 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 125.048 1.339 . . . . 462.44 111.934 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.3 178.06 2.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.971 0.891 . . . . 652.37 111.168 171.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.7 86.35 2.16 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 128.473 2.709 . . . . 905.99 107.947 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -67.97 -36.36 79.93 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.203 -1.036 . . . . 570.43 108.203 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.37 82.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.345 1.458 . . . . 453.22 111.146 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.954 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.57 178.68 33.86 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.716 -1.707 . . . . 445.63 109.875 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.778 HD21 ' CE1' ' B' ' 371' ' ' PHE . 89.1 mt -56.45 -41.23 76.13 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.208 1.403 . . . . 457.72 112.374 -170.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.57 -47.02 85.66 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.69 -1.204 . . . . 340.58 109.266 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.68 -32.14 71.76 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.802 -1.159 . . . . 453.6 111.59 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.36 73.37 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.15 75.99 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.949 0.781 . . . . 466.68 110.873 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.75 -47.09 86.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.296 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.16 -36.76 82.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 112.365 0.506 . . . . 537.87 112.365 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.39 -42.68 74.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 116.882 -1.927 . . . . 422.12 111.604 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.8 t80 -59.04 -50.09 75.4 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 121.34 -0.85 . . . . 340.17 111.84 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.3 m-85 -65.34 -46.48 70.82 Favored Pre-proline 0 N--CA 1.443 -0.776 0 C-N-CA 119.085 -1.046 . . . . 258.06 111.705 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.996 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.55 -31.57 87.43 Favored 'Trans proline' 0 N--CA 1.435 -1.954 0 N-CA-C 115.324 1.24 . . . . 305.71 115.324 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.702 -0.851 . . . . 252.7 108.702 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.66 93.93 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.776 -1.194 . . . . 149.27 107.776 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.85 95.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.661 -0.416 . . . . 138.08 111.509 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.749 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.92 -42.35 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 121.587 -0.696 . . . . 132.89 110.996 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.947 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.81 -44.66 92.63 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.84 -0.8 . . . . 193.61 108.84 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.69 84.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.846 0.458 . . . . 63.83 110.063 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -64.04 -52.41 59.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 122.068 -0.395 . . . . 76.4 111.228 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.96 -41.63 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.188 -1.041 . . . . 171.13 108.188 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.074 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.58 91.63 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.82 -0.55 . . . . 78.3 110.599 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.74 80.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 118.886 -1.126 . . . . 92.36 109.217 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.08 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.45 -34.26 76.45 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.199 -1.037 . . . . 93.73 108.199 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.48 -41.61 84.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.193 -1.003 . . . . 132.74 109.34 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.05 94.65 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.194 -1.41 . . . . 43.39 107.194 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.5 -41.97 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.593 -0.891 . . . . 59.34 108.593 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.43 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 121.781 -0.574 . . . . 69.68 110.491 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.48 -42.79 91.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.287 -1.005 . . . . 106.98 108.287 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.659 -0.817 . . . . 147.63 108.917 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.761 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.17 -41.54 99.25 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.549 -0.908 . . . . 190.06 108.549 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.962 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.32 -44.08 97.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.306 -0.998 . . . . 118.85 108.306 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.124 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.3 -42.76 99.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.99 -0.374 . . . . 102.5 109.99 -177.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.61 95.34 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 121.875 -0.516 . . . . 89.98 109.853 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.52 -50.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 C-N-CA 118.151 -1.419 . . . . 106.09 111.003 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.32 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.847 -174.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.83 100.09 51.01 Favored Pre-proline 0 CA--C 1.486 -1.511 0 C-N-CA 116.261 -2.176 . . . . 262.55 110.047 -175.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.1 Cg_endo -69.65 -10.33 28.38 Favored 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 121.606 1.537 . . . . 210.25 111.332 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.521 -1.659 . . . . 270.58 106.521 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.893 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.8 -39.52 24.18 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-N 115.377 -0.829 . . . . 129.84 112.312 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.5 Cg_exo -61.36 -26.65 81.85 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 116.296 1.614 . . . . 330.71 116.296 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -80.99 77.16 7.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 114.502 -2.879 . . . . 204.51 107.3 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.88 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.35 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.431 -1.322 . . . . 387.41 107.431 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.88 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.65 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 118.761 -1.176 . . . . 166.22 109.461 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.821 -1.177 . . . . 44.23 107.821 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.28 -39.13 85.77 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.206 -1.035 . . . . 28.8 108.206 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.83 92.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.074 -0.714 . . . . 30.29 109.074 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.956 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.4 m -59.56 -43.06 93.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.016 -0.735 . . . . 46.11 109.016 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.47 -42.1 99.25 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.683 -1.229 . . . . 87.33 107.683 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.5 t -61.68 -42.1 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.883 -1.155 . . . . 23.69 107.883 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.23 -44.31 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 109.649 -0.5 . . . . 43.86 109.649 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.937 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.59 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.352 -0.981 . . . . 91.13 108.352 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.3 t -62.53 -37.97 88.15 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.768 -0.827 . . . . 65.88 108.768 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.07 -41.96 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.536 -0.542 . . . . 33.86 109.536 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.34 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.595 -1.261 . . . . 146.52 107.595 -176.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.33 90.5 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.512 -0.875 . . . . 75.44 108.849 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.58 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 O-C-N 121.031 -1.043 . . . . 43.64 109.725 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.81 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.73 -37.95 89.26 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 109.027 -0.731 . . . . 102.57 109.027 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.09 87.01 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.383 -1.34 . . . . 58.16 107.383 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.817 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.03 -32.52 73.91 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.043 -0.725 . . . . 121.11 109.043 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.99 -42.37 84.97 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 118.586 -1.245 . . . . 153.15 109.895 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.993 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.1 -43.73 19.02 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 113.051 -3.46 . . . . 133.67 113.488 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.9 96.07 Favored 'General case' 0 CA--C 1.489 -1.402 0 O-C-N 120.893 -1.13 . . . . 157.42 112.226 -171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.09 2.44 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 115.037 1.495 . . . . 250.91 115.037 -173.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.6 Cg_exo -59.51 -25.47 78.82 Favored 'Trans proline' 0 CA--C 1.488 -1.816 0 N-CA-C 118.018 2.276 . . . . 207.34 118.018 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.028 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.15 -34.21 74.65 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.978 -1.49 . . . . 192.46 106.978 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.55 -40.99 98.07 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 107.938 -2.065 . . . . 261.0 107.938 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.83 159.09 26.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 101.554 -3.499 . . . . 491.4 101.554 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 116.287 -2.165 . . . . 386.1 109.797 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.028 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 103.54 -2.763 . . . . 289.8 103.54 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.118 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.41 0.86 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.725 -1.131 . . . . 402.06 109.556 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.78 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 71.9 p -165.29 177.48 7.56 Favored 'General case' 0 CA--C 1.587 2.373 0 C-N-CA 127.323 2.249 . . . . 690.53 114.902 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.35 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.698 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.792 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.84 22.09 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 127.399 2.28 . . . . 617.99 110.916 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.99 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.246 3.419 . . . . 434.98 113.455 -175.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 122.397 3.96 . . . . 365.88 122.397 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.89 1.7 Allowed 'General case' 0 CA--C 1.467 -2.235 0 N-CA-C 104.83 -2.285 . . . . 635.81 104.83 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.776 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.33 152.21 18.83 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.975 7.768 . . . . 999.99 131.975 -135.735 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.069 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.909 36.9 t -131.85 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.73 1 CA-C-N 103.311 -6.313 . . . . 594.32 113.588 149.175 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.18 144.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.792 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.55 45.91 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.05 -1.86 . . . . 999.99 109.374 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.7 mmm -147.22 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.009 0.909 . . . . 431.86 110.038 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.14 148.64 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 124.351 1.06 . . . . 457.18 108.8 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.829 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.29 85.51 3.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.109 0.963 . . . . 458.77 113.486 -174.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.54 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.928 1.291 . . . . 999.99 112.479 168.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.943 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.76 5.65 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 N-CA-C 120.865 3.371 . . . . 999.99 120.865 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.59 171.69 8.19 Favored 'General case' 0 CA--C 1.472 -2.032 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.274 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.84 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.518 -2.473 . . . . 999.99 108.767 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.051 ' HB2' HD11 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.55 101.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.167 1 C-N-CA 126.015 4.477 . . . . 999.99 105.716 -170.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.18 -44.02 97.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 126.786 2.034 . . . . 967.72 112.092 -165.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.3 -36.57 78.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.711 -1.589 . . . . 934.3 106.711 -175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.26 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.212 3.005 . . . . 565.15 113.898 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.51 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 118.468 0.576 . . . . 755.61 109.863 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.118 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.28 67.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.557 1.143 . . . . 325.89 113.274 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.98 78.37 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 123.55 0.74 . . . . 250.21 111.64 -169.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.544 0.688 . . . . 142.46 110.38 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.14 -41.5 96.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.942 0.897 . . . . 247.69 108.832 -173.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.893 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.48 -51.35 69.85 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.467 1.507 . . . . 199.61 113.103 -175.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.36 -44.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 107.694 -1.225 . . . . 106.73 107.694 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.787 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.13 -48.48 81.46 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.88 -0.6 . . . . 115.01 110.251 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.993 HG13 HD12 ' A' ' 161' ' ' LEU . 85.8 t -65.28 -49.17 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 C-N-CA 119.433 -0.907 . . . . 129.42 111.801 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.817 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.9 -53.16 59.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 118.23 -1.388 . . . . 172.48 109.933 -172.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.83 -54.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 123.471 0.482 . . . . 55.86 110.982 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.95 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 118.551 -1.259 . . . . 184.68 111.509 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.975 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.41 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 116.67 -2.012 . . . . 291.81 114.715 -174.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.431 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.06 -55.05 4.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.817 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.54 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.485 1.291 . . . . 80.16 114.485 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.933 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.48 83.22 Favored Pre-proline 0 N--CA 1.435 -1.198 0 C-N-CA 119.963 -0.695 . . . . 136.02 109.48 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.933 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.8 -27.11 59.7 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.707 0.574 . . . . 92.17 110.62 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.35 76.63 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.486 -1.302 . . . . 135.6 107.486 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.14 -44.72 91.33 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.603 -0.517 . . . . 52.1 109.603 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.68 -43.51 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.111 -0.7 . . . . 95.89 109.111 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.33 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.725 -1.583 . . . . 43.41 106.725 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.33 99.14 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.907 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.37 75.71 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 122.195 -0.591 . . . . 54.41 110.476 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.42 -34.1 74.82 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.976 -1.49 . . . . 53.88 106.976 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.85 93.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.469 -0.937 . . . . 68.29 108.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.907 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.84 -39.01 92.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.672 -0.811 . . . . 107.59 110.604 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -62.95 -38.41 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.553 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.5 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.87 99.43 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.088 -0.805 . . . . 40.71 111.088 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.08 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.399 -0.963 . . . . 95.86 108.399 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.4 p -76.93 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.401 -0.962 . . . . 144.37 108.401 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.57 -1.27 . . . . 326.72 107.57 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.447 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.29 -168.03 1.5 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.072 -1.825 . . . . 158.38 106.072 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.96 98.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.659 -0.496 . . . . 36.78 109.659 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.12 125.84 25.2 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.17 -1.012 . . . . 85.46 109.808 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.772 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.47 8.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.53 -2.026 . . . . 127.78 105.53 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.96 139.87 34.96 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 106.023 -1.843 . . . . 164.84 106.023 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.6 Cg_exo -56.77 -39.97 87.57 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.935 0.706 . . . . 222.35 113.935 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.12 166.97 44.94 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 106.445 -2.662 . . . . 45.22 106.445 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.923 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.73 93.49 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.035 -1.839 . . . . 107.57 106.035 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.735 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.78 141.83 58.18 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.9 -1.12 . . . . 167.96 109.168 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.87 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.52 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 126.734 2.014 . . . . 280.68 109.706 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.777 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.04 11.23 0.7 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.443 1.097 . . . . 218.25 110.698 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.934 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.36 137.64 54.79 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.241 -2.133 . . . . 343.57 105.241 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.579 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.93 1.54 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.839 -1.541 . . . . 263.29 106.839 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.658 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.26 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 126.568 1.947 . . . . 261.92 108.522 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.19 -38.1 89.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.893 -1.151 . . . . 106.81 107.893 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.35 -1.34 . . . . 112.2 107.594 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.24 -39.87 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 N-CA-C 109.259 -0.645 . . . . 45.41 109.259 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.868 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.9 p -70.88 -32.05 68.91 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.313 -0.255 . . . . 97.62 110.313 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.62 81.66 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.684 0.794 . . . . 59.29 110.992 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.55 84.01 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.656 1.182 . . . . 106.49 110.683 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.934 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.63 69.2 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.32 -0.993 . . . . 106.62 108.32 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.02 -41.02 91.51 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.809 -0.557 . . . . 75.97 110.079 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.57 -40.8 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 122.908 0.483 . . . . 65.27 109.788 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.837 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.06 -41.56 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.154 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.58 -40.76 97.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 121.712 -0.618 . . . . 87.98 110.27 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.66 -40.4 96.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 118.815 -1.154 . . . . 65.5 108.367 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.66 -36.41 80.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.162 -1.051 . . . . 85.05 108.162 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.6 mt -63.47 -45.77 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 109.053 -0.721 . . . . 42.25 109.053 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.26 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 119.542 -0.863 . . . . 91.01 109.419 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 65.6 t -58.86 -41.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.99 -1.115 . . . . 66.09 107.99 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 250' ' ' MET . 94.6 t -66.07 -43.15 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 120.758 -0.377 . . . . 52.39 110.293 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.7 m -61.8 -46.73 88.28 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.907 -0.496 . . . . 46.42 109.866 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.13 88.29 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.26 -48.23 82.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.402 -0.592 . . . . 65.18 109.402 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.7 97.2 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 120.824 0.345 . . . . 51.33 110.407 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.34 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 C-N-CA 118.941 -1.103 . . . . 126.3 109.015 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.565 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.5 m -65.64 -49.31 69.12 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.539 -0.864 . . . . 133.94 112.456 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.87 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.74 -33.32 35.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 116.826 2.158 . . . . 134.84 116.826 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.803 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.43 -41.64 90.37 Favored Pre-proline 0 CA--C 1.493 -1.237 0 CA-C-N 118.632 0.651 . . . . 72.23 111.644 -167.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.819 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.67 -35.98 87.07 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 CA-C-N 119.83 0.975 . . . . 106.13 111.375 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.848 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.35 -44.73 82.45 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 119.752 -0.779 . . . . 128.35 110.051 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.693 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.43 -37.85 88.98 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.174 -0.306 . . . . 100.73 110.174 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.819 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.3 -44.55 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 C-N-CA 119.274 -0.971 . . . . 172.72 109.123 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.8 m-85 -66.57 -28.06 68.22 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.273 -1.01 . . . . 249.23 108.273 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.6 -55.11 35.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.644 -1.613 . . . . 259.78 106.644 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.893 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.11 -44.23 72.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.574 0.953 . . . . 233.11 113.574 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 279' ' ' LEU . 88.9 mt -61.38 -48.29 91.41 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 119.162 -1.015 . . . . 169.54 110.596 -171.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.683 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.4 Cg_exo -61.12 -24.56 79.51 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 C-N-CA 116.771 -1.686 . . . . 255.47 114.655 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.7 t80 -63.54 -44.23 94.8 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.213 0.915 . . . . 279.03 108.929 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.79 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.073 -0.343 . . . . 162.21 110.073 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.83 59.38 Favored Pre-proline 0 N--CA 1.431 -1.399 0 C-N-CA 118.802 -1.159 . . . . 128.13 108.09 -178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.02 11.28 Favored 'Trans proline' 0 C--N 1.295 -2.264 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.849 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.07 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 123.829 0.705 . . . . 312.91 109.37 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.75 -170.64 2.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.534 -1.654 . . . . 353.54 106.534 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.024 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.9 p90 -115.7 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.854 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -77.01 -118.69 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.5 -45.0 96.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.837 -3.764 . . . . 99.07 100.837 172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.17 9.17 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.463 -2.791 . . . . 243.21 103.463 171.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.024 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.94 25.08 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 116.051 -2.259 . . . . 201.04 105.262 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.741 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.91 173.76 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 C-N-CA 115.954 -2.298 . . . . 201.36 108.781 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.06 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.281 0.6 OUTLIER -59.49 -41.45 89.84 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.248 -1.796 . . . . 203.82 107.905 174.44 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.912 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.21 -1.396 . . . . 215.06 112.562 -171.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.635 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.5 t -65.7 -46.4 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 118.529 -1.268 . . . . 125.28 112.928 -171.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.85 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.74 -37.07 86.36 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.191 -1.411 . . . . 268.9 107.191 -171.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.874 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.18 -45.0 74.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 125.6 1.56 . . . . 280.88 108.817 -172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.49 86.0 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.91 -1.116 . . . . 184.47 109.043 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.848 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.7 mp -67.88 -42.13 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 119.284 -0.966 . . . . 167.92 112.785 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.661 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.77 -38.73 89.86 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 117.772 -1.571 . . . . 367.18 110.765 -175.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.17 -32.74 74.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 121.844 -0.535 . . . . 173.97 110.468 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.72 85.09 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.505 0.722 . . . . 119.66 109.78 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.87 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.95 74.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.686 -1.228 . . . . 112.3 107.686 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.711 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.08 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.263 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.75 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 124.7 1.2 . . . . 145.27 110.586 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.832 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.64 -35.36 70.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.095 -1.076 . . . . 170.15 108.095 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.32 -34.15 63.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 116.295 -0.411 . . . . 214.57 110.609 -171.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.789 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.19 -33.18 56.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.084 1.754 . . . . 168.29 115.566 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.832 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.49 -34.82 79.11 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.007 1.114 . . . . 167.15 114.007 -168.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.745 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.22 -38.26 32.86 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 115.512 -2.475 . . . . 165.13 113.937 -171.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.745 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.7 Cg_exo -62.55 -31.86 79.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.771 2.025 . . . . 123.92 111.236 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.787 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.75 -42.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 118.874 -1.131 . . . . 110.55 109.823 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.2 pt -61.15 -40.04 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.86 -0.793 . . . . 145.31 108.86 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.254 63.2 m-85 -58.16 -48.82 79.1 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.371 -0.932 . . . . 246.68 109.81 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.18 -47.45 84.43 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.542 -0.863 . . . . 64.43 109.621 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.84 -45.07 79.36 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 118.968 -1.093 . . . . 80.72 110.223 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.02 1.859 . . . . 140.44 116.02 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.623 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.25 34.37 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 112.699 -3.6 . . . . 178.87 113.03 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.1 86.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.394 -1.275 . . . . 110.22 110.09 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.847 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.71 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.268 0 O-C-N 121.744 -0.598 . . . . 174.78 109.757 -174.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.84 -41.69 95.52 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.273 -1.01 . . . . 161.84 108.273 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.34 -50.23 73.61 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.179 -0.675 . . . . 117.2 109.179 -173.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.53 -44.08 75.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.384 -0.527 . . . . 112.6 111.056 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.115 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.06 -37.41 94.54 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.647 -0.981 . . . . 101.46 110.647 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.15 -45.99 91.0 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 118.54 1.17 . . . . 151.49 109.505 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.15 -36.28 77.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.94 -1.504 . . . . 142.32 106.94 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.115 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.8 m80 -59.81 -41.81 92.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.885 -1.524 . . . . 109.09 106.885 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.4 85.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.35 -0.219 . . . . 76.11 111.066 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.44 -55.48 30.78 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.888 -0.725 . . . . 120.24 109.305 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.749 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.52 41.22 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 102.942 -2.984 . . . . 192.73 102.942 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.22 92.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.048 -1.061 . . . . 176.29 109.185 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.815 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.13 0.82 Allowed Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 106.296 -1.742 . . . . 69.68 106.296 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.97 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-O 118.711 -0.62 . . . . 191.05 112.604 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.815 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.51 43.89 16.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.62 0.575 . . . . 287.03 109.753 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.849 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.54 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.94 0 C-N-CA 112.964 -3.494 . . . . 292.29 109.847 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.78 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.21 -2.515 . . . . 184.57 104.21 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.7 4.98 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.042 0.756 . . . . 274.56 113.042 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.83 57.25 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 117.737 -2.173 . . . . 268.24 113.47 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.68 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.68 1.24 . . . . 200.06 110.778 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.847 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.92 -33.0 74.72 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.858 -1.164 . . . . 114.44 107.858 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.0 21.97 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.65 -1.241 . . . . 263.81 107.65 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.37 -137.28 3.56 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.55 10.24 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 114.942 -2.703 . . . . 117.3 106.014 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.06 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.92 Favored 'General case' 0 CA--C 1.468 -2.19 1 N-CA-C 98.016 -4.809 . . . . 231.58 98.016 167.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.067 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.66 -48.57 78.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 116.047 -2.261 . . . . 112.72 108.39 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.07 -63.61 1.24 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.124 -0.695 . . . . 83.22 109.124 -176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.5 m -156.29 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.791 -2.67 . . . . 174.36 103.791 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.06 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.88 160.98 8.75 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.025 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.93 149.02 52.56 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.1 -1.445 . . . . 180.62 107.1 176.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.946 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.5 -171.87 0.27 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 105.362 -2.088 . . . . 145.25 105.362 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.946 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.07 -43.11 88.36 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.192 -1.781 . . . . 66.05 106.192 174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.762 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.74 -152.17 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.482 -2.785 . . . . 266.49 103.482 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.36 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.024 -1.87 . . . . 219.2 107.757 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.005 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.98 -37.43 94.25 Favored Glycine 0 N--CA 1.426 -2.018 0 CA-C-N 114.52 -1.218 . . . . 94.78 112.885 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.2 100.45 9.11 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 112.321 -3.752 . . . . 121.41 109.41 -171.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.673 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.7 t -73.08 145.5 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.957 -0.757 . . . . 85.34 108.957 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.504 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.819 -1.178 . . . . 267.57 107.819 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.06 69.56 0.6 Allowed 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.524 -0.547 . . . . 226.1 109.524 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.045 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.98 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.6 m -61.31 161.93 8.42 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.626 0.727 . . . . 180.01 110.681 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.879 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.97 23.51 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.97 -1.492 . . . . 333.78 106.97 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.986 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.08 142.54 48.79 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.347 -1.353 . . . . 335.2 107.347 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.986 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.8 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.744 -0.836 . . . . 266.47 108.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.3 m -60.62 -46.94 88.38 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.64 -1.985 . . . . 59.34 105.64 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.84 12.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 104.442 -2.429 . . . . 201.26 104.442 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.784 HG21 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.93 106.71 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 C-N-CA 116.347 -2.141 . . . . 56.23 105.505 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 71.0 m -61.14 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.316 -0.624 . . . . 87.58 109.316 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.893 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.75 22.28 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.813 -1.18 . . . . 219.95 107.813 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 C-N-CA 116.372 -2.131 . . . . 121.79 105.423 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.4 t -154.13 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 105.835 -1.913 . . . . 53.85 105.835 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.623 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.034 -2.826 . . . . 196.55 106.034 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.677 0 N-CA-C 107.832 -1.173 . . . . 35.88 107.832 -178.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.62 ' NH2' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.945 ' HG2' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -67.09 144.06 67.92 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.663 1.575 . . . . 1.0 111.833 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' B' ' 367' ' ' LYS . 0.1 OUTLIER -70.4 127.36 92.18 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.22 -0.446 . . . . 1.0 109.905 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.664 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.8 Cg_endo -69.04 -20.02 38.77 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.428 2.085 . . . . 1.0 114.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.28 -38.68 77.48 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.725 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -71.36 -10.44 59.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 1.0 110.604 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.778 ' CE1' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -58.63 -46.28 87.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 1.0 110.323 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -61.65 -49.03 78.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.551 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.12 78.32 0.31 Allowed Glycine 0 N--CA 1.455 -0.07 0 N-CA-C 109.819 -1.313 . . . . 1.0 109.819 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 374' ' ' LEU . 0.3 OUTLIER -61.02 -41.73 97.12 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.221 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.466 ' H ' ' HG3' ' B' ' 375' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.38 -0.97 . . . . 97.08 108.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.6 155.4 22.41 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.085 0.945 . . . . 123.41 110.774 -172.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.928 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.57 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.461 1 N-CA-C 100.064 -4.051 . . . . 151.3 100.064 173.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.981 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.58 58.35 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 115.952 -2.299 . . . . 169.25 106.148 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.981 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.29 168.52 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 122.301 0.632 . . . . 185.76 110.568 171.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.851 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.5 t -64.44 -25.96 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 127.042 2.137 . . . . 145.47 110.342 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.44 21.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.058 -1.027 . . . . 102.76 109.445 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.68 154.16 25.0 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.937 -1.134 . . . . 106.25 107.937 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.924 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.83 51.84 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.754 -1.578 . . . . 157.81 107.663 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.15 -45.9 91.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.553 -2.758 . . . . 150.2 103.553 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.67 35.33 Favored Pre-proline 0 N--CA 1.422 -1.852 0 N-CA-C 103.669 -2.715 . . . . 183.52 103.669 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.71 6.87 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 N-CA-C 110.014 -0.802 . . . . 235.61 110.014 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.99 -41.16 82.44 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 124.749 1.22 . . . . 113.77 113.409 -170.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.928 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.21 136.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 119.564 1.075 . . . . 150.85 110.973 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' HA ' HH12 ' B' ' 365' ' ' ARG . 47.7 t -140.5 156.28 46.38 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.59 -1.263 . . . . 100.42 107.59 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.041 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.93 0.871 . . . . 129.36 110.444 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.326 1.85 . . . . 112.34 106.663 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.955 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.2 m -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.618 -0.719 . . . . 131.73 111.739 177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.041 ' H ' HG21 ' A' ' 17' ' ' THR . 71.0 m -84.48 -42.85 15.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 116.984 2.216 . . . . 80.49 116.984 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -146.01 174.54 3.35 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 118.154 -1.418 . . . . 98.98 111.21 -169.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.8 Cg_exo -61.8 -10.74 18.09 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.953 6.482 . . . . 246.95 128.953 -170.103 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.66 17.49 8.7 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.112 4.051 . . . . 269.62 114.229 175.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.27 67.2 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.797 -1.186 . . . . 86.8 107.797 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.2 p90 -66.79 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.113 -0.992 . . . . 85.91 110.502 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.857 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.2 t -68.5 -40.23 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.718 0.807 . . . . 82.0 111.371 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.934 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.385 0 N-CA-C 108.522 -0.918 . . . . 120.73 108.522 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.843 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.03 149.75 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.882 . . . . 87.86 109.861 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.821 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.96 89.27 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.812 -0.81 . . . . 36.46 108.812 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.76 -33.87 76.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.87 -1.159 . . . . 150.6 107.87 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.934 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.2 -32.75 73.44 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 121.255 -0.903 . . . . 123.26 108.661 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.39 -47.21 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.95 -47.12 84.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.951 -0.7 . . . . 60.87 109.608 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.692 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.06 -35.63 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 120.004 -0.678 . . . . 157.57 110.361 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.67 -40.85 98.37 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.633 -0.877 . . . . 47.06 108.633 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.25 97.94 Favored 'General case' 0 CA--C 1.496 -1.12 0 O-C-N 121.721 -0.612 . . . . 43.94 109.544 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.85 -43.29 99.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.959 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.29 93.91 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 122.25 -0.281 . . . . 140.66 110.996 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.75 -44.02 97.72 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.605 -1.238 . . . . 116.04 110.22 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.38 -38.81 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.759 -0.83 . . . . 97.16 108.759 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.913 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -40.03 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.978 -0.749 . . . . 54.85 108.978 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.966 HG23 HG22 ' A' ' 86' ' ' THR . 93.2 t -57.65 -42.37 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.91 -0.774 . . . . 45.39 108.91 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.4 t -63.48 -50.99 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 C-N-CA 118.819 -1.152 . . . . 48.64 110.203 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.792 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.7 t -65.25 -47.03 78.17 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.167 -0.613 . . . . 116.65 111.73 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.95 -43.96 97.74 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.701 -0.481 . . . . 51.16 109.701 -174.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.58 -48.9 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 119.829 -0.748 . . . . 44.3 110.854 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 94.0 t -64.74 -46.97 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 120.299 -0.561 . . . . 48.82 111.027 -174.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.2 95.18 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.561 -0.828 . . . . 58.7 111.994 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.61 -34.26 67.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.018 -0.695 . . . . 101.4 111.039 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.89 -38.72 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 107.757 -1.201 . . . . 103.57 107.757 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.45 -43.01 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.977 -0.749 . . . . 61.89 108.977 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.641 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.7 t -63.43 -50.93 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.303 -0.559 . . . . 70.01 109.525 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.43 98.81 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.108 -0.701 . . . . 132.1 109.108 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.62 83.08 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.649 -0.251 . . . . 104.5 110.443 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 C-N-CA 120.213 -0.595 . . . . 142.96 111.253 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.043 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.7 pt -64.82 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.957 -1.897 . . . . 158.32 110.838 -175.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.71 -41.4 98.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 117.698 -1.601 . . . . 137.11 109.5 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.52 91.14 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.156 -0.34 . . . . 54.66 111.015 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.95 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.612 0.72 . . . . 127.18 109.577 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.79 -36.86 80.08 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.102 0.961 . . . . 87.93 110.859 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.067 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.69 78.75 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.69 -0.631 . . . . 131.12 111.514 -175.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.52 7.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.294 -2.562 . . . . 246.56 109.598 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 105.475 -2.046 . . . . 339.35 105.475 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.14 165.3 17.79 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.961 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.19 -39.4 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.766 -1.568 . . . . 143.28 106.766 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.999 HG21 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.72 -38.04 80.56 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.67 -0.863 . . . . 160.22 108.67 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.2 m-20 -62.4 -31.78 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.823 -0.806 . . . . 120.54 108.823 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.57 -43.8 95.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.466 -0.568 . . . . 67.22 109.466 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.59 -39.78 88.59 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.505 -0.747 . . . . 138.6 109.623 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.999 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.53 -35.89 81.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.468 0.307 . . . . 151.46 110.679 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.043 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.6 -37.89 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.724 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.96 91.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.855 -1.165 . . . . 56.82 107.855 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.912 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.937 -0.764 . . . . 145.3 108.937 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.38 95.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.495 -0.928 . . . . 45.71 108.495 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.37 -42.04 99.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.364 -0.606 . . . . 105.61 109.364 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 -39.54 92.78 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.611 -0.885 . . . . 47.89 108.611 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.37 84.84 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.953 -0.388 . . . . 124.53 109.953 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.24 99.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.968 -0.458 . . . . 35.89 109.838 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.29 -37.28 84.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.022 -1.473 . . . . 88.97 107.022 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.16 76.96 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.086 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.4 -43.41 90.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.511 -0.743 . . . . 146.1 110.591 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 117.423 -1.711 . . . . 91.74 113.829 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.47 1.95 Allowed 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 115.719 1.748 . . . . 197.45 115.719 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.23 -42.2 55.88 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 117.866 -1.534 . . . . 242.6 114.073 -170.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.966 HG22 HG23 ' A' ' 43' ' ' VAL . 4.7 t -65.48 -36.5 84.04 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.919 -1.113 . . . . 215.61 109.797 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' HG23 ' A' ' 86' ' ' THR . 73.0 t -60.36 -46.95 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 O-C-N 121.782 -0.574 . . . . 87.19 110.399 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.89 -41.84 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 O-C-N 121.942 -0.474 . . . . 231.82 109.776 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.959 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.39 -34.12 76.09 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.306 -0.998 . . . . 364.98 108.306 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.2 -44.74 75.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.533 -0.729 . . . . 181.63 111.228 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.866 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.3 m -60.8 -45.81 92.95 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 107.468 -1.308 . . . . 269.02 107.468 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.068 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.07 93.25 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 118.679 -1.209 . . . . 562.66 110.004 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.856 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.22 95.59 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 118.634 -1.226 . . . . 446.75 108.103 -167.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.46 -26.35 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.875 -2.33 . . . . 370.05 112.197 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.866 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.51 60.06 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.565 -0.71 . . . . 354.91 112.491 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.88 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.49 0.98 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.047 1.339 . . . . 462.44 111.868 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.9 mm-40 -172.35 178.09 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.009 0.909 . . . . 652.37 111.129 171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.78 86.31 2.2 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 128.492 2.717 . . . . 905.99 107.906 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.83 -36.45 80.38 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.261 -1.014 . . . . 570.43 108.261 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.842 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.34 82.36 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 125.331 1.453 . . . . 453.22 111.129 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.955 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.48 178.65 33.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.939 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.924 HD21 ' NZ ' ' B' ' 367' ' ' LYS . 89.0 mt -56.4 -41.21 75.92 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 125.274 1.43 . . . . 457.72 112.38 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.02 Favored 'General case' 0 CA--C 1.484 -1.569 0 C-N-CA 118.678 -1.209 . . . . 340.58 109.335 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.842 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.66 -32.23 71.92 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 118.819 -1.152 . . . . 453.6 111.544 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.3 73.26 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.013 -1.847 . . . . 541.48 106.013 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.21 75.83 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 123.972 0.795 . . . . 466.68 110.86 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.72 -47.09 86.85 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 117.527 -1.669 . . . . 427.34 107.306 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.82 82.77 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 112.402 0.519 . . . . 537.87 112.402 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.33 -42.73 74.93 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 116.845 -1.942 . . . . 422.12 111.576 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.914 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.15 75.18 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.314 -0.866 . . . . 340.17 111.84 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.8 m-85 -65.27 -46.49 71.52 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.084 -1.047 . . . . 258.06 111.75 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.53 -31.56 87.52 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 N-CA-C 115.323 1.24 . . . . 305.71 115.323 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.941 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.712 -0.848 . . . . 252.7 108.712 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.56 93.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.8 -1.185 . . . . 149.27 107.8 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.05 -44.78 95.95 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 120.632 -0.427 . . . . 138.08 111.506 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.75 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.93 -42.42 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.523 -0.735 . . . . 132.89 110.966 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.948 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.71 -44.68 92.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.749 -0.78 . . . . 193.61 108.925 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.7 84.55 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 122.838 0.455 . . . . 63.83 110.079 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.98 -52.4 59.81 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.057 -0.402 . . . . 76.4 111.233 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.99 -41.68 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.166 -1.05 . . . . 171.13 108.166 -174.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.078 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.82 -38.52 91.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 121.889 -0.507 . . . . 78.3 110.612 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.13 -35.71 80.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.897 -1.121 . . . . 92.36 109.231 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.083 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.31 76.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.131 -1.062 . . . . 93.73 108.131 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.39 -41.65 84.63 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.248 -0.981 . . . . 132.74 109.346 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.1 94.86 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.17 -1.419 . . . . 43.39 107.17 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.864 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.9 t -58.43 -42.03 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.59 -0.893 . . . . 59.34 108.59 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.4 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.04 95.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 121.838 -0.539 . . . . 69.68 110.523 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.46 -42.77 91.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.333 -0.988 . . . . 106.98 108.333 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.864 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.58 81.36 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 119.712 -0.795 . . . . 147.63 108.928 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.761 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.56 99.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.514 -0.921 . . . . 190.06 108.514 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.962 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.3 t80 -61.32 -44.04 97.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.313 -0.995 . . . . 118.85 108.313 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.126 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.68 98.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.64 95.28 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 121.827 -0.546 . . . . 89.98 109.86 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.887 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.72 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 C-N-CA 118.098 -1.441 . . . . 106.09 111.035 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.802 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.29 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.062 -1.855 . . . . 227.74 111.799 -174.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.89 100.06 50.94 Favored Pre-proline 0 CA--C 1.486 -1.515 0 C-N-CA 116.237 -2.185 . . . . 262.55 110.05 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.57 -10.42 28.66 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.678 1.586 . . . . 210.25 111.341 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.03 1.0 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 106.556 -1.646 . . . . 270.58 106.556 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.894 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.49 23.54 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 115.382 -0.826 . . . . 129.84 112.325 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.38 -26.59 81.68 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 N-CA-C 116.31 1.619 . . . . 330.71 116.31 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 114.467 -2.893 . . . . 204.51 107.289 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.881 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.415 -1.328 . . . . 387.41 107.415 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.881 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.5 t -143.73 147.04 33.64 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 118.729 -1.188 . . . . 166.22 109.446 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.73 87.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.841 -1.17 . . . . 44.23 107.841 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG22 ' A' ' 149' ' ' VAL . 87.0 m -60.29 -39.11 85.76 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.2 -1.037 . . . . 28.8 108.2 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.646 ' O ' HG22 ' A' ' 150' ' ' VAL . . . -62.86 -38.73 92.0 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.103 -0.702 . . . . 30.29 109.103 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.961 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.65 -42.99 94.03 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.981 -0.748 . . . . 46.11 108.981 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.5 -42.11 99.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.671 -1.233 . . . . 87.33 107.671 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.4 t -61.67 -42.07 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.916 -1.142 . . . . 23.69 107.916 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.21 -44.31 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.625 -0.509 . . . . 43.86 109.625 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.934 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.55 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.263 -1.014 . . . . 91.13 108.263 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.503 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.58 -37.98 88.32 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.72 -0.844 . . . . 65.88 108.72 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.86 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.52 -0.548 . . . . 33.86 109.52 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.078 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.35 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.556 -1.275 . . . . 146.52 107.556 -176.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.781 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.0 m95 -62.84 -38.35 90.41 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.475 -0.89 . . . . 75.44 108.878 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.4 t -60.58 -48.4 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.063 -1.023 . . . . 43.64 109.72 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.812 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -37.95 89.29 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.096 -0.705 . . . . 102.57 109.096 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.08 86.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.403 -1.332 . . . . 58.16 107.403 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.865 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.53 73.93 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.989 -0.745 . . . . 121.11 108.989 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.03 -42.26 84.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 C-N-CA 118.55 -1.26 . . . . 153.15 109.948 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.99 HD12 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.05 -43.76 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 113.09 -3.444 . . . . 133.67 113.533 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.899 -1.126 . . . . 157.42 112.167 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.12 2.45 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 115.011 1.485 . . . . 250.91 115.011 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.5 Cg_exo -59.54 -25.42 78.7 Favored 'Trans proline' 0 CA--C 1.488 -1.81 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.19 -34.21 74.71 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.915 -1.513 . . . . 192.46 106.915 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.02 98.1 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 108.033 -2.027 . . . . 261.0 108.033 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.77 159.13 25.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.529 -3.508 . . . . 491.4 101.529 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 116.278 -2.169 . . . . 386.1 109.819 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.08 -166.61 2.41 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 103.511 -2.774 . . . . 289.8 103.511 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.115 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 117.745 -1.121 . . . . 402.06 109.534 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.781 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.5 p -165.3 177.54 7.51 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.314 2.246 . . . . 690.53 114.94 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.181 4.511 . . . . 633.62 123.181 162.742 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.58 153.79 22.17 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.415 2.286 . . . . 617.99 110.918 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.125 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.67 174.39 6.01 Favored Pre-proline 0 C--N 1.364 1.222 0 C-N-CA 130.255 3.422 . . . . 434.98 113.417 -175.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.125 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.5 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 N-CA-C 122.408 3.965 . . . . 365.88 122.408 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.7 m -84.88 20.92 1.7 Allowed 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.791 -2.3 . . . . 635.81 104.791 178.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.774 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.36 152.27 18.77 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.934 7.753 . . . . 999.99 131.934 -135.746 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.068 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.85 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.747 1 CA-C-N 103.264 -6.335 . . . . 594.32 113.573 149.195 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.821 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.21 144.07 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 1 N-CA-C 98.337 -4.69 . . . . 811.91 98.337 162.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.47 144.55 45.92 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.074 -1.851 . . . . 999.99 109.419 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.24 -175.65 4.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.007 0.908 . . . . 431.86 110.018 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.06 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.12 148.68 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 124.384 1.074 . . . . 457.18 108.758 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.83 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.35 85.49 3.77 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 124.071 0.948 . . . . 458.77 113.506 -174.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.38 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.9 1.28 . . . . 999.99 112.424 168.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.78 5.63 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 120.84 3.362 . . . . 999.99 120.84 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.164 -1.814 . . . . 81.18 107.248 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.12 45.12 0.19 Allowed Pre-proline 0 N--CA 1.423 -1.817 0 CA-C-O 114.866 -2.492 . . . . 999.99 108.748 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.059 ' HB2' HD11 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.52 101.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.141 1 C-N-CA 126.051 4.501 . . . . 999.99 105.7 -170.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.03 97.47 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 126.748 2.019 . . . . 967.72 112.045 -165.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.28 -36.5 77.99 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.779 -1.563 . . . . 934.3 106.779 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.059 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.27 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 129.196 2.998 . . . . 565.15 113.938 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.55 55.4 2.79 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 118.423 0.556 . . . . 755.61 109.849 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.115 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.48 -49.35 66.9 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.59 1.156 . . . . 325.89 113.203 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.94 78.32 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 123.557 0.743 . . . . 250.21 111.61 -169.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.81 -43.28 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.552 0.691 . . . . 142.46 110.375 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.06 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.7 t80 -61.1 -41.56 96.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 123.983 0.913 . . . . 247.69 108.806 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.5 -51.34 69.85 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.453 1.501 . . . . 199.61 113.086 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.35 -44.45 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.754 -1.202 . . . . 106.73 107.754 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.592 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.14 -48.53 81.28 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.832 -0.622 . . . . 115.01 110.241 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.99 HG13 HD12 ' A' ' 161' ' ' LEU . 85.8 t -65.25 -49.2 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.431 -0.908 . . . . 129.42 111.811 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.816 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.3 m -61.79 -53.18 59.38 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.223 -1.391 . . . . 172.48 109.969 -172.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.6 t -63.9 -54.19 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 120.489 -0.484 . . . . 55.86 110.987 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.62 -51.52 58.98 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.513 -1.275 . . . . 184.68 111.501 -174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.979 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.64 -52.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.635 -2.026 . . . . 291.81 114.695 -174.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.431 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.7 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 115.153 1.538 . . . . 130.66 115.153 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.816 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.9 -48.46 68.66 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.493 1.294 . . . . 80.16 114.493 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.53 83.3 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.483 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.4 Cg_exo -64.79 -27.11 59.75 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.617 -0.57 . . . . 92.17 110.617 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.36 76.62 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.478 -1.304 . . . . 135.6 107.478 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.63 91.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.61 -0.515 . . . . 52.1 109.61 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.72 -43.51 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.056 -0.72 . . . . 95.89 109.056 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.31 -42.33 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.655 -1.609 . . . . 43.41 106.655 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.22 99.06 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.338 -1.505 . . . . 27.69 109.338 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.905 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.76 -47.35 75.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 117.411 0.605 . . . . 54.41 110.423 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 107.005 -1.479 . . . . 53.88 107.005 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.71 -40.83 93.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.517 -0.92 . . . . 68.29 108.517 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.905 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -39.04 92.94 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 119.71 -0.796 . . . . 107.59 110.634 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.41 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.514 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.887 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.3 -22.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.414 -0.958 . . . . 85.26 108.414 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.91 99.43 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.089 -0.804 . . . . 40.71 111.089 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.7 -44.12 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 108.386 -0.968 . . . . 95.86 108.386 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.89 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.445 -0.946 . . . . 144.37 108.445 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.38 132.15 47.48 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.025 -1.843 . . . . 158.38 106.025 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.85 98.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.676 -0.49 . . . . 36.78 109.676 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.14 125.8 25.05 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.15 -1.02 . . . . 85.46 109.812 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.539 -2.023 . . . . 127.78 105.539 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.89 34.77 Favored Pre-proline 0 CA--C 1.493 -1.233 0 N-CA-C 105.929 -1.878 . . . . 164.84 105.929 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.7 Cg_exo -56.82 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.189 0 N-CA-C 113.926 0.702 . . . . 222.35 113.926 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.807 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.1 166.95 44.94 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 106.435 -2.666 . . . . 45.22 106.435 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.923 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.9 -45.81 93.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.058 -1.83 . . . . 107.57 106.058 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.735 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.4 m -65.73 141.77 58.23 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 118.924 -1.11 . . . . 167.96 109.151 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.56 106.71 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.67 1.988 . . . . 280.68 109.71 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.98 11.31 0.7 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.455 1.102 . . . . 218.25 110.694 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.934 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.58 54.78 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.234 -2.135 . . . . 343.57 105.234 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.89 1.53 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.868 -1.53 . . . . 263.29 106.868 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.35 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 126.565 1.946 . . . . 261.92 108.484 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.1 89.83 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.891 -1.151 . . . . 106.81 107.891 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.391 -1.324 . . . . 112.2 107.531 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.751 HG13 ' NH1' ' A' ' 244' ' ' ARG . 76.0 t -64.36 -39.77 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 109.247 -0.649 . . . . 45.41 109.247 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.865 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.07 68.91 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.28 -0.267 . . . . 97.62 110.28 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.6 81.71 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.691 0.796 . . . . 59.29 110.976 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.26 -36.49 83.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.624 1.17 . . . . 106.49 110.668 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.934 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.68 69.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.302 -0.999 . . . . 106.62 108.302 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.08 91.62 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 121.87 -0.518 . . . . 75.97 110.039 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.52 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 C-N-CA 122.909 0.484 . . . . 65.27 109.802 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.838 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.95 -41.64 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 C-N-CA 120.391 -0.524 . . . . 107.94 110.174 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.49 -40.82 98.09 Favored 'General case' 0 N--CA 1.434 -1.235 0 O-C-N 121.649 -0.657 . . . . 87.98 110.3 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.62 -40.4 96.81 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.794 -1.162 . . . . 65.5 108.378 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.127 -1.064 . . . . 85.05 108.127 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.5 -45.72 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 109.076 -0.712 . . . . 42.25 109.076 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.31 -38.3 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.55 -0.86 . . . . 91.01 109.378 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 66.0 t -58.89 -41.54 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.96 -1.126 . . . . 66.09 107.96 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.23 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 O-C-N 122.108 -0.37 . . . . 52.39 110.324 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.77 88.2 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 121.883 -0.511 . . . . 46.42 109.856 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.4 t -62.35 -38.12 88.28 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.311 -0.996 . . . . 116.51 108.311 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.26 -48.22 82.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.384 -0.599 . . . . 65.18 109.384 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.67 97.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 122.118 -0.364 . . . . 51.33 110.432 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.32 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 C-N-CA 118.91 -1.116 . . . . 126.3 109.016 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.31 69.25 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.476 -0.889 . . . . 133.94 112.491 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.67 -33.43 35.54 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.853 2.168 . . . . 134.84 116.853 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.802 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.41 -41.61 90.22 Favored Pre-proline 0 CA--C 1.493 -1.236 0 O-C-N 121.671 -0.643 . . . . 72.23 111.647 -167.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.82 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.2 Cg_exo -60.66 -35.98 87.15 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 CA-C-N 119.887 0.995 . . . . 106.13 111.334 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.905 ' N ' HG22 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.7 82.21 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.728 -0.789 . . . . 128.35 110.027 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.693 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.8 88.79 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.24 -0.281 . . . . 100.73 110.24 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.82 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.55 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 119.285 -0.966 . . . . 172.72 109.137 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.749 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.59 -28.07 68.22 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.195 -1.039 . . . . 249.23 108.195 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.58 -55.1 35.96 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.667 -1.605 . . . . 259.78 106.667 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.2 -44.15 72.7 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.568 0.951 . . . . 233.11 113.568 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.29 91.35 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 119.182 -1.007 . . . . 169.54 110.588 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.07 -24.59 79.72 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.707 -1.728 . . . . 255.47 114.708 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.57 -44.22 94.72 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 119.189 0.904 . . . . 279.03 108.899 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.29 -44.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.87 59.36 Favored Pre-proline 0 N--CA 1.431 -1.394 0 C-N-CA 118.712 -1.195 . . . . 128.13 108.028 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.28 164.04 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.274 0 N-CA-C 107.443 -1.791 . . . . 278.35 107.443 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.862 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.12 15.03 9.93 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 123.756 0.66 . . . . 312.91 109.343 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.7 -170.65 2.48 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.506 -1.664 . . . . 353.54 106.506 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.28 46.95 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.829 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.069 -3.308 . . . . 175.26 102.069 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.775 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.96 96.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 100.894 -3.743 . . . . 99.07 100.894 172.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.775 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.46 124.16 9.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.455 -2.794 . . . . 243.21 103.455 171.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.99 112.97 25.11 Favored 'General case' 0 CA--C 1.473 -2.0 0 C-N-CA 115.992 -2.283 . . . . 201.04 105.316 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.765 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.92 173.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 C-N-CA 116.02 -2.272 . . . . 201.36 108.82 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.065 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.52 -41.44 89.98 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.834 174.516 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.912 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.77 86.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 118.213 -1.395 . . . . 215.06 112.538 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.635 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.61 -46.47 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.607 -1.237 . . . . 125.28 112.917 -171.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.852 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -36.94 85.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.229 -1.397 . . . . 268.9 107.229 -171.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.29 -44.97 74.32 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.617 1.567 . . . . 280.88 108.792 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.48 86.06 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.004 -1.078 . . . . 184.47 108.958 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.905 HG22 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.99 -42.09 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 119.285 -0.966 . . . . 167.92 112.709 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.66 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.73 -38.81 90.18 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 117.792 -1.563 . . . . 367.18 110.734 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.2 -32.7 73.95 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.824 -0.547 . . . . 173.97 110.402 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.52 -36.73 85.14 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.559 0.744 . . . . 119.66 109.797 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.21 -34.0 74.39 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.703 -1.221 . . . . 112.3 107.703 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.08 73.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.228 -0.442 . . . . 174.17 110.235 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.6 m -64.7 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 124.685 1.194 . . . . 145.27 110.627 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.831 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.62 -35.4 70.41 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.093 -1.077 . . . . 170.15 108.093 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.26 -34.17 63.81 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 122.721 0.408 . . . . 214.57 110.63 -171.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.792 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.21 -33.2 56.29 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.022 1.729 . . . . 168.29 115.548 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.831 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.35 -34.9 79.22 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 114.096 1.147 . . . . 167.15 114.096 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.745 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.18 -38.32 33.67 Favored Pre-proline 0 N--CA 1.434 -1.234 0 C-N-CA 115.485 -2.486 . . . . 165.13 113.931 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.745 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.57 -31.81 79.82 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 CA-C-N 122.809 2.039 . . . . 123.92 111.231 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.788 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.77 -42.54 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.845 -1.142 . . . . 110.55 109.807 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.0 pt -61.16 -39.99 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.849 -0.797 . . . . 145.31 108.849 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.08 -48.88 78.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.447 -0.901 . . . . 246.68 109.789 -177.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.18 -47.48 84.29 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.524 -0.87 . . . . 64.43 109.565 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.06 79.34 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.2 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.72 75.91 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 116.022 1.86 . . . . 140.44 116.022 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.79 132.24 34.45 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 112.71 -3.596 . . . . 178.87 113.031 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.35 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.358 -1.292 . . . . 110.22 110.112 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.71 -50.61 72.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 121.74 -0.6 . . . . 174.78 109.756 -174.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.95 -41.63 95.32 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.478 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.31 -50.23 73.59 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.011 -0.676 . . . . 117.2 109.214 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.84 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.08 75.54 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.375 -0.53 . . . . 112.6 111.113 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.12 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.11 -37.44 94.57 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.596 -1.002 . . . . 101.46 110.596 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.13 -45.98 91.05 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 118.485 1.143 . . . . 151.49 109.541 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.13 -36.31 77.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.931 -1.507 . . . . 142.32 106.931 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.12 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.72 -41.9 91.9 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.46 85.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 122.309 -0.244 . . . . 76.11 111.019 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -55.51 30.77 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.374 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.29 131.5 41.23 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.94 -2.985 . . . . 192.73 102.94 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.18 92.14 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.192 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.8 m -79.4 -177.1 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.464 0 N-CA-C 106.332 -1.729 . . . . 69.68 106.332 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -58.97 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 118.368 -0.621 . . . . 191.05 112.583 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.54 43.87 16.43 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 123.562 0.539 . . . . 287.03 109.756 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.849 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.5 78.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 112.977 -3.489 . . . . 292.29 109.847 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.41 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 104.195 -2.52 . . . . 184.57 104.195 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.69 4.94 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 113.038 0.755 . . . . 274.56 113.038 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.92 57.3 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 117.69 -2.195 . . . . 268.24 113.487 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.722 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.5 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.641 1.221 . . . . 200.06 110.788 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.1 21.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.593 -1.262 . . . . 263.81 107.593 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.37 3.61 Favored Glycine 0 CA--C 1.479 -2.206 1 N-CA-C 102.518 -4.233 . . . . 103.79 102.518 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.993 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.29 95.64 10.26 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 114.914 -2.715 . . . . 117.3 106.016 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.067 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.93 -39.82 90.84 Favored 'General case' 0 CA--C 1.468 -2.179 1 N-CA-C 97.989 -4.819 . . . . 231.58 97.989 167.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.067 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.45 29.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.097 -3.297 . . . . 303.24 102.097 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.993 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.62 78.64 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 116.022 -2.271 . . . . 112.72 108.391 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -60.99 -63.71 1.2 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.095 -0.706 . . . . 83.22 109.095 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.7 m -156.24 -126.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.86 -2.644 . . . . 174.36 103.86 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.067 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.9 160.97 8.81 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.787 -1.931 . . . . 202.73 105.787 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.92 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.093 -1.447 . . . . 180.62 107.093 176.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.52 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 105.356 -2.09 . . . . 145.25 105.356 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.948 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.05 -43.17 88.27 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.171 -1.789 . . . . 66.05 106.171 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.69 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.536 -2.764 . . . . 266.49 103.536 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.61 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.31 -124.96 0.28 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.793 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.005 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.38 94.15 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.552 -1.204 . . . . 94.78 112.877 -176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.19 100.41 9.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.324 -3.751 . . . . 121.41 109.469 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.01 145.49 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 108.948 -0.76 . . . . 85.34 108.948 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.506 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.47 41.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.518 -0.549 . . . . 226.1 109.518 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.6 p -50.93 156.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.997 -1.483 . . . . 154.84 106.997 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.505 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.7 m -61.36 161.94 8.53 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.627 0.727 . . . . 180.01 110.679 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.881 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.44 156.91 23.66 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.964 -1.495 . . . . 333.78 106.964 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.985 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.48 48.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.985 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.4 mm-40 82.85 158.84 0.13 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.739 -0.838 . . . . 266.47 108.739 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.53 -46.93 88.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.674 -1.972 . . . . 59.34 105.674 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.6 173.83 11.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.415 -2.439 . . . . 201.26 104.415 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.0 mt -95.87 106.68 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 116.322 -2.151 . . . . 56.23 105.562 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.518 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.11 -59.46 5.3 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.309 -0.626 . . . . 87.58 109.309 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.894 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.53 153.74 22.24 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 107.841 -1.17 . . . . 219.95 107.841 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.04 83.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.435 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.625 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 105.86 -1.904 . . . . 53.85 105.86 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.625 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.24 16.58 77.09 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 106.067 -2.813 . . . . 196.55 106.067 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.683 0 N-CA-C 107.848 -1.167 . . . . 35.88 107.848 -178.866 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.441 HH12 ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.04 144.09 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.67 1.58 . . . . 1.0 111.831 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.924 ' NZ ' HD21 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -70.52 127.39 92.07 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.248 -0.433 . . . . 1.0 109.864 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.835 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.4 Cg_endo -69.09 -19.96 38.61 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.496 2.13 . . . . 1.0 114.504 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.549 ' HB3' ' HD2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -58.31 -38.66 77.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.789 -178.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.482 ' O ' HD23 ' B' ' 374' ' ' LEU . 17.2 tt0 -71.28 -10.48 59.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.812 0.339 . . . . 1.0 110.578 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.835 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.66 -46.34 87.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.28 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -49.03 78.29 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.596 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.06 78.35 0.31 Allowed Glycine 0 CA--C 1.516 0.113 0 N-CA-C 109.764 -1.334 . . . . 1.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 374' ' ' LEU . 0.1 OUTLIER -61.01 -41.89 97.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.759 0.314 . . . . 1.0 110.191 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.07 -0.967 . . . . 1.0 110.522 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.365 -0.976 . . . . 97.08 108.365 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.425 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.088 0.946 . . . . 123.41 110.766 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.934 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.62 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.513 1 N-CA-C 100.056 -4.053 . . . . 151.3 100.056 173.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.979 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.57 58.05 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.939 -2.305 . . . . 169.25 106.139 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.979 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.27 0.616 . . . . 185.76 110.53 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.854 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.5 -25.86 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.988 2.115 . . . . 145.47 110.383 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.717 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.38 21.48 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.099 -1.0 . . . . 102.76 109.427 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.58 154.2 25.1 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.994 -1.113 . . . . 106.25 107.994 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.9 51.9 0.74 Allowed 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 117.807 -1.557 . . . . 157.81 107.616 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.24 -45.87 91.75 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.585 -2.746 . . . . 150.2 103.585 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.01 164.71 35.26 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 103.652 -2.721 . . . . 183.52 103.652 172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -76.82 6.92 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.982 0 N-CA-C 109.973 -0.818 . . . . 235.61 109.973 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.95 -41.24 82.44 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 124.781 1.233 . . . . 113.77 113.377 -170.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.934 HD13 HG11 ' A' ' 4' ' ' VAL . 33.3 pt -52.21 136.2 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 119.605 1.093 . . . . 150.85 110.989 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.595 -1.261 . . . . 100.42 107.595 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.022 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.967 0.889 . . . . 129.36 110.389 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.763 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.43 68.36 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 126.241 1.816 . . . . 112.34 106.702 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.95 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.4 m -74.1 -40.2 62.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.545 -0.752 . . . . 131.73 111.766 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.022 ' H ' HG23 ' A' ' 17' ' ' THR . 71.6 m -84.42 -42.85 15.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 117.036 2.236 . . . . 80.49 117.036 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -146.0 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 118.151 -1.42 . . . . 98.98 111.198 -169.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.0 Cg_exo -61.81 -10.8 18.29 Favored 'Trans proline' 0 C--N 1.321 -0.898 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.09 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.58 8.75 Favored 'General case' 0 C--N 1.324 -0.542 1 CA-C-N 126.152 4.069 . . . . 269.62 114.209 175.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.12 -27.33 67.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.816 -1.179 . . . . 86.8 107.816 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.119 -0.988 . . . . 85.91 110.493 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.57 -40.18 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.728 0.811 . . . . 82.0 111.339 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.73 12.49 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.518 -0.919 . . . . 120.73 108.518 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.841 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.97 149.76 89.85 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 120.578 0.852 . . . . 87.86 109.937 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.05 -37.92 89.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.884 -0.784 . . . . 36.46 108.884 -176.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.843 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.91 76.73 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.16 -32.74 73.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 121.301 -0.874 . . . . 123.26 108.645 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.49 -47.15 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.4 -31.02 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.918 -1.141 . . . . 112.19 107.918 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.843 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.4 tp -63.02 -47.09 84.55 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.924 -0.71 . . . . 60.87 109.576 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.707 ' CD1' HD22 ' A' ' 288' ' ' LEU . 3.5 m-90 -66.07 -35.6 80.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.933 -0.707 . . . . 157.57 110.392 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.818 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.61 -40.92 98.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.622 -0.881 . . . . 47.06 108.622 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.19 97.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.745 -0.597 . . . . 43.94 109.526 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.88 -43.29 99.14 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.688 -0.856 . . . . 42.61 108.688 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.956 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.22 93.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.625 -0.261 . . . . 140.66 111.024 -178.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.81 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.566 -1.254 . . . . 116.04 110.211 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.43 -38.72 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.747 -0.835 . . . . 97.16 108.747 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.911 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.34 -39.94 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.99 -0.744 . . . . 54.85 108.99 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 86' ' ' THR . 93.0 t -57.72 -42.39 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 108.877 -0.786 . . . . 45.39 108.877 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.6 t -63.49 -50.94 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.217 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.793 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.26 -47.07 78.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.196 -0.601 . . . . 116.65 111.693 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.64 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -62.0 -43.93 97.81 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.705 -0.48 . . . . 51.16 109.705 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.7 t -65.5 -48.93 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.878 -0.729 . . . . 44.3 110.878 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.5 t -64.8 -46.94 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 120.308 -0.557 . . . . 48.82 110.995 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.2 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.505 -0.855 . . . . 58.7 111.987 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.66 -34.17 67.07 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 122.118 -0.637 . . . . 101.4 111.032 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 107.748 -1.204 . . . . 103.57 107.748 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.4 -43.06 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 108.965 -0.754 . . . . 61.89 108.965 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.641 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.9 t -63.45 -50.93 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 109.453 -0.573 . . . . 70.01 109.453 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.716 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.41 98.87 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.165 -0.68 . . . . 132.1 109.165 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.671 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.16 -46.64 83.14 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.623 -0.262 . . . . 104.5 110.472 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.89 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.91 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.026 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.9 pt -64.77 -41.67 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 116.96 -1.896 . . . . 158.32 110.859 -175.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.34 98.04 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.459 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.53 90.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.173 -0.329 . . . . 54.66 110.994 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.956 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.17 29.45 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.651 0.739 . . . . 127.18 109.575 -174.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.099 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.88 80.3 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.067 0.947 . . . . 87.93 110.813 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.065 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.63 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.655 -0.653 . . . . 131.12 111.481 -175.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.009 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.43 7.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 115.319 -2.553 . . . . 246.56 109.607 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.48 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.471 -2.048 . . . . 339.35 105.471 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.85 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.6 p -124.22 165.26 17.92 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 102.989 -2.967 . . . . 114.66 102.989 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.946 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.13 -39.46 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.783 -1.562 . . . . 143.28 106.783 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.999 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.67 -38.05 80.44 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.673 -0.862 . . . . 160.22 108.673 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.85 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.37 -31.75 72.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.88 -0.785 . . . . 120.54 108.88 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.94 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.56 -43.86 95.8 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.507 -0.553 . . . . 67.22 109.507 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.94 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.49 -39.8 88.92 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.504 -0.747 . . . . 138.6 109.654 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.999 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.54 -35.94 82.14 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 122.529 0.332 . . . . 151.46 110.631 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.026 HG13 HD12 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 C-N-CA 117.397 -1.721 . . . . 117.93 106.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.53 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.0 -46.01 90.88 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.928 -1.138 . . . . 56.82 107.928 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.91 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.4 -43.94 98.01 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.911 -0.774 . . . . 145.3 108.911 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.38 95.47 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.523 -0.917 . . . . 45.71 108.523 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.35 -42.06 99.09 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.384 -0.599 . . . . 105.61 109.384 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.5 92.67 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.608 -0.886 . . . . 47.89 108.608 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.703 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.942 -0.392 . . . . 124.53 109.942 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.23 99.28 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 121.979 -0.45 . . . . 35.89 109.851 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.19 -37.31 84.8 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 107.038 -1.467 . . . . 88.97 107.038 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.839 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.23 -49.2 76.69 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.978 -0.749 . . . . 239.91 108.978 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.36 -43.38 91.02 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.594 -0.691 . . . . 146.1 110.635 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.14 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 117.422 -1.711 . . . . 91.74 113.86 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.6 -61.31 2.0 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.74 1.755 . . . . 197.45 115.74 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 1.003 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.32 -42.2 55.01 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.872 -1.531 . . . . 242.6 114.042 -170.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.971 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.921 -1.112 . . . . 215.61 109.813 -172.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' N ' HG23 ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 O-C-N 121.843 -0.535 . . . . 87.19 110.462 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.8 t -65.96 -41.83 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.956 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.15 76.07 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.655 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.1 t80 -68.13 -44.8 75.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.568 -0.708 . . . . 181.63 111.29 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.1 m -60.81 -45.78 93.07 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.471 -1.307 . . . . 269.02 107.471 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.071 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.75 -45.0 93.56 Favored 'General case' 0 N--CA 1.415 -2.183 0 C-N-CA 118.646 -1.222 . . . . 562.66 110.03 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.854 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.26 95.42 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 118.725 -1.19 . . . . 446.75 108.076 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.818 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.47 -26.37 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 C-N-CA 115.842 -2.343 . . . . 370.05 112.22 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.901 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.1 m-70 -74.45 -26.5 60.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.555 -0.716 . . . . 354.91 112.507 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.77 4.59 0.99 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.09 1.356 . . . . 462.44 111.891 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.8 mm-40 -172.36 178.04 2.91 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.989 0.9 . . . . 652.37 111.107 171.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.835 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.31 2.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.477 2.711 . . . . 905.99 107.905 -174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.95 -36.37 79.99 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.2 -1.037 . . . . 570.43 108.2 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.34 82.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 125.303 1.441 . . . . 453.22 111.171 -174.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.54 178.67 33.91 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 118.799 -1.667 . . . . 445.63 109.925 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.21 75.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 125.274 1.429 . . . . 457.72 112.358 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.6 -46.99 85.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.701 -1.2 . . . . 340.58 109.262 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 87.8 m-85 -68.71 -32.17 71.78 Favored 'General case' 0 N--CA 1.424 -1.747 0 C-N-CA 118.755 -1.178 . . . . 453.6 111.552 -176.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.4 t -56.03 -40.32 73.27 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.86 -47.18 75.8 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 123.976 0.798 . . . . 466.68 110.803 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.07 86.92 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.457 -1.697 . . . . 427.34 107.287 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.12 -36.78 82.64 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.398 0.518 . . . . 537.87 112.398 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.42 -42.67 74.73 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.852 -1.939 . . . . 422.12 111.585 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.912 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.08 -50.09 75.41 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 121.336 -0.853 . . . . 340.17 111.818 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.49 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.8 m-85 -65.24 -46.58 71.95 Favored Pre-proline 0 N--CA 1.443 -0.821 0 C-N-CA 119.097 -1.041 . . . . 258.06 111.754 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.7 Cg_exo -61.53 -31.54 87.56 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 N-CA-C 115.37 1.258 . . . . 305.71 115.37 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.683 -0.858 . . . . 252.7 108.683 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.65 93.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.785 -1.191 . . . . 149.27 107.785 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.77 95.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.621 -0.432 . . . . 138.08 111.485 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.749 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 64.7 t -66.91 -42.41 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 O-C-N 121.588 -0.695 . . . . 132.89 110.998 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.948 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.69 -44.75 92.74 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.875 -0.787 . . . . 193.61 108.875 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.46 -37.68 84.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 122.773 0.429 . . . . 63.83 110.057 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.97 -52.45 59.61 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.092 -0.38 . . . . 76.4 111.231 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.805 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -62.99 -41.65 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.203 -1.036 . . . . 171.13 108.203 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.063 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.4 m-85 -63.69 -38.68 92.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.845 -0.534 . . . . 78.3 110.649 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.02 -35.78 80.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.925 -1.11 . . . . 92.36 109.249 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.076 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.48 -34.3 76.57 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.188 -1.042 . . . . 93.73 108.188 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.68 84.55 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.194 -1.002 . . . . 132.74 109.341 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.05 94.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.217 -1.401 . . . . 43.39 107.217 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.867 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.6 t -58.48 -41.97 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.08 95.48 Favored 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 121.765 -0.584 . . . . 69.68 110.553 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.74 91.78 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.339 -0.985 . . . . 106.98 108.339 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.867 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.64 81.54 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.69 -0.804 . . . . 147.63 108.956 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.763 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.18 -41.49 99.22 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.957 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.2 t80 -61.36 -44.03 97.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.298 -1.001 . . . . 118.85 108.298 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.39 -42.63 98.82 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 110.022 -0.362 . . . . 102.5 110.022 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.64 95.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.808 -0.558 . . . . 89.98 109.818 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.891 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.76 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 118.201 -1.4 . . . . 106.09 110.985 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.31 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 C-N-CA 117.119 -1.832 . . . . 227.74 111.81 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.12 50.94 Favored Pre-proline 0 CA--C 1.486 -1.494 0 C-N-CA 116.18 -2.208 . . . . 262.55 110.057 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.42 28.62 Favored 'Trans proline' 0 C--N 1.289 -2.581 0 C-N-CA 121.616 1.544 . . . . 210.25 111.326 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.95 0.98 Allowed 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.533 -1.655 . . . . 270.58 106.533 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.373 -0.831 . . . . 129.84 112.382 -176.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.4 -26.56 81.53 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 N-CA-C 116.27 1.604 . . . . 330.71 116.27 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.2 7.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.51 -2.876 . . . . 204.51 107.275 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.71 147.41 0.09 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.419 -1.326 . . . . 387.41 107.419 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.879 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.69 147.07 33.72 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 118.781 -1.168 . . . . 166.22 109.466 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.91 -40.69 87.75 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.851 -1.166 . . . . 44.23 107.851 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.3 -39.13 85.88 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.195 -1.039 . . . . 28.8 108.195 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.87 -38.76 92.14 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.079 -0.712 . . . . 30.29 109.079 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.946 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.7 m -59.63 -42.99 93.95 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.988 -0.745 . . . . 46.11 108.988 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.47 -42.18 99.3 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.644 -1.243 . . . . 87.33 107.644 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.788 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.8 t -61.64 -42.09 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.953 -1.129 . . . . 23.69 107.953 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.17 -44.32 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 109.703 -0.48 . . . . 43.86 109.703 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.94 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.22 -42.59 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.303 -0.999 . . . . 91.13 108.303 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.1 t -62.6 -37.94 88.2 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.727 -0.842 . . . . 65.88 108.727 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.13 -41.84 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 109.521 -0.548 . . . . 33.86 109.521 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.063 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.43 -40.31 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.264 . . . . 146.52 107.586 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.779 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.28 90.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.469 -0.892 . . . . 75.44 108.929 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.42 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 O-C-N 121.056 -1.028 . . . . 43.64 109.726 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.804 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -38.02 89.52 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.042 -0.725 . . . . 102.57 109.042 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.07 86.76 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.428 -1.323 . . . . 58.16 107.428 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.82 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.56 73.96 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.999 -0.741 . . . . 121.11 108.999 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.804 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.96 -42.32 84.73 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 118.56 -1.256 . . . . 153.15 109.98 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.08 -43.73 19.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.518 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 120.91 -1.119 . . . . 157.42 112.187 -171.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.516 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.43 -36.06 2.44 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 115.038 1.496 . . . . 250.91 115.038 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.1 Cg_exo -59.58 -25.46 78.92 Favored 'Trans proline' 0 CA--C 1.488 -1.805 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.029 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.2 -34.17 74.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.93 -1.508 . . . . 192.46 106.93 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.05 98.09 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.959 -2.056 . . . . 261.0 107.959 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.76 159.15 25.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 101.512 -3.514 . . . . 491.4 101.512 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -60.02 106.86 0.55 Allowed 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 116.25 -2.18 . . . . 386.1 109.799 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.029 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.2 m -154.02 -166.63 2.42 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 103.563 -2.755 . . . . 289.8 103.563 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.118 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.93 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 117.757 -1.116 . . . . 402.06 109.567 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.78 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.22 177.52 7.58 Favored 'General case' 0 CA--C 1.586 2.34 0 C-N-CA 127.302 2.241 . . . . 690.53 114.922 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.62 0.0 OUTLIER 'General case' 1 C--N 1.429 4.046 1 N-CA-C 123.203 4.52 . . . . 633.62 123.203 162.672 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.792 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.69 153.84 22.06 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.354 2.262 . . . . 617.99 110.917 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.98 Favored Pre-proline 0 C--N 1.364 1.22 0 C-N-CA 130.291 3.436 . . . . 434.98 113.381 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.3 Cg_endo -44.25 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 122.428 3.972 . . . . 365.88 122.428 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.79 ' OG ' HD13 ' A' ' 288' ' ' LEU 0.306 70.5 m -84.89 20.96 1.69 Allowed 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 104.774 -2.306 . . . . 635.81 104.774 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.782 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.41 152.24 18.77 Favored 'General case' 1 CA--C 1.419 -4.087 3 N-CA-C 132.002 7.779 . . . . 999.99 132.002 -135.767 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.071 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.84 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.774 1 CA-C-N 103.337 -6.301 . . . . 594.32 113.615 149.237 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.818 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.14 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 1 N-CA-C 98.277 -4.712 . . . . 811.91 98.277 162.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.792 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.48 45.98 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.424 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' N ' ' HE2' ' A' ' 174' ' ' MET . 70.7 mmm -147.15 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.003 0.906 . . . . 431.86 110.05 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.063 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.13 148.65 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 124.39 1.076 . . . . 457.18 108.766 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.823 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.48 3.74 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.106 0.962 . . . . 458.77 113.535 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.016 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.975 1.31 . . . . 999.99 112.401 168.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.1 Cg_exo -65.95 -45.84 5.56 Favored 'Trans proline' 0 N--CA 1.438 -1.794 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.556 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.037 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.283 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.866 0 CA-C-O 114.908 -2.472 . . . . 999.99 108.743 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.041 ' HB2' HD11 ' A' ' 191' ' ' ILE . 88.1 Cg_endo -41.63 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.144 1 C-N-CA 126.045 4.497 . . . . 999.99 105.692 -170.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.31 -44.01 97.51 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 126.721 2.008 . . . . 967.72 112.04 -165.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.27 -36.52 78.0 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.75 -1.574 . . . . 934.3 106.75 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.041 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.61 -30.21 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 129.18 2.992 . . . . 565.15 113.92 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.52 55.43 2.8 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 118.451 0.568 . . . . 755.61 109.846 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.118 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.29 66.99 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.554 1.142 . . . . 325.89 113.254 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.98 78.31 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 123.582 0.753 . . . . 250.21 111.602 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.77 -43.28 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.575 0.702 . . . . 142.46 110.399 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.063 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.6 t80 -61.09 -41.55 96.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.953 0.901 . . . . 247.69 108.83 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.894 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.9 t60 -60.51 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.429 1.491 . . . . 199.61 113.122 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.37 -44.52 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 107.673 -1.232 . . . . 106.73 107.673 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.786 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.12 -48.57 81.14 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 115.875 -0.602 . . . . 115.01 110.217 -173.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.21 -49.1 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 119.393 -0.923 . . . . 129.42 111.875 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.817 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.88 -53.18 59.28 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 118.209 -1.396 . . . . 172.48 109.919 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.2 t -63.82 -54.3 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 120.53 -0.468 . . . . 55.86 110.942 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.56 58.97 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 118.546 -1.262 . . . . 184.68 111.525 -174.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.972 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 116.641 -2.023 . . . . 291.81 114.74 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.7 t80 -82.02 -55.02 4.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 115.172 1.545 . . . . 130.66 115.172 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.817 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.92 -48.48 68.52 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.459 1.281 . . . . 80.16 114.459 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.936 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.53 -45.49 83.33 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.503 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.83 -27.12 59.46 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.627 -0.566 . . . . 92.17 110.627 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.35 -41.37 76.67 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.475 -1.305 . . . . 135.6 107.475 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.15 -44.73 91.22 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.67 -43.46 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.147 -0.686 . . . . 95.89 109.147 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.683 -1.599 . . . . 43.41 106.683 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.29 99.11 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.363 -1.495 . . . . 27.69 109.363 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.908 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.65 -47.4 75.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 122.177 -0.602 . . . . 54.41 110.47 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.894 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.8 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.984 -1.488 . . . . 53.88 106.984 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.8 -40.81 94.02 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.466 -0.938 . . . . 68.29 108.466 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.908 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.02 92.91 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 119.679 -0.808 . . . . 107.59 110.625 -175.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 119.64 -0.824 . . . . 111.61 109.549 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.891 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.29 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.393 -0.965 . . . . 85.26 108.393 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.42 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.072 -0.811 . . . . 40.71 111.072 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.73 -44.11 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.384 -0.969 . . . . 95.86 108.384 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.2 p -76.91 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.926 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.34 132.13 47.31 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.589 -1.263 . . . . 326.72 107.589 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.449 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.02 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.991 -1.855 . . . . 158.38 105.991 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.91 98.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.662 -0.496 . . . . 36.78 109.662 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.09 125.87 25.29 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.148 -1.021 . . . . 85.46 109.816 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.56 8.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.498 -2.038 . . . . 127.78 105.498 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.91 34.81 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.981 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.8 Cg_exo -56.78 -39.92 87.94 Favored 'Trans proline' 0 N--CA 1.431 -2.174 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.14 167.0 44.92 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.922 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.92 -45.76 93.37 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.057 -1.831 . . . . 107.57 106.057 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.84 58.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 118.842 -1.143 . . . . 167.96 109.177 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.867 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.47 106.75 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 126.754 2.022 . . . . 280.68 109.732 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.78 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 56.02 11.24 0.7 Allowed 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.503 1.121 . . . . 218.25 110.695 174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.934 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.61 54.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.251 -2.129 . . . . 343.57 105.251 177.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.88 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.844 -1.539 . . . . 263.29 106.844 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.656 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.33 147.01 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 126.503 1.921 . . . . 261.92 108.475 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.15 90.04 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.887 -1.153 . . . . 106.81 107.887 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.44 -39.95 95.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.392 -1.323 . . . . 112.2 107.526 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.747 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.24 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.288 -0.634 . . . . 45.41 109.288 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.871 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.3 p -70.92 -32.01 68.8 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.57 81.52 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.634 0.774 . . . . 59.29 111.014 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.649 1.18 . . . . 106.49 110.673 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.934 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.61 69.18 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.331 -0.989 . . . . 106.62 108.331 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.02 91.27 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.848 -0.532 . . . . 75.97 110.058 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.88 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 C-N-CA 122.89 0.476 . . . . 65.27 109.817 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.837 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 120.357 -0.537 . . . . 107.94 110.147 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.51 -40.82 98.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.652 -0.655 . . . . 87.98 110.293 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.057 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.68 -40.33 96.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 118.834 -1.147 . . . . 65.5 108.382 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.6 mtt -61.72 -36.35 80.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.173 -1.047 . . . . 85.05 108.173 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.54 -45.68 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.067 -0.716 . . . . 42.25 109.067 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.33 -38.32 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 119.544 -0.862 . . . . 91.01 109.344 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.58 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.978 -1.119 . . . . 66.09 107.978 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.1 -43.12 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 120.731 -0.388 . . . . 52.39 110.312 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.2 m -61.81 -46.73 88.23 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 121.869 -0.52 . . . . 46.42 109.834 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.36 -38.17 88.51 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.286 -1.005 . . . . 116.51 108.286 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.542 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.19 -48.22 82.64 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.437 -0.579 . . . . 65.18 109.437 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.93 -42.73 97.27 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 122.13 -0.356 . . . . 51.33 110.437 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.816 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.39 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 118.898 -1.121 . . . . 126.3 109.013 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.508 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.7 -33.36 35.44 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.8 tp -58.44 -41.64 90.35 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.686 -0.633 . . . . 72.23 111.618 -167.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.4 Cg_exo -60.61 -36.02 87.27 Favored 'Trans proline' 0 N--CA 1.429 -2.272 0 CA-C-N 119.88 0.993 . . . . 106.13 111.343 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.848 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.68 82.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.723 -0.791 . . . . 128.35 110.021 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.83 88.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 110.207 -0.294 . . . . 100.73 110.207 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.35 -44.43 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 C-N-CA 119.268 -0.973 . . . . 172.72 109.144 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.753 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.7 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.192 -1.04 . . . . 249.23 108.192 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.61 -55.05 36.62 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.615 -1.624 . . . . 259.78 106.615 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.894 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.24 -44.13 72.62 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.856 HD12 HD21 ' A' ' 279' ' ' LEU . 88.7 mt -61.38 -48.28 91.45 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 119.153 -1.019 . . . . 169.54 110.592 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.686 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.5 Cg_exo -61.18 -24.52 79.28 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 116.72 -1.72 . . . . 255.47 114.629 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.58 -44.21 94.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 119.255 0.934 . . . . 279.03 108.886 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.79 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.078 -0.342 . . . . 162.21 110.078 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.778 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.9 59.25 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.75 -1.18 . . . . 128.13 108.083 -178.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.29 164.03 11.2 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 N-CA-C 107.395 -1.81 . . . . 278.35 107.395 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.86 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.01 9.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.813 0.695 . . . . 312.91 109.335 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.86 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.69 -170.7 2.49 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.56 -1.645 . . . . 353.54 106.56 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.026 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 43.0 p90 -115.66 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.856 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.95 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 102.092 -3.299 . . . . 175.26 102.092 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.53 -44.97 96.09 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 100.88 -3.748 . . . . 99.07 100.88 172.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.41 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.52 -2.77 . . . . 243.21 103.52 171.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.026 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.93 112.91 25.04 Favored 'General case' 0 CA--C 1.473 -1.995 0 C-N-CA 116.109 -2.237 . . . . 201.04 105.293 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.742 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 C-N-CA 116.033 -2.267 . . . . 201.36 108.831 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.051 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.02 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.278 -1.783 . . . . 203.82 107.85 174.481 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.915 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.196 -1.401 . . . . 215.06 112.56 -171.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.633 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.4 t -65.7 -46.37 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 C-N-CA 118.567 -1.253 . . . . 125.28 112.937 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.85 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.8 -36.99 86.12 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.177 -1.416 . . . . 268.9 107.177 -171.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.876 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.21 -45.02 74.49 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 125.65 1.58 . . . . 280.88 108.815 -172.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.54 85.79 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 118.957 -1.097 . . . . 184.47 108.971 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.848 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.07 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 119.27 -0.972 . . . . 167.92 112.772 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.665 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.79 -38.77 89.91 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 117.796 -1.562 . . . . 367.18 110.77 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.573 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.74 74.05 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.877 -0.514 . . . . 173.97 110.439 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.44 -36.79 85.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.495 0.718 . . . . 119.66 109.788 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.19 -34.0 74.36 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.725 -1.213 . . . . 112.3 107.725 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.708 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.239 -0.437 . . . . 174.17 110.246 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 124.685 1.194 . . . . 145.27 110.616 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.833 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.58 -35.36 70.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.113 -1.069 . . . . 170.15 108.113 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.839 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.17 63.97 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.3 -0.409 . . . . 214.57 110.621 -171.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.793 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.19 56.51 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.063 1.745 . . . . 168.29 115.562 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.833 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.88 79.22 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.008 1.114 . . . . 167.15 114.008 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.745 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.2 -38.28 33.18 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 115.521 -2.472 . . . . 165.13 113.942 -171.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.745 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.53 -31.88 80.08 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.751 2.018 . . . . 123.92 111.21 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.74 -42.57 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 118.879 -1.128 . . . . 110.55 109.802 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.2 pt -61.07 -40.08 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 108.846 -0.798 . . . . 145.31 108.846 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.057 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.3 m-85 -58.05 -48.85 78.85 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.408 -0.917 . . . . 246.68 109.84 -177.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.22 -47.52 84.09 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 119.557 -0.857 . . . . 64.43 109.555 -173.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.75 -45.13 79.53 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.04 -1.064 . . . . 80.72 110.204 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.754 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 115.989 1.848 . . . . 140.44 115.989 -173.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.089 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.36 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.35 -1.295 . . . . 110.22 110.094 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.846 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.54 72.9 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.731 -0.606 . . . . 174.78 109.739 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.95 -41.71 95.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.248 -1.019 . . . . 161.84 108.248 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.481 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.24 -50.27 73.42 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.029 -0.668 . . . . 117.2 109.25 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.13 75.46 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.374 -0.53 . . . . 112.6 111.063 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.109 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.01 -37.43 94.59 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.626 -0.99 . . . . 101.46 110.626 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.15 -46.01 90.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 118.458 1.129 . . . . 151.49 109.52 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.08 -36.31 77.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.962 -1.496 . . . . 142.32 106.962 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.109 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.8 m80 -59.8 -41.8 92.0 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.41 85.67 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 122.358 -0.213 . . . . 76.11 111.02 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.49 30.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.879 -0.728 . . . . 120.24 109.318 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.749 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.54 41.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 102.912 -2.996 . . . . 192.73 102.912 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.22 -44.17 92.31 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 118.994 -1.082 . . . . 176.29 109.163 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.816 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.0 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.46 0 N-CA-C 106.303 -1.739 . . . . 69.68 106.303 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.97 -75.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 118.364 -0.624 . . . . 191.05 112.605 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.816 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.47 43.88 16.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 O-C-N 123.578 0.549 . . . . 287.03 109.778 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.848 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.945 0 C-N-CA 112.956 -3.498 . . . . 292.29 109.818 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.213 -2.514 . . . . 184.57 104.213 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.71 4.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.026 0.75 . . . . 274.56 113.026 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.24 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.748 -2.167 . . . . 268.24 113.453 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.6 m-20 51.56 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 118.685 1.242 . . . . 200.06 110.764 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.846 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.98 74.7 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.885 -1.154 . . . . 114.44 107.885 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.29 46.04 21.87 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.611 -1.255 . . . . 263.81 107.611 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.195 1 N-CA-C 102.563 -4.215 . . . . 103.79 102.563 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.99 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.3 95.6 10.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 114.943 -2.703 . . . . 117.3 106.016 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.045 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.76 90.77 Favored 'General case' 0 CA--C 1.468 -2.187 1 N-CA-C 98.041 -4.8 . . . . 231.58 98.041 167.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.065 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.97 163.44 29.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 102.063 -3.31 . . . . 303.24 102.063 168.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.99 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.55 78.9 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.024 -2.271 . . . . 112.72 108.424 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.413 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.8 t -61.06 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.072 -0.714 . . . . 83.22 109.072 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.3 m -156.28 -126.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.829 -2.656 . . . . 174.36 103.829 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.045 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.81 160.94 8.71 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 105.768 -1.938 . . . . 202.73 105.768 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.023 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.051 -1.463 . . . . 180.62 107.051 176.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.943 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.51 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.943 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.13 -43.11 88.06 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.492 -2.781 . . . . 266.49 103.492 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.606 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.93 0.28 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 117.055 -1.858 . . . . 219.2 107.753 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.0 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.08 -37.36 94.08 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 114.542 -1.208 . . . . 94.78 112.881 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.099 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.21 100.41 9.1 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.34 -3.744 . . . . 121.41 109.452 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.673 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.4 t -73.08 145.54 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.517 -0.765 . . . . 85.34 108.949 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.502 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.8 143.45 42.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.832 -1.174 . . . . 267.57 107.832 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.63 0.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.502 -0.555 . . . . 226.1 109.502 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.043 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.989 -1.485 . . . . 154.84 106.989 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.93 8.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.622 0.725 . . . . 180.01 110.696 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.875 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.91 23.63 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.989 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.5 48.77 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.399 -1.334 . . . . 335.2 107.399 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.989 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.63 -46.81 88.87 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.698 -1.964 . . . . 59.34 105.698 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.62 173.81 11.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.422 -2.436 . . . . 201.26 104.422 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.786 HG21 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.89 106.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.525 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.4 5.37 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.337 -0.616 . . . . 87.58 109.337 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.52 153.71 22.26 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.847 -1.168 . . . . 219.95 107.847 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 C-N-CA 116.348 -2.141 . . . . 121.79 105.434 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.9 t -154.14 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.816 -1.92 . . . . 53.85 105.816 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.618 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.26 16.56 77.11 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.886 -1.153 . . . . 35.88 107.886 -178.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' B' ' 365' ' ' ARG . 1.7 tpp180 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.02 68.13 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.665 1.577 . . . . 1.0 111.877 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.507 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 1.2 mtpt -70.5 127.38 92.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.267 -0.424 . . . . 1.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.84 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -69.01 -19.97 38.99 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.397 2.065 . . . . 1.0 114.601 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' B' ' 369' ' ' GLN . 0.0 OUTLIER -58.39 -38.63 77.72 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.71 -178.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -71.29 -10.53 59.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.355 . . . . 1.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.84 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.61 -46.34 87.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.332 -178.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 0.494 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -61.51 -49.11 78.05 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.587 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.08 78.31 0.31 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.174 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.432 ' N ' HD13 ' B' ' 374' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.518 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 108.361 -0.977 . . . . 97.08 108.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.7 t30 -110.59 155.46 22.32 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.161 0.981 . . . . 123.41 110.745 -172.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.928 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.63 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.469 1 N-CA-C 100.106 -4.035 . . . . 151.3 100.106 173.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.022 HD22 ' HG3' ' B' ' 366' ' ' PRO . 5.2 mp -60.66 -38.61 58.5 Favored Pre-proline 0 N--CA 1.439 -1.01 0 C-N-CA 115.98 -2.288 . . . . 169.25 106.101 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.98 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_exo -81.29 168.54 16.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 122.265 0.613 . . . . 185.76 110.508 171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.851 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.2 t -64.51 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.051 2.141 . . . . 145.47 110.324 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.35 157.42 21.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.064 -1.023 . . . . 102.76 109.446 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.61 154.18 25.07 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.994 -1.114 . . . . 106.25 107.994 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.92 51.91 0.74 Allowed 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 117.757 -1.577 . . . . 157.81 107.658 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.19 -45.9 91.56 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.541 -2.763 . . . . 150.2 103.541 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.7 m -87.01 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.874 0 N-CA-C 103.68 -2.711 . . . . 183.52 103.68 172.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -76.77 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 N-CA-C 109.995 -0.81 . . . . 235.61 109.995 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.99 -41.22 82.56 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.847 1.259 . . . . 113.77 113.354 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.928 HD13 HG11 ' A' ' 4' ' ' VAL . 33.5 pt -52.17 136.24 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 119.616 1.098 . . . . 150.85 110.965 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.52 156.29 46.37 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 107.594 -1.262 . . . . 100.42 107.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.041 HG21 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.63 58.33 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.955 0.883 . . . . 129.36 110.436 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.288 1.835 . . . . 112.34 106.693 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.006 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.7 m -74.11 -40.16 62.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.553 -0.749 . . . . 131.73 111.777 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.041 ' H ' HG21 ' A' ' 17' ' ' THR . 71.2 m -84.4 -42.9 15.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 117.018 2.229 . . . . 80.49 117.018 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.53 3.35 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.196 -1.402 . . . . 98.98 111.252 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.84 -10.7 18.09 Favored 'Trans proline' 0 C--N 1.32 -0.921 1 N-CA-C 128.937 6.476 . . . . 246.95 128.937 -170.061 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.62 17.55 8.71 Favored 'General case' 0 C--N 1.325 -0.484 1 CA-C-N 126.12 4.055 . . . . 269.62 114.236 175.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.15 -27.3 67.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.793 -1.188 . . . . 86.8 107.793 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.83 -29.28 69.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.088 -1.007 . . . . 85.91 110.498 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 123.65 0.78 . . . . 82.0 111.364 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.934 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.76 12.43 Favored Pre-proline 0 CA--C 1.488 -1.417 0 N-CA-C 108.555 -0.906 . . . . 120.73 108.555 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.844 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 C-N-CA 120.659 0.906 . . . . 87.86 109.935 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.814 -0.81 . . . . 36.46 108.814 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.1 p-90 -63.8 -33.89 76.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.934 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.18 -32.7 73.37 Favored 'General case' 0 CA--C 1.491 -1.322 0 O-C-N 121.301 -0.874 . . . . 123.26 108.685 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.822 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.14 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 109.196 -0.668 . . . . 120.14 109.196 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.43 -31.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.91 -47.21 84.24 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.633 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.692 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.65 81.16 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 119.977 -0.689 . . . . 157.57 110.362 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.814 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.58 -40.9 98.36 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.682 -0.858 . . . . 47.06 108.682 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.84 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.02 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 121.751 -0.593 . . . . 43.94 109.569 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.83 -43.29 99.15 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.705 -0.85 . . . . 42.61 108.705 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.35 -41.26 94.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.653 -0.249 . . . . 140.66 111.064 -178.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.79 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 118.613 -1.235 . . . . 116.04 110.221 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.44 -38.76 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.745 -0.835 . . . . 97.16 108.745 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.913 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.4 mt -61.32 -39.95 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.968 HG23 HG22 ' A' ' 86' ' ' THR . 93.1 t -57.7 -42.34 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 108.891 -0.781 . . . . 45.39 108.891 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 96.9 t -63.56 -50.97 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.837 -1.145 . . . . 48.64 110.156 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.7 t -65.21 -47.11 78.02 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.137 -0.625 . . . . 116.65 111.71 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.93 -43.93 97.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.695 -0.483 . . . . 51.16 109.695 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.96 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 119.864 -0.734 . . . . 44.3 110.828 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 94.1 t -64.71 -46.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 120.349 -0.54 . . . . 48.82 111.039 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.12 95.2 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.492 -0.861 . . . . 58.7 112.006 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.13 66.99 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 117.452 0.626 . . . . 101.4 111.006 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.77 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.727 -1.212 . . . . 103.57 107.727 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.41 -43.02 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.996 -0.742 . . . . 61.89 108.996 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.5 t -63.5 -50.94 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.45 -0.574 . . . . 70.01 109.45 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.91 -43.45 98.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.118 -0.697 . . . . 132.1 109.118 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.672 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.19 -46.63 83.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.652 -0.249 . . . . 104.5 110.458 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.64 -49.89 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.041 HD12 HG13 ' A' ' 72' ' ' VAL 0.28 25.0 pt -64.75 -41.76 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 C-N-CA 116.936 -1.906 . . . . 158.32 110.897 -175.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 117.692 -1.603 . . . . 137.11 109.516 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.155 -0.341 . . . . 54.66 111.02 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.39 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 121.615 0.721 . . . . 127.18 109.591 -174.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.094 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.78 -36.89 80.12 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.099 0.96 . . . . 87.93 110.884 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.067 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.618 -0.676 . . . . 131.12 111.526 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.007 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.46 7.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.25 -2.58 . . . . 246.56 109.613 -175.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.949 0 N-CA-C 105.489 -2.041 . . . . 339.35 105.489 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.857 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.4 p -124.12 165.23 17.89 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.033 -2.951 . . . . 114.66 103.033 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.96 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.42 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.799 -1.556 . . . . 143.28 106.799 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.999 HG21 HD13 ' A' ' 71' ' ' LEU . 95.5 m -59.66 -38.1 80.51 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.687 -0.857 . . . . 160.22 108.687 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.857 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.4 m-20 -62.3 -31.78 72.43 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.908 -0.775 . . . . 120.54 108.908 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.56 -43.8 96.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.508 -0.553 . . . . 67.22 109.508 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.935 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.54 -39.75 88.72 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.494 -0.754 . . . . 138.6 109.71 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.999 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.57 -35.94 82.15 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.451 0.301 . . . . 151.46 110.614 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.041 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.97 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 117.426 -1.71 . . . . 117.93 106.686 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.03 -46.01 90.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.891 -1.152 . . . . 56.82 107.891 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.41 -43.92 98.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.885 -0.783 . . . . 145.3 108.885 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.39 95.54 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.494 -0.928 . . . . 45.71 108.494 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.41 -42.03 99.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.357 -0.609 . . . . 105.61 109.357 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.617 -0.883 . . . . 47.89 108.617 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.35 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.935 -0.395 . . . . 124.53 109.935 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 121.966 -0.459 . . . . 35.89 109.831 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -37.29 84.83 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.999 -1.482 . . . . 88.97 106.999 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.18 76.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 119.859 -0.737 . . . . 239.91 109.075 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.45 -43.39 90.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.529 -0.732 . . . . 146.1 110.565 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.15 -58.2 3.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 117.358 -1.737 . . . . 91.74 113.874 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.6 -61.33 2.0 Allowed 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.991 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.26 -42.31 55.34 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.896 -1.521 . . . . 242.6 114.026 -170.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.968 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.61 84.55 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 118.957 -1.097 . . . . 215.61 109.831 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 86' ' ' THR . 72.0 t -60.26 -46.96 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.803 -0.561 . . . . 87.19 110.489 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.897 HG22 ' CD2' ' A' ' 108' ' ' HIS . 64.0 t -65.95 -41.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.754 -0.462 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.295 -1.002 . . . . 364.98 108.295 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.543 -0.723 . . . . 181.63 111.242 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.896 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.5 m -60.83 -45.83 92.91 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.423 -1.325 . . . . 269.02 107.423 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.07 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.67 -45.13 92.98 Favored 'General case' 0 CA--C 1.469 -2.15 0 C-N-CA 118.677 -1.209 . . . . 562.66 110.013 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.696 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -61.08 -45.21 95.67 Favored 'General case' 0 CA--C 1.479 -1.777 0 C-N-CA 118.713 -1.195 . . . . 446.75 108.108 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.814 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.0 m -70.52 -26.31 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 115.826 -2.35 . . . . 370.05 112.202 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.896 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.5 -26.48 60.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.598 -0.689 . . . . 354.91 112.53 175.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.83 4.55 0.98 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 125.057 1.343 . . . . 462.44 111.87 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.8 mm-40 -172.39 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.067 0.936 . . . . 652.37 111.085 171.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.829 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 128.508 2.723 . . . . 905.99 107.931 -174.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.88 -36.42 80.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.223 -1.028 . . . . 570.43 108.223 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.52 -36.37 82.35 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 125.31 1.444 . . . . 453.22 111.191 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.006 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.67 33.88 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 118.781 -1.676 . . . . 445.63 109.897 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.569 ' CD1' ' HB2' ' B' ' 368' ' ' PRO . 89.1 mt -56.39 -41.23 75.91 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.249 1.419 . . . . 457.72 112.378 -170.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.64 -46.93 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.688 -1.205 . . . . 340.58 109.299 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.74 -32.13 71.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.769 -1.172 . . . . 453.6 111.585 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.04 -40.33 73.32 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.9 -47.08 76.0 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 124.025 0.828 . . . . 466.68 110.888 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.06 86.86 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.491 -1.684 . . . . 427.34 107.263 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.897 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.12 -36.77 82.61 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 112.423 0.527 . . . . 537.87 112.423 -174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.66 74.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 116.86 -1.936 . . . . 422.12 111.617 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.7 t80 -59.05 -50.11 75.32 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.339 -0.85 . . . . 340.17 111.853 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.4 m-85 -65.35 -46.5 70.74 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.089 -1.045 . . . . 258.06 111.695 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.991 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.3 Cg_exo -61.47 -31.58 87.97 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.54 93.78 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.791 -1.188 . . . . 149.27 107.791 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.96 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.649 -0.42 . . . . 138.08 111.5 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.96 -42.41 88.72 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 O-C-N 121.556 -0.715 . . . . 132.89 110.936 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.947 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.75 -44.72 92.63 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.849 -0.797 . . . . 193.61 108.849 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.607 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.66 84.31 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 122.842 0.457 . . . . 63.83 110.128 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.4 59.68 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.75 -0.38 . . . . 76.4 111.214 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.804 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.0 -41.64 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.163 -1.051 . . . . 171.13 108.163 -174.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.077 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.84 -38.53 91.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.866 -0.521 . . . . 78.3 110.639 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.06 -35.78 80.59 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 118.9 -1.12 . . . . 92.36 109.236 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.083 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.45 -34.28 76.49 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.184 -1.043 . . . . 93.73 108.184 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.979 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.49 -41.59 84.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 119.205 -0.998 . . . . 132.74 109.323 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.13 94.72 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.188 -1.412 . . . . 43.39 107.188 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.47 -41.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 108.639 -0.875 . . . . 59.34 108.639 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.06 95.27 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.796 -0.565 . . . . 69.68 110.5 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.71 91.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.334 -0.987 . . . . 106.98 108.334 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.64 81.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.648 -0.821 . . . . 147.63 108.933 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.762 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.54 99.38 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.557 -0.905 . . . . 190.06 108.557 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.964 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.32 -44.13 97.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.273 -1.01 . . . . 118.85 108.273 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.125 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.65 98.97 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 110.008 -0.367 . . . . 102.5 110.008 -177.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.61 95.23 Favored 'General case' 0 CA--C 1.489 -1.375 0 O-C-N 121.866 -0.521 . . . . 89.98 109.812 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 C-N-CA 118.104 -1.438 . . . . 106.09 111.012 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.11 -48.26 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 C-N-CA 117.087 -1.845 . . . . 227.74 111.798 -174.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.08 50.94 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.238 -2.185 . . . . 262.55 110.052 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.47 28.81 Favored 'Trans proline' 0 C--N 1.289 -2.56 0 C-N-CA 121.685 1.59 . . . . 210.25 111.35 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.23 112.0 0.99 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 106.537 -1.653 . . . . 270.58 106.537 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.892 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.53 24.04 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-N 115.37 -0.832 . . . . 129.84 112.316 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 83.0 Cg_exo -61.36 -26.58 81.75 Favored 'Trans proline' 0 N--CA 1.432 -2.142 0 N-CA-C 116.321 1.623 . . . . 330.71 116.321 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.04 77.21 7.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 114.452 -2.899 . . . . 204.51 107.286 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.88 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.44 0.09 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.425 -1.324 . . . . 387.41 107.425 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.88 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.04 33.66 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 118.753 -1.179 . . . . 166.22 109.435 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.79 88.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.804 -1.184 . . . . 44.23 107.804 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.76 -38.83 92.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.085 -0.709 . . . . 30.29 109.085 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.96 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.04 93.88 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.962 -0.755 . . . . 46.11 108.962 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.47 -42.12 99.26 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.699 -1.223 . . . . 87.33 107.699 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.8 t -61.63 -42.13 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.954 -1.128 . . . . 23.69 107.954 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.22 -44.26 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.676 -0.49 . . . . 43.86 109.676 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.3 -42.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 108.351 -0.981 . . . . 91.13 108.351 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.4 t -62.56 -38.0 88.37 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.743 -0.836 . . . . 65.88 108.743 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.11 -41.81 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 109.58 -0.526 . . . . 33.86 109.58 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.077 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.41 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.173 0 N-CA-C 107.577 -1.268 . . . . 146.52 107.577 -176.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.84 -38.36 90.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.499 -0.88 . . . . 75.44 108.936 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.53 -48.39 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 O-C-N 121.04 -1.038 . . . . 43.64 109.733 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.812 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.48 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 109.045 -0.724 . . . . 102.57 109.045 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.1 86.87 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.398 -1.334 . . . . 58.16 107.398 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.815 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.5 73.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.993 -0.743 . . . . 121.11 108.993 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.812 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.3 84.93 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.565 -1.254 . . . . 153.15 109.938 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.992 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.11 -43.76 18.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 113.084 -3.446 . . . . 133.67 113.477 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.92 -39.93 96.07 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 120.918 -1.114 . . . . 157.42 112.193 -171.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.517 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 114.993 1.479 . . . . 250.91 114.993 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.3 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.488 -1.786 0 N-CA-C 117.984 2.263 . . . . 207.34 117.984 -174.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.027 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.2 -34.22 74.73 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.94 -1.504 . . . . 192.46 106.94 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.46 -41.06 98.16 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.01 -2.036 . . . . 261.0 108.01 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.71 159.11 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 101.519 -3.512 . . . . 491.4 101.519 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.437 0 C-N-CA 116.257 -2.177 . . . . 386.1 109.87 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.027 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.03 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 103.552 -2.758 . . . . 289.8 103.552 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.114 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 117.771 -1.109 . . . . 402.06 109.576 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.781 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.29 177.46 7.57 Favored 'General case' 0 CA--C 1.586 2.357 0 C-N-CA 127.32 2.248 . . . . 690.53 114.9 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.59 0.0 OUTLIER 'General case' 1 C--N 1.43 4.09 1 N-CA-C 123.178 4.511 . . . . 633.62 123.178 162.696 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.67 153.85 22.07 Favored 'General case' 0 C--N 1.389 2.305 0 C-N-CA 127.362 2.265 . . . . 617.99 110.889 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.42 5.96 Favored Pre-proline 0 C--N 1.364 1.227 0 C-N-CA 130.289 3.435 . . . . 434.98 113.382 -175.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.1 Cg_endo -44.21 -65.7 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 122.409 3.965 . . . . 365.88 122.409 -168.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.3 m -84.91 20.98 1.69 Allowed 'General case' 0 CA--C 1.467 -2.247 0 N-CA-C 104.832 -2.284 . . . . 635.81 104.832 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.35 152.19 18.83 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.959 7.762 . . . . 999.99 131.959 -135.764 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.07 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.913 37.2 t -131.79 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.773 1 CA-C-N 103.314 -6.312 . . . . 594.32 113.613 149.206 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.1 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.307 -4.701 . . . . 811.91 98.307 162.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.47 144.58 45.89 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 117.063 -1.855 . . . . 999.99 109.411 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.23 -175.63 4.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.036 0.922 . . . . 431.86 110.042 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.06 148.63 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 124.384 1.074 . . . . 457.18 108.823 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.829 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.29 85.45 3.72 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.134 0.973 . . . . 458.77 113.523 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.017 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.41 -31.56 0.97 Allowed Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.983 1.313 . . . . 999.99 112.38 168.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.944 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.73 5.68 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 N-CA-C 120.916 3.391 . . . . 999.99 120.916 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.57 171.76 8.13 Favored 'General case' 0 CA--C 1.472 -2.041 0 C-N-CA 117.133 -1.827 . . . . 81.18 107.235 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.14 45.12 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.881 0 C-N-CA 115.537 -2.465 . . . . 999.99 108.798 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.083 ' HB3' ' HD2' ' B' ' 365' ' ' ARG . 87.8 Cg_endo -41.61 101.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.126 1 C-N-CA 126.045 4.496 . . . . 999.99 105.677 -170.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.99 97.55 Favored 'General case' 0 CA--C 1.483 -1.621 0 C-N-CA 126.717 2.007 . . . . 967.72 112.043 -165.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.55 78.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.72 -1.585 . . . . 934.3 106.72 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.058 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.5 -30.29 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 129.188 2.995 . . . . 565.15 113.951 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.59 55.36 2.78 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 118.468 0.577 . . . . 755.61 109.854 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.114 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.25 67.21 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.559 1.144 . . . . 325.89 113.259 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -45.02 78.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.582 0.753 . . . . 250.21 111.639 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.66 -43.38 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-O 121.592 0.711 . . . . 142.46 110.379 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.953 0.901 . . . . 247.69 108.855 -173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 22.9 t60 -60.49 -51.32 69.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 125.444 1.498 . . . . 199.61 113.111 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.37 -44.49 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.701 -1.222 . . . . 106.73 107.701 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.786 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.59 81.03 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.853 -0.612 . . . . 115.01 110.232 -173.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.992 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.19 -49.13 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 119.411 -0.916 . . . . 129.42 111.857 -174.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.816 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.6 m -61.94 -53.09 60.5 Favored 'General case' 0 CA--C 1.482 -1.646 0 C-N-CA 118.178 -1.409 . . . . 172.48 109.943 -172.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.84 -54.32 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 120.51 -0.476 . . . . 55.86 110.973 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.5 -51.55 59.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.504 -1.278 . . . . 184.68 111.524 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.977 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.42 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.618 -2.033 . . . . 291.81 114.749 -174.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.98 4.86 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.181 1.548 . . . . 130.66 115.181 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.816 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.499 1.296 . . . . 80.16 114.499 -170.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.931 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.44 83.1 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.906 -0.717 . . . . 136.02 109.509 -174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.2 Cg_exo -64.83 -27.11 59.49 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.596 -0.579 . . . . 92.17 110.596 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.33 -41.44 76.68 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.441 -1.318 . . . . 135.6 107.441 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.11 -44.7 91.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.604 -0.517 . . . . 52.1 109.604 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.49 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 109.079 -0.711 . . . . 95.89 109.079 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.979 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.33 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.714 -1.587 . . . . 43.41 106.714 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.28 99.12 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.382 -1.487 . . . . 27.69 109.382 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.905 ' O ' HG21 ' A' ' 217' ' ' THR . 77.8 t80 -65.71 -47.38 75.57 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 117.32 0.56 . . . . 54.41 110.45 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.36 -34.19 74.88 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.957 -1.497 . . . . 53.88 106.957 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.84 93.85 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.503 -0.925 . . . . 68.29 108.503 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.905 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.04 92.96 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.682 -0.807 . . . . 107.59 110.626 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -63.0 -38.38 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.609 -0.837 . . . . 111.61 109.525 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.23 -22.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.45 -0.944 . . . . 85.26 108.45 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.92 99.42 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.074 -0.81 . . . . 40.71 111.074 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.71 -44.09 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.382 -0.97 . . . . 95.86 108.382 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.2 p -76.9 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.416 -0.957 . . . . 144.37 108.416 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.8 mt -55.34 132.12 47.29 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 107.606 -1.257 . . . . 326.72 107.606 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.446 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.1 1.52 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.015 -1.846 . . . . 158.38 106.015 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.28 -41.94 99.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.688 -0.486 . . . . 36.78 109.688 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.7 m -61.13 125.88 25.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.168 -1.013 . . . . 85.46 109.77 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.57 8.83 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 105.534 -2.024 . . . . 127.78 105.534 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.78 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 105.938 -1.875 . . . . 164.84 105.938 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.0 Cg_exo -56.77 -39.95 87.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 113.958 0.714 . . . . 222.35 113.958 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.806 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 106.403 -2.679 . . . . 45.22 106.403 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.77 93.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.017 -1.846 . . . . 107.57 106.017 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.735 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.83 141.82 58.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.897 -1.121 . . . . 167.96 109.142 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.71 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.686 1.994 . . . . 280.68 109.715 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.33 0.71 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.493 1.117 . . . . 218.25 110.686 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.212 -2.144 . . . . 343.57 105.212 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.04 81.93 1.54 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.875 -1.528 . . . . 263.29 106.875 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 126.57 1.948 . . . . 261.92 108.471 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.08 89.78 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 107.903 -1.147 . . . . 106.81 107.903 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.757 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.88 94.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 118.374 -1.33 . . . . 112.2 107.576 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.3 t -64.31 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.294 -0.632 . . . . 45.41 109.294 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.865 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.06 68.89 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.287 -0.264 . . . . 97.62 110.287 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.62 81.7 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.735 0.814 . . . . 59.29 111.025 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.757 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.27 -36.48 83.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.615 1.166 . . . . 106.49 110.687 -174.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.7 69.24 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.28 -1.007 . . . . 106.62 108.28 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.01 -41.03 91.53 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 121.836 -0.54 . . . . 75.97 110.028 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.88 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.7 t -65.56 -40.83 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 122.94 0.496 . . . . 65.27 109.754 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.838 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.6 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 C-N-CA 120.419 -0.512 . . . . 107.94 110.135 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.56 -40.78 97.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 121.68 -0.637 . . . . 87.98 110.275 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.63 -40.45 96.92 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.847 -1.141 . . . . 65.5 108.389 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.88 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.65 -36.37 80.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.157 -1.053 . . . . 85.05 108.157 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.5 -45.75 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 109.028 -0.73 . . . . 42.25 109.028 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.39 -38.17 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 C-N-CA 119.535 -0.866 . . . . 91.01 109.377 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.029 HG21 HD11 ' A' ' 304' ' ' ILE . 66.1 t -58.93 -41.55 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 107.973 -1.121 . . . . 66.09 107.973 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 120.726 -0.39 . . . . 52.39 110.331 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.3 m -61.75 -46.77 88.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.899 -0.501 . . . . 46.42 109.858 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.37 -38.05 88.09 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.337 -0.986 . . . . 116.51 108.337 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.35 -48.17 82.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.392 -0.595 . . . . 65.18 109.392 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.7 97.33 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 120.827 0.346 . . . . 51.33 110.472 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.61 -43.41 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 118.936 -1.106 . . . . 126.3 108.982 -176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.4 35.34 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 116.842 2.164 . . . . 134.84 116.842 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.802 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.36 -41.62 90.37 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.692 -0.63 . . . . 72.23 111.66 -167.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.819 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.5 Cg_exo -60.69 -35.98 86.94 Favored 'Trans proline' 0 N--CA 1.429 -2.286 0 CA-C-N 119.851 0.983 . . . . 106.13 111.341 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.848 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.69 82.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 119.754 -0.779 . . . . 128.35 110.068 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.87 89.04 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 110.218 -0.29 . . . . 100.73 110.218 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.819 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.27 -44.51 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.279 -0.969 . . . . 172.72 109.185 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.4 m-85 -66.62 -28.09 68.21 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.216 -1.031 . . . . 249.23 108.216 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.49 -55.17 34.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.701 -1.592 . . . . 259.78 106.701 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.892 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.16 -44.15 72.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.593 0.96 . . . . 233.11 113.593 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.852 HD12 HD21 ' A' ' 279' ' ' LEU . 88.6 mt -61.38 -48.33 91.31 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 119.22 -0.992 . . . . 169.54 110.544 -170.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.9 Favored 'Trans proline' 0 N--CA 1.429 -2.282 0 C-N-CA 116.784 -1.677 . . . . 255.47 114.66 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.57 -44.19 94.8 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 119.238 0.926 . . . . 279.03 108.893 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.055 -0.35 . . . . 162.21 110.055 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.4 84.9 59.27 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 118.779 -1.168 . . . . 128.13 108.052 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.25 164.0 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.289 0 N-CA-C 107.499 -1.769 . . . . 278.35 107.499 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.17 15.0 9.93 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 123.778 0.674 . . . . 312.91 109.325 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.73 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.54 -1.652 . . . . 353.54 106.54 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.26 46.97 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.852 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 102.06 -3.311 . . . . 175.26 102.06 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.97 96.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 100.857 -3.757 . . . . 99.07 100.857 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.14 9.16 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.496 -2.779 . . . . 243.21 103.496 171.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.97 112.93 25.07 Favored 'General case' 0 CA--C 1.474 -1.948 0 C-N-CA 116.047 -2.261 . . . . 201.04 105.293 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.789 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.064 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.44 -41.48 89.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.256 -1.793 . . . . 203.82 107.872 174.441 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.914 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.27 -45.69 86.94 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 118.181 -1.408 . . . . 215.06 112.552 -171.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.634 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.39 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.934 -171.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.851 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.84 -37.01 86.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.181 -1.414 . . . . 268.9 107.181 -171.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.19 -45.01 74.57 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 125.658 1.583 . . . . 280.88 108.809 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.52 85.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 118.981 -1.088 . . . . 184.47 108.982 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.848 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.7 mp -67.91 -42.13 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 119.262 -0.975 . . . . 167.92 112.769 -175.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.66 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.69 -38.87 90.44 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 117.787 -1.565 . . . . 367.18 110.783 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.57 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.73 74.06 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.819 -0.551 . . . . 173.97 110.471 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 123.541 0.736 . . . . 119.66 109.764 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.99 74.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.675 -1.231 . . . . 112.3 107.675 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.02 73.3 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.244 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 m -64.74 -22.74 67.05 Favored 'General case' 0 CA--C 1.485 -1.542 0 C-N-CA 124.656 1.182 . . . . 145.27 110.627 -175.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.831 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.36 70.42 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.066 -1.086 . . . . 170.15 108.066 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.37 -34.05 63.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 122.702 0.401 . . . . 214.57 110.639 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.27 -33.18 55.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.056 1.742 . . . . 168.29 115.514 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.831 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.91 79.29 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 114.024 1.12 . . . . 167.15 114.024 -168.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.746 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.8 p-10 -64.24 -38.23 32.49 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.472 -2.491 . . . . 165.13 113.932 -171.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.746 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.54 -31.82 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 122.846 2.052 . . . . 123.92 111.241 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.788 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.79 -42.53 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.769 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.22 -39.99 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.803 -0.814 . . . . 145.31 108.803 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.252 63.4 m-85 -58.11 -48.83 78.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 119.386 -0.926 . . . . 246.68 109.854 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.1 m -62.16 -47.51 84.19 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.608 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.1 79.52 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.005 -1.078 . . . . 80.72 110.222 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 115.98 1.844 . . . . 140.44 115.98 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.77 132.22 34.46 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 112.753 -3.579 . . . . 178.87 113.061 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.7 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -64.98 -37.12 86.61 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.4 -1.273 . . . . 110.22 110.125 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.62 72.62 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 121.772 -0.58 . . . . 174.78 109.708 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.67 95.52 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.274 -1.009 . . . . 161.84 108.274 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.478 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.35 -50.17 73.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 120.01 -0.676 . . . . 117.2 109.232 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.838 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.06 75.47 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.328 -0.549 . . . . 112.6 111.114 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.121 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.08 -37.36 94.47 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.671 -0.972 . . . . 101.46 110.671 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.21 -46.02 90.76 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 118.47 1.135 . . . . 151.49 109.511 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.0 -36.34 76.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.984 -1.487 . . . . 142.32 106.984 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.121 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.1 m80 -59.78 -41.85 92.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.41 85.93 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 122.287 -0.258 . . . . 76.11 111.047 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -61.48 -55.46 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.829 -0.748 . . . . 120.24 109.301 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.31 131.57 41.28 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 102.944 -2.984 . . . . 192.73 102.944 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.15 -44.22 92.07 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.017 -1.073 . . . . 176.29 109.22 -172.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.3 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.488 -1.431 0 N-CA-C 106.277 -1.749 . . . . 69.68 106.277 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.02 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.431 0 C-N-CA 118.381 -0.612 . . . . 191.05 112.595 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.48 43.92 16.23 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 123.504 0.502 . . . . 287.03 109.772 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.848 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.56 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.916 0 C-N-CA 112.948 -3.501 . . . . 292.29 109.795 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.51 -152.8 0.05 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.206 -2.516 . . . . 184.57 104.206 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.62 8.75 5.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.061 0.763 . . . . 274.56 113.061 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.85 57.28 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 117.72 -2.181 . . . . 268.24 113.451 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.723 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.58 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 118.694 1.247 . . . . 200.06 110.722 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.76 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.868 -1.16 . . . . 114.44 107.868 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.24 46.07 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.635 -1.246 . . . . 263.81 107.635 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.653 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.218 1 N-CA-C 102.475 -4.25 . . . . 103.79 102.475 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.992 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.27 95.66 10.26 Favored 'General case' 0 N--CA 1.419 -2.014 0 C-N-CA 114.933 -2.707 . . . . 117.3 106.0 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.065 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.82 90.81 Favored 'General case' 0 CA--C 1.468 -2.178 1 N-CA-C 97.986 -4.82 . . . . 231.58 97.986 167.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.067 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.061 -3.311 . . . . 303.24 102.061 169.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.992 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.62 78.61 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.051 -2.26 . . . . 112.72 108.402 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 48.0 t -61.07 -63.6 1.24 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.1 -0.704 . . . . 83.22 109.1 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.28 -126.23 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.81 -2.663 . . . . 174.36 103.81 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.065 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.85 160.96 8.73 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.91 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.085 -1.45 . . . . 180.62 107.085 176.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.947 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.406 -2.072 . . . . 145.25 105.406 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.947 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.12 -43.12 88.05 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.155 -1.795 . . . . 66.05 106.155 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.759 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.509 -2.775 . . . . 266.49 103.509 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.29 -124.9 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.029 -1.868 . . . . 219.2 107.788 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.004 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.14 -37.32 93.98 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 114.546 -1.207 . . . . 94.78 112.853 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.094 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.2 100.42 9.09 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 112.285 -3.766 . . . . 121.41 109.489 -171.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.8 t -73.02 145.5 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.947 -0.76 . . . . 85.34 108.947 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.39 42.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.843 -1.169 . . . . 267.57 107.843 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.11 69.6 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.472 -0.566 . . . . 226.1 109.472 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 107.02 -1.474 . . . . 154.84 107.02 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.505 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.7 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.585 0.707 . . . . 180.01 110.728 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.881 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.47 156.94 23.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.945 -1.502 . . . . 333.78 106.945 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.986 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.5 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.986 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.768 -0.827 . . . . 266.47 108.768 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.59 -46.93 88.41 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.633 -1.988 . . . . 59.34 105.633 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.59 173.85 11.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.428 -2.434 . . . . 201.26 104.428 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.91 106.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 116.298 -2.161 . . . . 56.23 105.509 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.519 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.26 -59.45 5.28 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.24 -0.652 . . . . 87.58 109.24 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.892 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.5 153.77 22.23 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.842 -1.17 . . . . 219.95 107.842 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 116.335 -2.146 . . . . 121.79 105.476 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.13 159.75 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 N-CA-C 105.797 -1.927 . . . . 53.85 105.797 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.623 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 106.021 -2.832 . . . . 196.55 106.021 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.661 0 N-CA-C 107.843 -1.169 . . . . 35.88 107.843 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 1.083 ' HD2' ' HB3' ' A' ' 188' ' ' PRO . 32.6 ttt180 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.841 -0.799 . . . . 1.0 108.841 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 1.022 ' HG3' HD22 ' A' ' 5' ' ' LEU . 50.1 Cg_endo -67.07 143.95 67.58 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.771 1.647 . . . . 1.0 111.815 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.521 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -70.33 127.28 92.28 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.941 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . 0.75 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -68.98 -20.02 39.08 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 122.386 2.057 . . . . 1.0 114.567 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -38.58 77.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.711 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' B' ' 367' ' ' LYS . 2.4 pt20 -71.33 -10.63 60.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.354 . . . . 1.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.75 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 3.1 m-85 -58.56 -46.34 87.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.277 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.66 -48.98 78.39 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.555 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.09 78.27 0.31 Allowed Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 109.878 -1.289 . . . . 1.0 109.878 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -41.72 97.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.333 . . . . 1.0 110.176 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 10.3 mtm . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.477 179.889 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.30000000000001 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.75999999999999 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76000000000001 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.19999999999999 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52000000000001 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61000000000001 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.84999999999999 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36000000000001 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.72999999999999 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.94999999999999 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.799999999999997 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.909999999999997 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.859999999999999 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.460000000000001 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.59999999999999 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26000000000001 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.869999999999997 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.56999999999999 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.060000000000002 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.939999999999998 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.609999999999999 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04000000000001 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.159999999999997 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.850000000000001 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.390000000000001 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65000000000001 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.159999999999997 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.299999999999997 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.40000000000001 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.56999999999999 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.890000000000001 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.010000000000005 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96000000000001 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.31999999999999 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11000000000001 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.659999999999997 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18000000000001 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35000000000002 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.523 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54000000000001 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.219999999999999 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.59999999999999 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46000000000001 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93000000000001 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.30000000000001 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.710000000000001 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.890000000000001 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.890000000000001 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.09999999999999 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.44999999999999 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.59999999999999 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61000000000001 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.189999999999998 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.81999999999999 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98000000000002 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.01999999999998 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05000000000001 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99000000000001 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.42999999999995 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22000000000003 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72000000000003 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.57999999999998 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.60000000000002 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48000000000002 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68000000000001 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.33999999999997 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27000000000001 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08000000000001 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.88999999999999 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61000000000001 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.829999999999998 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.400000000000006 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.299999999999997 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.359999999999999 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.730000000000004 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74000000000001 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.390000000000001 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.340000000000003 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.680000000000007 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.980000000000004 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74000000000001 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55000000000001 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.57999999999998 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.70999999999998 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.50999999999999 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41000000000003 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.229999999999997 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.289999999999999 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.109999999999999 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.329999999999998 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.859999999999999 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.129999999999995 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.879999999999995 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.859999999999999 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.439999999999998 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.640000000000001 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.56999999999999 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.159999999999997 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15000000000001 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.66999999999999 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.41999999999999 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.39999999999998 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.10000000000002 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.80000000000001 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.52999999999997 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99000000000001 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98000000000002 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.80999999999995 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99000000000001 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32000000000005 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.90999999999997 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99000000000001 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86000000000001 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.76999999999998 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99000000000001 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99000000000001 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.180000000000007 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99000000000001 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99000000000001 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72000000000003 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61000000000001 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.88999999999999 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21000000000001 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46000000000001 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61000000000001 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.47999999999999 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.859999999999999 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68000000000001 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.159999999999997 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02000000000001 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.170000000000002 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.59999999999999 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.100000000000001 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.890000000000001 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.409999999999997 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.690000000000001 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.880000000000003 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.290000000000006 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.260000000000005 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.710000000000001 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.859999999999999 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72000000000003 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.780000000000001 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.459999999999994 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.34999999999999 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.56999999999999 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96000000000001 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68000000000001 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.56999999999999 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29000000000002 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92000000000002 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.620000000000005 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.289999999999999 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.969999999999999 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.269999999999996 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.980000000000004 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.049999999999997 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.010000000000005 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.090000000000003 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.390000000000001 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.420000000000002 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51000000000001 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.180000000000007 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.329999999999998 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.230000000000004 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.34999999999999 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.22999999999999 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.77999999999997 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11000000000001 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.53999999999999 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.02999999999997 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21000000000001 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.868 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35000000000002 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91000000000003 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.25999999999999 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.25999999999999 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21000000000001 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.03999999999999 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36000000000001 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.81999999999999 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.89999999999998 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.91999999999999 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18000000000001 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.16999999999999 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27000000000001 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15000000000001 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.56999999999999 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.28999999999999 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15000000000001 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.719999999999999 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.59999999999999 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.45999999999999 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49000000000001 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.31999999999999 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.109999999999999 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.72999999999999 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.28999999999999 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.680000000000007 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05000000000001 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.02999999999997 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29000000000002 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.56999999999999 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24000000000001 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79000000000001 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58000000000001 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.219999999999999 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36000000000001 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.72999999999999 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.049999999999997 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.780000000000001 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.340000000000003 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.56999999999999 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.09999999999999 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.00999999999999 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.893 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.77999999999997 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.19999999999999 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47000000000003 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.340000000000003 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.25999999999999 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.579999999999998 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.94999999999999 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79000000000001 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.850000000000001 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.880000000000003 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.525 ' N ' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.07 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.703 1.602 . . . . 1.0 111.856 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 127.36 92.1 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.276 -0.42 . . . . 1.0 109.876 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.664 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.5 Cg_endo -69.01 -20.03 38.89 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.458 2.106 . . . . 1.0 114.543 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.3 -38.67 77.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.702 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -10.55 59.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 1.0 110.55 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.664 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 4.2 m-30 -58.57 -46.36 87.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.307 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.56 -49.06 78.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.55 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.098 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.368 -0.975 . . . . 97.079999999999998 108.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.63 155.41 22.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.072 0.939 . . . . 123.41 110.739 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.52 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.51 1 N-CA-C 100.136 -4.024 . . . . 151.30000000000001 100.136 173.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.903 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.65 -38.6 58.39 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 115.981 -2.288 . . . . 169.25 106.145 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.903 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.27 168.51 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 122.273 0.617 . . . . 185.75999999999999 110.585 171.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.4 t -64.48 -25.9 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 C-N-CA 126.984 2.114 . . . . 145.47 110.336 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.4 21.51 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.088 -1.007 . . . . 102.76000000000001 109.453 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.58 154.17 25.13 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.014 -1.106 . . . . 106.25 108.014 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.87 51.87 0.74 Allowed 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.645 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.15 -45.9 91.5 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 103.619 -2.734 . . . . 150.19999999999999 103.619 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -86.98 164.7 35.38 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 103.711 -2.699 . . . . 183.52000000000001 103.711 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.79 6.87 3.85 Favored 'Trans proline' 0 C--N 1.281 -3.012 0 N-CA-C 109.948 -0.828 . . . . 235.61000000000001 109.948 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.97 -41.19 82.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.813 1.245 . . . . 113.77 113.375 -170.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.19 136.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 119.555 1.071 . . . . 150.84999999999999 110.947 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.48 156.24 46.4 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.624 -1.25 . . . . 100.42 107.624 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.04 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.974 0.892 . . . . 129.36000000000001 110.445 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.11 -25.45 68.36 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.278 1.831 . . . . 112.34 106.67 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.19 -40.11 62.73 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.565 -0.743 . . . . 131.72999999999999 111.75 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.48 -42.86 15.15 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.95 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.825 0 C-N-CA 118.155 -1.418 . . . . 98.980000000000004 111.21 -169.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.5 Cg_exo -61.82 -10.8 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.917 1 N-CA-C 128.862 6.447 . . . . 246.94999999999999 128.862 -170.05 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.67 17.56 8.77 Favored 'General case' 0 C--N 1.324 -0.523 1 CA-C-N 126.19 4.086 . . . . 269.62 114.183 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.17 -27.25 67.12 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.785 -1.191 . . . . 86.799999999999997 107.785 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.87 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.126 -0.984 . . . . 85.909999999999997 110.517 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 123.663 0.785 . . . . 82.0 111.388 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.44 167.7 12.55 Favored Pre-proline 0 CA--C 1.489 -1.378 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.9 149.75 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.881 . . . . 87.859999999999999 109.913 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.99 89.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.851 -0.796 . . . . 36.460000000000001 108.851 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.8 -33.83 76.54 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.812 -1.181 . . . . 150.59999999999999 107.812 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.4 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.296 -0.877 . . . . 123.26000000000001 108.645 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.53 -47.16 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.42 -31.01 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 107.845 -1.169 . . . . 112.19 107.845 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.12 84.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.899 -0.72 . . . . 60.869999999999997 109.622 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -65.99 -35.65 81.14 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 119.953 -0.699 . . . . 157.56999999999999 110.388 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.614 -0.884 . . . . 47.060000000000002 108.614 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.74 -41.32 98.05 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.743 -0.598 . . . . 43.939999999999998 109.573 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.35 99.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.717 -0.846 . . . . 42.609999999999999 108.717 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.9 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.34 -41.28 94.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.616 -0.266 . . . . 140.66 111.002 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.76 -43.97 97.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 118.596 -1.241 . . . . 116.04000000000001 110.236 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.75 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 N-CA-C 108.728 -0.842 . . . . 97.159999999999997 108.728 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -39.97 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 108.952 -0.759 . . . . 54.850000000000001 108.952 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.74 -42.36 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.835 -0.802 . . . . 45.390000000000001 108.835 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.1 t -63.54 -50.94 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 118.826 -1.15 . . . . 48.640000000000001 110.166 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.25 -47.07 78.04 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.14 -0.624 . . . . 116.65000000000001 111.703 -174.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.96 -43.92 97.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.683 -0.488 . . . . 51.159999999999997 109.683 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.58 -48.92 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 C-N-CA 119.85 -0.74 . . . . 44.299999999999997 110.834 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.78 -46.91 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 120.239 -0.585 . . . . 48.82 111.034 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.76 -44.14 95.23 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.474 -0.87 . . . . 58.700000000000003 112.016 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.64 -34.18 67.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 122.136 -0.626 . . . . 101.40000000000001 111.056 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.97 -38.64 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.742 -1.207 . . . . 103.56999999999999 107.742 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.45 -43.06 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.972 -0.751 . . . . 61.890000000000001 108.972 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.98 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 109.463 -0.569 . . . . 70.010000000000005 109.463 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.37 98.97 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.128 -0.693 . . . . 132.09999999999999 109.128 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.65 82.95 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.706 -0.225 . . . . 104.5 110.435 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.61 -49.91 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 120.233 -0.587 . . . . 142.96000000000001 111.303 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.946 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.68 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.926 -1.91 . . . . 158.31999999999999 110.893 -175.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.73 -41.39 98.05 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 117.71 -1.596 . . . . 137.11000000000001 109.496 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.55 91.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 122.089 -0.382 . . . . 54.659999999999997 110.997 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.44 117.17 29.45 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.646 0.736 . . . . 127.18000000000001 109.559 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.89 -36.74 80.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 124.039 0.935 . . . . 87.930000000000007 110.859 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.045 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.43 -34.62 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.65 -0.656 . . . . 131.12 111.482 -175.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.027 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.67 69.47 7.19 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 115.271 -2.571 . . . . 246.56 109.6 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.24 91.49 3.49 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 105.453 -2.055 . . . . 339.35000000000002 105.453 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.24 17.93 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 102.97 -2.974 . . . . 114.66 102.97 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.11 -39.5 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 106.754 -1.573 . . . . 143.28 106.754 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.7 m -59.67 -38.03 80.38 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.697 -0.853 . . . . 160.22 108.697 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.3 m-20 -62.35 -31.75 72.44 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.893 -0.78 . . . . 120.54000000000001 108.893 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.66 -43.74 95.85 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.482 -0.562 . . . . 67.219999999999999 109.482 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.54 -39.77 88.75 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.537 -0.727 . . . . 138.59999999999999 109.683 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.59 -35.9 82.03 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.449 0.3 . . . . 151.46000000000001 110.644 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.946 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.51 -38.02 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 C-N-CA 117.406 -1.718 . . . . 117.93000000000001 106.719 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.1 -45.97 91.16 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.889 -1.152 . . . . 56.82 107.889 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.94 98.01 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.917 -0.771 . . . . 145.30000000000001 108.917 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.34 95.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.574 -0.898 . . . . 45.710000000000001 108.574 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.36 -42.04 99.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.387 -0.597 . . . . 105.61 109.387 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.47 92.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.668 -0.864 . . . . 47.890000000000001 108.668 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.34 84.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.976 -0.379 . . . . 124.53 109.976 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.19 99.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.944 -0.473 . . . . 35.890000000000001 109.807 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.26 -37.3 84.95 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.966 -1.494 . . . . 88.969999999999999 106.966 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.21 -49.11 77.06 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.809 -0.756 . . . . 239.91 109.064 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.36 90.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.522 -0.736 . . . . 146.09999999999999 110.611 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.872 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.4 1.97 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.764 1.765 . . . . 197.44999999999999 115.764 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.927 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.26 55.63 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 117.891 -1.524 . . . . 242.59999999999999 114.039 -170.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.37 -36.57 84.39 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.862 -1.135 . . . . 215.61000000000001 109.886 -172.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.25 -46.92 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 120.361 -0.536 . . . . 87.189999999999998 110.493 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.88 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 109.754 -0.461 . . . . 231.81999999999999 109.754 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.9 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.1 75.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.349 -0.982 . . . . 364.98000000000002 108.349 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.23 -44.69 75.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.559 -0.713 . . . . 181.63 111.236 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.478 HG22 ' ND1' ' A' ' 95' ' ' HIS . 58.1 m -60.91 -45.76 93.33 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 107.409 -1.33 . . . . 269.01999999999998 107.409 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.78 -45.01 93.62 Favored 'General case' 0 CA--C 1.469 -2.146 0 C-N-CA 118.625 -1.23 . . . . 562.65999999999997 109.983 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.28 95.34 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.685 -1.206 . . . . 446.75 108.066 -167.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.48 -26.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.859 -2.336 . . . . 370.05000000000001 112.195 -178.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.49 -26.49 60.04 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.552 -0.717 . . . . 354.91000000000003 112.478 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.3 m-20 82.76 4.45 1.01 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 125.048 1.339 . . . . 462.44 111.934 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.3 178.06 2.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.971 0.891 . . . . 652.37 111.168 171.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.7 86.35 2.16 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 128.473 2.709 . . . . 905.99000000000001 107.947 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -67.97 -36.36 79.93 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.203 -1.036 . . . . 570.42999999999995 108.203 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.37 82.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.345 1.458 . . . . 453.22000000000003 111.146 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.57 178.68 33.86 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.716 -1.707 . . . . 445.63 109.875 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.754 HD21 ' CE1' ' B' ' 371' ' ' PHE . 89.1 mt -56.45 -41.23 76.13 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.208 1.403 . . . . 457.72000000000003 112.374 -170.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.57 -47.02 85.66 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.69 -1.204 . . . . 340.57999999999998 109.266 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.68 -32.14 71.76 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.802 -1.159 . . . . 453.60000000000002 111.59 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.36 73.37 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.971 -1.863 . . . . 541.48000000000002 105.971 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 75.99 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.949 0.781 . . . . 466.68000000000001 110.873 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.75 -47.09 86.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 117.501 -1.68 . . . . 427.33999999999997 107.296 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.16 -36.76 82.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 112.365 0.506 . . . . 537.87 112.365 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.39 -42.68 74.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 116.882 -1.927 . . . . 422.12 111.604 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.8 t80 -59.04 -50.09 75.4 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 121.34 -0.85 . . . . 340.17000000000002 111.84 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -65.34 -46.48 70.82 Favored Pre-proline 0 N--CA 1.443 -0.776 0 C-N-CA 119.085 -1.046 . . . . 258.06 111.705 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.55 -31.57 87.43 Favored 'Trans proline' 0 N--CA 1.435 -1.954 0 N-CA-C 115.324 1.24 . . . . 305.70999999999998 115.324 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.702 -0.851 . . . . 252.69999999999999 108.702 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.66 93.93 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.776 -1.194 . . . . 149.27000000000001 107.776 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.85 95.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.661 -0.416 . . . . 138.08000000000001 111.509 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.92 -42.35 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 121.587 -0.696 . . . . 132.88999999999999 110.996 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.81 -44.66 92.63 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.84 -0.8 . . . . 193.61000000000001 108.84 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.69 84.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.846 0.458 . . . . 63.829999999999998 110.063 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -64.04 -52.41 59.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 122.068 -0.395 . . . . 76.400000000000006 111.228 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.63 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.188 -1.041 . . . . 171.13 108.188 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.58 91.63 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.82 -0.55 . . . . 78.299999999999997 110.599 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.74 80.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 118.886 -1.126 . . . . 92.359999999999999 109.217 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.26 76.45 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.199 -1.037 . . . . 93.730000000000004 108.199 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.48 -41.61 84.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.193 -1.003 . . . . 132.74000000000001 109.34 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.05 94.65 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.194 -1.41 . . . . 43.390000000000001 107.194 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.5 -41.97 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.593 -0.891 . . . . 59.340000000000003 108.593 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.43 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 121.781 -0.574 . . . . 69.680000000000007 110.491 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.48 -42.79 91.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.287 -1.005 . . . . 106.98 108.287 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.659 -0.817 . . . . 147.63 108.917 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.707 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.17 -41.54 99.25 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.549 -0.908 . . . . 190.06 108.549 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.08 97.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.306 -0.998 . . . . 118.84999999999999 108.306 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.3 -42.76 99.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.99 -0.374 . . . . 102.5 109.99 -177.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.61 95.34 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 121.875 -0.516 . . . . 89.980000000000004 109.853 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.52 -50.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 C-N-CA 118.151 -1.419 . . . . 106.09 111.003 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.746 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.32 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.078 -1.849 . . . . 227.74000000000001 111.847 -174.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.83 100.09 51.01 Favored Pre-proline 0 CA--C 1.486 -1.511 0 C-N-CA 116.261 -2.176 . . . . 262.55000000000001 110.047 -175.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.1 Cg_endo -69.65 -10.33 28.38 Favored 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 121.606 1.537 . . . . 210.25 111.332 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.521 -1.659 . . . . 270.57999999999998 106.521 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.8 -39.52 24.18 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-N 115.377 -0.829 . . . . 129.84 112.312 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.862 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.5 Cg_exo -61.36 -26.65 81.85 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 116.296 1.614 . . . . 330.70999999999998 116.296 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -80.99 77.16 7.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 114.502 -2.879 . . . . 204.50999999999999 107.3 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.35 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.431 -1.322 . . . . 387.41000000000003 107.431 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.65 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 118.761 -1.176 . . . . 166.22 109.461 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.821 -1.177 . . . . 44.229999999999997 107.821 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.28 -39.13 85.77 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.206 -1.035 . . . . 28.800000000000001 108.206 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.83 92.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.074 -0.714 . . . . 30.289999999999999 109.074 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.4 m -59.56 -43.06 93.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.016 -0.735 . . . . 46.109999999999999 109.016 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.1 99.25 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.683 -1.229 . . . . 87.329999999999998 107.683 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.68 -42.1 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.883 -1.155 . . . . 23.690000000000001 107.883 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.23 -44.31 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 109.649 -0.5 . . . . 43.859999999999999 109.649 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.59 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.352 -0.981 . . . . 91.129999999999995 108.352 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.53 -37.97 88.15 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.768 -0.827 . . . . 65.879999999999995 108.768 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.07 -41.96 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.536 -0.542 . . . . 33.859999999999999 109.536 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.34 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.595 -1.261 . . . . 146.52000000000001 107.595 -176.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.33 90.5 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.512 -0.875 . . . . 75.439999999999998 108.849 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.58 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 O-C-N 121.031 -1.043 . . . . 43.640000000000001 109.725 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.73 -37.95 89.26 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 109.027 -0.731 . . . . 102.56999999999999 109.027 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.09 87.01 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.383 -1.34 . . . . 58.159999999999997 107.383 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.03 -32.52 73.91 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.043 -0.725 . . . . 121.11 109.043 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.99 -42.37 84.97 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 118.586 -1.245 . . . . 153.15000000000001 109.895 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.1 -43.73 19.02 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 113.051 -3.46 . . . . 133.66999999999999 113.488 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.9 96.07 Favored 'General case' 0 CA--C 1.489 -1.402 0 O-C-N 120.893 -1.13 . . . . 157.41999999999999 112.226 -171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.521 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.09 2.44 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 115.037 1.495 . . . . 250.91 115.037 -173.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.6 Cg_exo -59.51 -25.47 78.82 Favored 'Trans proline' 0 CA--C 1.488 -1.816 0 N-CA-C 118.018 2.276 . . . . 207.34 118.018 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.914 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.15 -34.21 74.65 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.978 -1.49 . . . . 192.46000000000001 106.978 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.99 98.07 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 107.938 -2.065 . . . . 261.0 107.938 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.83 159.09 26.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 101.554 -3.499 . . . . 491.39999999999998 101.554 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 116.287 -2.165 . . . . 386.10000000000002 109.797 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 103.54 -2.763 . . . . 289.80000000000001 103.54 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.41 0.86 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.725 -1.131 . . . . 402.06 109.556 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 71.9 p -165.29 177.48 7.56 Favored 'General case' 0 CA--C 1.587 2.373 0 C-N-CA 127.323 2.249 . . . . 690.52999999999997 114.902 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.35 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.698 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.84 22.09 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 127.399 2.28 . . . . 617.99000000000001 110.916 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.99 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.246 3.419 . . . . 434.98000000000002 113.455 -175.423 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 122.397 3.96 . . . . 365.88 122.397 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.89 1.7 Allowed 'General case' 0 CA--C 1.467 -2.235 0 N-CA-C 104.83 -2.285 . . . . 635.80999999999995 104.83 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.21 18.83 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.975 7.768 . . . . 999.99000000000001 131.975 -135.735 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.909 36.9 t -131.85 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.73 1 CA-C-N 103.311 -6.313 . . . . 594.32000000000005 113.588 149.175 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.18 144.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.289 -4.708 . . . . 811.90999999999997 98.289 162.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.55 45.91 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.05 -1.86 . . . . 999.99000000000001 109.374 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.22 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.009 0.909 . . . . 431.86000000000001 110.038 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.039 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.14 148.64 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.8 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.51 3.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.109 0.963 . . . . 458.76999999999998 113.486 -174.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.54 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.928 1.291 . . . . 999.99000000000001 112.479 168.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.76 5.65 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 N-CA-C 120.865 3.371 . . . . 999.99000000000001 120.865 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.59 171.69 8.19 Favored 'General case' 0 CA--C 1.472 -2.032 0 C-N-CA 117.2 -1.8 . . . . 81.180000000000007 107.274 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.518 -2.473 . . . . 999.99000000000001 108.767 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.55 101.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.167 1 C-N-CA 126.015 4.477 . . . . 999.99000000000001 105.716 -170.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.18 -44.02 97.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 126.786 2.034 . . . . 967.72000000000003 112.092 -165.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.57 78.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.711 -1.589 . . . . 934.29999999999995 106.711 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.26 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.212 3.005 . . . . 565.14999999999998 113.898 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.51 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 118.468 0.576 . . . . 755.61000000000001 109.863 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.28 67.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.557 1.143 . . . . 325.88999999999999 113.274 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.98 78.37 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 123.55 0.74 . . . . 250.21000000000001 111.64 -169.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.544 0.688 . . . . 142.46000000000001 110.38 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.039 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.14 -41.5 96.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.942 0.897 . . . . 247.69 108.832 -173.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.48 -51.35 69.85 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.467 1.507 . . . . 199.61000000000001 113.103 -175.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.36 -44.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 107.694 -1.225 . . . . 106.73 107.694 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.725 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.13 -48.48 81.46 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.88 -0.6 . . . . 115.01000000000001 110.251 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.28 -49.17 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 C-N-CA 119.433 -0.907 . . . . 129.41999999999999 111.801 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.9 -53.16 59.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 118.23 -1.388 . . . . 172.47999999999999 109.933 -172.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.83 -54.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 123.471 0.482 . . . . 55.859999999999999 110.982 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.95 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 118.551 -1.259 . . . . 184.68000000000001 111.509 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.04 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.41 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 116.67 -2.012 . . . . 291.81 114.715 -174.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -55.05 4.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.54 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.485 1.291 . . . . 80.159999999999997 114.485 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.897 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.48 83.22 Favored Pre-proline 0 N--CA 1.435 -1.198 0 C-N-CA 119.963 -0.695 . . . . 136.02000000000001 109.48 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.8 -27.11 59.7 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.707 0.574 . . . . 92.170000000000002 110.62 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.35 76.63 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.486 -1.302 . . . . 135.59999999999999 107.486 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.14 -44.72 91.33 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.603 -0.517 . . . . 52.100000000000001 109.603 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.68 -43.51 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.111 -0.7 . . . . 95.890000000000001 109.111 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.906 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.33 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.725 -1.583 . . . . 43.409999999999997 106.725 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.33 99.14 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.343 -1.503 . . . . 27.690000000000001 109.343 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.37 75.71 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.476 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.1 74.82 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.976 -1.49 . . . . 53.880000000000003 106.976 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.85 93.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.469 -0.937 . . . . 68.290000000000006 108.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.84 -39.01 92.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.672 -0.811 . . . . 107.59 110.604 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -62.95 -38.41 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.553 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.5 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.358 -0.979 . . . . 85.260000000000005 108.358 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.87 99.43 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.088 -0.805 . . . . 40.710000000000001 111.088 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.08 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.399 -0.963 . . . . 95.859999999999999 108.399 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.93 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.401 -0.962 . . . . 144.37 108.401 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.57 -1.27 . . . . 326.72000000000003 107.57 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.29 -168.03 1.5 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.072 -1.825 . . . . 158.38 106.072 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.458 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.96 98.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.659 -0.496 . . . . 36.780000000000001 109.659 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.12 125.84 25.2 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.17 -1.012 . . . . 85.459999999999994 109.808 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.47 8.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.53 -2.026 . . . . 127.78 105.53 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.96 139.87 34.96 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 106.023 -1.843 . . . . 164.84 106.023 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.6 Cg_exo -56.77 -39.97 87.57 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.935 0.706 . . . . 222.34999999999999 113.935 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.97 44.94 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 106.445 -2.662 . . . . 45.219999999999999 106.445 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.73 93.49 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.035 -1.839 . . . . 107.56999999999999 106.035 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.78 141.83 58.18 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.9 -1.12 . . . . 167.96000000000001 109.168 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.52 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 126.734 2.014 . . . . 280.68000000000001 109.706 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.04 11.23 0.7 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.443 1.097 . . . . 218.25 110.698 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.36 137.64 54.79 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.241 -2.133 . . . . 343.56999999999999 105.241 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.477 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.93 1.54 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.839 -1.541 . . . . 263.29000000000002 106.839 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.26 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 126.568 1.947 . . . . 261.92000000000002 108.522 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.19 -38.1 89.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.893 -1.151 . . . . 106.81 107.893 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.35 -1.34 . . . . 112.2 107.594 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.24 -39.87 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 N-CA-C 109.259 -0.645 . . . . 45.409999999999997 109.259 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.81 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.9 p -70.88 -32.05 68.91 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.313 -0.255 . . . . 97.620000000000005 110.313 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.62 81.66 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.684 0.794 . . . . 59.289999999999999 110.992 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.55 84.01 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.656 1.182 . . . . 106.48999999999999 110.683 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.63 69.2 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.32 -0.993 . . . . 106.62 108.32 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.02 -41.02 91.51 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.809 -0.557 . . . . 75.969999999999999 110.079 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.446 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.6 t -65.57 -40.8 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 122.908 0.483 . . . . 65.269999999999996 109.788 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.06 -41.56 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.154 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.58 -40.76 97.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 121.712 -0.618 . . . . 87.980000000000004 110.27 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.4 96.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 118.815 -1.154 . . . . 65.5 108.367 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.774 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.66 -36.41 80.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.162 -1.051 . . . . 85.049999999999997 108.162 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.6 mt -63.47 -45.77 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 109.053 -0.721 . . . . 42.25 109.053 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.26 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 119.542 -0.863 . . . . 91.010000000000005 109.419 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.86 -41.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.99 -1.115 . . . . 66.090000000000003 107.99 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.6 t -66.07 -43.15 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 120.758 -0.377 . . . . 52.390000000000001 110.293 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.7 m -61.8 -46.73 88.28 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.907 -0.496 . . . . 46.420000000000002 109.866 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.13 88.29 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.323 -0.991 . . . . 116.51000000000001 108.323 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.486 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.26 -48.23 82.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.402 -0.592 . . . . 65.180000000000007 109.402 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.7 97.2 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 120.824 0.345 . . . . 51.329999999999998 110.407 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.34 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 C-N-CA 118.941 -1.103 . . . . 126.3 109.015 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.64 -49.31 69.12 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.539 -0.864 . . . . 133.94 112.456 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.821 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.74 -33.32 35.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 116.826 2.158 . . . . 134.84 116.826 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.43 -41.64 90.37 Favored Pre-proline 0 CA--C 1.493 -1.237 0 CA-C-N 118.632 0.651 . . . . 72.230000000000004 111.644 -167.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.67 -35.98 87.07 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 CA-C-N 119.83 0.975 . . . . 106.13 111.375 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.35 -44.73 82.45 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 119.752 -0.779 . . . . 128.34999999999999 110.051 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.43 -37.85 88.98 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.174 -0.306 . . . . 100.73 110.174 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.3 -44.55 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 C-N-CA 119.274 -0.971 . . . . 172.72 109.123 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.57 -28.06 68.22 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.273 -1.01 . . . . 249.22999999999999 108.273 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.6 -55.11 35.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.644 -1.613 . . . . 259.77999999999997 106.644 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.11 -44.23 72.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.574 0.953 . . . . 233.11000000000001 113.574 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.9 mt -61.38 -48.29 91.41 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 119.162 -1.015 . . . . 169.53999999999999 110.596 -171.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.4 Cg_exo -61.12 -24.56 79.51 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 C-N-CA 116.771 -1.686 . . . . 255.47 114.655 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.54 -44.23 94.8 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.213 0.915 . . . . 279.02999999999997 108.929 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.79 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.073 -0.343 . . . . 162.21000000000001 110.073 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.871 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.83 59.38 Favored Pre-proline 0 N--CA 1.431 -1.399 0 C-N-CA 118.802 -1.159 . . . . 128.13 108.09 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.02 11.28 Favored 'Trans proline' 0 C--N 1.295 -2.264 0 N-CA-C 107.445 -1.79 . . . . 278.35000000000002 107.445 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.07 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 123.829 0.705 . . . . 312.91000000000003 109.37 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 274' ' ' ASN . 28.2 mt -132.75 -170.64 2.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.534 -1.654 . . . . 353.54000000000002 106.534 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.7 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.389 -1.337 . . . . 251.25999999999999 107.389 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.01 -118.69 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.103 -3.295 . . . . 175.25999999999999 102.103 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.5 -45.0 96.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.837 -3.764 . . . . 99.069999999999993 100.837 172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.17 9.17 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.463 -2.791 . . . . 243.21000000000001 103.463 171.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.94 25.08 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 116.051 -2.259 . . . . 201.03999999999999 105.262 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.91 173.76 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 C-N-CA 115.954 -2.298 . . . . 201.36000000000001 108.781 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.281 0.6 OUTLIER -59.49 -41.45 89.84 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.248 -1.796 . . . . 203.81999999999999 107.905 174.44 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.33 -45.69 86.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.21 -1.396 . . . . 215.06 112.562 -171.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.5 t -65.7 -46.4 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 118.529 -1.268 . . . . 125.28 112.928 -171.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.74 -37.07 86.36 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.191 -1.411 . . . . 268.89999999999998 107.191 -171.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.8 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.18 -45.0 74.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 125.6 1.56 . . . . 280.88 108.817 -172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.49 86.0 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.91 -1.116 . . . . 184.47 109.043 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.88 -42.13 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 119.284 -0.966 . . . . 167.91999999999999 112.785 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.86 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 117.772 -1.571 . . . . 367.18000000000001 110.765 -175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.17 -32.74 74.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 121.844 -0.535 . . . . 173.97 110.468 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.72 85.09 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.505 0.722 . . . . 119.66 109.78 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.821 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.95 74.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.686 -1.228 . . . . 112.3 107.686 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.08 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.24 -0.436 . . . . 174.16999999999999 110.263 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.75 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 124.7 1.2 . . . . 145.27000000000001 110.586 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.761 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.64 -35.36 70.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.095 -1.076 . . . . 170.15000000000001 108.095 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.32 -34.15 63.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 116.295 -0.411 . . . . 214.56999999999999 110.609 -171.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.19 -33.18 56.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.084 1.754 . . . . 168.28999999999999 115.566 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.49 -34.82 79.11 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.007 1.114 . . . . 167.15000000000001 114.007 -168.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.22 -38.26 32.86 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 115.512 -2.475 . . . . 165.13 113.937 -171.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.7 Cg_exo -62.55 -31.86 79.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.771 2.025 . . . . 123.92 111.236 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.75 -42.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 118.874 -1.131 . . . . 110.55 109.823 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.15 -40.04 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.86 -0.793 . . . . 145.31 108.86 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.2 m-85 -58.16 -48.82 79.1 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.371 -0.932 . . . . 246.68000000000001 109.81 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.18 -47.45 84.43 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.542 -0.863 . . . . 64.430000000000007 109.621 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.84 -45.07 79.36 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 118.968 -1.093 . . . . 80.719999999999999 110.223 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.02 1.859 . . . . 140.44 116.02 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.25 34.37 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 112.699 -3.6 . . . . 178.87 113.03 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.1 86.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.394 -1.275 . . . . 110.22 110.09 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.71 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.268 0 O-C-N 121.744 -0.598 . . . . 174.78 109.757 -174.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.84 -41.69 95.52 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.273 -1.01 . . . . 161.84 108.273 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.34 -50.23 73.61 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.179 -0.675 . . . . 117.2 109.179 -173.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.53 -44.08 75.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.384 -0.527 . . . . 112.59999999999999 111.056 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.41 94.54 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.647 -0.981 . . . . 101.45999999999999 110.647 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.023 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 91.0 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 118.54 1.17 . . . . 151.49000000000001 109.505 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.15 -36.28 77.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.94 -1.504 . . . . 142.31999999999999 106.94 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.81 -41.81 92.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.885 -1.524 . . . . 109.09 106.885 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.4 85.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.35 -0.219 . . . . 76.109999999999999 111.066 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.44 -55.48 30.78 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.888 -0.725 . . . . 120.23999999999999 109.305 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.52 41.22 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 102.942 -2.984 . . . . 192.72999999999999 102.942 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.22 92.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.048 -1.061 . . . . 176.28999999999999 109.185 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.13 0.82 Allowed Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 106.296 -1.742 . . . . 69.680000000000007 106.296 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.97 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-O 118.711 -0.62 . . . . 191.05000000000001 112.604 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.51 43.89 16.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.62 0.575 . . . . 287.02999999999997 109.753 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.54 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.94 0 C-N-CA 112.964 -3.494 . . . . 292.29000000000002 109.847 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.78 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.21 -2.515 . . . . 184.56999999999999 104.21 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.7 4.98 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.042 0.756 . . . . 274.56 113.042 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.83 57.25 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 117.737 -2.173 . . . . 268.24000000000001 113.47 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.68 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.68 1.24 . . . . 200.06 110.778 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.92 -33.0 74.72 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.858 -1.164 . . . . 114.44 107.858 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.0 21.97 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.65 -1.241 . . . . 263.81 107.65 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.37 -137.28 3.56 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.529 -4.228 . . . . 103.79000000000001 102.529 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.55 10.24 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 114.942 -2.703 . . . . 117.3 106.014 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.92 Favored 'General case' 0 CA--C 1.468 -2.19 1 N-CA-C 98.016 -4.809 . . . . 231.58000000000001 98.016 167.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.045 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.066 -3.309 . . . . 303.24000000000001 102.066 168.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.66 -48.57 78.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 116.047 -2.261 . . . . 112.72 108.39 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.61 1.24 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.124 -0.695 . . . . 83.219999999999999 109.124 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.5 m -156.29 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.791 -2.67 . . . . 174.36000000000001 103.791 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.88 160.98 8.75 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 105.762 -1.94 . . . . 202.72999999999999 105.762 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.027 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.93 149.02 52.56 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.1 -1.445 . . . . 180.62 107.1 176.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.5 -171.87 0.27 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 105.362 -2.088 . . . . 145.25 105.362 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.07 -43.11 88.36 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.192 -1.781 . . . . 66.049999999999997 106.192 174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.74 -152.17 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.482 -2.785 . . . . 266.49000000000001 103.482 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.697 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.36 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.024 -1.87 . . . . 219.19999999999999 107.757 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.98 -37.43 94.25 Favored Glycine 0 N--CA 1.426 -2.018 0 CA-C-N 114.52 -1.218 . . . . 94.780000000000001 112.885 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.2 100.45 9.11 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 112.321 -3.752 . . . . 121.41 109.41 -171.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.7 t -73.08 145.5 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.957 -0.757 . . . . 85.340000000000003 108.957 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.819 -1.178 . . . . 267.56999999999999 107.819 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.06 69.56 0.6 Allowed 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.524 -0.547 . . . . 226.09999999999999 109.524 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.98 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.31 161.93 8.42 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.626 0.727 . . . . 180.00999999999999 110.681 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.97 23.51 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.97 -1.492 . . . . 333.77999999999997 106.97 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.972 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.08 142.54 48.79 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.347 -1.353 . . . . 335.19999999999999 107.347 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.972 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.8 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.744 -0.836 . . . . 266.47000000000003 108.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.3 m -60.62 -46.94 88.38 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.64 -1.985 . . . . 59.340000000000003 105.64 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.84 12.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 104.442 -2.429 . . . . 201.25999999999999 104.442 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.93 106.71 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 C-N-CA 116.347 -2.141 . . . . 56.229999999999997 105.505 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 71.0 m -61.14 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.316 -0.624 . . . . 87.579999999999998 109.316 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.75 22.28 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.813 -1.18 . . . . 219.94999999999999 107.813 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 C-N-CA 116.372 -2.131 . . . . 121.79000000000001 105.423 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.4 t -154.13 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 105.835 -1.913 . . . . 53.850000000000001 105.835 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.034 -2.826 . . . . 196.55000000000001 106.034 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.677 0 N-CA-C 107.832 -1.173 . . . . 35.880000000000003 107.832 -178.934 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.61 ' NH2' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -67.09 144.06 67.92 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.663 1.575 . . . . 1.0 111.833 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' B' ' 367' ' ' LYS . 0.1 OUTLIER -70.4 127.36 92.18 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.22 -0.446 . . . . 1.0 109.905 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.8 Cg_endo -69.04 -20.02 38.77 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.428 2.085 . . . . 1.0 114.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.28 -38.68 77.48 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.725 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -71.36 -10.44 59.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 1.0 110.604 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.754 ' CE1' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -58.63 -46.28 87.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 1.0 110.323 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -61.65 -49.03 78.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.551 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.07 0 N-CA-C 109.819 -1.313 . . . . 1.0 109.819 179.821 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.38 -0.97 . . . . 97.079999999999998 108.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.6 155.4 22.41 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.085 0.945 . . . . 123.41 110.774 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.88 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.57 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.461 1 N-CA-C 100.064 -4.051 . . . . 151.30000000000001 100.064 173.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.58 58.35 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 115.952 -2.299 . . . . 169.25 106.148 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.29 168.52 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 122.301 0.632 . . . . 185.75999999999999 110.568 171.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.5 t -64.44 -25.96 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 127.042 2.137 . . . . 145.47 110.342 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.44 21.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.058 -1.027 . . . . 102.76000000000001 109.445 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.68 154.16 25.0 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.937 -1.134 . . . . 106.25 107.937 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.83 51.84 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.754 -1.578 . . . . 157.81 107.663 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.15 -45.9 91.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.553 -2.758 . . . . 150.19999999999999 103.553 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.67 35.33 Favored Pre-proline 0 N--CA 1.422 -1.852 0 N-CA-C 103.669 -2.715 . . . . 183.52000000000001 103.669 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.71 6.87 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 N-CA-C 110.014 -0.802 . . . . 235.61000000000001 110.014 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.99 -41.16 82.44 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 124.749 1.22 . . . . 113.77 113.409 -170.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.21 136.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 119.564 1.075 . . . . 150.84999999999999 110.973 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.487 ' HA ' HH12 ' B' ' 365' ' ' ARG . 47.7 t -140.5 156.28 46.38 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.59 -1.263 . . . . 100.42 107.59 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.93 0.871 . . . . 129.36000000000001 110.444 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.326 1.85 . . . . 112.34 106.663 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.2 m -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.618 -0.719 . . . . 131.72999999999999 111.739 177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.0 m -84.48 -42.85 15.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 116.984 2.216 . . . . 80.489999999999995 116.984 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -146.01 174.54 3.35 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 118.154 -1.418 . . . . 98.980000000000004 111.21 -169.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.8 Cg_exo -61.8 -10.74 18.09 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.953 6.482 . . . . 246.94999999999999 128.953 -170.103 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.66 17.49 8.7 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.112 4.051 . . . . 269.62 114.229 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.12 -27.27 67.2 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.797 -1.186 . . . . 86.799999999999997 107.797 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.79 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.113 -0.992 . . . . 85.909999999999997 110.502 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.2 t -68.5 -40.23 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.718 0.807 . . . . 82.0 111.371 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.385 0 N-CA-C 108.522 -0.918 . . . . 120.73 108.522 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.905 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.03 149.75 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.882 . . . . 87.859999999999999 109.861 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.96 89.27 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.812 -0.81 . . . . 36.460000000000001 108.812 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.76 -33.87 76.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.87 -1.159 . . . . 150.59999999999999 107.87 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.2 -32.75 73.44 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 121.255 -0.903 . . . . 123.26000000000001 108.661 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.39 -47.21 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.95 -47.12 84.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.951 -0.7 . . . . 60.869999999999997 109.608 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.06 -35.63 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 120.004 -0.678 . . . . 157.56999999999999 110.361 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.67 -40.85 98.37 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.633 -0.877 . . . . 47.060000000000002 108.633 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.25 97.94 Favored 'General case' 0 CA--C 1.496 -1.12 0 O-C-N 121.721 -0.612 . . . . 43.939999999999998 109.544 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.29 99.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.744 -0.836 . . . . 42.609999999999999 108.744 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.29 93.91 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 122.25 -0.281 . . . . 140.66 110.996 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.75 -44.02 97.72 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.605 -1.238 . . . . 116.04000000000001 110.22 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.38 -38.81 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.759 -0.83 . . . . 97.159999999999997 108.759 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -40.03 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.978 -0.749 . . . . 54.850000000000001 108.978 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 93.2 t -57.65 -42.37 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.91 -0.774 . . . . 45.390000000000001 108.91 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.4 t -63.48 -50.99 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 C-N-CA 118.819 -1.152 . . . . 48.640000000000001 110.203 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.25 -47.03 78.17 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.167 -0.613 . . . . 116.65000000000001 111.73 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.95 -43.96 97.74 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.701 -0.481 . . . . 51.159999999999997 109.701 -174.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.58 -48.9 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 119.829 -0.748 . . . . 44.299999999999997 110.854 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.74 -46.97 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 120.299 -0.561 . . . . 48.82 111.027 -174.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.2 95.18 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.561 -0.828 . . . . 58.700000000000003 111.994 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.61 -34.26 67.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.018 -0.695 . . . . 101.40000000000001 111.039 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.89 -38.72 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 107.757 -1.201 . . . . 103.56999999999999 107.757 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.45 -43.01 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.977 -0.749 . . . . 61.890000000000001 108.977 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.43 -50.93 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.303 -0.559 . . . . 70.010000000000005 109.525 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.809 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.43 98.81 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.108 -0.701 . . . . 132.09999999999999 109.108 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.62 83.08 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.649 -0.251 . . . . 104.5 110.443 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.022 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 C-N-CA 120.213 -0.595 . . . . 142.96000000000001 111.253 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.7 pt -64.82 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.957 -1.897 . . . . 158.31999999999999 110.838 -175.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.809 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.71 -41.4 98.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 117.698 -1.601 . . . . 137.11000000000001 109.5 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.52 91.14 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.156 -0.34 . . . . 54.659999999999997 111.015 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.612 0.72 . . . . 127.18000000000001 109.577 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.79 -36.86 80.08 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.102 0.961 . . . . 87.930000000000007 110.859 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.042 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.69 78.75 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.69 -0.631 . . . . 131.12 111.514 -175.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.52 7.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.294 -2.562 . . . . 246.56 109.598 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 105.475 -2.046 . . . . 339.35000000000002 105.475 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.14 165.3 17.79 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.19 -39.4 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.766 -1.568 . . . . 143.28 106.766 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.72 -38.04 80.56 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.67 -0.863 . . . . 160.22 108.67 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.2 m-20 -62.4 -31.78 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.823 -0.806 . . . . 120.54000000000001 108.823 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.57 -43.8 95.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.466 -0.568 . . . . 67.219999999999999 109.466 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.59 -39.78 88.59 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.505 -0.747 . . . . 138.59999999999999 109.623 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.918 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.53 -35.89 81.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.468 0.307 . . . . 151.46000000000001 110.679 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.6 -37.89 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 C-N-CA 117.406 -1.718 . . . . 117.93000000000001 106.724 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.448 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.96 91.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.855 -1.165 . . . . 56.82 107.855 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.017 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.937 -0.764 . . . . 145.30000000000001 108.937 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.38 95.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.495 -0.928 . . . . 45.710000000000001 108.495 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.37 -42.04 99.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.364 -0.606 . . . . 105.61 109.364 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 -39.54 92.78 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.611 -0.885 . . . . 47.890000000000001 108.611 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.37 84.84 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.953 -0.388 . . . . 124.53 109.953 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.24 99.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.968 -0.458 . . . . 35.890000000000001 109.838 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.29 -37.28 84.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.022 -1.473 . . . . 88.969999999999999 107.022 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.822 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.16 76.96 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.086 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.4 -43.41 90.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.511 -0.743 . . . . 146.09999999999999 110.591 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 117.423 -1.711 . . . . 91.739999999999995 113.829 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.47 1.95 Allowed 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 115.719 1.748 . . . . 197.44999999999999 115.719 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.932 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.23 -42.2 55.88 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 117.866 -1.534 . . . . 242.59999999999999 114.073 -170.024 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.48 -36.5 84.04 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.919 -1.113 . . . . 215.61000000000001 109.797 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 73.0 t -60.36 -46.95 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 O-C-N 121.782 -0.574 . . . . 87.189999999999998 110.399 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.89 -41.84 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 O-C-N 121.942 -0.474 . . . . 231.81999999999999 109.776 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.9 m-20 -62.39 -34.12 76.09 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.306 -0.998 . . . . 364.98000000000002 108.306 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.2 -44.74 75.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.533 -0.729 . . . . 181.63 111.228 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.3 m -60.8 -45.81 92.95 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 107.468 -1.308 . . . . 269.01999999999998 107.468 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.07 93.25 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 118.679 -1.209 . . . . 562.65999999999997 110.004 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.22 95.59 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 118.634 -1.226 . . . . 446.75 108.103 -167.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.46 -26.35 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.875 -2.33 . . . . 370.05000000000001 112.197 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.49 -26.51 60.06 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.565 -0.71 . . . . 354.91000000000003 112.491 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.49 0.98 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.047 1.339 . . . . 462.44 111.868 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.9 mm-40 -172.35 178.09 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.009 0.909 . . . . 652.37 111.129 171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.78 86.31 2.2 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 128.492 2.717 . . . . 905.99000000000001 107.906 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.83 -36.45 80.38 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.261 -1.014 . . . . 570.42999999999995 108.261 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.34 82.36 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 125.331 1.453 . . . . 453.22000000000003 111.129 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.48 178.65 33.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.939 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.91 HD21 ' NZ ' ' B' ' 367' ' ' LYS . 89.0 mt -56.4 -41.21 75.92 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 125.274 1.43 . . . . 457.72000000000003 112.38 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.02 Favored 'General case' 0 CA--C 1.484 -1.569 0 C-N-CA 118.678 -1.209 . . . . 340.57999999999998 109.335 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.66 -32.23 71.92 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 118.819 -1.152 . . . . 453.60000000000002 111.544 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.3 73.26 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.013 -1.847 . . . . 541.48000000000002 106.013 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.21 75.83 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 123.972 0.795 . . . . 466.68000000000001 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.72 -47.09 86.85 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 117.527 -1.669 . . . . 427.33999999999997 107.306 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.82 82.77 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 112.402 0.519 . . . . 537.87 112.402 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.33 -42.73 74.93 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 116.845 -1.942 . . . . 422.12 111.576 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.15 75.18 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.314 -0.866 . . . . 340.17000000000002 111.84 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.27 -46.49 71.52 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.084 -1.047 . . . . 258.06 111.75 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.53 -31.56 87.52 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 N-CA-C 115.323 1.24 . . . . 305.70999999999998 115.323 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.712 -0.848 . . . . 252.69999999999999 108.712 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.56 93.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.8 -1.185 . . . . 149.27000000000001 107.8 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.05 -44.78 95.95 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 120.632 -0.427 . . . . 138.08000000000001 111.506 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.93 -42.42 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.523 -0.735 . . . . 132.88999999999999 110.966 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.71 -44.68 92.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.749 -0.78 . . . . 193.61000000000001 108.925 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.7 84.55 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 122.838 0.455 . . . . 63.829999999999998 110.079 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.98 -52.4 59.81 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.057 -0.402 . . . . 76.400000000000006 111.233 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.68 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.166 -1.05 . . . . 171.13 108.166 -174.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.82 -38.52 91.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 121.889 -0.507 . . . . 78.299999999999997 110.612 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.13 -35.71 80.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.897 -1.121 . . . . 92.359999999999999 109.231 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . 1.017 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.51 -34.31 76.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.131 -1.062 . . . . 93.730000000000004 108.131 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.908 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.39 -41.65 84.63 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.248 -0.981 . . . . 132.74000000000001 109.346 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.1 94.86 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.17 -1.419 . . . . 43.390000000000001 107.17 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.826 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.9 t -58.43 -42.03 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.59 -0.893 . . . . 59.340000000000003 108.59 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.04 95.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 121.838 -0.539 . . . . 69.680000000000007 110.523 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.46 -42.77 91.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.333 -0.988 . . . . 106.98 108.333 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.826 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.58 81.36 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 119.712 -0.795 . . . . 147.63 108.928 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.56 99.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.514 -0.921 . . . . 190.06 108.514 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.32 -44.04 97.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.313 -0.995 . . . . 118.84999999999999 108.313 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.808 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.68 98.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.64 95.28 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 121.827 -0.546 . . . . 89.980000000000004 109.86 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.72 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 C-N-CA 118.098 -1.441 . . . . 106.09 111.035 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.29 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.062 -1.855 . . . . 227.74000000000001 111.799 -174.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.89 100.06 50.94 Favored Pre-proline 0 CA--C 1.486 -1.515 0 C-N-CA 116.237 -2.185 . . . . 262.55000000000001 110.05 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.57 -10.42 28.66 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.678 1.586 . . . . 210.25 111.341 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.03 1.0 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 106.556 -1.646 . . . . 270.57999999999998 106.556 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.893 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.49 23.54 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 115.382 -0.826 . . . . 129.84 112.325 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.38 -26.59 81.68 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 N-CA-C 116.31 1.619 . . . . 330.70999999999998 116.31 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 114.467 -2.893 . . . . 204.50999999999999 107.289 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.415 -1.328 . . . . 387.41000000000003 107.415 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.73 147.04 33.64 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 118.729 -1.188 . . . . 166.22 109.446 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.73 87.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.841 -1.17 . . . . 44.229999999999997 107.841 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.0 m -60.29 -39.11 85.76 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.2 -1.037 . . . . 28.800000000000001 108.2 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.73 92.0 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.103 -0.702 . . . . 30.289999999999999 109.103 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.65 -42.99 94.03 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.981 -0.748 . . . . 46.109999999999999 108.981 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -42.11 99.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.671 -1.233 . . . . 87.329999999999998 107.671 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.67 -42.07 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.916 -1.142 . . . . 23.690000000000001 107.916 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.21 -44.31 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.625 -0.509 . . . . 43.859999999999999 109.625 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.55 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.263 -1.014 . . . . 91.129999999999995 108.263 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.58 -37.98 88.32 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.72 -0.844 . . . . 65.879999999999995 108.72 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.86 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.52 -0.548 . . . . 33.859999999999999 109.52 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.35 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.556 -1.275 . . . . 146.52000000000001 107.556 -176.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.84 -38.35 90.41 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.475 -0.89 . . . . 75.439999999999998 108.878 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.4 t -60.58 -48.4 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.063 -1.023 . . . . 43.640000000000001 109.72 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.795 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -37.95 89.29 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.096 -0.705 . . . . 102.56999999999999 109.096 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.08 86.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.403 -1.332 . . . . 58.159999999999997 107.403 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.53 73.93 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.989 -0.745 . . . . 121.11 108.989 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.03 -42.26 84.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 C-N-CA 118.55 -1.26 . . . . 153.15000000000001 109.948 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.05 -43.76 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 113.09 -3.444 . . . . 133.66999999999999 113.533 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.899 -1.126 . . . . 157.41999999999999 112.167 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.12 2.45 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 115.011 1.485 . . . . 250.91 115.011 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.5 Cg_exo -59.54 -25.42 78.7 Favored 'Trans proline' 0 CA--C 1.488 -1.81 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.913 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.19 -34.21 74.71 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.915 -1.513 . . . . 192.46000000000001 106.915 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.02 98.1 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 108.033 -2.027 . . . . 261.0 108.033 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.77 159.13 25.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.529 -3.508 . . . . 491.39999999999998 101.529 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 116.278 -2.169 . . . . 386.10000000000002 109.819 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.08 -166.61 2.41 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 103.511 -2.774 . . . . 289.80000000000001 103.511 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.137 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 117.745 -1.121 . . . . 402.06 109.534 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.5 p -165.3 177.54 7.51 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.314 2.246 . . . . 690.52999999999997 114.94 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.181 4.511 . . . . 633.62 123.181 162.742 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.58 153.79 22.17 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.415 2.286 . . . . 617.99000000000001 110.918 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.67 174.39 6.01 Favored Pre-proline 0 C--N 1.364 1.222 0 C-N-CA 130.255 3.422 . . . . 434.98000000000002 113.417 -175.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 N-CA-C 122.408 3.965 . . . . 365.88 122.408 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.7 m -84.88 20.92 1.7 Allowed 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.791 -2.3 . . . . 635.80999999999995 104.791 178.16 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.36 152.27 18.77 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.934 7.753 . . . . 999.99000000000001 131.934 -135.746 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.85 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.747 1 CA-C-N 103.264 -6.335 . . . . 594.32000000000005 113.573 149.195 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.21 144.07 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 1 N-CA-C 98.337 -4.69 . . . . 811.90999999999997 98.337 162.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.47 144.55 45.92 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.074 -1.851 . . . . 999.99000000000001 109.419 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.972 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.24 -175.65 4.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.007 0.908 . . . . 431.86000000000001 110.018 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.12 148.68 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 124.384 1.074 . . . . 457.18000000000001 108.758 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.49 3.77 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 124.071 0.948 . . . . 458.76999999999998 113.506 -174.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.38 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.9 1.28 . . . . 999.99000000000001 112.424 168.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.78 5.63 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 120.84 3.362 . . . . 999.99000000000001 120.84 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.164 -1.814 . . . . 81.180000000000007 107.248 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.12 45.12 0.19 Allowed Pre-proline 0 N--CA 1.423 -1.817 0 CA-C-O 114.866 -2.492 . . . . 999.99000000000001 108.748 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.52 101.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.141 1 C-N-CA 126.051 4.501 . . . . 999.99000000000001 105.7 -170.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.03 97.47 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 126.748 2.019 . . . . 967.72000000000003 112.045 -165.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.5 77.99 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.779 -1.563 . . . . 934.29999999999995 106.779 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.27 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 129.196 2.998 . . . . 565.14999999999998 113.938 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.55 55.4 2.79 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 118.423 0.556 . . . . 755.61000000000001 109.849 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.137 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.48 -49.35 66.9 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.59 1.156 . . . . 325.88999999999999 113.203 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.94 78.32 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 123.557 0.743 . . . . 250.21000000000001 111.61 -169.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.81 -43.28 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.552 0.691 . . . . 142.46000000000001 110.375 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.1 -41.56 96.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 123.983 0.913 . . . . 247.69 108.806 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.5 -51.34 69.85 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.453 1.501 . . . . 199.61000000000001 113.086 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.35 -44.45 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.754 -1.202 . . . . 106.73 107.754 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.14 -48.53 81.28 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.832 -0.622 . . . . 115.01000000000001 110.241 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.25 -49.2 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.431 -0.908 . . . . 129.41999999999999 111.811 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.3 m -61.79 -53.18 59.38 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.223 -1.391 . . . . 172.47999999999999 109.969 -172.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.6 t -63.9 -54.19 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 120.489 -0.484 . . . . 55.859999999999999 110.987 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.62 -51.52 58.98 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.513 -1.275 . . . . 184.68000000000001 111.501 -174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.64 -52.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.635 -2.026 . . . . 291.81 114.695 -174.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 115.153 1.538 . . . . 130.66 115.153 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.9 -48.46 68.66 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.493 1.294 . . . . 80.159999999999997 114.493 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.53 83.3 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 119.996 -0.682 . . . . 136.02000000000001 109.483 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.4 Cg_exo -64.79 -27.11 59.75 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.617 -0.57 . . . . 92.170000000000002 110.617 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.36 76.62 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.478 -1.304 . . . . 135.59999999999999 107.478 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.63 91.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.61 -0.515 . . . . 52.100000000000001 109.61 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.72 -43.51 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.056 -0.72 . . . . 95.890000000000001 109.056 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.908 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.31 -42.33 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.655 -1.609 . . . . 43.409999999999997 106.655 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.22 99.06 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.338 -1.505 . . . . 27.690000000000001 109.338 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.888 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.76 -47.35 75.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 117.411 0.605 . . . . 54.409999999999997 110.423 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 107.005 -1.479 . . . . 53.880000000000003 107.005 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.71 -40.83 93.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.517 -0.92 . . . . 68.290000000000006 108.517 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -39.04 92.94 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 119.71 -0.796 . . . . 107.59 110.634 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.41 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.514 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.3 -22.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.414 -0.958 . . . . 85.260000000000005 108.414 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.91 99.43 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.089 -0.804 . . . . 40.710000000000001 111.089 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.7 -44.12 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 108.386 -0.968 . . . . 95.859999999999999 108.386 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.89 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.445 -0.946 . . . . 144.37 108.445 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.38 132.15 47.48 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 107.61 -1.255 . . . . 326.72000000000003 107.61 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.025 -1.843 . . . . 158.38 106.025 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.85 98.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.676 -0.49 . . . . 36.780000000000001 109.676 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.14 125.8 25.05 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.15 -1.02 . . . . 85.459999999999994 109.812 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.539 -2.023 . . . . 127.78 105.539 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.89 34.77 Favored Pre-proline 0 CA--C 1.493 -1.233 0 N-CA-C 105.929 -1.878 . . . . 164.84 105.929 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.7 Cg_exo -56.82 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.189 0 N-CA-C 113.926 0.702 . . . . 222.34999999999999 113.926 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.1 166.95 44.94 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 106.435 -2.666 . . . . 45.219999999999999 106.435 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.9 -45.81 93.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.058 -1.83 . . . . 107.56999999999999 106.058 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.4 m -65.73 141.77 58.23 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 118.924 -1.11 . . . . 167.96000000000001 109.151 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.56 106.71 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.67 1.988 . . . . 280.68000000000001 109.71 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.98 11.31 0.7 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.455 1.102 . . . . 218.25 110.694 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.58 54.78 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.234 -2.135 . . . . 343.56999999999999 105.234 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.95 81.89 1.53 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.868 -1.53 . . . . 263.29000000000002 106.868 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.35 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 126.565 1.946 . . . . 261.92000000000002 108.484 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.1 89.83 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.891 -1.151 . . . . 106.81 107.891 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.391 -1.324 . . . . 112.2 107.531 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.735 HG12 ' NH1' ' A' ' 244' ' ' ARG . 76.0 t -64.36 -39.77 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 109.247 -0.649 . . . . 45.409999999999997 109.247 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.07 68.91 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.28 -0.267 . . . . 97.620000000000005 110.28 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.6 81.71 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.691 0.796 . . . . 59.289999999999999 110.976 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.26 -36.49 83.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.624 1.17 . . . . 106.48999999999999 110.668 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.68 69.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.302 -0.999 . . . . 106.62 108.302 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.08 91.62 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 121.87 -0.518 . . . . 75.969999999999999 110.039 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.52 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 C-N-CA 122.909 0.484 . . . . 65.269999999999996 109.802 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.95 -41.64 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 C-N-CA 120.391 -0.524 . . . . 107.94 110.174 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.49 -40.82 98.09 Favored 'General case' 0 N--CA 1.434 -1.235 0 O-C-N 121.649 -0.657 . . . . 87.980000000000004 110.3 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.62 -40.4 96.81 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.794 -1.162 . . . . 65.5 108.378 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.127 -1.064 . . . . 85.049999999999997 108.127 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.5 -45.72 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 109.076 -0.712 . . . . 42.25 109.076 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.31 -38.3 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.55 -0.86 . . . . 91.010000000000005 109.378 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.003 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.0 t -58.89 -41.54 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.96 -1.126 . . . . 66.090000000000003 107.96 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.23 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 O-C-N 122.108 -0.37 . . . . 52.390000000000001 110.324 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.77 88.2 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 121.883 -0.511 . . . . 46.420000000000002 109.856 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.742 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.35 -38.12 88.28 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.311 -0.996 . . . . 116.51000000000001 108.311 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.26 -48.22 82.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.384 -0.599 . . . . 65.180000000000007 109.384 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.67 97.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 122.118 -0.364 . . . . 51.329999999999998 110.432 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.32 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 C-N-CA 118.91 -1.116 . . . . 126.3 109.016 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.31 69.25 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.476 -0.889 . . . . 133.94 112.491 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.67 -33.43 35.54 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.853 2.168 . . . . 134.84 116.853 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.41 -41.61 90.22 Favored Pre-proline 0 CA--C 1.493 -1.236 0 O-C-N 121.671 -0.643 . . . . 72.230000000000004 111.647 -167.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.2 Cg_exo -60.66 -35.98 87.15 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 CA-C-N 119.887 0.995 . . . . 106.13 111.334 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.7 82.21 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.728 -0.789 . . . . 128.34999999999999 110.027 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.639 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.8 88.79 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.24 -0.281 . . . . 100.73 110.24 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.55 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 119.285 -0.966 . . . . 172.72 109.137 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.59 -28.07 68.22 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.195 -1.039 . . . . 249.22999999999999 108.195 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.58 -55.1 35.96 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.667 -1.605 . . . . 259.77999999999997 106.667 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.2 -44.15 72.7 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.568 0.951 . . . . 233.11000000000001 113.568 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.839 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.29 91.35 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 119.182 -1.007 . . . . 169.53999999999999 110.588 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.07 -24.59 79.72 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.707 -1.728 . . . . 255.47 114.708 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.57 -44.22 94.72 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 119.189 0.904 . . . . 279.02999999999997 108.899 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.29 -44.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 110.091 -0.337 . . . . 162.21000000000001 110.091 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.87 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.43 84.87 59.36 Favored Pre-proline 0 N--CA 1.431 -1.394 0 C-N-CA 118.712 -1.195 . . . . 128.13 108.028 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.28 164.04 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.274 0 N-CA-C 107.443 -1.791 . . . . 278.35000000000002 107.443 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.12 15.03 9.93 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 123.756 0.66 . . . . 312.91000000000003 109.343 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.7 -170.65 2.48 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.506 -1.664 . . . . 353.54000000000002 106.506 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.28 46.95 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.389 -1.337 . . . . 251.25999999999999 107.389 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.069 -3.308 . . . . 175.25999999999999 102.069 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.96 96.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 100.894 -3.743 . . . . 99.069999999999993 100.894 172.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.46 124.16 9.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.455 -2.794 . . . . 243.21000000000001 103.455 171.198 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.99 112.97 25.11 Favored 'General case' 0 CA--C 1.473 -2.0 0 C-N-CA 115.992 -2.283 . . . . 201.03999999999999 105.316 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 C-N-CA 116.02 -2.272 . . . . 201.36000000000001 108.82 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.52 -41.44 89.98 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.28 -1.782 . . . . 203.81999999999999 107.834 174.516 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.92 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.26 -45.77 86.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 118.213 -1.395 . . . . 215.06 112.538 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.61 -46.47 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.607 -1.237 . . . . 125.28 112.917 -171.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -36.94 85.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.229 -1.397 . . . . 268.89999999999998 107.229 -171.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.29 -44.97 74.32 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.617 1.567 . . . . 280.88 108.792 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.48 86.06 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.004 -1.078 . . . . 184.47 108.958 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.99 -42.09 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 119.285 -0.966 . . . . 167.91999999999999 112.709 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.81 90.18 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 117.792 -1.563 . . . . 367.18000000000001 110.734 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.2 -32.7 73.95 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.824 -0.547 . . . . 173.97 110.402 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.52 -36.73 85.14 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.559 0.744 . . . . 119.66 109.797 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.21 -34.0 74.39 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.703 -1.221 . . . . 112.3 107.703 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.08 73.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.228 -0.442 . . . . 174.16999999999999 110.235 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.6 m -64.7 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 124.685 1.194 . . . . 145.27000000000001 110.627 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.62 -35.4 70.41 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.093 -1.077 . . . . 170.15000000000001 108.093 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.822 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.26 -34.17 63.81 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 122.721 0.408 . . . . 214.56999999999999 110.63 -171.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.21 -33.2 56.29 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.022 1.729 . . . . 168.28999999999999 115.548 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.35 -34.9 79.22 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 114.096 1.147 . . . . 167.15000000000001 114.096 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.18 -38.32 33.67 Favored Pre-proline 0 N--CA 1.434 -1.234 0 C-N-CA 115.485 -2.486 . . . . 165.13 113.931 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.57 -31.81 79.82 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 CA-C-N 122.809 2.039 . . . . 123.92 111.231 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.77 -42.54 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.845 -1.142 . . . . 110.55 109.807 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.003 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.16 -39.99 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.849 -0.797 . . . . 145.31 108.849 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.918 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.08 -48.88 78.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.447 -0.901 . . . . 246.68000000000001 109.789 -177.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.18 -47.48 84.29 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.524 -0.87 . . . . 64.430000000000007 109.565 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.06 79.34 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 118.985 -1.086 . . . . 80.719999999999999 110.2 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.72 75.91 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 116.022 1.86 . . . . 140.44 116.022 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.79 132.24 34.45 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 112.71 -3.596 . . . . 178.87 113.031 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.35 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.358 -1.292 . . . . 110.22 110.112 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.71 -50.61 72.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 121.74 -0.6 . . . . 174.78 109.756 -174.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.95 -41.63 95.32 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.31 -50.23 73.59 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.011 -0.676 . . . . 117.2 109.214 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.08 75.54 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.375 -0.53 . . . . 112.59999999999999 111.113 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.11 -37.44 94.57 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.596 -1.002 . . . . 101.45999999999999 110.596 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.022 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.13 -45.98 91.05 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 118.485 1.143 . . . . 151.49000000000001 109.541 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.13 -36.31 77.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.931 -1.507 . . . . 142.31999999999999 106.931 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.72 -41.9 91.9 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.46 85.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 122.309 -0.244 . . . . 76.109999999999999 111.019 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -55.51 30.77 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.374 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.29 131.5 41.23 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.94 -2.985 . . . . 192.72999999999999 102.94 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.18 92.14 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 119.0 -1.08 . . . . 176.28999999999999 109.192 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.8 m -79.4 -177.1 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.464 0 N-CA-C 106.332 -1.729 . . . . 69.680000000000007 106.332 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -58.97 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 118.368 -0.621 . . . . 191.05000000000001 112.583 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.54 43.87 16.43 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 123.562 0.539 . . . . 287.02999999999997 109.756 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.5 78.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 112.977 -3.489 . . . . 292.29000000000002 109.847 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.41 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 104.195 -2.52 . . . . 184.56999999999999 104.195 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.69 4.94 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 113.038 0.755 . . . . 274.56 113.038 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.92 57.3 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 117.69 -2.195 . . . . 268.24000000000001 113.487 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.5 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.641 1.221 . . . . 200.06 110.788 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.1 21.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.593 -1.262 . . . . 263.81 107.593 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.37 3.61 Favored Glycine 0 CA--C 1.479 -2.206 1 N-CA-C 102.518 -4.233 . . . . 103.79000000000001 102.518 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.054 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.29 95.64 10.26 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 114.914 -2.715 . . . . 117.3 106.016 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.93 -39.82 90.84 Favored 'General case' 0 CA--C 1.468 -2.179 1 N-CA-C 97.989 -4.819 . . . . 231.58000000000001 97.989 167.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.042 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.45 29.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.097 -3.297 . . . . 303.24000000000001 102.097 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.054 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.62 78.64 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 116.022 -2.271 . . . . 112.72 108.391 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.71 1.2 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.095 -0.706 . . . . 83.219999999999999 109.095 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.7 m -156.24 -126.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.86 -2.644 . . . . 174.36000000000001 103.86 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.9 160.97 8.81 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.787 -1.931 . . . . 202.72999999999999 105.787 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.093 -1.447 . . . . 180.62 107.093 176.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.52 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 105.356 -2.09 . . . . 145.25 105.356 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.05 -43.17 88.27 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.171 -1.789 . . . . 66.049999999999997 106.171 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.69 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.536 -2.764 . . . . 266.49000000000001 103.536 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.31 -124.96 0.28 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.023 -1.871 . . . . 219.19999999999999 107.793 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.38 94.15 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.552 -1.204 . . . . 94.780000000000001 112.877 -176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.19 100.41 9.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.324 -3.751 . . . . 121.41 109.469 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.01 145.49 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 108.948 -0.76 . . . . 85.340000000000003 108.948 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.47 41.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.865 -1.161 . . . . 267.56999999999999 107.865 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.518 -0.549 . . . . 226.09999999999999 109.518 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.6 p -50.93 156.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.997 -1.483 . . . . 154.84 106.997 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.58 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.36 161.94 8.53 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.627 0.727 . . . . 180.00999999999999 110.679 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.898 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.44 156.91 23.66 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.964 -1.495 . . . . 333.77999999999997 106.964 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.48 48.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.355 -1.35 . . . . 335.19999999999999 107.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.4 mm-40 82.85 158.84 0.13 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.739 -0.838 . . . . 266.47000000000003 108.739 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.53 -46.93 88.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.674 -1.972 . . . . 59.340000000000003 105.674 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.6 173.83 11.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.415 -2.439 . . . . 201.25999999999999 104.415 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.0 mt -95.87 106.68 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 116.322 -2.151 . . . . 56.229999999999997 105.562 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.11 -59.46 5.3 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.309 -0.626 . . . . 87.579999999999998 109.309 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.893 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.53 153.74 22.24 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 107.841 -1.17 . . . . 219.94999999999999 107.841 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.04 83.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.35 -2.14 . . . . 121.79000000000001 105.435 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 105.86 -1.904 . . . . 53.850000000000001 105.86 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.58 77.09 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 106.067 -2.813 . . . . 196.55000000000001 106.067 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.683 0 N-CA-C 107.848 -1.167 . . . . 35.880000000000003 107.848 -178.866 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.487 HH12 ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.04 144.09 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.67 1.58 . . . . 1.0 111.831 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.91 ' NZ ' HD21 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -70.52 127.39 92.07 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.248 -0.433 . . . . 1.0 109.864 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.4 Cg_endo -69.09 -19.96 38.61 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.496 2.13 . . . . 1.0 114.504 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.512 ' HB3' ' HD2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -58.31 -38.66 77.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.789 -178.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -71.28 -10.48 59.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.812 0.339 . . . . 1.0 110.578 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.811 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.66 -46.34 87.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.28 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -49.03 78.29 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.596 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.113 0 N-CA-C 109.764 -1.334 . . . . 1.0 109.764 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.365 -0.976 . . . . 97.079999999999998 108.365 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.088 0.946 . . . . 123.41 110.766 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.888 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.62 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.513 1 N-CA-C 100.056 -4.053 . . . . 151.30000000000001 100.056 173.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.904 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.57 58.05 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.939 -2.305 . . . . 169.25 106.139 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.27 0.616 . . . . 185.75999999999999 110.53 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.5 -25.86 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.988 2.115 . . . . 145.47 110.383 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.77 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.38 21.48 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.099 -1.0 . . . . 102.76000000000001 109.427 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.58 154.2 25.1 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.994 -1.113 . . . . 106.25 107.994 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.914 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.9 51.9 0.74 Allowed 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 117.807 -1.557 . . . . 157.81 107.616 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.24 -45.87 91.75 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.585 -2.746 . . . . 150.19999999999999 103.585 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.01 164.71 35.26 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 103.652 -2.721 . . . . 183.52000000000001 103.652 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -76.82 6.92 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.982 0 N-CA-C 109.973 -0.818 . . . . 235.61000000000001 109.973 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.95 -41.24 82.44 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 124.781 1.233 . . . . 113.77 113.377 -170.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.21 136.2 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 119.605 1.093 . . . . 150.84999999999999 110.989 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.595 -1.261 . . . . 100.42 107.595 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.077 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.967 0.889 . . . . 129.36000000000001 110.389 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.1 -25.43 68.36 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 126.241 1.816 . . . . 112.34 106.702 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.4 m -74.1 -40.2 62.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.545 -0.752 . . . . 131.72999999999999 111.766 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.077 ' H ' HG23 ' A' ' 17' ' ' THR . 71.6 m -84.42 -42.85 15.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 117.036 2.236 . . . . 80.489999999999995 117.036 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -146.0 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 118.151 -1.42 . . . . 98.980000000000004 111.198 -169.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.0 Cg_exo -61.81 -10.8 18.29 Favored 'Trans proline' 0 C--N 1.321 -0.898 1 N-CA-C 128.919 6.469 . . . . 246.94999999999999 128.919 -170.09 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.58 8.75 Favored 'General case' 0 C--N 1.324 -0.542 1 CA-C-N 126.152 4.069 . . . . 269.62 114.209 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.12 -27.33 67.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.816 -1.179 . . . . 86.799999999999997 107.816 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.119 -0.988 . . . . 85.909999999999997 110.493 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.869 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.57 -40.18 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.728 0.811 . . . . 82.0 111.339 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.894 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.44 167.73 12.49 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.518 -0.919 . . . . 120.73 108.518 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.97 149.76 89.85 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 120.578 0.852 . . . . 87.859999999999999 109.937 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.05 -37.92 89.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.884 -0.784 . . . . 36.460000000000001 108.884 -176.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.91 76.73 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.812 -1.181 . . . . 150.59999999999999 107.812 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.16 -32.74 73.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 121.301 -0.874 . . . . 123.26000000000001 108.645 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.15 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.4 -31.02 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.918 -1.141 . . . . 112.19 107.918 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.4 tp -63.02 -47.09 84.55 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.924 -0.71 . . . . 60.869999999999997 109.576 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.6 80.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.933 -0.707 . . . . 157.56999999999999 110.392 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.92 98.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.622 -0.881 . . . . 47.060000000000002 108.622 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.19 97.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.745 -0.597 . . . . 43.939999999999998 109.526 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.735 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.88 -43.29 99.14 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.688 -0.856 . . . . 42.609999999999999 108.688 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.22 93.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.625 -0.261 . . . . 140.66 111.024 -178.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.81 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.566 -1.254 . . . . 116.04000000000001 110.211 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.43 -38.72 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.747 -0.835 . . . . 97.159999999999997 108.747 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.34 -39.94 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.99 -0.744 . . . . 54.850000000000001 108.99 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.72 -42.39 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 108.877 -0.786 . . . . 45.390000000000001 108.877 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.6 t -63.49 -50.94 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.217 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.26 -47.07 78.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.196 -0.601 . . . . 116.65000000000001 111.693 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -62.0 -43.93 97.81 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.705 -0.48 . . . . 51.159999999999997 109.705 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.7 t -65.5 -48.93 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.878 -0.729 . . . . 44.299999999999997 110.878 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.8 -46.94 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 120.308 -0.557 . . . . 48.82 110.995 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.2 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.505 -0.855 . . . . 58.700000000000003 111.987 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.66 -34.17 67.07 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 122.118 -0.637 . . . . 101.40000000000001 111.032 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 107.748 -1.204 . . . . 103.56999999999999 107.748 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.4 -43.06 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 108.965 -0.754 . . . . 61.890000000000001 108.965 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.9 t -63.45 -50.93 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 109.453 -0.573 . . . . 70.010000000000005 109.453 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.804 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.41 98.87 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.165 -0.68 . . . . 132.09999999999999 109.165 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.16 -46.64 83.14 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.623 -0.262 . . . . 104.5 110.472 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.91 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 120.237 -0.585 . . . . 142.96000000000001 111.241 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.941 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.9 pt -64.77 -41.67 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 116.96 -1.896 . . . . 158.31999999999999 110.859 -175.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.34 98.04 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 117.755 -1.578 . . . . 137.11000000000001 109.459 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.53 90.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.173 -0.329 . . . . 54.659999999999997 110.994 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.928 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.17 29.45 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.651 0.739 . . . . 127.18000000000001 109.575 -174.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.618 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.88 80.3 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.067 0.947 . . . . 87.930000000000007 110.813 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.04 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.63 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.655 -0.653 . . . . 131.12 111.481 -175.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.43 7.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 115.319 -2.553 . . . . 246.56 109.607 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.48 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.471 -2.048 . . . . 339.35000000000002 105.471 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.22 165.26 17.92 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 102.989 -2.967 . . . . 114.66 102.989 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.13 -39.46 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.783 -1.562 . . . . 143.28 106.783 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.67 -38.05 80.44 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.673 -0.862 . . . . 160.22 108.673 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.37 -31.75 72.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.88 -0.785 . . . . 120.54000000000001 108.88 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.56 -43.86 95.8 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.507 -0.553 . . . . 67.219999999999999 109.507 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.49 -39.8 88.92 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.504 -0.747 . . . . 138.59999999999999 109.654 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.94 82.14 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 122.529 0.332 . . . . 151.46000000000001 110.631 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.941 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 C-N-CA 117.397 -1.721 . . . . 117.93000000000001 106.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.0 -46.01 90.88 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.928 -1.138 . . . . 56.82 107.928 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.89 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.4 -43.94 98.01 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.911 -0.774 . . . . 145.30000000000001 108.911 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.38 95.47 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.523 -0.917 . . . . 45.710000000000001 108.523 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.35 -42.06 99.09 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.384 -0.599 . . . . 105.61 109.384 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.5 92.67 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.608 -0.886 . . . . 47.890000000000001 108.608 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.942 -0.392 . . . . 124.53 109.942 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.23 99.28 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 121.979 -0.45 . . . . 35.890000000000001 109.851 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.19 -37.31 84.8 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 107.038 -1.467 . . . . 88.969999999999999 107.038 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.819 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.23 -49.2 76.69 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.978 -0.749 . . . . 239.91 108.978 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.38 91.02 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.594 -0.691 . . . . 146.09999999999999 110.635 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 117.422 -1.711 . . . . 91.739999999999995 113.86 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.6 -61.31 2.0 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.74 1.755 . . . . 197.44999999999999 115.74 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.923 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.32 -42.2 55.01 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.872 -1.531 . . . . 242.59999999999999 114.042 -170.014 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.959 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.921 -1.112 . . . . 215.61000000000001 109.813 -172.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 O-C-N 121.843 -0.535 . . . . 87.189999999999998 110.462 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.8 t -65.96 -41.83 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 109.72 -0.474 . . . . 231.81999999999999 109.72 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.6 m-20 -62.32 -34.15 76.07 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.326 -0.99 . . . . 364.98000000000002 108.326 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.13 -44.8 75.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.568 -0.708 . . . . 181.63 111.29 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.1 m -60.81 -45.78 93.07 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.471 -1.307 . . . . 269.01999999999998 107.471 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.75 -45.0 93.56 Favored 'General case' 0 N--CA 1.415 -2.183 0 C-N-CA 118.646 -1.222 . . . . 562.65999999999997 110.03 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.26 95.42 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 118.725 -1.19 . . . . 446.75 108.076 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.47 -26.37 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 C-N-CA 115.842 -2.343 . . . . 370.05000000000001 112.22 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.45 -26.5 60.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.555 -0.716 . . . . 354.91000000000003 112.507 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.77 4.59 0.99 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.09 1.356 . . . . 462.44 111.891 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.8 mm-40 -172.36 178.04 2.91 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.989 0.9 . . . . 652.37 111.107 171.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.31 2.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.477 2.711 . . . . 905.99000000000001 107.905 -174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.95 -36.37 79.99 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.2 -1.037 . . . . 570.42999999999995 108.2 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.34 82.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 125.303 1.441 . . . . 453.22000000000003 111.171 -174.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.54 178.67 33.91 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 118.799 -1.667 . . . . 445.63 109.925 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.21 75.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 125.274 1.429 . . . . 457.72000000000003 112.358 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.6 -46.99 85.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.701 -1.2 . . . . 340.57999999999998 109.262 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 87.8 m-85 -68.71 -32.17 71.78 Favored 'General case' 0 N--CA 1.424 -1.747 0 C-N-CA 118.755 -1.178 . . . . 453.60000000000002 111.552 -176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.4 t -56.03 -40.32 73.27 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.993 -1.855 . . . . 541.48000000000002 105.993 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.86 -47.18 75.8 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 123.976 0.798 . . . . 466.68000000000001 110.803 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.07 86.92 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.457 -1.697 . . . . 427.33999999999997 107.287 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.12 -36.78 82.64 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.398 0.518 . . . . 537.87 112.398 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.67 74.73 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.852 -1.939 . . . . 422.12 111.585 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.08 -50.09 75.41 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 121.336 -0.853 . . . . 340.17000000000002 111.818 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.24 -46.58 71.95 Favored Pre-proline 0 N--CA 1.443 -0.821 0 C-N-CA 119.097 -1.041 . . . . 258.06 111.754 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.923 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.7 Cg_exo -61.53 -31.54 87.56 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 N-CA-C 115.37 1.258 . . . . 305.70999999999998 115.37 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.683 -0.858 . . . . 252.69999999999999 108.683 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.65 93.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.785 -1.191 . . . . 149.27000000000001 107.785 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.77 95.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.621 -0.432 . . . . 138.08000000000001 111.485 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.655 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.7 t -66.91 -42.41 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 O-C-N 121.588 -0.695 . . . . 132.88999999999999 110.998 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.69 -44.75 92.74 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.875 -0.787 . . . . 193.61000000000001 108.875 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.46 -37.68 84.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 122.773 0.429 . . . . 63.829999999999998 110.057 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.97 -52.45 59.61 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.092 -0.38 . . . . 76.400000000000006 111.231 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.65 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.203 -1.036 . . . . 171.13 108.203 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.4 m-85 -63.69 -38.68 92.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.845 -0.534 . . . . 78.299999999999997 110.649 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.02 -35.78 80.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.925 -1.11 . . . . 92.359999999999999 109.249 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.967 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.48 -34.3 76.57 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.188 -1.042 . . . . 93.730000000000004 108.188 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.68 84.55 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.194 -1.002 . . . . 132.74000000000001 109.341 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.05 94.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.217 -1.401 . . . . 43.390000000000001 107.217 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.6 t -58.48 -41.97 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.606 -0.887 . . . . 59.340000000000003 108.606 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.08 95.48 Favored 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 121.765 -0.584 . . . . 69.680000000000007 110.553 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.74 91.78 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.339 -0.985 . . . . 106.98 108.339 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.64 81.54 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.69 -0.804 . . . . 147.63 108.956 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.18 -41.49 99.22 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.2 t80 -61.36 -44.03 97.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.298 -1.001 . . . . 118.84999999999999 108.298 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.39 -42.63 98.82 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 110.022 -0.362 . . . . 102.5 110.022 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.64 95.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.808 -0.558 . . . . 89.980000000000004 109.818 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.919 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.76 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 118.201 -1.4 . . . . 106.09 110.985 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.31 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 C-N-CA 117.119 -1.832 . . . . 227.74000000000001 111.81 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.12 50.94 Favored Pre-proline 0 CA--C 1.486 -1.494 0 C-N-CA 116.18 -2.208 . . . . 262.55000000000001 110.057 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.42 28.62 Favored 'Trans proline' 0 C--N 1.289 -2.581 0 C-N-CA 121.616 1.544 . . . . 210.25 111.326 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.95 0.98 Allowed 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.533 -1.655 . . . . 270.57999999999998 106.533 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.878 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.373 -0.831 . . . . 129.84 112.382 -176.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.4 -26.56 81.53 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 N-CA-C 116.27 1.604 . . . . 330.70999999999998 116.27 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.2 7.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.51 -2.876 . . . . 204.50999999999999 107.275 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.71 147.41 0.09 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.419 -1.326 . . . . 387.41000000000003 107.419 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.69 147.07 33.72 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 118.781 -1.168 . . . . 166.22 109.466 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.91 -40.69 87.75 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.851 -1.166 . . . . 44.229999999999997 107.851 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.3 -39.13 85.88 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.195 -1.039 . . . . 28.800000000000001 108.195 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.87 -38.76 92.14 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.079 -0.712 . . . . 30.289999999999999 109.079 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.844 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.63 -42.99 93.95 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.988 -0.745 . . . . 46.109999999999999 108.988 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.18 99.3 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.644 -1.243 . . . . 87.329999999999998 107.644 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.64 -42.09 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.953 -1.129 . . . . 23.690000000000001 107.953 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.17 -44.32 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 109.703 -0.48 . . . . 43.859999999999999 109.703 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.22 -42.59 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.303 -0.999 . . . . 91.129999999999995 108.303 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.486 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.6 -37.94 88.2 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.727 -0.842 . . . . 65.879999999999995 108.727 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.13 -41.84 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 109.521 -0.548 . . . . 33.859999999999999 109.521 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.43 -40.31 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.264 . . . . 146.52000000000001 107.586 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.703 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.28 90.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.469 -0.892 . . . . 75.439999999999998 108.929 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.42 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 O-C-N 121.056 -1.028 . . . . 43.640000000000001 109.726 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.788 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -38.02 89.52 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.042 -0.725 . . . . 102.56999999999999 109.042 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.07 86.76 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.428 -1.323 . . . . 58.159999999999997 107.428 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.8 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.56 73.96 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.999 -0.741 . . . . 121.11 108.999 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.96 -42.32 84.73 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 118.56 -1.256 . . . . 153.15000000000001 109.98 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.08 -43.73 19.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 113.125 -3.43 . . . . 133.66999999999999 113.518 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 120.91 -1.119 . . . . 157.41999999999999 112.187 -171.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.43 -36.06 2.44 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 115.038 1.496 . . . . 250.91 115.038 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.1 Cg_exo -59.58 -25.46 78.92 Favored 'Trans proline' 0 CA--C 1.488 -1.805 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.912 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.2 -34.17 74.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.93 -1.508 . . . . 192.46000000000001 106.93 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.05 98.09 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.959 -2.056 . . . . 261.0 107.959 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.76 159.15 25.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 101.512 -3.514 . . . . 491.39999999999998 101.512 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -60.02 106.86 0.55 Allowed 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 116.25 -2.18 . . . . 386.10000000000002 109.799 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.912 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.2 m -154.02 -166.63 2.42 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 103.563 -2.755 . . . . 289.80000000000001 103.563 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.93 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 117.757 -1.116 . . . . 402.06 109.567 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.22 177.52 7.58 Favored 'General case' 0 CA--C 1.586 2.34 0 C-N-CA 127.302 2.241 . . . . 690.52999999999997 114.922 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.62 0.0 OUTLIER 'General case' 1 C--N 1.429 4.046 1 N-CA-C 123.203 4.52 . . . . 633.62 123.203 162.672 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.69 153.84 22.06 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.354 2.262 . . . . 617.99000000000001 110.917 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.045 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.98 Favored Pre-proline 0 C--N 1.364 1.22 0 C-N-CA 130.291 3.436 . . . . 434.98000000000002 113.381 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.3 Cg_endo -44.25 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 122.428 3.972 . . . . 365.88 122.428 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.96 1.69 Allowed 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 104.774 -2.306 . . . . 635.80999999999995 104.774 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.41 152.24 18.77 Favored 'General case' 1 CA--C 1.419 -4.087 3 N-CA-C 132.002 7.779 . . . . 999.99000000000001 132.002 -135.767 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.84 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.774 1 CA-C-N 103.337 -6.301 . . . . 594.32000000000005 113.615 149.237 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.14 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 1 N-CA-C 98.277 -4.712 . . . . 811.90999999999997 98.277 162.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.48 45.98 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.099 -1.84 . . . . 999.99000000000001 109.424 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.976 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.15 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.003 0.906 . . . . 431.86000000000001 110.05 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.13 148.65 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 124.39 1.076 . . . . 457.18000000000001 108.766 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.48 3.74 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.106 0.962 . . . . 458.76999999999998 113.535 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.975 1.31 . . . . 999.99000000000001 112.401 168.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.1 Cg_exo -65.95 -45.84 5.56 Favored 'Trans proline' 0 N--CA 1.438 -1.794 0 N-CA-C 120.855 3.367 . . . . 999.99000000000001 120.855 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.037 0 C-N-CA 117.2 -1.8 . . . . 81.180000000000007 107.283 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.866 0 CA-C-O 114.908 -2.472 . . . . 999.99000000000001 108.743 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.1 Cg_endo -41.63 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.144 1 C-N-CA 126.045 4.497 . . . . 999.99000000000001 105.692 -170.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.31 -44.01 97.51 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 126.721 2.008 . . . . 967.72000000000003 112.04 -165.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.27 -36.52 78.0 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.75 -1.574 . . . . 934.29999999999995 106.75 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.61 -30.21 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 129.18 2.992 . . . . 565.14999999999998 113.92 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.52 55.43 2.8 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 118.451 0.568 . . . . 755.61000000000001 109.846 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.29 66.99 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.554 1.142 . . . . 325.88999999999999 113.254 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.98 78.31 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 123.582 0.753 . . . . 250.21000000000001 111.602 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.77 -43.28 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.575 0.702 . . . . 142.46000000000001 110.399 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.04 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.6 t80 -61.09 -41.55 96.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.953 0.901 . . . . 247.69 108.83 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.826 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.51 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.429 1.491 . . . . 199.61000000000001 113.122 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.37 -44.52 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 107.673 -1.232 . . . . 106.73 107.673 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.12 -48.57 81.14 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 115.875 -0.602 . . . . 115.01000000000001 110.217 -173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.21 -49.1 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 119.393 -0.923 . . . . 129.41999999999999 111.875 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.797 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.88 -53.18 59.28 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 118.209 -1.396 . . . . 172.47999999999999 109.919 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.2 t -63.82 -54.3 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 120.53 -0.468 . . . . 55.859999999999999 110.942 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.56 58.97 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 118.546 -1.262 . . . . 184.68000000000001 111.525 -174.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 116.641 -2.023 . . . . 291.81 114.74 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.02 -55.02 4.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 115.172 1.545 . . . . 130.66 115.172 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.797 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.92 -48.48 68.52 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.459 1.281 . . . . 80.159999999999997 114.459 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.9 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.53 -45.49 83.33 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 119.996 -0.682 . . . . 136.02000000000001 109.503 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.83 -27.12 59.46 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.627 -0.566 . . . . 92.170000000000002 110.627 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.35 -41.37 76.67 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.475 -1.305 . . . . 135.59999999999999 107.475 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.15 -44.73 91.22 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.563 -0.532 . . . . 52.100000000000001 109.563 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.67 -43.46 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.147 -0.686 . . . . 95.890000000000001 109.147 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.683 -1.599 . . . . 43.409999999999997 106.683 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.29 99.11 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.363 -1.495 . . . . 27.690000000000001 109.363 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.65 -47.4 75.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 122.177 -0.602 . . . . 54.409999999999997 110.47 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.8 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.984 -1.488 . . . . 53.880000000000003 106.984 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.8 -40.81 94.02 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.466 -0.938 . . . . 68.290000000000006 108.466 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.02 92.91 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 119.679 -0.808 . . . . 107.59 110.625 -175.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 119.64 -0.824 . . . . 111.61 109.549 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.919 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.29 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.393 -0.965 . . . . 85.260000000000005 108.393 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.42 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.072 -0.811 . . . . 40.710000000000001 111.072 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.73 -44.11 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.384 -0.969 . . . . 95.859999999999999 108.384 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.91 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.907 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.34 132.13 47.31 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.589 -1.263 . . . . 326.72000000000003 107.589 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.457 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.02 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.991 -1.855 . . . . 158.38 105.991 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.457 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.91 98.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.662 -0.496 . . . . 36.780000000000001 109.662 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.09 125.87 25.29 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.148 -1.021 . . . . 85.459999999999994 109.816 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.696 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.56 8.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.498 -2.038 . . . . 127.78 105.498 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.91 34.81 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.8 Cg_exo -56.78 -39.92 87.94 Favored 'Trans proline' 0 N--CA 1.431 -2.174 0 N-CA-C 113.977 0.722 . . . . 222.34999999999999 113.977 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.14 167.0 44.92 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.92 -45.76 93.37 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.057 -1.831 . . . . 107.56999999999999 106.057 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.729 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.84 58.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 118.842 -1.143 . . . . 167.96000000000001 109.177 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.47 106.75 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 126.754 2.022 . . . . 280.68000000000001 109.732 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 56.02 11.24 0.7 Allowed 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.503 1.121 . . . . 218.25 110.695 174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.61 54.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.251 -2.129 . . . . 343.56999999999999 105.251 177.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.476 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.95 81.88 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.844 -1.539 . . . . 263.29000000000002 106.844 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.33 147.01 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 126.503 1.921 . . . . 261.92000000000002 108.475 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.15 90.04 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.887 -1.153 . . . . 106.81 107.887 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.735 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.44 -39.95 95.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.392 -1.323 . . . . 112.2 107.526 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.24 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.288 -0.634 . . . . 45.409999999999997 109.288 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.814 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.3 p -70.92 -32.01 68.8 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 110.289 -0.263 . . . . 97.620000000000005 110.289 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.57 81.52 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.634 0.774 . . . . 59.289999999999999 111.014 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.735 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.649 1.18 . . . . 106.48999999999999 110.673 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.61 69.18 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.331 -0.989 . . . . 106.62 108.331 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.02 91.27 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.848 -0.532 . . . . 75.969999999999999 110.058 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.481 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.88 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 C-N-CA 122.89 0.476 . . . . 65.269999999999996 109.817 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 120.357 -0.537 . . . . 107.94 110.147 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.51 -40.82 98.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.652 -0.655 . . . . 87.980000000000004 110.293 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.33 96.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 118.834 -1.147 . . . . 65.5 108.382 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.72 -36.35 80.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.173 -1.047 . . . . 85.049999999999997 108.173 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.54 -45.68 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.067 -0.716 . . . . 42.25 109.067 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.33 -38.32 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 119.544 -0.862 . . . . 91.010000000000005 109.344 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.58 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.978 -1.119 . . . . 66.090000000000003 107.978 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.1 -43.12 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 120.731 -0.388 . . . . 52.390000000000001 110.312 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.2 m -61.81 -46.73 88.23 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 121.869 -0.52 . . . . 46.420000000000002 109.834 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.36 -38.17 88.51 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.286 -1.005 . . . . 116.51000000000001 108.286 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.485 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.19 -48.22 82.64 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.437 -0.579 . . . . 65.180000000000007 109.437 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.93 -42.73 97.27 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 122.13 -0.356 . . . . 51.329999999999998 110.437 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.39 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 118.898 -1.121 . . . . 126.3 109.013 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.513 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.508 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.822 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.7 -33.36 35.44 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.8 tp -58.44 -41.64 90.35 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.686 -0.633 . . . . 72.230000000000004 111.618 -167.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.61 -36.02 87.27 Favored 'Trans proline' 0 N--CA 1.429 -2.272 0 CA-C-N 119.88 0.993 . . . . 106.13 111.343 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.68 82.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.723 -0.791 . . . . 128.34999999999999 110.021 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.83 88.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 110.207 -0.294 . . . . 100.73 110.207 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.35 -44.43 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 C-N-CA 119.268 -0.973 . . . . 172.72 109.144 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.192 -1.04 . . . . 249.22999999999999 108.192 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.61 -55.05 36.62 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.615 -1.624 . . . . 259.77999999999997 106.615 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.24 -44.13 72.62 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 113.611 0.967 . . . . 233.11000000000001 113.611 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.38 -48.28 91.45 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 119.153 -1.019 . . . . 169.53999999999999 110.592 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.5 Cg_exo -61.18 -24.52 79.28 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 116.72 -1.72 . . . . 255.47 114.629 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.826 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.21 94.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 119.255 0.934 . . . . 279.02999999999997 108.886 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.79 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.078 -0.342 . . . . 162.21000000000001 110.078 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.87 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.39 84.9 59.25 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.75 -1.18 . . . . 128.13 108.083 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.29 164.03 11.2 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 N-CA-C 107.395 -1.81 . . . . 278.35000000000002 107.395 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.873 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.01 9.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.813 0.695 . . . . 312.91000000000003 109.335 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.873 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.69 -170.7 2.49 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.56 -1.645 . . . . 353.54000000000002 106.56 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.019 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 43.0 p90 -115.66 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.4 -1.333 . . . . 251.25999999999999 107.4 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.95 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 102.092 -3.299 . . . . 175.25999999999999 102.092 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.53 -44.97 96.09 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 100.88 -3.748 . . . . 99.069999999999993 100.88 172.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.41 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.52 -2.77 . . . . 243.21000000000001 103.52 171.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.019 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.93 112.91 25.04 Favored 'General case' 0 CA--C 1.473 -1.995 0 C-N-CA 116.109 -2.237 . . . . 201.03999999999999 105.293 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 C-N-CA 116.033 -2.267 . . . . 201.36000000000001 108.831 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.02 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.278 -1.783 . . . . 203.81999999999999 107.85 174.481 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.927 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.33 -45.69 86.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.196 -1.401 . . . . 215.06 112.56 -171.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.548 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.4 t -65.7 -46.37 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 C-N-CA 118.567 -1.253 . . . . 125.28 112.937 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.954 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.8 -36.99 86.12 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.177 -1.416 . . . . 268.89999999999998 107.177 -171.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.801 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.21 -45.02 74.49 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 125.65 1.58 . . . . 280.88 108.815 -172.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.54 85.79 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 118.957 -1.097 . . . . 184.47 108.971 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.07 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 119.27 -0.972 . . . . 167.91999999999999 112.772 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.77 89.91 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 117.796 -1.562 . . . . 367.18000000000001 110.77 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.74 74.05 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.877 -0.514 . . . . 173.97 110.439 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.44 -36.79 85.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.495 0.718 . . . . 119.66 109.788 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.822 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.19 -34.0 74.36 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.725 -1.213 . . . . 112.3 107.725 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.239 -0.437 . . . . 174.16999999999999 110.246 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 124.685 1.194 . . . . 145.27000000000001 110.616 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.764 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.58 -35.36 70.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.113 -1.069 . . . . 170.15000000000001 108.113 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.819 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.17 63.97 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.3 -0.409 . . . . 214.56999999999999 110.621 -171.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.19 56.51 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.063 1.745 . . . . 168.28999999999999 115.562 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.764 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.88 79.22 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.008 1.114 . . . . 167.15000000000001 114.008 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.2 -38.28 33.18 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 115.521 -2.472 . . . . 165.13 113.942 -171.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.53 -31.88 80.08 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.751 2.018 . . . . 123.92 111.21 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.74 -42.57 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 118.879 -1.128 . . . . 110.55 109.802 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.07 -40.08 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 108.846 -0.798 . . . . 145.31 108.846 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.05 -48.85 78.85 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.408 -0.917 . . . . 246.68000000000001 109.84 -177.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.22 -47.52 84.09 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 119.557 -0.857 . . . . 64.430000000000007 109.555 -173.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.75 -45.13 79.53 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.04 -1.064 . . . . 80.719999999999999 110.204 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 115.989 1.848 . . . . 140.44 115.989 -173.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.089 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.36 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.35 -1.295 . . . . 110.22 110.094 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.54 72.9 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.731 -0.606 . . . . 174.78 109.739 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.95 -41.71 95.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.248 -1.019 . . . . 161.84 108.248 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.521 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.24 -50.27 73.42 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.029 -0.668 . . . . 117.2 109.25 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.13 75.46 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.374 -0.53 . . . . 112.59999999999999 111.063 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.01 -37.43 94.59 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.626 -0.99 . . . . 101.45999999999999 110.626 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.026 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.15 -46.01 90.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 118.458 1.129 . . . . 151.49000000000001 109.52 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.08 -36.31 77.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.962 -1.496 . . . . 142.31999999999999 106.962 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.8 -41.8 92.0 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.41 85.67 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 122.358 -0.213 . . . . 76.109999999999999 111.02 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.49 30.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.879 -0.728 . . . . 120.23999999999999 109.318 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.575 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.54 41.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 102.912 -2.996 . . . . 192.72999999999999 102.912 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.22 -44.17 92.31 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 118.994 -1.082 . . . . 176.28999999999999 109.163 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.758 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.0 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.46 0 N-CA-C 106.303 -1.739 . . . . 69.680000000000007 106.303 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.97 -75.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 118.364 -0.624 . . . . 191.05000000000001 112.605 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.758 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.47 43.88 16.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 O-C-N 123.578 0.549 . . . . 287.02999999999997 109.778 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.945 0 C-N-CA 112.956 -3.498 . . . . 292.29000000000002 109.818 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.213 -2.514 . . . . 184.56999999999999 104.213 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.71 4.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.026 0.75 . . . . 274.56 113.026 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.24 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.748 -2.167 . . . . 268.24000000000001 113.453 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.6 m-20 51.56 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 118.685 1.242 . . . . 200.06 110.764 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.98 74.7 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.885 -1.154 . . . . 114.44 107.885 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.29 46.04 21.87 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.611 -1.255 . . . . 263.81 107.611 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.195 1 N-CA-C 102.563 -4.215 . . . . 103.79000000000001 102.563 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.3 95.6 10.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 114.943 -2.703 . . . . 117.3 106.016 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.76 90.77 Favored 'General case' 0 CA--C 1.468 -2.187 1 N-CA-C 98.041 -4.8 . . . . 231.58000000000001 98.041 167.21 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.04 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.97 163.44 29.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 102.063 -3.31 . . . . 303.24000000000001 102.063 168.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.55 78.9 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.024 -2.271 . . . . 112.72 108.424 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.8 t -61.06 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.072 -0.714 . . . . 83.219999999999999 109.072 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.3 m -156.28 -126.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.829 -2.656 . . . . 174.36000000000001 103.829 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.81 160.94 8.71 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 105.768 -1.938 . . . . 202.72999999999999 105.768 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.051 -1.463 . . . . 180.62 107.051 176.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.937 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.51 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.937 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.13 -43.11 88.06 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.136 -1.802 . . . . 66.049999999999997 106.136 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.492 -2.781 . . . . 266.49000000000001 103.492 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.93 0.28 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 117.055 -1.858 . . . . 219.19999999999999 107.753 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.08 -37.36 94.08 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 114.542 -1.208 . . . . 94.780000000000001 112.881 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.21 100.41 9.1 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.34 -3.744 . . . . 121.41 109.452 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.08 145.54 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.517 -0.765 . . . . 85.340000000000003 108.949 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.8 143.45 42.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.832 -1.174 . . . . 267.56999999999999 107.832 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.52 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.63 0.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.502 -0.555 . . . . 226.09999999999999 109.502 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.989 -1.485 . . . . 154.84 106.989 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.93 8.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.622 0.725 . . . . 180.00999999999999 110.696 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.888 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.91 23.63 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.971 -1.492 . . . . 333.77999999999997 106.971 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.5 48.77 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.399 -1.334 . . . . 335.19999999999999 107.399 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.729 -0.841 . . . . 266.47000000000003 108.729 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.63 -46.81 88.87 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.698 -1.964 . . . . 59.340000000000003 105.698 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.62 173.81 11.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.422 -2.436 . . . . 201.25999999999999 104.422 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.89 106.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.525 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.4 5.37 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.337 -0.616 . . . . 87.579999999999998 109.337 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.878 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.52 153.71 22.26 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.847 -1.168 . . . . 219.94999999999999 107.847 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 C-N-CA 116.348 -2.141 . . . . 121.79000000000001 105.434 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.9 t -154.14 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.816 -1.92 . . . . 53.850000000000001 105.816 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.26 16.56 77.11 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.886 -1.153 . . . . 35.880000000000003 107.886 -178.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 365' ' ' ARG . 1.7 tpp180 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.02 68.13 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.665 1.577 . . . . 1.0 111.877 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' B' ' 367' ' ' LYS . 1.2 mtpt -70.5 127.38 92.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.267 -0.424 . . . . 1.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.821 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -69.01 -19.97 38.99 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.397 2.065 . . . . 1.0 114.601 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -38.63 77.72 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.71 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -71.29 -10.53 59.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.355 . . . . 1.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.821 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.61 -46.34 87.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.332 -178.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 372' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -61.51 -49.11 78.05 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.587 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 -0.068 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 108.361 -0.977 . . . . 97.079999999999998 108.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.59 155.46 22.32 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.161 0.981 . . . . 123.41 110.745 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.879 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.63 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.469 1 N-CA-C 100.106 -4.035 . . . . 151.30000000000001 100.106 173.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.993 HD21 ' HG3' ' B' ' 366' ' ' PRO . 5.2 mp -60.66 -38.61 58.5 Favored Pre-proline 0 N--CA 1.439 -1.01 0 C-N-CA 115.98 -2.288 . . . . 169.25 106.101 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_exo -81.29 168.54 16.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 122.265 0.613 . . . . 185.75999999999999 110.508 171.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.2 t -64.51 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.051 2.141 . . . . 145.47 110.324 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.35 157.42 21.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.064 -1.023 . . . . 102.76000000000001 109.446 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.61 154.18 25.07 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.994 -1.114 . . . . 106.25 107.994 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.92 51.91 0.74 Allowed 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 117.757 -1.577 . . . . 157.81 107.658 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.19 -45.9 91.56 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.541 -2.763 . . . . 150.19999999999999 103.541 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.01 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.874 0 N-CA-C 103.68 -2.711 . . . . 183.52000000000001 103.68 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -76.77 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 N-CA-C 109.995 -0.81 . . . . 235.61000000000001 109.995 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.99 -41.22 82.56 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.847 1.259 . . . . 113.77 113.354 -170.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.24 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 119.616 1.098 . . . . 150.84999999999999 110.965 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.52 156.29 46.37 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 107.594 -1.262 . . . . 100.42 107.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.63 58.33 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.955 0.883 . . . . 129.36000000000001 110.436 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.07 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.288 1.835 . . . . 112.34 106.693 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.7 m -74.11 -40.16 62.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.553 -0.749 . . . . 131.72999999999999 111.777 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.4 -42.9 15.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 117.018 2.229 . . . . 80.489999999999995 117.018 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.53 3.35 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.196 -1.402 . . . . 98.980000000000004 111.252 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.84 -10.7 18.09 Favored 'Trans proline' 0 C--N 1.32 -0.921 1 N-CA-C 128.937 6.476 . . . . 246.94999999999999 128.937 -170.061 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.62 17.55 8.71 Favored 'General case' 0 C--N 1.325 -0.484 1 CA-C-N 126.12 4.055 . . . . 269.62 114.236 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.15 -27.3 67.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.793 -1.188 . . . . 86.799999999999997 107.793 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.83 -29.28 69.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.088 -1.007 . . . . 85.909999999999997 110.498 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 123.65 0.78 . . . . 82.0 111.364 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.76 12.43 Favored Pre-proline 0 CA--C 1.488 -1.417 0 N-CA-C 108.555 -0.906 . . . . 120.73 108.555 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 C-N-CA 120.659 0.906 . . . . 87.859999999999999 109.935 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.814 -0.81 . . . . 36.460000000000001 108.814 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.1 p-90 -63.8 -33.89 76.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.797 -1.186 . . . . 150.59999999999999 107.797 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.18 -32.7 73.37 Favored 'General case' 0 CA--C 1.491 -1.322 0 O-C-N 121.301 -0.874 . . . . 123.26000000000001 108.685 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.14 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 109.196 -0.668 . . . . 120.14 109.196 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.43 -31.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.91 -47.21 84.24 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 119.917 -0.713 . . . . 60.869999999999997 109.633 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.65 81.16 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 119.977 -0.689 . . . . 157.56999999999999 110.362 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.58 -40.9 98.36 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.682 -0.858 . . . . 47.060000000000002 108.682 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.02 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 121.751 -0.593 . . . . 43.939999999999998 109.569 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.29 99.15 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.705 -0.85 . . . . 42.609999999999999 108.705 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.35 -41.26 94.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.653 -0.249 . . . . 140.66 111.064 -178.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.79 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 118.613 -1.235 . . . . 116.04000000000001 110.221 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.44 -38.76 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.745 -0.835 . . . . 97.159999999999997 108.745 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.4 mt -61.32 -39.95 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 108.969 -0.752 . . . . 54.850000000000001 108.969 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.962 HG22 HG21 ' A' ' 86' ' ' THR . 93.1 t -57.7 -42.34 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 108.891 -0.781 . . . . 45.390000000000001 108.891 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.56 -50.97 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.837 -1.145 . . . . 48.640000000000001 110.156 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.21 -47.11 78.02 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.137 -0.625 . . . . 116.65000000000001 111.71 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.93 -43.93 97.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.695 -0.483 . . . . 51.159999999999997 109.695 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.96 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 119.864 -0.734 . . . . 44.299999999999997 110.828 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.1 t -64.71 -46.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 120.349 -0.54 . . . . 48.82 111.039 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.12 95.2 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.492 -0.861 . . . . 58.700000000000003 112.006 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.68 -34.13 66.99 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 117.452 0.626 . . . . 101.40000000000001 111.006 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.77 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.727 -1.212 . . . . 103.56999999999999 107.727 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.41 -43.02 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.996 -0.742 . . . . 61.890000000000001 108.996 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.5 t -63.5 -50.94 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.45 -0.574 . . . . 70.010000000000005 109.45 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.91 -43.45 98.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.118 -0.697 . . . . 132.09999999999999 109.118 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.19 -46.63 83.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.652 -0.249 . . . . 104.5 110.458 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.64 -49.89 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.237 -0.585 . . . . 142.96000000000001 111.241 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.0 pt -64.75 -41.76 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 C-N-CA 116.936 -1.906 . . . . 158.31999999999999 110.897 -175.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 117.692 -1.603 . . . . 137.11000000000001 109.516 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.155 -0.341 . . . . 54.659999999999997 111.02 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.39 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 121.615 0.721 . . . . 127.18000000000001 109.591 -174.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.78 -36.89 80.12 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.884 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.041 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.618 -0.676 . . . . 131.12 111.526 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.023 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.46 7.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.25 -2.58 . . . . 246.56 109.613 -175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.949 0 N-CA-C 105.489 -2.041 . . . . 339.35000000000002 105.489 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.12 165.23 17.89 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.033 -2.951 . . . . 114.66 103.033 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.42 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.799 -1.556 . . . . 143.28 106.799 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.5 m -59.66 -38.1 80.51 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.687 -0.857 . . . . 160.22 108.687 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.4 m-20 -62.3 -31.78 72.43 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.908 -0.775 . . . . 120.54000000000001 108.908 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.56 -43.8 96.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.508 -0.553 . . . . 67.219999999999999 109.508 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.54 -39.75 88.72 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.494 -0.754 . . . . 138.59999999999999 109.71 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.94 82.15 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.451 0.301 . . . . 151.46000000000001 110.614 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.97 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 117.426 -1.71 . . . . 117.93000000000001 106.686 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.03 -46.01 90.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.891 -1.152 . . . . 56.82 107.891 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.016 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.41 -43.92 98.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.885 -0.783 . . . . 145.30000000000001 108.885 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.39 95.54 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.494 -0.928 . . . . 45.710000000000001 108.494 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.41 -42.03 99.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.357 -0.609 . . . . 105.61 109.357 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.617 -0.883 . . . . 47.890000000000001 108.617 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.35 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.935 -0.395 . . . . 124.53 109.935 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 121.966 -0.459 . . . . 35.890000000000001 109.831 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -37.29 84.83 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.999 -1.482 . . . . 88.969999999999999 106.999 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.18 76.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 119.859 -0.737 . . . . 239.91 109.075 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.45 -43.39 90.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.529 -0.732 . . . . 146.09999999999999 110.565 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.2 3.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 117.358 -1.737 . . . . 91.739999999999995 113.874 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.6 -61.33 2.0 Allowed 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 115.745 1.757 . . . . 197.44999999999999 115.745 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.26 -42.31 55.34 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.896 -1.521 . . . . 242.59999999999999 114.026 -170.033 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.962 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.61 84.55 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 118.957 -1.097 . . . . 215.61000000000001 109.831 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.0 t -60.26 -46.96 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.803 -0.561 . . . . 87.189999999999998 110.489 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 64.0 t -65.95 -41.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.754 -0.462 . . . . 231.81999999999999 109.754 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.9 m-20 -62.33 -34.14 76.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.295 -1.002 . . . . 364.98000000000002 108.295 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.543 -0.723 . . . . 181.63 111.242 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.5 m -60.83 -45.83 92.91 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.423 -1.325 . . . . 269.01999999999998 107.423 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.67 -45.13 92.98 Favored 'General case' 0 CA--C 1.469 -2.15 0 C-N-CA 118.677 -1.209 . . . . 562.65999999999997 110.013 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.21 95.67 Favored 'General case' 0 CA--C 1.479 -1.777 0 C-N-CA 118.713 -1.195 . . . . 446.75 108.108 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.0 m -70.52 -26.31 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 115.826 -2.35 . . . . 370.05000000000001 112.202 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.5 -26.48 60.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.598 -0.689 . . . . 354.91000000000003 112.53 175.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.83 4.55 0.98 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 125.057 1.343 . . . . 462.44 111.87 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.8 mm-40 -172.39 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.067 0.936 . . . . 652.37 111.085 171.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 128.508 2.723 . . . . 905.99000000000001 107.931 -174.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.88 -36.42 80.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.223 -1.028 . . . . 570.42999999999995 108.223 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.52 -36.37 82.35 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 125.31 1.444 . . . . 453.22000000000003 111.191 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.67 33.88 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 118.781 -1.676 . . . . 445.63 109.897 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' CD1' ' HB2' ' B' ' 368' ' ' PRO . 89.1 mt -56.39 -41.23 75.91 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.249 1.419 . . . . 457.72000000000003 112.378 -170.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.64 -46.93 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.688 -1.205 . . . . 340.57999999999998 109.299 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.74 -32.13 71.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.769 -1.172 . . . . 453.60000000000002 111.585 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.04 -40.33 73.32 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.993 -1.855 . . . . 541.48000000000002 105.993 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.9 -47.08 76.0 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 124.025 0.828 . . . . 466.68000000000001 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.06 86.86 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.491 -1.684 . . . . 427.33999999999997 107.263 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.12 -36.77 82.61 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 112.423 0.527 . . . . 537.87 112.423 -174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.66 74.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 116.86 -1.936 . . . . 422.12 111.617 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.05 -50.11 75.32 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.339 -0.85 . . . . 340.17000000000002 111.853 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.35 -46.5 70.74 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.089 -1.045 . . . . 258.06 111.695 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.3 Cg_exo -61.47 -31.58 87.97 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.54 93.78 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.791 -1.188 . . . . 149.27000000000001 107.791 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.96 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.649 -0.42 . . . . 138.08000000000001 111.5 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.96 -42.41 88.72 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 O-C-N 121.556 -0.715 . . . . 132.88999999999999 110.936 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.75 -44.72 92.63 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.849 -0.797 . . . . 193.61000000000001 108.849 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.66 84.31 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 122.842 0.457 . . . . 63.829999999999998 110.128 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.4 59.68 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.75 -0.38 . . . . 76.400000000000006 111.214 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.64 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.163 -1.051 . . . . 171.13 108.163 -174.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.84 -38.53 91.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.866 -0.521 . . . . 78.299999999999997 110.639 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.06 -35.78 80.59 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 118.9 -1.12 . . . . 92.359999999999999 109.236 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . 1.016 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.28 76.49 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.184 -1.043 . . . . 93.730000000000004 108.184 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.49 -41.59 84.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 119.205 -0.998 . . . . 132.74000000000001 109.323 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.13 94.72 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.188 -1.412 . . . . 43.390000000000001 107.188 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.47 -41.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 108.639 -0.875 . . . . 59.340000000000003 108.639 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.06 95.27 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.796 -0.565 . . . . 69.680000000000007 110.5 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.71 91.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.334 -0.987 . . . . 106.98 108.334 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.64 81.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.648 -0.821 . . . . 147.63 108.933 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.54 99.38 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.557 -0.905 . . . . 190.06 108.557 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.13 97.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.273 -1.01 . . . . 118.84999999999999 108.273 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.809 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.65 98.97 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 110.008 -0.367 . . . . 102.5 110.008 -177.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.61 95.23 Favored 'General case' 0 CA--C 1.489 -1.375 0 O-C-N 121.866 -0.521 . . . . 89.980000000000004 109.812 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 C-N-CA 118.104 -1.438 . . . . 106.09 111.012 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.11 -48.26 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 C-N-CA 117.087 -1.845 . . . . 227.74000000000001 111.798 -174.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.08 50.94 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.238 -2.185 . . . . 262.55000000000001 110.052 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.47 28.81 Favored 'Trans proline' 0 C--N 1.289 -2.56 0 C-N-CA 121.685 1.59 . . . . 210.25 111.35 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.23 112.0 0.99 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 106.537 -1.653 . . . . 270.57999999999998 106.537 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.53 24.04 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-N 115.37 -0.832 . . . . 129.84 112.316 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 83.0 Cg_exo -61.36 -26.58 81.75 Favored 'Trans proline' 0 N--CA 1.432 -2.142 0 N-CA-C 116.321 1.623 . . . . 330.70999999999998 116.321 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.04 77.21 7.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 114.452 -2.899 . . . . 204.50999999999999 107.286 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.44 0.09 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.425 -1.324 . . . . 387.41000000000003 107.425 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.04 33.66 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 118.753 -1.179 . . . . 166.22 109.435 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.79 88.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.804 -1.184 . . . . 44.229999999999997 107.804 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.76 -38.83 92.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.085 -0.709 . . . . 30.289999999999999 109.085 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.04 93.88 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.962 -0.755 . . . . 46.109999999999999 108.962 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.12 99.26 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.699 -1.223 . . . . 87.329999999999998 107.699 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.63 -42.13 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.954 -1.128 . . . . 23.690000000000001 107.954 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.22 -44.26 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.676 -0.49 . . . . 43.859999999999999 109.676 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.3 -42.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 108.351 -0.981 . . . . 91.129999999999995 108.351 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.4 t -62.56 -38.0 88.37 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.743 -0.836 . . . . 65.879999999999995 108.743 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.11 -41.81 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 109.58 -0.526 . . . . 33.859999999999999 109.58 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.41 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.173 0 N-CA-C 107.577 -1.268 . . . . 146.52000000000001 107.577 -176.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.84 -38.36 90.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.499 -0.88 . . . . 75.439999999999998 108.936 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.53 -48.39 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 O-C-N 121.04 -1.038 . . . . 43.640000000000001 109.733 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.48 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 109.045 -0.724 . . . . 102.56999999999999 109.045 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.1 86.87 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.398 -1.334 . . . . 58.159999999999997 107.398 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.5 73.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.993 -0.743 . . . . 121.11 108.993 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.3 84.93 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.565 -1.254 . . . . 153.15000000000001 109.938 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.11 -43.76 18.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 113.084 -3.446 . . . . 133.66999999999999 113.477 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.92 -39.93 96.07 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 120.918 -1.114 . . . . 157.41999999999999 112.193 -171.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 114.993 1.479 . . . . 250.91 114.993 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.3 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.488 -1.786 0 N-CA-C 117.984 2.263 . . . . 207.34 117.984 -174.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.914 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.2 -34.22 74.73 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.94 -1.504 . . . . 192.46000000000001 106.94 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.06 98.16 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.01 -2.036 . . . . 261.0 108.01 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.71 159.11 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 101.519 -3.512 . . . . 491.39999999999998 101.519 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.437 0 C-N-CA 116.257 -2.177 . . . . 386.10000000000002 109.87 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.03 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 103.552 -2.758 . . . . 289.80000000000001 103.552 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 117.771 -1.109 . . . . 402.06 109.576 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.29 177.46 7.57 Favored 'General case' 0 CA--C 1.586 2.357 0 C-N-CA 127.32 2.248 . . . . 690.52999999999997 114.9 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.59 0.0 OUTLIER 'General case' 1 C--N 1.43 4.09 1 N-CA-C 123.178 4.511 . . . . 633.62 123.178 162.696 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.67 153.85 22.07 Favored 'General case' 0 C--N 1.389 2.305 0 C-N-CA 127.362 2.265 . . . . 617.99000000000001 110.889 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.42 5.96 Favored Pre-proline 0 C--N 1.364 1.227 0 C-N-CA 130.289 3.435 . . . . 434.98000000000002 113.382 -175.379 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.1 Cg_endo -44.21 -65.7 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 122.409 3.965 . . . . 365.88 122.409 -168.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.3 m -84.91 20.98 1.69 Allowed 'General case' 0 CA--C 1.467 -2.247 0 N-CA-C 104.832 -2.284 . . . . 635.80999999999995 104.832 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.35 152.19 18.83 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.959 7.762 . . . . 999.99000000000001 131.959 -135.764 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.913 37.2 t -131.79 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.773 1 CA-C-N 103.314 -6.312 . . . . 594.32000000000005 113.613 149.206 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.1 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.307 -4.701 . . . . 811.90999999999997 98.307 162.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.47 144.58 45.89 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 117.063 -1.855 . . . . 999.99000000000001 109.411 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.23 -175.63 4.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.036 0.922 . . . . 431.86000000000001 110.042 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.06 148.63 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 124.384 1.074 . . . . 457.18000000000001 108.823 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.45 3.72 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.134 0.973 . . . . 458.76999999999998 113.523 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.41 -31.56 0.97 Allowed Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.983 1.313 . . . . 999.99000000000001 112.38 168.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.953 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.73 5.68 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 N-CA-C 120.916 3.391 . . . . 999.99000000000001 120.916 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.57 171.76 8.13 Favored 'General case' 0 CA--C 1.472 -2.041 0 C-N-CA 117.133 -1.827 . . . . 81.180000000000007 107.235 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.831 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.12 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.881 0 C-N-CA 115.537 -2.465 . . . . 999.99000000000001 108.798 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.8 Cg_endo -41.61 101.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.126 1 C-N-CA 126.045 4.496 . . . . 999.99000000000001 105.677 -170.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.99 97.55 Favored 'General case' 0 CA--C 1.483 -1.621 0 C-N-CA 126.717 2.007 . . . . 967.72000000000003 112.043 -165.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.31 -36.55 78.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.72 -1.585 . . . . 934.29999999999995 106.72 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.5 -30.29 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 129.188 2.995 . . . . 565.14999999999998 113.951 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.59 55.36 2.78 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 118.468 0.577 . . . . 755.61000000000001 109.854 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.25 67.21 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.559 1.144 . . . . 325.88999999999999 113.259 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -45.02 78.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.582 0.753 . . . . 250.21000000000001 111.639 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.66 -43.38 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-O 121.592 0.711 . . . . 142.46000000000001 110.379 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.953 0.901 . . . . 247.69 108.855 -173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.49 -51.32 69.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 125.444 1.498 . . . . 199.61000000000001 113.111 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.37 -44.49 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.701 -1.222 . . . . 106.73 107.701 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.59 81.03 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.853 -0.612 . . . . 115.01000000000001 110.232 -173.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.19 -49.13 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 119.411 -0.916 . . . . 129.41999999999999 111.857 -174.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.6 m -61.94 -53.09 60.5 Favored 'General case' 0 CA--C 1.482 -1.646 0 C-N-CA 118.178 -1.409 . . . . 172.47999999999999 109.943 -172.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.84 -54.32 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 120.51 -0.476 . . . . 55.859999999999999 110.973 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.5 -51.55 59.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.504 -1.278 . . . . 184.68000000000001 111.524 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.42 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.618 -2.033 . . . . 291.81 114.749 -174.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.98 4.86 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.181 1.548 . . . . 130.66 115.181 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.499 1.296 . . . . 80.159999999999997 114.499 -170.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.44 83.1 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.906 -0.717 . . . . 136.02000000000001 109.509 -174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.2 Cg_exo -64.83 -27.11 59.49 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.596 -0.579 . . . . 92.170000000000002 110.596 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.33 -41.44 76.68 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.441 -1.318 . . . . 135.59999999999999 107.441 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.11 -44.7 91.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.604 -0.517 . . . . 52.100000000000001 109.604 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.49 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 109.079 -0.711 . . . . 95.890000000000001 109.079 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.33 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.714 -1.587 . . . . 43.409999999999997 106.714 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.28 99.12 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.382 -1.487 . . . . 27.690000000000001 109.382 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.71 -47.38 75.57 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 117.32 0.56 . . . . 54.409999999999997 110.45 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.36 -34.19 74.88 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.957 -1.497 . . . . 53.880000000000003 106.957 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.84 93.85 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.503 -0.925 . . . . 68.290000000000006 108.503 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.04 92.96 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.682 -0.807 . . . . 107.59 110.626 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -63.0 -38.38 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.609 -0.837 . . . . 111.61 109.525 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.23 -22.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.45 -0.944 . . . . 85.260000000000005 108.45 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.92 99.42 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.074 -0.81 . . . . 40.710000000000001 111.074 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.71 -44.09 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.382 -0.97 . . . . 95.859999999999999 108.382 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.9 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.416 -0.957 . . . . 144.37 108.416 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.8 mt -55.34 132.12 47.29 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 107.606 -1.257 . . . . 326.72000000000003 107.606 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.1 1.52 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.015 -1.846 . . . . 158.38 106.015 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.28 -41.94 99.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.688 -0.486 . . . . 36.780000000000001 109.688 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.7 m -61.13 125.88 25.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.168 -1.013 . . . . 85.459999999999994 109.77 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.57 8.83 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 105.534 -2.024 . . . . 127.78 105.534 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.78 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 105.938 -1.875 . . . . 164.84 105.938 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.0 Cg_exo -56.77 -39.95 87.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 113.958 0.714 . . . . 222.34999999999999 113.958 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 106.403 -2.679 . . . . 45.219999999999999 106.403 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.77 93.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.017 -1.846 . . . . 107.56999999999999 106.017 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.83 141.82 58.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.897 -1.121 . . . . 167.96000000000001 109.142 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.71 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.686 1.994 . . . . 280.68000000000001 109.715 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.33 0.71 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.493 1.117 . . . . 218.25 110.686 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.212 -2.144 . . . . 343.56999999999999 105.212 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -112.04 81.93 1.54 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.875 -1.528 . . . . 263.29000000000002 106.875 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 126.57 1.948 . . . . 261.92000000000002 108.471 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.08 89.78 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 107.903 -1.147 . . . . 106.81 107.903 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.88 94.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 118.374 -1.33 . . . . 112.2 107.576 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.3 t -64.31 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.294 -0.632 . . . . 45.409999999999997 109.294 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.06 68.89 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.287 -0.264 . . . . 97.620000000000005 110.287 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.62 81.7 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.735 0.814 . . . . 59.289999999999999 111.025 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.27 -36.48 83.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.615 1.166 . . . . 106.48999999999999 110.687 -174.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.7 69.24 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.28 -1.007 . . . . 106.62 108.28 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.01 -41.03 91.53 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 121.836 -0.54 . . . . 75.969999999999999 110.028 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.7 t -65.56 -40.83 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 122.94 0.496 . . . . 65.269999999999996 109.754 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.6 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 C-N-CA 120.419 -0.512 . . . . 107.94 110.135 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.56 -40.78 97.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 121.68 -0.637 . . . . 87.980000000000004 110.275 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.63 -40.45 96.92 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.847 -1.141 . . . . 65.5 108.389 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.65 -36.37 80.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.157 -1.053 . . . . 85.049999999999997 108.157 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.5 -45.75 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 109.028 -0.73 . . . . 42.25 109.028 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.39 -38.17 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 C-N-CA 119.535 -0.866 . . . . 91.010000000000005 109.377 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.93 -41.55 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 107.973 -1.121 . . . . 66.090000000000003 107.973 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 120.726 -0.39 . . . . 52.390000000000001 110.331 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.3 m -61.75 -46.77 88.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.899 -0.501 . . . . 46.420000000000002 109.858 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.37 -38.05 88.09 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.337 -0.986 . . . . 116.51000000000001 108.337 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.35 -48.17 82.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.392 -0.595 . . . . 65.180000000000007 109.392 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.7 97.33 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 120.827 0.346 . . . . 51.329999999999998 110.472 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.61 -43.41 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 118.936 -1.106 . . . . 126.3 108.982 -176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.4 35.34 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 116.842 2.164 . . . . 134.84 116.842 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.787 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.36 -41.62 90.37 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.692 -0.63 . . . . 72.230000000000004 111.66 -167.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.5 Cg_exo -60.69 -35.98 86.94 Favored 'Trans proline' 0 N--CA 1.429 -2.286 0 CA-C-N 119.851 0.983 . . . . 106.13 111.341 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.69 82.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 119.754 -0.779 . . . . 128.34999999999999 110.068 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.87 89.04 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 110.218 -0.29 . . . . 100.73 110.218 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.27 -44.51 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.279 -0.969 . . . . 172.72 109.185 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.4 m-85 -66.62 -28.09 68.21 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.216 -1.031 . . . . 249.22999999999999 108.216 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.49 -55.17 34.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.701 -1.592 . . . . 259.77999999999997 106.701 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.16 -44.15 72.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.593 0.96 . . . . 233.11000000000001 113.593 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.38 -48.33 91.31 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 119.22 -0.992 . . . . 169.53999999999999 110.544 -170.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.9 Favored 'Trans proline' 0 N--CA 1.429 -2.282 0 C-N-CA 116.784 -1.677 . . . . 255.47 114.66 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.19 94.8 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 119.238 0.926 . . . . 279.02999999999997 108.893 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.055 -0.35 . . . . 162.21000000000001 110.055 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.869 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.4 84.9 59.27 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 118.779 -1.168 . . . . 128.13 108.052 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.25 164.0 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.289 0 N-CA-C 107.499 -1.769 . . . . 278.35000000000002 107.499 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.17 15.0 9.93 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 123.778 0.674 . . . . 312.91000000000003 109.325 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.73 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.54 -1.652 . . . . 353.54000000000002 106.54 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.26 46.97 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.426 -1.324 . . . . 251.25999999999999 107.426 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 102.06 -3.311 . . . . 175.25999999999999 102.06 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.97 96.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 100.857 -3.757 . . . . 99.069999999999993 100.857 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.14 9.16 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.496 -2.779 . . . . 243.21000000000001 103.496 171.2 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.97 112.93 25.07 Favored 'General case' 0 CA--C 1.474 -1.948 0 C-N-CA 116.047 -2.261 . . . . 201.03999999999999 105.293 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 C-N-CA 115.992 -2.283 . . . . 201.36000000000001 108.789 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.44 -41.48 89.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.256 -1.793 . . . . 203.81999999999999 107.872 174.441 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.27 -45.69 86.94 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 118.181 -1.408 . . . . 215.06 112.552 -171.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.39 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.934 -171.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.84 -37.01 86.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.181 -1.414 . . . . 268.89999999999998 107.181 -171.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.19 -45.01 74.57 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 125.658 1.583 . . . . 280.88 108.809 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.52 85.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 118.981 -1.088 . . . . 184.47 108.982 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.91 -42.13 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 119.262 -0.975 . . . . 167.91999999999999 112.769 -175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.498 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.69 -38.87 90.44 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 117.787 -1.565 . . . . 367.18000000000001 110.783 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.73 74.06 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.819 -0.551 . . . . 173.97 110.471 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 123.541 0.736 . . . . 119.66 109.764 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.99 74.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.675 -1.231 . . . . 112.3 107.675 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.02 73.3 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.24 -0.436 . . . . 174.16999999999999 110.244 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 m -64.74 -22.74 67.05 Favored 'General case' 0 CA--C 1.485 -1.542 0 C-N-CA 124.656 1.182 . . . . 145.27000000000001 110.627 -175.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.762 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.36 70.42 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.066 -1.086 . . . . 170.15000000000001 108.066 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.37 -34.05 63.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 122.702 0.401 . . . . 214.56999999999999 110.639 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.27 -33.18 55.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.056 1.742 . . . . 168.28999999999999 115.514 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.762 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.91 79.29 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 114.024 1.12 . . . . 167.15000000000001 114.024 -168.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.72 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.8 p-10 -64.24 -38.23 32.49 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.472 -2.491 . . . . 165.13 113.932 -171.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.72 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.54 -31.82 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 122.846 2.052 . . . . 123.92 111.241 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.79 -42.53 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.769 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.22 -39.99 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.803 -0.814 . . . . 145.31 108.803 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.11 -48.83 78.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 119.386 -0.926 . . . . 246.68000000000001 109.854 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.1 m -62.16 -47.51 84.19 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.608 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.1 79.52 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.005 -1.078 . . . . 80.719999999999999 110.222 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 115.98 1.844 . . . . 140.44 115.98 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.77 132.22 34.46 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 112.753 -3.579 . . . . 178.87 113.061 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -64.98 -37.12 86.61 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.4 -1.273 . . . . 110.22 110.125 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.62 72.62 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 121.772 -0.58 . . . . 174.78 109.708 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.67 95.52 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.274 -1.009 . . . . 161.84 108.274 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.35 -50.17 73.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 120.01 -0.676 . . . . 117.2 109.232 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.06 75.47 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.328 -0.549 . . . . 112.59999999999999 111.114 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.36 94.47 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.671 -0.972 . . . . 101.45999999999999 110.671 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.21 -46.02 90.76 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 118.47 1.135 . . . . 151.49000000000001 109.511 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.0 -36.34 76.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.984 -1.487 . . . . 142.31999999999999 106.984 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.829 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.85 92.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.41 85.93 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 122.287 -0.258 . . . . 76.109999999999999 111.047 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -61.48 -55.46 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.829 -0.748 . . . . 120.23999999999999 109.301 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.31 131.57 41.28 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 102.944 -2.984 . . . . 192.72999999999999 102.944 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.15 -44.22 92.07 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.017 -1.073 . . . . 176.28999999999999 109.22 -172.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.3 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.488 -1.431 0 N-CA-C 106.277 -1.749 . . . . 69.680000000000007 106.277 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.02 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.431 0 C-N-CA 118.381 -0.612 . . . . 191.05000000000001 112.595 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.48 43.92 16.23 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 123.504 0.502 . . . . 287.02999999999997 109.772 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.829 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.56 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.916 0 C-N-CA 112.948 -3.501 . . . . 292.29000000000002 109.795 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.51 -152.8 0.05 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.206 -2.516 . . . . 184.56999999999999 104.206 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.62 8.75 5.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.061 0.763 . . . . 274.56 113.061 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.85 57.28 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 117.72 -2.181 . . . . 268.24000000000001 113.451 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.58 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 118.694 1.247 . . . . 200.06 110.722 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.76 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.868 -1.16 . . . . 114.44 107.868 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.24 46.07 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.635 -1.246 . . . . 263.81 107.635 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.218 1 N-CA-C 102.475 -4.25 . . . . 103.79000000000001 102.475 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.27 95.66 10.26 Favored 'General case' 0 N--CA 1.419 -2.014 0 C-N-CA 114.933 -2.707 . . . . 117.3 106.0 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.03 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.82 90.81 Favored 'General case' 0 CA--C 1.468 -2.178 1 N-CA-C 97.986 -4.82 . . . . 231.58000000000001 97.986 167.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.041 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.061 -3.311 . . . . 303.24000000000001 102.061 169.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.62 78.61 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.051 -2.26 . . . . 112.72 108.402 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.0 t -61.07 -63.6 1.24 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.1 -0.704 . . . . 83.219999999999999 109.1 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.885 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.28 -126.23 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.81 -2.663 . . . . 174.36000000000001 103.81 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.03 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.85 160.96 8.73 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.746 -1.946 . . . . 202.72999999999999 105.746 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.023 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.91 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.085 -1.45 . . . . 180.62 107.085 176.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.406 -2.072 . . . . 145.25 105.406 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.12 -43.12 88.05 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.155 -1.795 . . . . 66.049999999999997 106.155 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.509 -2.775 . . . . 266.49000000000001 103.509 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.29 -124.9 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.029 -1.868 . . . . 219.19999999999999 107.788 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.904 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.14 -37.32 93.98 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 114.546 -1.207 . . . . 94.780000000000001 112.853 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.2 100.42 9.09 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 112.285 -3.766 . . . . 121.41 109.489 -171.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -73.02 145.5 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.947 -0.76 . . . . 85.340000000000003 108.947 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.39 42.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.843 -1.169 . . . . 267.56999999999999 107.843 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.11 69.6 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.472 -0.566 . . . . 226.09999999999999 109.472 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 107.02 -1.474 . . . . 154.84 107.02 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.585 0.707 . . . . 180.00999999999999 110.728 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.47 156.94 23.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.945 -1.502 . . . . 333.77999999999997 106.945 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.5 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.355 -1.35 . . . . 335.19999999999999 107.355 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.768 -0.827 . . . . 266.47000000000003 108.768 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.59 -46.93 88.41 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.633 -1.988 . . . . 59.340000000000003 105.633 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.59 173.85 11.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.428 -2.434 . . . . 201.25999999999999 104.428 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.91 106.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 116.298 -2.161 . . . . 56.229999999999997 105.509 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.26 -59.45 5.28 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.24 -0.652 . . . . 87.579999999999998 109.24 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.5 153.77 22.23 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.842 -1.17 . . . . 219.94999999999999 107.842 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 116.335 -2.146 . . . . 121.79000000000001 105.476 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.13 159.75 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 N-CA-C 105.797 -1.927 . . . . 53.850000000000001 105.797 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 106.021 -2.832 . . . . 196.55000000000001 106.021 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.661 0 N-CA-C 107.843 -1.169 . . . . 35.880000000000003 107.843 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 1.039 ' HD2' ' HB3' ' A' ' 188' ' ' PRO . 32.6 ttt180 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.841 -0.799 . . . . 1.0 108.841 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.993 ' HG3' HD21 ' A' ' 5' ' ' LEU . 50.1 Cg_endo -67.07 143.95 67.58 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.771 1.647 . . . . 1.0 111.815 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -70.33 127.28 92.28 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.941 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 368' ' ' PRO . . . . . 0.77 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -68.98 -20.02 39.08 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 122.386 2.057 . . . . 1.0 114.567 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -38.58 77.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.711 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 370' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 367' ' ' LYS . 2.4 pt20 -71.33 -10.63 60.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.354 . . . . 1.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.77 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 3.1 m-85 -58.56 -46.34 87.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.277 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.66 -48.98 78.39 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.555 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.086 0 N-CA-C 109.878 -1.289 . . . . 1.0 109.878 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.30000000000001 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.75999999999999 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76000000000001 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.19999999999999 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52000000000001 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61000000000001 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.84999999999999 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36000000000001 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.72999999999999 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.94999999999999 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.799999999999997 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.909999999999997 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.859999999999999 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.460000000000001 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.59999999999999 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26000000000001 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.869999999999997 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.56999999999999 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.060000000000002 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.939999999999998 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.609999999999999 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04000000000001 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.159999999999997 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.850000000000001 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.390000000000001 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65000000000001 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.159999999999997 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.299999999999997 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.40000000000001 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.56999999999999 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.890000000000001 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.010000000000005 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96000000000001 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.31999999999999 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11000000000001 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.659999999999997 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18000000000001 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35000000000002 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.523 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54000000000001 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.219999999999999 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.59999999999999 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46000000000001 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93000000000001 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.30000000000001 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.710000000000001 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.890000000000001 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.890000000000001 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.09999999999999 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.44999999999999 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.59999999999999 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61000000000001 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.189999999999998 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.81999999999999 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98000000000002 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.01999999999998 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05000000000001 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99000000000001 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.42999999999995 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22000000000003 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72000000000003 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.57999999999998 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.60000000000002 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48000000000002 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68000000000001 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.33999999999997 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27000000000001 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08000000000001 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.88999999999999 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61000000000001 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.829999999999998 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.400000000000006 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.299999999999997 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.359999999999999 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.730000000000004 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74000000000001 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.390000000000001 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.340000000000003 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.680000000000007 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.980000000000004 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74000000000001 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55000000000001 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.57999999999998 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.70999999999998 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.50999999999999 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41000000000003 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.229999999999997 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.289999999999999 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.109999999999999 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.329999999999998 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.859999999999999 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.129999999999995 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.879999999999995 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.859999999999999 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.439999999999998 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.640000000000001 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.56999999999999 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.159999999999997 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15000000000001 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.66999999999999 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.41999999999999 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.39999999999998 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.10000000000002 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.80000000000001 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.52999999999997 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99000000000001 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98000000000002 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.80999999999995 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99000000000001 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32000000000005 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.90999999999997 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99000000000001 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86000000000001 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.76999999999998 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99000000000001 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99000000000001 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.180000000000007 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99000000000001 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99000000000001 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72000000000003 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61000000000001 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.88999999999999 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21000000000001 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46000000000001 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61000000000001 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.47999999999999 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.859999999999999 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68000000000001 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.159999999999997 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02000000000001 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.170000000000002 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.59999999999999 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.100000000000001 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.890000000000001 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.409999999999997 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.690000000000001 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.880000000000003 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.290000000000006 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.260000000000005 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.710000000000001 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.859999999999999 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72000000000003 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.780000000000001 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.459999999999994 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.34999999999999 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.56999999999999 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96000000000001 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68000000000001 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.56999999999999 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29000000000002 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92000000000002 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.620000000000005 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.289999999999999 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.969999999999999 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.269999999999996 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.980000000000004 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.049999999999997 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.010000000000005 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.090000000000003 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.390000000000001 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.420000000000002 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51000000000001 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.180000000000007 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.329999999999998 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.230000000000004 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.34999999999999 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.22999999999999 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.77999999999997 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11000000000001 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.53999999999999 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.02999999999997 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21000000000001 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.868 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35000000000002 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91000000000003 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.25999999999999 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.25999999999999 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21000000000001 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.03999999999999 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36000000000001 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.81999999999999 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.89999999999998 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.91999999999999 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18000000000001 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.16999999999999 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27000000000001 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15000000000001 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.56999999999999 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.28999999999999 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15000000000001 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.719999999999999 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.59999999999999 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.45999999999999 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49000000000001 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.31999999999999 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.109999999999999 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.72999999999999 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.28999999999999 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.680000000000007 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05000000000001 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.02999999999997 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29000000000002 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.56999999999999 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24000000000001 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79000000000001 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58000000000001 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.219999999999999 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36000000000001 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.72999999999999 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.049999999999997 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.780000000000001 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.340000000000003 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.56999999999999 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.09999999999999 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.00999999999999 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.893 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.77999999999997 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.19999999999999 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47000000000003 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.340000000000003 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.25999999999999 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.579999999999998 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.94999999999999 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79000000000001 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.850000000000001 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.880000000000003 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.525 ' N ' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.07 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.703 1.602 . . . . 1.0 111.856 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 127.36 92.1 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.276 -0.42 . . . . 1.0 109.876 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.664 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.5 Cg_endo -69.01 -20.03 38.89 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.458 2.106 . . . . 1.0 114.543 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.3 -38.67 77.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.702 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -10.55 59.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 1.0 110.55 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.664 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 4.2 m-30 -58.57 -46.36 87.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.307 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.56 -49.06 78.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.55 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.12 78.31 0.31 Allowed Glycine 0 CA--C 1.516 0.098 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -41.75 97.21 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.139 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.485 ' HA ' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.532 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.368 -0.975 . . . . 97.079999999999998 108.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.63 155.41 22.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.072 0.939 . . . . 123.41 110.739 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.52 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.51 1 N-CA-C 100.136 -4.024 . . . . 151.30000000000001 100.136 173.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.903 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.65 -38.6 58.39 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 115.981 -2.288 . . . . 169.25 106.145 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.903 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.27 168.51 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 122.273 0.617 . . . . 185.75999999999999 110.585 171.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.4 t -64.48 -25.9 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 C-N-CA 126.984 2.114 . . . . 145.47 110.336 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.4 21.51 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.088 -1.007 . . . . 102.76000000000001 109.453 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.58 154.17 25.13 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.014 -1.106 . . . . 106.25 108.014 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.87 51.87 0.74 Allowed 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.645 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.15 -45.9 91.5 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 103.619 -2.734 . . . . 150.19999999999999 103.619 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -86.98 164.7 35.38 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 103.711 -2.699 . . . . 183.52000000000001 103.711 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.79 6.87 3.85 Favored 'Trans proline' 0 C--N 1.281 -3.012 0 N-CA-C 109.948 -0.828 . . . . 235.61000000000001 109.948 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.97 -41.19 82.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.813 1.245 . . . . 113.77 113.375 -170.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.19 136.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 119.555 1.071 . . . . 150.84999999999999 110.947 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.48 156.24 46.4 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.624 -1.25 . . . . 100.42 107.624 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.04 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.974 0.892 . . . . 129.36000000000001 110.445 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.11 -25.45 68.36 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.278 1.831 . . . . 112.34 106.67 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.19 -40.11 62.73 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.565 -0.743 . . . . 131.72999999999999 111.75 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.48 -42.86 15.15 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.95 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.825 0 C-N-CA 118.155 -1.418 . . . . 98.980000000000004 111.21 -169.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.5 Cg_exo -61.82 -10.8 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.917 1 N-CA-C 128.862 6.447 . . . . 246.94999999999999 128.862 -170.05 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.67 17.56 8.77 Favored 'General case' 0 C--N 1.324 -0.523 1 CA-C-N 126.19 4.086 . . . . 269.62 114.183 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.17 -27.25 67.12 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.785 -1.191 . . . . 86.799999999999997 107.785 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.87 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.126 -0.984 . . . . 85.909999999999997 110.517 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 123.663 0.785 . . . . 82.0 111.388 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.44 167.7 12.55 Favored Pre-proline 0 CA--C 1.489 -1.378 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.9 149.75 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.881 . . . . 87.859999999999999 109.913 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.99 89.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.851 -0.796 . . . . 36.460000000000001 108.851 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.8 -33.83 76.54 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.812 -1.181 . . . . 150.59999999999999 107.812 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.4 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.296 -0.877 . . . . 123.26000000000001 108.645 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.53 -47.16 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.42 -31.01 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 107.845 -1.169 . . . . 112.19 107.845 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.12 84.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.899 -0.72 . . . . 60.869999999999997 109.622 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -65.99 -35.65 81.14 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 119.953 -0.699 . . . . 157.56999999999999 110.388 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.614 -0.884 . . . . 47.060000000000002 108.614 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.74 -41.32 98.05 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.743 -0.598 . . . . 43.939999999999998 109.573 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.35 99.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.717 -0.846 . . . . 42.609999999999999 108.717 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.9 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.34 -41.28 94.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.616 -0.266 . . . . 140.66 111.002 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.76 -43.97 97.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 118.596 -1.241 . . . . 116.04000000000001 110.236 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.75 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 N-CA-C 108.728 -0.842 . . . . 97.159999999999997 108.728 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -39.97 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 108.952 -0.759 . . . . 54.850000000000001 108.952 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.74 -42.36 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.835 -0.802 . . . . 45.390000000000001 108.835 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.1 t -63.54 -50.94 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 118.826 -1.15 . . . . 48.640000000000001 110.166 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.25 -47.07 78.04 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.14 -0.624 . . . . 116.65000000000001 111.703 -174.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.96 -43.92 97.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.683 -0.488 . . . . 51.159999999999997 109.683 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.58 -48.92 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 C-N-CA 119.85 -0.74 . . . . 44.299999999999997 110.834 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.78 -46.91 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 120.239 -0.585 . . . . 48.82 111.034 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.76 -44.14 95.23 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.474 -0.87 . . . . 58.700000000000003 112.016 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.64 -34.18 67.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 122.136 -0.626 . . . . 101.40000000000001 111.056 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.97 -38.64 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.742 -1.207 . . . . 103.56999999999999 107.742 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.45 -43.06 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.972 -0.751 . . . . 61.890000000000001 108.972 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.98 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 109.463 -0.569 . . . . 70.010000000000005 109.463 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.37 98.97 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.128 -0.693 . . . . 132.09999999999999 109.128 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.65 82.95 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.706 -0.225 . . . . 104.5 110.435 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.61 -49.91 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 120.233 -0.587 . . . . 142.96000000000001 111.303 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.946 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.68 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.926 -1.91 . . . . 158.31999999999999 110.893 -175.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.73 -41.39 98.05 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 117.71 -1.596 . . . . 137.11000000000001 109.496 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.55 91.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 122.089 -0.382 . . . . 54.659999999999997 110.997 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.44 117.17 29.45 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.646 0.736 . . . . 127.18000000000001 109.559 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.89 -36.74 80.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 124.039 0.935 . . . . 87.930000000000007 110.859 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.045 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.43 -34.62 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.65 -0.656 . . . . 131.12 111.482 -175.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.027 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.67 69.47 7.19 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 115.271 -2.571 . . . . 246.56 109.6 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.24 91.49 3.49 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 105.453 -2.055 . . . . 339.35000000000002 105.453 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.24 17.93 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 102.97 -2.974 . . . . 114.66 102.97 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.11 -39.5 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 106.754 -1.573 . . . . 143.28 106.754 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.7 m -59.67 -38.03 80.38 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.697 -0.853 . . . . 160.22 108.697 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.3 m-20 -62.35 -31.75 72.44 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.893 -0.78 . . . . 120.54000000000001 108.893 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.66 -43.74 95.85 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.482 -0.562 . . . . 67.219999999999999 109.482 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.54 -39.77 88.75 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.537 -0.727 . . . . 138.59999999999999 109.683 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.59 -35.9 82.03 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.449 0.3 . . . . 151.46000000000001 110.644 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.946 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.51 -38.02 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 C-N-CA 117.406 -1.718 . . . . 117.93000000000001 106.719 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.1 -45.97 91.16 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.889 -1.152 . . . . 56.82 107.889 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.94 98.01 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.917 -0.771 . . . . 145.30000000000001 108.917 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.34 95.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.574 -0.898 . . . . 45.710000000000001 108.574 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.36 -42.04 99.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.387 -0.597 . . . . 105.61 109.387 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.47 92.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.668 -0.864 . . . . 47.890000000000001 108.668 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.34 84.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.976 -0.379 . . . . 124.53 109.976 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.19 99.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.944 -0.473 . . . . 35.890000000000001 109.807 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.26 -37.3 84.95 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.966 -1.494 . . . . 88.969999999999999 106.966 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.21 -49.11 77.06 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.809 -0.756 . . . . 239.91 109.064 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.36 90.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.522 -0.736 . . . . 146.09999999999999 110.611 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.872 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.4 1.97 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.764 1.765 . . . . 197.44999999999999 115.764 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.927 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.26 55.63 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 117.891 -1.524 . . . . 242.59999999999999 114.039 -170.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.37 -36.57 84.39 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.862 -1.135 . . . . 215.61000000000001 109.886 -172.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.25 -46.92 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 120.361 -0.536 . . . . 87.189999999999998 110.493 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.88 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 109.754 -0.461 . . . . 231.81999999999999 109.754 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.9 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.1 75.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.349 -0.982 . . . . 364.98000000000002 108.349 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.23 -44.69 75.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.559 -0.713 . . . . 181.63 111.236 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.478 HG22 ' ND1' ' A' ' 95' ' ' HIS . 58.1 m -60.91 -45.76 93.33 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 107.409 -1.33 . . . . 269.01999999999998 107.409 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.78 -45.01 93.62 Favored 'General case' 0 CA--C 1.469 -2.146 0 C-N-CA 118.625 -1.23 . . . . 562.65999999999997 109.983 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.28 95.34 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.685 -1.206 . . . . 446.75 108.066 -167.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.48 -26.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.859 -2.336 . . . . 370.05000000000001 112.195 -178.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.49 -26.49 60.04 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.552 -0.717 . . . . 354.91000000000003 112.478 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.3 m-20 82.76 4.45 1.01 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 125.048 1.339 . . . . 462.44 111.934 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.3 178.06 2.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.971 0.891 . . . . 652.37 111.168 171.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.7 86.35 2.16 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 128.473 2.709 . . . . 905.99000000000001 107.947 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -67.97 -36.36 79.93 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.203 -1.036 . . . . 570.42999999999995 108.203 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.37 82.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.345 1.458 . . . . 453.22000000000003 111.146 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.57 178.68 33.86 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.716 -1.707 . . . . 445.63 109.875 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.754 HD21 ' CE1' ' B' ' 371' ' ' PHE . 89.1 mt -56.45 -41.23 76.13 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.208 1.403 . . . . 457.72000000000003 112.374 -170.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.57 -47.02 85.66 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.69 -1.204 . . . . 340.57999999999998 109.266 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.68 -32.14 71.76 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.802 -1.159 . . . . 453.60000000000002 111.59 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.36 73.37 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.971 -1.863 . . . . 541.48000000000002 105.971 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 75.99 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.949 0.781 . . . . 466.68000000000001 110.873 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.75 -47.09 86.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 117.501 -1.68 . . . . 427.33999999999997 107.296 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.16 -36.76 82.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 112.365 0.506 . . . . 537.87 112.365 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.39 -42.68 74.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 116.882 -1.927 . . . . 422.12 111.604 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.8 t80 -59.04 -50.09 75.4 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 121.34 -0.85 . . . . 340.17000000000002 111.84 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -65.34 -46.48 70.82 Favored Pre-proline 0 N--CA 1.443 -0.776 0 C-N-CA 119.085 -1.046 . . . . 258.06 111.705 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.55 -31.57 87.43 Favored 'Trans proline' 0 N--CA 1.435 -1.954 0 N-CA-C 115.324 1.24 . . . . 305.70999999999998 115.324 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.702 -0.851 . . . . 252.69999999999999 108.702 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.66 93.93 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.776 -1.194 . . . . 149.27000000000001 107.776 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.85 95.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.661 -0.416 . . . . 138.08000000000001 111.509 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.92 -42.35 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 121.587 -0.696 . . . . 132.88999999999999 110.996 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.81 -44.66 92.63 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.84 -0.8 . . . . 193.61000000000001 108.84 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.69 84.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.846 0.458 . . . . 63.829999999999998 110.063 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -64.04 -52.41 59.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 122.068 -0.395 . . . . 76.400000000000006 111.228 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.63 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.188 -1.041 . . . . 171.13 108.188 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.58 91.63 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.82 -0.55 . . . . 78.299999999999997 110.599 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.74 80.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 118.886 -1.126 . . . . 92.359999999999999 109.217 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.26 76.45 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.199 -1.037 . . . . 93.730000000000004 108.199 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.48 -41.61 84.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.193 -1.003 . . . . 132.74000000000001 109.34 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.05 94.65 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.194 -1.41 . . . . 43.390000000000001 107.194 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.5 -41.97 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.593 -0.891 . . . . 59.340000000000003 108.593 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.43 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 121.781 -0.574 . . . . 69.680000000000007 110.491 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.48 -42.79 91.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.287 -1.005 . . . . 106.98 108.287 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.659 -0.817 . . . . 147.63 108.917 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.707 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.17 -41.54 99.25 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.549 -0.908 . . . . 190.06 108.549 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.08 97.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.306 -0.998 . . . . 118.84999999999999 108.306 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.3 -42.76 99.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.99 -0.374 . . . . 102.5 109.99 -177.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.61 95.34 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 121.875 -0.516 . . . . 89.980000000000004 109.853 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.52 -50.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 C-N-CA 118.151 -1.419 . . . . 106.09 111.003 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.746 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.32 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.078 -1.849 . . . . 227.74000000000001 111.847 -174.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.83 100.09 51.01 Favored Pre-proline 0 CA--C 1.486 -1.511 0 C-N-CA 116.261 -2.176 . . . . 262.55000000000001 110.047 -175.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.1 Cg_endo -69.65 -10.33 28.38 Favored 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 121.606 1.537 . . . . 210.25 111.332 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.521 -1.659 . . . . 270.57999999999998 106.521 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.8 -39.52 24.18 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-N 115.377 -0.829 . . . . 129.84 112.312 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.862 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.5 Cg_exo -61.36 -26.65 81.85 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 116.296 1.614 . . . . 330.70999999999998 116.296 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -80.99 77.16 7.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 114.502 -2.879 . . . . 204.50999999999999 107.3 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.35 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.431 -1.322 . . . . 387.41000000000003 107.431 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.65 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 118.761 -1.176 . . . . 166.22 109.461 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.821 -1.177 . . . . 44.229999999999997 107.821 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.28 -39.13 85.77 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.206 -1.035 . . . . 28.800000000000001 108.206 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.83 92.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.074 -0.714 . . . . 30.289999999999999 109.074 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.4 m -59.56 -43.06 93.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.016 -0.735 . . . . 46.109999999999999 109.016 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.1 99.25 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.683 -1.229 . . . . 87.329999999999998 107.683 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.68 -42.1 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.883 -1.155 . . . . 23.690000000000001 107.883 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.23 -44.31 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 109.649 -0.5 . . . . 43.859999999999999 109.649 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.59 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.352 -0.981 . . . . 91.129999999999995 108.352 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.53 -37.97 88.15 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.768 -0.827 . . . . 65.879999999999995 108.768 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.07 -41.96 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.536 -0.542 . . . . 33.859999999999999 109.536 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.34 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.595 -1.261 . . . . 146.52000000000001 107.595 -176.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.33 90.5 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.512 -0.875 . . . . 75.439999999999998 108.849 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.58 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 O-C-N 121.031 -1.043 . . . . 43.640000000000001 109.725 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.73 -37.95 89.26 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 109.027 -0.731 . . . . 102.56999999999999 109.027 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.09 87.01 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.383 -1.34 . . . . 58.159999999999997 107.383 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.03 -32.52 73.91 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.043 -0.725 . . . . 121.11 109.043 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.99 -42.37 84.97 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 118.586 -1.245 . . . . 153.15000000000001 109.895 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.1 -43.73 19.02 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 113.051 -3.46 . . . . 133.66999999999999 113.488 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.9 96.07 Favored 'General case' 0 CA--C 1.489 -1.402 0 O-C-N 120.893 -1.13 . . . . 157.41999999999999 112.226 -171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.521 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.09 2.44 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 115.037 1.495 . . . . 250.91 115.037 -173.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.6 Cg_exo -59.51 -25.47 78.82 Favored 'Trans proline' 0 CA--C 1.488 -1.816 0 N-CA-C 118.018 2.276 . . . . 207.34 118.018 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.914 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.15 -34.21 74.65 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.978 -1.49 . . . . 192.46000000000001 106.978 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.99 98.07 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 107.938 -2.065 . . . . 261.0 107.938 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.83 159.09 26.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 101.554 -3.499 . . . . 491.39999999999998 101.554 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 116.287 -2.165 . . . . 386.10000000000002 109.797 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 103.54 -2.763 . . . . 289.80000000000001 103.54 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.41 0.86 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.725 -1.131 . . . . 402.06 109.556 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 71.9 p -165.29 177.48 7.56 Favored 'General case' 0 CA--C 1.587 2.373 0 C-N-CA 127.323 2.249 . . . . 690.52999999999997 114.902 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.35 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.698 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.84 22.09 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 127.399 2.28 . . . . 617.99000000000001 110.916 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.99 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.246 3.419 . . . . 434.98000000000002 113.455 -175.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 122.397 3.96 . . . . 365.88 122.397 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.89 1.7 Allowed 'General case' 0 CA--C 1.467 -2.235 0 N-CA-C 104.83 -2.285 . . . . 635.80999999999995 104.83 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.21 18.83 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.975 7.768 . . . . 999.99000000000001 131.975 -135.735 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.909 36.9 t -131.85 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.73 1 CA-C-N 103.311 -6.313 . . . . 594.32000000000005 113.588 149.175 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.18 144.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.289 -4.708 . . . . 811.90999999999997 98.289 162.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.55 45.91 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.05 -1.86 . . . . 999.99000000000001 109.374 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.22 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.009 0.909 . . . . 431.86000000000001 110.038 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.039 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.14 148.64 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.8 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.51 3.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.109 0.963 . . . . 458.76999999999998 113.486 -174.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.54 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.928 1.291 . . . . 999.99000000000001 112.479 168.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.76 5.65 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 N-CA-C 120.865 3.371 . . . . 999.99000000000001 120.865 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.59 171.69 8.19 Favored 'General case' 0 CA--C 1.472 -2.032 0 C-N-CA 117.2 -1.8 . . . . 81.180000000000007 107.274 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.518 -2.473 . . . . 999.99000000000001 108.767 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.55 101.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.167 1 C-N-CA 126.015 4.477 . . . . 999.99000000000001 105.716 -170.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.18 -44.02 97.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 126.786 2.034 . . . . 967.72000000000003 112.092 -165.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.57 78.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.711 -1.589 . . . . 934.29999999999995 106.711 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.26 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.212 3.005 . . . . 565.14999999999998 113.898 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.51 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 118.468 0.576 . . . . 755.61000000000001 109.863 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.28 67.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.557 1.143 . . . . 325.88999999999999 113.274 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.98 78.37 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 123.55 0.74 . . . . 250.21000000000001 111.64 -169.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.544 0.688 . . . . 142.46000000000001 110.38 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.039 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.14 -41.5 96.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.942 0.897 . . . . 247.69 108.832 -173.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.48 -51.35 69.85 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.467 1.507 . . . . 199.61000000000001 113.103 -175.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.36 -44.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 107.694 -1.225 . . . . 106.73 107.694 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.725 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.13 -48.48 81.46 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.88 -0.6 . . . . 115.01000000000001 110.251 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.28 -49.17 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 C-N-CA 119.433 -0.907 . . . . 129.41999999999999 111.801 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.9 -53.16 59.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 118.23 -1.388 . . . . 172.47999999999999 109.933 -172.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.83 -54.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 123.471 0.482 . . . . 55.859999999999999 110.982 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.95 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 118.551 -1.259 . . . . 184.68000000000001 111.509 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.04 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.41 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 116.67 -2.012 . . . . 291.81 114.715 -174.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -55.05 4.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.54 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.485 1.291 . . . . 80.159999999999997 114.485 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.897 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.48 83.22 Favored Pre-proline 0 N--CA 1.435 -1.198 0 C-N-CA 119.963 -0.695 . . . . 136.02000000000001 109.48 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.8 -27.11 59.7 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.707 0.574 . . . . 92.170000000000002 110.62 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.35 76.63 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.486 -1.302 . . . . 135.59999999999999 107.486 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.14 -44.72 91.33 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.603 -0.517 . . . . 52.100000000000001 109.603 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.68 -43.51 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.111 -0.7 . . . . 95.890000000000001 109.111 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.906 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.33 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.725 -1.583 . . . . 43.409999999999997 106.725 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.33 99.14 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.343 -1.503 . . . . 27.690000000000001 109.343 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.37 75.71 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.476 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.1 74.82 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.976 -1.49 . . . . 53.880000000000003 106.976 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.85 93.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.469 -0.937 . . . . 68.290000000000006 108.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.84 -39.01 92.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.672 -0.811 . . . . 107.59 110.604 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -62.95 -38.41 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.553 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.5 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.358 -0.979 . . . . 85.260000000000005 108.358 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.87 99.43 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.088 -0.805 . . . . 40.710000000000001 111.088 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.08 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.399 -0.963 . . . . 95.859999999999999 108.399 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.93 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.401 -0.962 . . . . 144.37 108.401 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.57 -1.27 . . . . 326.72000000000003 107.57 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.29 -168.03 1.5 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.072 -1.825 . . . . 158.38 106.072 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.458 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.96 98.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.659 -0.496 . . . . 36.780000000000001 109.659 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.12 125.84 25.2 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.17 -1.012 . . . . 85.459999999999994 109.808 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.47 8.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.53 -2.026 . . . . 127.78 105.53 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.96 139.87 34.96 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 106.023 -1.843 . . . . 164.84 106.023 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.6 Cg_exo -56.77 -39.97 87.57 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.935 0.706 . . . . 222.34999999999999 113.935 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.97 44.94 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 106.445 -2.662 . . . . 45.219999999999999 106.445 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.73 93.49 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.035 -1.839 . . . . 107.56999999999999 106.035 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.78 141.83 58.18 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.9 -1.12 . . . . 167.96000000000001 109.168 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.52 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 126.734 2.014 . . . . 280.68000000000001 109.706 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.04 11.23 0.7 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.443 1.097 . . . . 218.25 110.698 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.36 137.64 54.79 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.241 -2.133 . . . . 343.56999999999999 105.241 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.477 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.93 1.54 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.839 -1.541 . . . . 263.29000000000002 106.839 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.26 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 126.568 1.947 . . . . 261.92000000000002 108.522 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.19 -38.1 89.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.893 -1.151 . . . . 106.81 107.893 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.35 -1.34 . . . . 112.2 107.594 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.24 -39.87 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 N-CA-C 109.259 -0.645 . . . . 45.409999999999997 109.259 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.81 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.9 p -70.88 -32.05 68.91 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.313 -0.255 . . . . 97.620000000000005 110.313 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.62 81.66 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.684 0.794 . . . . 59.289999999999999 110.992 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.55 84.01 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.656 1.182 . . . . 106.48999999999999 110.683 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.63 69.2 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.32 -0.993 . . . . 106.62 108.32 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.02 -41.02 91.51 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.809 -0.557 . . . . 75.969999999999999 110.079 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.446 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.6 t -65.57 -40.8 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 122.908 0.483 . . . . 65.269999999999996 109.788 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.06 -41.56 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.154 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.58 -40.76 97.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 121.712 -0.618 . . . . 87.980000000000004 110.27 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.4 96.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 118.815 -1.154 . . . . 65.5 108.367 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.774 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.66 -36.41 80.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.162 -1.051 . . . . 85.049999999999997 108.162 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.6 mt -63.47 -45.77 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 109.053 -0.721 . . . . 42.25 109.053 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.26 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 119.542 -0.863 . . . . 91.010000000000005 109.419 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.86 -41.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.99 -1.115 . . . . 66.090000000000003 107.99 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.6 t -66.07 -43.15 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 120.758 -0.377 . . . . 52.390000000000001 110.293 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.7 m -61.8 -46.73 88.28 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.907 -0.496 . . . . 46.420000000000002 109.866 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.13 88.29 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.323 -0.991 . . . . 116.51000000000001 108.323 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.486 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.26 -48.23 82.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.402 -0.592 . . . . 65.180000000000007 109.402 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.7 97.2 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 120.824 0.345 . . . . 51.329999999999998 110.407 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.34 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 C-N-CA 118.941 -1.103 . . . . 126.3 109.015 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.64 -49.31 69.12 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.539 -0.864 . . . . 133.94 112.456 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.821 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.74 -33.32 35.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 116.826 2.158 . . . . 134.84 116.826 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.43 -41.64 90.37 Favored Pre-proline 0 CA--C 1.493 -1.237 0 CA-C-N 118.632 0.651 . . . . 72.230000000000004 111.644 -167.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.67 -35.98 87.07 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 CA-C-N 119.83 0.975 . . . . 106.13 111.375 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.35 -44.73 82.45 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 119.752 -0.779 . . . . 128.34999999999999 110.051 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.43 -37.85 88.98 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.174 -0.306 . . . . 100.73 110.174 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.3 -44.55 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 C-N-CA 119.274 -0.971 . . . . 172.72 109.123 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.57 -28.06 68.22 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.273 -1.01 . . . . 249.22999999999999 108.273 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.6 -55.11 35.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.644 -1.613 . . . . 259.77999999999997 106.644 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.11 -44.23 72.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.574 0.953 . . . . 233.11000000000001 113.574 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.9 mt -61.38 -48.29 91.41 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 119.162 -1.015 . . . . 169.53999999999999 110.596 -171.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.4 Cg_exo -61.12 -24.56 79.51 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 C-N-CA 116.771 -1.686 . . . . 255.47 114.655 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.54 -44.23 94.8 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.213 0.915 . . . . 279.02999999999997 108.929 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.79 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.073 -0.343 . . . . 162.21000000000001 110.073 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.871 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.83 59.38 Favored Pre-proline 0 N--CA 1.431 -1.399 0 C-N-CA 118.802 -1.159 . . . . 128.13 108.09 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.02 11.28 Favored 'Trans proline' 0 C--N 1.295 -2.264 0 N-CA-C 107.445 -1.79 . . . . 278.35000000000002 107.445 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.07 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 123.829 0.705 . . . . 312.91000000000003 109.37 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 274' ' ' ASN . 28.2 mt -132.75 -170.64 2.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.534 -1.654 . . . . 353.54000000000002 106.534 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.7 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.389 -1.337 . . . . 251.25999999999999 107.389 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.01 -118.69 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.103 -3.295 . . . . 175.25999999999999 102.103 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.5 -45.0 96.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.837 -3.764 . . . . 99.069999999999993 100.837 172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.17 9.17 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.463 -2.791 . . . . 243.21000000000001 103.463 171.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.94 25.08 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 116.051 -2.259 . . . . 201.03999999999999 105.262 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.91 173.76 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 C-N-CA 115.954 -2.298 . . . . 201.36000000000001 108.781 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.281 0.6 OUTLIER -59.49 -41.45 89.84 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.248 -1.796 . . . . 203.81999999999999 107.905 174.44 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.33 -45.69 86.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.21 -1.396 . . . . 215.06 112.562 -171.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.5 t -65.7 -46.4 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 118.529 -1.268 . . . . 125.28 112.928 -171.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.74 -37.07 86.36 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.191 -1.411 . . . . 268.89999999999998 107.191 -171.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.8 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.18 -45.0 74.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 125.6 1.56 . . . . 280.88 108.817 -172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.49 86.0 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.91 -1.116 . . . . 184.47 109.043 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.88 -42.13 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 119.284 -0.966 . . . . 167.91999999999999 112.785 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.86 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 117.772 -1.571 . . . . 367.18000000000001 110.765 -175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.17 -32.74 74.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 121.844 -0.535 . . . . 173.97 110.468 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.72 85.09 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.505 0.722 . . . . 119.66 109.78 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.821 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.95 74.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.686 -1.228 . . . . 112.3 107.686 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.08 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.24 -0.436 . . . . 174.16999999999999 110.263 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.75 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 124.7 1.2 . . . . 145.27000000000001 110.586 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.761 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.64 -35.36 70.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.095 -1.076 . . . . 170.15000000000001 108.095 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.32 -34.15 63.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 116.295 -0.411 . . . . 214.56999999999999 110.609 -171.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.19 -33.18 56.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.084 1.754 . . . . 168.28999999999999 115.566 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.49 -34.82 79.11 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.007 1.114 . . . . 167.15000000000001 114.007 -168.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.22 -38.26 32.86 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 115.512 -2.475 . . . . 165.13 113.937 -171.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.7 Cg_exo -62.55 -31.86 79.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.771 2.025 . . . . 123.92 111.236 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.75 -42.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 118.874 -1.131 . . . . 110.55 109.823 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.15 -40.04 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.86 -0.793 . . . . 145.31 108.86 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.2 m-85 -58.16 -48.82 79.1 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.371 -0.932 . . . . 246.68000000000001 109.81 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.18 -47.45 84.43 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.542 -0.863 . . . . 64.430000000000007 109.621 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.84 -45.07 79.36 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 118.968 -1.093 . . . . 80.719999999999999 110.223 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.02 1.859 . . . . 140.44 116.02 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.25 34.37 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 112.699 -3.6 . . . . 178.87 113.03 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.1 86.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.394 -1.275 . . . . 110.22 110.09 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.71 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.268 0 O-C-N 121.744 -0.598 . . . . 174.78 109.757 -174.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.84 -41.69 95.52 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.273 -1.01 . . . . 161.84 108.273 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.34 -50.23 73.61 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.179 -0.675 . . . . 117.2 109.179 -173.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.53 -44.08 75.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.384 -0.527 . . . . 112.59999999999999 111.056 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.41 94.54 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.647 -0.981 . . . . 101.45999999999999 110.647 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.023 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 91.0 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 118.54 1.17 . . . . 151.49000000000001 109.505 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.15 -36.28 77.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.94 -1.504 . . . . 142.31999999999999 106.94 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.81 -41.81 92.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.885 -1.524 . . . . 109.09 106.885 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.4 85.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.35 -0.219 . . . . 76.109999999999999 111.066 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.44 -55.48 30.78 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.888 -0.725 . . . . 120.23999999999999 109.305 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.52 41.22 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 102.942 -2.984 . . . . 192.72999999999999 102.942 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.22 92.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.048 -1.061 . . . . 176.28999999999999 109.185 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.13 0.82 Allowed Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 106.296 -1.742 . . . . 69.680000000000007 106.296 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.97 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-O 118.711 -0.62 . . . . 191.05000000000001 112.604 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.51 43.89 16.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.62 0.575 . . . . 287.02999999999997 109.753 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.54 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.94 0 C-N-CA 112.964 -3.494 . . . . 292.29000000000002 109.847 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.78 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.21 -2.515 . . . . 184.56999999999999 104.21 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.7 4.98 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.042 0.756 . . . . 274.56 113.042 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.83 57.25 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 117.737 -2.173 . . . . 268.24000000000001 113.47 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.68 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.68 1.24 . . . . 200.06 110.778 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.92 -33.0 74.72 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.858 -1.164 . . . . 114.44 107.858 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.0 21.97 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.65 -1.241 . . . . 263.81 107.65 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.37 -137.28 3.56 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.529 -4.228 . . . . 103.79000000000001 102.529 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.55 10.24 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 114.942 -2.703 . . . . 117.3 106.014 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.92 Favored 'General case' 0 CA--C 1.468 -2.19 1 N-CA-C 98.016 -4.809 . . . . 231.58000000000001 98.016 167.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.045 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.066 -3.309 . . . . 303.24000000000001 102.066 168.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.66 -48.57 78.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 116.047 -2.261 . . . . 112.72 108.39 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.61 1.24 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.124 -0.695 . . . . 83.219999999999999 109.124 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.5 m -156.29 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.791 -2.67 . . . . 174.36000000000001 103.791 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.88 160.98 8.75 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 105.762 -1.94 . . . . 202.72999999999999 105.762 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.027 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.93 149.02 52.56 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.1 -1.445 . . . . 180.62 107.1 176.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.5 -171.87 0.27 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 105.362 -2.088 . . . . 145.25 105.362 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.07 -43.11 88.36 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.192 -1.781 . . . . 66.049999999999997 106.192 174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.74 -152.17 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.482 -2.785 . . . . 266.49000000000001 103.482 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.697 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.36 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.024 -1.87 . . . . 219.19999999999999 107.757 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.98 -37.43 94.25 Favored Glycine 0 N--CA 1.426 -2.018 0 CA-C-N 114.52 -1.218 . . . . 94.780000000000001 112.885 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.2 100.45 9.11 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 112.321 -3.752 . . . . 121.41 109.41 -171.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.7 t -73.08 145.5 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.957 -0.757 . . . . 85.340000000000003 108.957 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.819 -1.178 . . . . 267.56999999999999 107.819 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.06 69.56 0.6 Allowed 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.524 -0.547 . . . . 226.09999999999999 109.524 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.98 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.31 161.93 8.42 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.626 0.727 . . . . 180.00999999999999 110.681 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.97 23.51 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.97 -1.492 . . . . 333.77999999999997 106.97 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.972 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.08 142.54 48.79 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.347 -1.353 . . . . 335.19999999999999 107.347 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.972 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.8 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.744 -0.836 . . . . 266.47000000000003 108.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.3 m -60.62 -46.94 88.38 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.64 -1.985 . . . . 59.340000000000003 105.64 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.84 12.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 104.442 -2.429 . . . . 201.25999999999999 104.442 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.93 106.71 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 C-N-CA 116.347 -2.141 . . . . 56.229999999999997 105.505 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 71.0 m -61.14 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.316 -0.624 . . . . 87.579999999999998 109.316 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.75 22.28 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.813 -1.18 . . . . 219.94999999999999 107.813 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 C-N-CA 116.372 -2.131 . . . . 121.79000000000001 105.423 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.4 t -154.13 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 105.835 -1.913 . . . . 53.850000000000001 105.835 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.034 -2.826 . . . . 196.55000000000001 106.034 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.677 0 N-CA-C 107.832 -1.173 . . . . 35.880000000000003 107.832 -178.934 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.61 ' NH2' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -67.09 144.06 67.92 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.663 1.575 . . . . 1.0 111.833 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' B' ' 367' ' ' LYS . 0.1 OUTLIER -70.4 127.36 92.18 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.22 -0.446 . . . . 1.0 109.905 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.8 Cg_endo -69.04 -20.02 38.77 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.428 2.085 . . . . 1.0 114.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.28 -38.68 77.48 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.725 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -71.36 -10.44 59.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 1.0 110.604 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.754 ' CE1' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -58.63 -46.28 87.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 1.0 110.323 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -61.65 -49.03 78.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.551 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.12 78.32 0.31 Allowed Glycine 0 N--CA 1.455 -0.07 0 N-CA-C 109.819 -1.313 . . . . 1.0 109.819 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' B' ' 374' ' ' LEU . 0.3 OUTLIER -61.02 -41.73 97.12 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.221 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.505 ' H ' ' HG3' ' B' ' 375' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.38 -0.97 . . . . 97.079999999999998 108.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.6 155.4 22.41 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.085 0.945 . . . . 123.41 110.774 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.88 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.57 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.461 1 N-CA-C 100.064 -4.051 . . . . 151.30000000000001 100.064 173.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.58 58.35 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 115.952 -2.299 . . . . 169.25 106.148 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.29 168.52 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 122.301 0.632 . . . . 185.75999999999999 110.568 171.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.5 t -64.44 -25.96 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 127.042 2.137 . . . . 145.47 110.342 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.44 21.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.058 -1.027 . . . . 102.76000000000001 109.445 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.68 154.16 25.0 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.937 -1.134 . . . . 106.25 107.937 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.83 51.84 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.754 -1.578 . . . . 157.81 107.663 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.15 -45.9 91.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.553 -2.758 . . . . 150.19999999999999 103.553 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.67 35.33 Favored Pre-proline 0 N--CA 1.422 -1.852 0 N-CA-C 103.669 -2.715 . . . . 183.52000000000001 103.669 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.71 6.87 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 N-CA-C 110.014 -0.802 . . . . 235.61000000000001 110.014 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.99 -41.16 82.44 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 124.749 1.22 . . . . 113.77 113.409 -170.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.21 136.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 119.564 1.075 . . . . 150.84999999999999 110.973 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.487 ' HA ' HH12 ' B' ' 365' ' ' ARG . 47.7 t -140.5 156.28 46.38 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.59 -1.263 . . . . 100.42 107.59 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.93 0.871 . . . . 129.36000000000001 110.444 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.326 1.85 . . . . 112.34 106.663 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.2 m -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.618 -0.719 . . . . 131.72999999999999 111.739 177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.0 m -84.48 -42.85 15.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 116.984 2.216 . . . . 80.489999999999995 116.984 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -146.01 174.54 3.35 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 118.154 -1.418 . . . . 98.980000000000004 111.21 -169.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.8 Cg_exo -61.8 -10.74 18.09 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.953 6.482 . . . . 246.94999999999999 128.953 -170.103 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.66 17.49 8.7 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.112 4.051 . . . . 269.62 114.229 175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.12 -27.27 67.2 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.797 -1.186 . . . . 86.799999999999997 107.797 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.79 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.113 -0.992 . . . . 85.909999999999997 110.502 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.2 t -68.5 -40.23 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.718 0.807 . . . . 82.0 111.371 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.385 0 N-CA-C 108.522 -0.918 . . . . 120.73 108.522 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.905 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.03 149.75 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.882 . . . . 87.859999999999999 109.861 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.96 89.27 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.812 -0.81 . . . . 36.460000000000001 108.812 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.76 -33.87 76.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.87 -1.159 . . . . 150.59999999999999 107.87 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.2 -32.75 73.44 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 121.255 -0.903 . . . . 123.26000000000001 108.661 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.39 -47.21 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.95 -47.12 84.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.951 -0.7 . . . . 60.869999999999997 109.608 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.06 -35.63 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 120.004 -0.678 . . . . 157.56999999999999 110.361 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.67 -40.85 98.37 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.633 -0.877 . . . . 47.060000000000002 108.633 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.25 97.94 Favored 'General case' 0 CA--C 1.496 -1.12 0 O-C-N 121.721 -0.612 . . . . 43.939999999999998 109.544 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.29 99.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.744 -0.836 . . . . 42.609999999999999 108.744 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.29 93.91 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 122.25 -0.281 . . . . 140.66 110.996 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.75 -44.02 97.72 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.605 -1.238 . . . . 116.04000000000001 110.22 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.38 -38.81 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.759 -0.83 . . . . 97.159999999999997 108.759 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -40.03 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.978 -0.749 . . . . 54.850000000000001 108.978 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 93.2 t -57.65 -42.37 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.91 -0.774 . . . . 45.390000000000001 108.91 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.4 t -63.48 -50.99 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 C-N-CA 118.819 -1.152 . . . . 48.640000000000001 110.203 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.25 -47.03 78.17 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.167 -0.613 . . . . 116.65000000000001 111.73 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.95 -43.96 97.74 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.701 -0.481 . . . . 51.159999999999997 109.701 -174.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.58 -48.9 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 119.829 -0.748 . . . . 44.299999999999997 110.854 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.74 -46.97 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 120.299 -0.561 . . . . 48.82 111.027 -174.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.2 95.18 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.561 -0.828 . . . . 58.700000000000003 111.994 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.61 -34.26 67.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.018 -0.695 . . . . 101.40000000000001 111.039 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.89 -38.72 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 107.757 -1.201 . . . . 103.56999999999999 107.757 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.45 -43.01 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.977 -0.749 . . . . 61.890000000000001 108.977 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.43 -50.93 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.303 -0.559 . . . . 70.010000000000005 109.525 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.809 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.43 98.81 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.108 -0.701 . . . . 132.09999999999999 109.108 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.62 83.08 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.649 -0.251 . . . . 104.5 110.443 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.022 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 C-N-CA 120.213 -0.595 . . . . 142.96000000000001 111.253 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.7 pt -64.82 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.957 -1.897 . . . . 158.31999999999999 110.838 -175.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.809 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.71 -41.4 98.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 117.698 -1.601 . . . . 137.11000000000001 109.5 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.52 91.14 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.156 -0.34 . . . . 54.659999999999997 111.015 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.612 0.72 . . . . 127.18000000000001 109.577 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.79 -36.86 80.08 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.102 0.961 . . . . 87.930000000000007 110.859 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.042 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.69 78.75 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.69 -0.631 . . . . 131.12 111.514 -175.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.52 7.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.294 -2.562 . . . . 246.56 109.598 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 105.475 -2.046 . . . . 339.35000000000002 105.475 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.14 165.3 17.79 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.19 -39.4 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.766 -1.568 . . . . 143.28 106.766 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.72 -38.04 80.56 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.67 -0.863 . . . . 160.22 108.67 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.2 m-20 -62.4 -31.78 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.823 -0.806 . . . . 120.54000000000001 108.823 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.57 -43.8 95.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.466 -0.568 . . . . 67.219999999999999 109.466 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.59 -39.78 88.59 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.505 -0.747 . . . . 138.59999999999999 109.623 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.918 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.53 -35.89 81.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.468 0.307 . . . . 151.46000000000001 110.679 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.6 -37.89 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 C-N-CA 117.406 -1.718 . . . . 117.93000000000001 106.724 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.448 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.96 91.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.855 -1.165 . . . . 56.82 107.855 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.017 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.937 -0.764 . . . . 145.30000000000001 108.937 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.38 95.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.495 -0.928 . . . . 45.710000000000001 108.495 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.37 -42.04 99.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.364 -0.606 . . . . 105.61 109.364 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 -39.54 92.78 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.611 -0.885 . . . . 47.890000000000001 108.611 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.37 84.84 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.953 -0.388 . . . . 124.53 109.953 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.24 99.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.968 -0.458 . . . . 35.890000000000001 109.838 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.29 -37.28 84.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.022 -1.473 . . . . 88.969999999999999 107.022 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.822 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.16 76.96 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.086 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.4 -43.41 90.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.511 -0.743 . . . . 146.09999999999999 110.591 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 117.423 -1.711 . . . . 91.739999999999995 113.829 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.47 1.95 Allowed 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 115.719 1.748 . . . . 197.44999999999999 115.719 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.932 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.23 -42.2 55.88 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 117.866 -1.534 . . . . 242.59999999999999 114.073 -170.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.48 -36.5 84.04 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.919 -1.113 . . . . 215.61000000000001 109.797 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 73.0 t -60.36 -46.95 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 O-C-N 121.782 -0.574 . . . . 87.189999999999998 110.399 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.89 -41.84 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 O-C-N 121.942 -0.474 . . . . 231.81999999999999 109.776 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.9 m-20 -62.39 -34.12 76.09 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.306 -0.998 . . . . 364.98000000000002 108.306 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.2 -44.74 75.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.533 -0.729 . . . . 181.63 111.228 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.3 m -60.8 -45.81 92.95 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 107.468 -1.308 . . . . 269.01999999999998 107.468 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.07 93.25 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 118.679 -1.209 . . . . 562.65999999999997 110.004 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.22 95.59 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 118.634 -1.226 . . . . 446.75 108.103 -167.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.46 -26.35 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.875 -2.33 . . . . 370.05000000000001 112.197 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.49 -26.51 60.06 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.565 -0.71 . . . . 354.91000000000003 112.491 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.49 0.98 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.047 1.339 . . . . 462.44 111.868 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.9 mm-40 -172.35 178.09 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.009 0.909 . . . . 652.37 111.129 171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.78 86.31 2.2 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 128.492 2.717 . . . . 905.99000000000001 107.906 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.83 -36.45 80.38 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.261 -1.014 . . . . 570.42999999999995 108.261 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.34 82.36 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 125.331 1.453 . . . . 453.22000000000003 111.129 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.48 178.65 33.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.939 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.91 HD21 ' NZ ' ' B' ' 367' ' ' LYS . 89.0 mt -56.4 -41.21 75.92 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 125.274 1.43 . . . . 457.72000000000003 112.38 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.02 Favored 'General case' 0 CA--C 1.484 -1.569 0 C-N-CA 118.678 -1.209 . . . . 340.57999999999998 109.335 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.66 -32.23 71.92 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 118.819 -1.152 . . . . 453.60000000000002 111.544 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.3 73.26 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.013 -1.847 . . . . 541.48000000000002 106.013 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.21 75.83 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 123.972 0.795 . . . . 466.68000000000001 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.72 -47.09 86.85 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 117.527 -1.669 . . . . 427.33999999999997 107.306 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.82 82.77 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 112.402 0.519 . . . . 537.87 112.402 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.33 -42.73 74.93 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 116.845 -1.942 . . . . 422.12 111.576 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.15 75.18 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.314 -0.866 . . . . 340.17000000000002 111.84 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.27 -46.49 71.52 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.084 -1.047 . . . . 258.06 111.75 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.53 -31.56 87.52 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 N-CA-C 115.323 1.24 . . . . 305.70999999999998 115.323 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.712 -0.848 . . . . 252.69999999999999 108.712 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.56 93.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.8 -1.185 . . . . 149.27000000000001 107.8 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.05 -44.78 95.95 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 120.632 -0.427 . . . . 138.08000000000001 111.506 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.93 -42.42 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.523 -0.735 . . . . 132.88999999999999 110.966 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.71 -44.68 92.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.749 -0.78 . . . . 193.61000000000001 108.925 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.7 84.55 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 122.838 0.455 . . . . 63.829999999999998 110.079 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.98 -52.4 59.81 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.057 -0.402 . . . . 76.400000000000006 111.233 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.68 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.166 -1.05 . . . . 171.13 108.166 -174.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.82 -38.52 91.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 121.889 -0.507 . . . . 78.299999999999997 110.612 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.13 -35.71 80.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.897 -1.121 . . . . 92.359999999999999 109.231 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . 1.017 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.51 -34.31 76.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.131 -1.062 . . . . 93.730000000000004 108.131 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.908 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.39 -41.65 84.63 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.248 -0.981 . . . . 132.74000000000001 109.346 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.1 94.86 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.17 -1.419 . . . . 43.390000000000001 107.17 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.826 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.9 t -58.43 -42.03 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.59 -0.893 . . . . 59.340000000000003 108.59 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.04 95.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 121.838 -0.539 . . . . 69.680000000000007 110.523 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.46 -42.77 91.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.333 -0.988 . . . . 106.98 108.333 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.826 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.58 81.36 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 119.712 -0.795 . . . . 147.63 108.928 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.56 99.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.514 -0.921 . . . . 190.06 108.514 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.32 -44.04 97.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.313 -0.995 . . . . 118.84999999999999 108.313 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.808 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.68 98.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.64 95.28 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 121.827 -0.546 . . . . 89.980000000000004 109.86 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.72 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 C-N-CA 118.098 -1.441 . . . . 106.09 111.035 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.29 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.062 -1.855 . . . . 227.74000000000001 111.799 -174.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.89 100.06 50.94 Favored Pre-proline 0 CA--C 1.486 -1.515 0 C-N-CA 116.237 -2.185 . . . . 262.55000000000001 110.05 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.57 -10.42 28.66 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.678 1.586 . . . . 210.25 111.341 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.03 1.0 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 106.556 -1.646 . . . . 270.57999999999998 106.556 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.893 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.49 23.54 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 115.382 -0.826 . . . . 129.84 112.325 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.38 -26.59 81.68 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 N-CA-C 116.31 1.619 . . . . 330.70999999999998 116.31 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 114.467 -2.893 . . . . 204.50999999999999 107.289 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.415 -1.328 . . . . 387.41000000000003 107.415 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.73 147.04 33.64 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 118.729 -1.188 . . . . 166.22 109.446 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.73 87.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.841 -1.17 . . . . 44.229999999999997 107.841 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.0 m -60.29 -39.11 85.76 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.2 -1.037 . . . . 28.800000000000001 108.2 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.73 92.0 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.103 -0.702 . . . . 30.289999999999999 109.103 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.65 -42.99 94.03 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.981 -0.748 . . . . 46.109999999999999 108.981 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -42.11 99.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.671 -1.233 . . . . 87.329999999999998 107.671 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.67 -42.07 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.916 -1.142 . . . . 23.690000000000001 107.916 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.21 -44.31 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.625 -0.509 . . . . 43.859999999999999 109.625 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.55 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.263 -1.014 . . . . 91.129999999999995 108.263 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.58 -37.98 88.32 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.72 -0.844 . . . . 65.879999999999995 108.72 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.86 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.52 -0.548 . . . . 33.859999999999999 109.52 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.35 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.556 -1.275 . . . . 146.52000000000001 107.556 -176.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.84 -38.35 90.41 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.475 -0.89 . . . . 75.439999999999998 108.878 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.4 t -60.58 -48.4 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.063 -1.023 . . . . 43.640000000000001 109.72 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.795 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -37.95 89.29 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.096 -0.705 . . . . 102.56999999999999 109.096 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.08 86.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.403 -1.332 . . . . 58.159999999999997 107.403 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.53 73.93 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.989 -0.745 . . . . 121.11 108.989 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.03 -42.26 84.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 C-N-CA 118.55 -1.26 . . . . 153.15000000000001 109.948 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.05 -43.76 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 113.09 -3.444 . . . . 133.66999999999999 113.533 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.899 -1.126 . . . . 157.41999999999999 112.167 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.12 2.45 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 115.011 1.485 . . . . 250.91 115.011 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.5 Cg_exo -59.54 -25.42 78.7 Favored 'Trans proline' 0 CA--C 1.488 -1.81 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.913 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.19 -34.21 74.71 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.915 -1.513 . . . . 192.46000000000001 106.915 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.02 98.1 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 108.033 -2.027 . . . . 261.0 108.033 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.77 159.13 25.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.529 -3.508 . . . . 491.39999999999998 101.529 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 116.278 -2.169 . . . . 386.10000000000002 109.819 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.08 -166.61 2.41 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 103.511 -2.774 . . . . 289.80000000000001 103.511 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.137 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 117.745 -1.121 . . . . 402.06 109.534 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.5 p -165.3 177.54 7.51 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.314 2.246 . . . . 690.52999999999997 114.94 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.181 4.511 . . . . 633.62 123.181 162.742 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.58 153.79 22.17 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.415 2.286 . . . . 617.99000000000001 110.918 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.67 174.39 6.01 Favored Pre-proline 0 C--N 1.364 1.222 0 C-N-CA 130.255 3.422 . . . . 434.98000000000002 113.417 -175.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 N-CA-C 122.408 3.965 . . . . 365.88 122.408 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.7 m -84.88 20.92 1.7 Allowed 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.791 -2.3 . . . . 635.80999999999995 104.791 178.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.36 152.27 18.77 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.934 7.753 . . . . 999.99000000000001 131.934 -135.746 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.85 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.747 1 CA-C-N 103.264 -6.335 . . . . 594.32000000000005 113.573 149.195 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.21 144.07 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 1 N-CA-C 98.337 -4.69 . . . . 811.90999999999997 98.337 162.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.47 144.55 45.92 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.074 -1.851 . . . . 999.99000000000001 109.419 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.972 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.24 -175.65 4.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.007 0.908 . . . . 431.86000000000001 110.018 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.12 148.68 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 124.384 1.074 . . . . 457.18000000000001 108.758 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.49 3.77 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 124.071 0.948 . . . . 458.76999999999998 113.506 -174.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.38 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.9 1.28 . . . . 999.99000000000001 112.424 168.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.78 5.63 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 120.84 3.362 . . . . 999.99000000000001 120.84 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.164 -1.814 . . . . 81.180000000000007 107.248 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.12 45.12 0.19 Allowed Pre-proline 0 N--CA 1.423 -1.817 0 CA-C-O 114.866 -2.492 . . . . 999.99000000000001 108.748 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.52 101.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.141 1 C-N-CA 126.051 4.501 . . . . 999.99000000000001 105.7 -170.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.03 97.47 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 126.748 2.019 . . . . 967.72000000000003 112.045 -165.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.5 77.99 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.779 -1.563 . . . . 934.29999999999995 106.779 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.27 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 129.196 2.998 . . . . 565.14999999999998 113.938 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.55 55.4 2.79 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 118.423 0.556 . . . . 755.61000000000001 109.849 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.137 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.48 -49.35 66.9 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.59 1.156 . . . . 325.88999999999999 113.203 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.94 78.32 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 123.557 0.743 . . . . 250.21000000000001 111.61 -169.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.81 -43.28 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.552 0.691 . . . . 142.46000000000001 110.375 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.1 -41.56 96.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 123.983 0.913 . . . . 247.69 108.806 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.5 -51.34 69.85 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.453 1.501 . . . . 199.61000000000001 113.086 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.35 -44.45 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.754 -1.202 . . . . 106.73 107.754 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.14 -48.53 81.28 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.832 -0.622 . . . . 115.01000000000001 110.241 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.25 -49.2 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.431 -0.908 . . . . 129.41999999999999 111.811 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.3 m -61.79 -53.18 59.38 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.223 -1.391 . . . . 172.47999999999999 109.969 -172.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.6 t -63.9 -54.19 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 120.489 -0.484 . . . . 55.859999999999999 110.987 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.62 -51.52 58.98 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.513 -1.275 . . . . 184.68000000000001 111.501 -174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.64 -52.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.635 -2.026 . . . . 291.81 114.695 -174.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 115.153 1.538 . . . . 130.66 115.153 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.9 -48.46 68.66 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.493 1.294 . . . . 80.159999999999997 114.493 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.53 83.3 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 119.996 -0.682 . . . . 136.02000000000001 109.483 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.4 Cg_exo -64.79 -27.11 59.75 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.617 -0.57 . . . . 92.170000000000002 110.617 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.36 76.62 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.478 -1.304 . . . . 135.59999999999999 107.478 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.63 91.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.61 -0.515 . . . . 52.100000000000001 109.61 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.72 -43.51 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.056 -0.72 . . . . 95.890000000000001 109.056 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.908 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.31 -42.33 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.655 -1.609 . . . . 43.409999999999997 106.655 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.22 99.06 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.338 -1.505 . . . . 27.690000000000001 109.338 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.888 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.76 -47.35 75.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 117.411 0.605 . . . . 54.409999999999997 110.423 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 107.005 -1.479 . . . . 53.880000000000003 107.005 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.71 -40.83 93.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.517 -0.92 . . . . 68.290000000000006 108.517 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -39.04 92.94 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 119.71 -0.796 . . . . 107.59 110.634 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.41 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.514 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.3 -22.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.414 -0.958 . . . . 85.260000000000005 108.414 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.91 99.43 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.089 -0.804 . . . . 40.710000000000001 111.089 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.7 -44.12 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 108.386 -0.968 . . . . 95.859999999999999 108.386 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.89 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.445 -0.946 . . . . 144.37 108.445 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.38 132.15 47.48 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 107.61 -1.255 . . . . 326.72000000000003 107.61 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.025 -1.843 . . . . 158.38 106.025 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.85 98.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.676 -0.49 . . . . 36.780000000000001 109.676 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.14 125.8 25.05 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.15 -1.02 . . . . 85.459999999999994 109.812 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.539 -2.023 . . . . 127.78 105.539 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.89 34.77 Favored Pre-proline 0 CA--C 1.493 -1.233 0 N-CA-C 105.929 -1.878 . . . . 164.84 105.929 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.7 Cg_exo -56.82 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.189 0 N-CA-C 113.926 0.702 . . . . 222.34999999999999 113.926 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.1 166.95 44.94 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 106.435 -2.666 . . . . 45.219999999999999 106.435 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.9 -45.81 93.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.058 -1.83 . . . . 107.56999999999999 106.058 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.4 m -65.73 141.77 58.23 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 118.924 -1.11 . . . . 167.96000000000001 109.151 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.56 106.71 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.67 1.988 . . . . 280.68000000000001 109.71 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.98 11.31 0.7 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.455 1.102 . . . . 218.25 110.694 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.58 54.78 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.234 -2.135 . . . . 343.56999999999999 105.234 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.95 81.89 1.53 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.868 -1.53 . . . . 263.29000000000002 106.868 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.35 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 126.565 1.946 . . . . 261.92000000000002 108.484 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.1 89.83 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.891 -1.151 . . . . 106.81 107.891 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.391 -1.324 . . . . 112.2 107.531 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.735 HG12 ' NH1' ' A' ' 244' ' ' ARG . 76.0 t -64.36 -39.77 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 109.247 -0.649 . . . . 45.409999999999997 109.247 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.07 68.91 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.28 -0.267 . . . . 97.620000000000005 110.28 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.6 81.71 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.691 0.796 . . . . 59.289999999999999 110.976 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.26 -36.49 83.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.624 1.17 . . . . 106.48999999999999 110.668 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.68 69.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.302 -0.999 . . . . 106.62 108.302 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.08 91.62 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 121.87 -0.518 . . . . 75.969999999999999 110.039 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.52 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 C-N-CA 122.909 0.484 . . . . 65.269999999999996 109.802 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.95 -41.64 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 C-N-CA 120.391 -0.524 . . . . 107.94 110.174 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.49 -40.82 98.09 Favored 'General case' 0 N--CA 1.434 -1.235 0 O-C-N 121.649 -0.657 . . . . 87.980000000000004 110.3 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.62 -40.4 96.81 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.794 -1.162 . . . . 65.5 108.378 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.127 -1.064 . . . . 85.049999999999997 108.127 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.5 -45.72 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 109.076 -0.712 . . . . 42.25 109.076 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.31 -38.3 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.55 -0.86 . . . . 91.010000000000005 109.378 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.003 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.0 t -58.89 -41.54 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.96 -1.126 . . . . 66.090000000000003 107.96 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.23 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 O-C-N 122.108 -0.37 . . . . 52.390000000000001 110.324 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.77 88.2 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 121.883 -0.511 . . . . 46.420000000000002 109.856 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.742 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.35 -38.12 88.28 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.311 -0.996 . . . . 116.51000000000001 108.311 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.26 -48.22 82.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.384 -0.599 . . . . 65.180000000000007 109.384 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.67 97.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 122.118 -0.364 . . . . 51.329999999999998 110.432 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.32 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 C-N-CA 118.91 -1.116 . . . . 126.3 109.016 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.31 69.25 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.476 -0.889 . . . . 133.94 112.491 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.67 -33.43 35.54 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.853 2.168 . . . . 134.84 116.853 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.41 -41.61 90.22 Favored Pre-proline 0 CA--C 1.493 -1.236 0 O-C-N 121.671 -0.643 . . . . 72.230000000000004 111.647 -167.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.2 Cg_exo -60.66 -35.98 87.15 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 CA-C-N 119.887 0.995 . . . . 106.13 111.334 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.7 82.21 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.728 -0.789 . . . . 128.34999999999999 110.027 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.639 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.8 88.79 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.24 -0.281 . . . . 100.73 110.24 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.55 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 119.285 -0.966 . . . . 172.72 109.137 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.59 -28.07 68.22 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.195 -1.039 . . . . 249.22999999999999 108.195 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.58 -55.1 35.96 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.667 -1.605 . . . . 259.77999999999997 106.667 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.2 -44.15 72.7 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.568 0.951 . . . . 233.11000000000001 113.568 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.839 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.29 91.35 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 119.182 -1.007 . . . . 169.53999999999999 110.588 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.07 -24.59 79.72 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.707 -1.728 . . . . 255.47 114.708 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.57 -44.22 94.72 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 119.189 0.904 . . . . 279.02999999999997 108.899 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.29 -44.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 110.091 -0.337 . . . . 162.21000000000001 110.091 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.87 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.43 84.87 59.36 Favored Pre-proline 0 N--CA 1.431 -1.394 0 C-N-CA 118.712 -1.195 . . . . 128.13 108.028 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.28 164.04 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.274 0 N-CA-C 107.443 -1.791 . . . . 278.35000000000002 107.443 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.12 15.03 9.93 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 123.756 0.66 . . . . 312.91000000000003 109.343 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.7 -170.65 2.48 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.506 -1.664 . . . . 353.54000000000002 106.506 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.28 46.95 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.389 -1.337 . . . . 251.25999999999999 107.389 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.069 -3.308 . . . . 175.25999999999999 102.069 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.96 96.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 100.894 -3.743 . . . . 99.069999999999993 100.894 172.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.46 124.16 9.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.455 -2.794 . . . . 243.21000000000001 103.455 171.198 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.99 112.97 25.11 Favored 'General case' 0 CA--C 1.473 -2.0 0 C-N-CA 115.992 -2.283 . . . . 201.03999999999999 105.316 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 C-N-CA 116.02 -2.272 . . . . 201.36000000000001 108.82 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.52 -41.44 89.98 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.28 -1.782 . . . . 203.81999999999999 107.834 174.516 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.92 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.26 -45.77 86.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 118.213 -1.395 . . . . 215.06 112.538 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.61 -46.47 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.607 -1.237 . . . . 125.28 112.917 -171.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -36.94 85.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.229 -1.397 . . . . 268.89999999999998 107.229 -171.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.29 -44.97 74.32 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.617 1.567 . . . . 280.88 108.792 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.48 86.06 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.004 -1.078 . . . . 184.47 108.958 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.99 -42.09 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 119.285 -0.966 . . . . 167.91999999999999 112.709 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.81 90.18 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 117.792 -1.563 . . . . 367.18000000000001 110.734 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.2 -32.7 73.95 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.824 -0.547 . . . . 173.97 110.402 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.52 -36.73 85.14 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.559 0.744 . . . . 119.66 109.797 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.21 -34.0 74.39 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.703 -1.221 . . . . 112.3 107.703 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.08 73.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.228 -0.442 . . . . 174.16999999999999 110.235 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.6 m -64.7 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 124.685 1.194 . . . . 145.27000000000001 110.627 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.62 -35.4 70.41 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.093 -1.077 . . . . 170.15000000000001 108.093 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.822 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.26 -34.17 63.81 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 122.721 0.408 . . . . 214.56999999999999 110.63 -171.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.21 -33.2 56.29 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.022 1.729 . . . . 168.28999999999999 115.548 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.35 -34.9 79.22 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 114.096 1.147 . . . . 167.15000000000001 114.096 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.18 -38.32 33.67 Favored Pre-proline 0 N--CA 1.434 -1.234 0 C-N-CA 115.485 -2.486 . . . . 165.13 113.931 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.57 -31.81 79.82 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 CA-C-N 122.809 2.039 . . . . 123.92 111.231 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.77 -42.54 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.845 -1.142 . . . . 110.55 109.807 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.003 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.16 -39.99 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.849 -0.797 . . . . 145.31 108.849 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.918 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.08 -48.88 78.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.447 -0.901 . . . . 246.68000000000001 109.789 -177.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.18 -47.48 84.29 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.524 -0.87 . . . . 64.430000000000007 109.565 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.06 79.34 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 118.985 -1.086 . . . . 80.719999999999999 110.2 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.72 75.91 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 116.022 1.86 . . . . 140.44 116.022 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.79 132.24 34.45 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 112.71 -3.596 . . . . 178.87 113.031 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.35 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.358 -1.292 . . . . 110.22 110.112 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.71 -50.61 72.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 121.74 -0.6 . . . . 174.78 109.756 -174.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.95 -41.63 95.32 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.31 -50.23 73.59 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.011 -0.676 . . . . 117.2 109.214 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.08 75.54 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.375 -0.53 . . . . 112.59999999999999 111.113 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.11 -37.44 94.57 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.596 -1.002 . . . . 101.45999999999999 110.596 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.022 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.13 -45.98 91.05 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 118.485 1.143 . . . . 151.49000000000001 109.541 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.13 -36.31 77.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.931 -1.507 . . . . 142.31999999999999 106.931 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.72 -41.9 91.9 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.46 85.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 122.309 -0.244 . . . . 76.109999999999999 111.019 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -55.51 30.77 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.374 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.29 131.5 41.23 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.94 -2.985 . . . . 192.72999999999999 102.94 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.18 92.14 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 119.0 -1.08 . . . . 176.28999999999999 109.192 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.8 m -79.4 -177.1 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.464 0 N-CA-C 106.332 -1.729 . . . . 69.680000000000007 106.332 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -58.97 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 118.368 -0.621 . . . . 191.05000000000001 112.583 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.54 43.87 16.43 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 123.562 0.539 . . . . 287.02999999999997 109.756 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.5 78.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 112.977 -3.489 . . . . 292.29000000000002 109.847 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.41 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 104.195 -2.52 . . . . 184.56999999999999 104.195 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.69 4.94 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 113.038 0.755 . . . . 274.56 113.038 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.92 57.3 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 117.69 -2.195 . . . . 268.24000000000001 113.487 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.5 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.641 1.221 . . . . 200.06 110.788 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.1 21.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.593 -1.262 . . . . 263.81 107.593 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.37 3.61 Favored Glycine 0 CA--C 1.479 -2.206 1 N-CA-C 102.518 -4.233 . . . . 103.79000000000001 102.518 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.054 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.29 95.64 10.26 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 114.914 -2.715 . . . . 117.3 106.016 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.93 -39.82 90.84 Favored 'General case' 0 CA--C 1.468 -2.179 1 N-CA-C 97.989 -4.819 . . . . 231.58000000000001 97.989 167.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.042 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.45 29.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.097 -3.297 . . . . 303.24000000000001 102.097 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.054 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.62 78.64 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 116.022 -2.271 . . . . 112.72 108.391 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.71 1.2 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.095 -0.706 . . . . 83.219999999999999 109.095 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.7 m -156.24 -126.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.86 -2.644 . . . . 174.36000000000001 103.86 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.9 160.97 8.81 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.787 -1.931 . . . . 202.72999999999999 105.787 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.093 -1.447 . . . . 180.62 107.093 176.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.52 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 105.356 -2.09 . . . . 145.25 105.356 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.05 -43.17 88.27 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.171 -1.789 . . . . 66.049999999999997 106.171 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.69 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.536 -2.764 . . . . 266.49000000000001 103.536 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.31 -124.96 0.28 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.023 -1.871 . . . . 219.19999999999999 107.793 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.38 94.15 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.552 -1.204 . . . . 94.780000000000001 112.877 -176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.19 100.41 9.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.324 -3.751 . . . . 121.41 109.469 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.01 145.49 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 108.948 -0.76 . . . . 85.340000000000003 108.948 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.47 41.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.865 -1.161 . . . . 267.56999999999999 107.865 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.518 -0.549 . . . . 226.09999999999999 109.518 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.6 p -50.93 156.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.997 -1.483 . . . . 154.84 106.997 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.58 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.36 161.94 8.53 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.627 0.727 . . . . 180.00999999999999 110.679 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.898 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.44 156.91 23.66 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.964 -1.495 . . . . 333.77999999999997 106.964 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.48 48.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.355 -1.35 . . . . 335.19999999999999 107.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.4 mm-40 82.85 158.84 0.13 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.739 -0.838 . . . . 266.47000000000003 108.739 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.53 -46.93 88.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.674 -1.972 . . . . 59.340000000000003 105.674 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.6 173.83 11.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.415 -2.439 . . . . 201.25999999999999 104.415 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.0 mt -95.87 106.68 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 116.322 -2.151 . . . . 56.229999999999997 105.562 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.11 -59.46 5.3 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.309 -0.626 . . . . 87.579999999999998 109.309 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.893 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.53 153.74 22.24 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 107.841 -1.17 . . . . 219.94999999999999 107.841 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.04 83.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.35 -2.14 . . . . 121.79000000000001 105.435 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 105.86 -1.904 . . . . 53.850000000000001 105.86 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.58 77.09 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 106.067 -2.813 . . . . 196.55000000000001 106.067 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.683 0 N-CA-C 107.848 -1.167 . . . . 35.880000000000003 107.848 -178.866 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.487 HH12 ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.04 144.09 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.67 1.58 . . . . 1.0 111.831 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.91 ' NZ ' HD21 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -70.52 127.39 92.07 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.248 -0.433 . . . . 1.0 109.864 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.4 Cg_endo -69.09 -19.96 38.61 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.496 2.13 . . . . 1.0 114.504 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.512 ' HB3' ' HD2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -58.31 -38.66 77.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.789 -178.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.486 ' O ' HD22 ' B' ' 374' ' ' LEU . 17.2 tt0 -71.28 -10.48 59.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.812 0.339 . . . . 1.0 110.578 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.811 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.66 -46.34 87.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.28 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -49.03 78.29 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.596 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.06 78.35 0.31 Allowed Glycine 0 CA--C 1.516 0.113 0 N-CA-C 109.764 -1.334 . . . . 1.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.486 HD22 ' O ' ' B' ' 370' ' ' GLN . 0.1 OUTLIER -61.01 -41.89 97.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.759 0.314 . . . . 1.0 110.191 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.07 -0.967 . . . . 1.0 110.522 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.365 -0.976 . . . . 97.079999999999998 108.365 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.088 0.946 . . . . 123.41 110.766 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.888 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.62 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.513 1 N-CA-C 100.056 -4.053 . . . . 151.30000000000001 100.056 173.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.904 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.57 58.05 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.939 -2.305 . . . . 169.25 106.139 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.27 0.616 . . . . 185.75999999999999 110.53 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.5 -25.86 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.988 2.115 . . . . 145.47 110.383 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.77 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.38 21.48 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.099 -1.0 . . . . 102.76000000000001 109.427 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.58 154.2 25.1 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.994 -1.113 . . . . 106.25 107.994 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.914 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.9 51.9 0.74 Allowed 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 117.807 -1.557 . . . . 157.81 107.616 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.24 -45.87 91.75 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.585 -2.746 . . . . 150.19999999999999 103.585 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.01 164.71 35.26 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 103.652 -2.721 . . . . 183.52000000000001 103.652 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -76.82 6.92 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.982 0 N-CA-C 109.973 -0.818 . . . . 235.61000000000001 109.973 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.95 -41.24 82.44 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 124.781 1.233 . . . . 113.77 113.377 -170.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.21 136.2 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 119.605 1.093 . . . . 150.84999999999999 110.989 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.595 -1.261 . . . . 100.42 107.595 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.077 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.967 0.889 . . . . 129.36000000000001 110.389 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.1 -25.43 68.36 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 126.241 1.816 . . . . 112.34 106.702 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.4 m -74.1 -40.2 62.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.545 -0.752 . . . . 131.72999999999999 111.766 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.077 ' H ' HG23 ' A' ' 17' ' ' THR . 71.6 m -84.42 -42.85 15.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 117.036 2.236 . . . . 80.489999999999995 117.036 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -146.0 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 118.151 -1.42 . . . . 98.980000000000004 111.198 -169.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.0 Cg_exo -61.81 -10.8 18.29 Favored 'Trans proline' 0 C--N 1.321 -0.898 1 N-CA-C 128.919 6.469 . . . . 246.94999999999999 128.919 -170.09 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.63 17.58 8.75 Favored 'General case' 0 C--N 1.324 -0.542 1 CA-C-N 126.152 4.069 . . . . 269.62 114.209 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.12 -27.33 67.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.816 -1.179 . . . . 86.799999999999997 107.816 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.119 -0.988 . . . . 85.909999999999997 110.493 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.869 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.57 -40.18 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.728 0.811 . . . . 82.0 111.339 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.894 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.44 167.73 12.49 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.518 -0.919 . . . . 120.73 108.518 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.97 149.76 89.85 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 120.578 0.852 . . . . 87.859999999999999 109.937 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.05 -37.92 89.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.884 -0.784 . . . . 36.460000000000001 108.884 -176.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.91 76.73 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.812 -1.181 . . . . 150.59999999999999 107.812 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.16 -32.74 73.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 121.301 -0.874 . . . . 123.26000000000001 108.645 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.15 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.4 -31.02 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.918 -1.141 . . . . 112.19 107.918 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.4 tp -63.02 -47.09 84.55 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.924 -0.71 . . . . 60.869999999999997 109.576 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.6 80.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.933 -0.707 . . . . 157.56999999999999 110.392 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.92 98.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.622 -0.881 . . . . 47.060000000000002 108.622 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.19 97.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.745 -0.597 . . . . 43.939999999999998 109.526 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.735 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.88 -43.29 99.14 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.688 -0.856 . . . . 42.609999999999999 108.688 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.22 93.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.625 -0.261 . . . . 140.66 111.024 -178.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.81 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.566 -1.254 . . . . 116.04000000000001 110.211 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.43 -38.72 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.747 -0.835 . . . . 97.159999999999997 108.747 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.34 -39.94 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.99 -0.744 . . . . 54.850000000000001 108.99 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.72 -42.39 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 108.877 -0.786 . . . . 45.390000000000001 108.877 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.6 t -63.49 -50.94 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.217 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.26 -47.07 78.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.196 -0.601 . . . . 116.65000000000001 111.693 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -62.0 -43.93 97.81 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.705 -0.48 . . . . 51.159999999999997 109.705 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.7 t -65.5 -48.93 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.878 -0.729 . . . . 44.299999999999997 110.878 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.8 -46.94 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 120.308 -0.557 . . . . 48.82 110.995 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.2 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.505 -0.855 . . . . 58.700000000000003 111.987 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.66 -34.17 67.07 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 122.118 -0.637 . . . . 101.40000000000001 111.032 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 107.748 -1.204 . . . . 103.56999999999999 107.748 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.4 -43.06 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 108.965 -0.754 . . . . 61.890000000000001 108.965 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.9 t -63.45 -50.93 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 109.453 -0.573 . . . . 70.010000000000005 109.453 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.804 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.41 98.87 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.165 -0.68 . . . . 132.09999999999999 109.165 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.16 -46.64 83.14 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.623 -0.262 . . . . 104.5 110.472 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.91 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 120.237 -0.585 . . . . 142.96000000000001 111.241 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.941 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.9 pt -64.77 -41.67 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 116.96 -1.896 . . . . 158.31999999999999 110.859 -175.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.34 98.04 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 117.755 -1.578 . . . . 137.11000000000001 109.459 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.53 90.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.173 -0.329 . . . . 54.659999999999997 110.994 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.928 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.17 29.45 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.651 0.739 . . . . 127.18000000000001 109.575 -174.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.618 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.88 80.3 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.067 0.947 . . . . 87.930000000000007 110.813 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.04 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.63 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.655 -0.653 . . . . 131.12 111.481 -175.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.43 7.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 115.319 -2.553 . . . . 246.56 109.607 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.48 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.471 -2.048 . . . . 339.35000000000002 105.471 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.22 165.26 17.92 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 102.989 -2.967 . . . . 114.66 102.989 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.13 -39.46 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.783 -1.562 . . . . 143.28 106.783 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.67 -38.05 80.44 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.673 -0.862 . . . . 160.22 108.673 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.37 -31.75 72.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.88 -0.785 . . . . 120.54000000000001 108.88 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.56 -43.86 95.8 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.507 -0.553 . . . . 67.219999999999999 109.507 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.49 -39.8 88.92 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.504 -0.747 . . . . 138.59999999999999 109.654 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.94 82.14 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 122.529 0.332 . . . . 151.46000000000001 110.631 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.941 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 C-N-CA 117.397 -1.721 . . . . 117.93000000000001 106.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.0 -46.01 90.88 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.928 -1.138 . . . . 56.82 107.928 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.89 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.4 -43.94 98.01 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.911 -0.774 . . . . 145.30000000000001 108.911 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.38 95.47 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.523 -0.917 . . . . 45.710000000000001 108.523 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.35 -42.06 99.09 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.384 -0.599 . . . . 105.61 109.384 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.5 92.67 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.608 -0.886 . . . . 47.890000000000001 108.608 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.942 -0.392 . . . . 124.53 109.942 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.23 99.28 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 121.979 -0.45 . . . . 35.890000000000001 109.851 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.19 -37.31 84.8 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 107.038 -1.467 . . . . 88.969999999999999 107.038 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.819 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.23 -49.2 76.69 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.978 -0.749 . . . . 239.91 108.978 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.38 91.02 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.594 -0.691 . . . . 146.09999999999999 110.635 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 117.422 -1.711 . . . . 91.739999999999995 113.86 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.6 -61.31 2.0 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.74 1.755 . . . . 197.44999999999999 115.74 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.923 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.32 -42.2 55.01 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.872 -1.531 . . . . 242.59999999999999 114.042 -170.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.959 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.921 -1.112 . . . . 215.61000000000001 109.813 -172.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 O-C-N 121.843 -0.535 . . . . 87.189999999999998 110.462 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.8 t -65.96 -41.83 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 109.72 -0.474 . . . . 231.81999999999999 109.72 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.6 m-20 -62.32 -34.15 76.07 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.326 -0.99 . . . . 364.98000000000002 108.326 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.13 -44.8 75.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.568 -0.708 . . . . 181.63 111.29 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.1 m -60.81 -45.78 93.07 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.471 -1.307 . . . . 269.01999999999998 107.471 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.75 -45.0 93.56 Favored 'General case' 0 N--CA 1.415 -2.183 0 C-N-CA 118.646 -1.222 . . . . 562.65999999999997 110.03 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.26 95.42 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 118.725 -1.19 . . . . 446.75 108.076 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.47 -26.37 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 C-N-CA 115.842 -2.343 . . . . 370.05000000000001 112.22 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.45 -26.5 60.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.555 -0.716 . . . . 354.91000000000003 112.507 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.77 4.59 0.99 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.09 1.356 . . . . 462.44 111.891 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.8 mm-40 -172.36 178.04 2.91 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.989 0.9 . . . . 652.37 111.107 171.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.31 2.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.477 2.711 . . . . 905.99000000000001 107.905 -174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.95 -36.37 79.99 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.2 -1.037 . . . . 570.42999999999995 108.2 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.34 82.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 125.303 1.441 . . . . 453.22000000000003 111.171 -174.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.54 178.67 33.91 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 118.799 -1.667 . . . . 445.63 109.925 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.21 75.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 125.274 1.429 . . . . 457.72000000000003 112.358 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.6 -46.99 85.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.701 -1.2 . . . . 340.57999999999998 109.262 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 87.8 m-85 -68.71 -32.17 71.78 Favored 'General case' 0 N--CA 1.424 -1.747 0 C-N-CA 118.755 -1.178 . . . . 453.60000000000002 111.552 -176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.4 t -56.03 -40.32 73.27 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.993 -1.855 . . . . 541.48000000000002 105.993 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.86 -47.18 75.8 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 123.976 0.798 . . . . 466.68000000000001 110.803 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.07 86.92 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.457 -1.697 . . . . 427.33999999999997 107.287 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.12 -36.78 82.64 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.398 0.518 . . . . 537.87 112.398 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.67 74.73 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.852 -1.939 . . . . 422.12 111.585 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.08 -50.09 75.41 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 121.336 -0.853 . . . . 340.17000000000002 111.818 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.24 -46.58 71.95 Favored Pre-proline 0 N--CA 1.443 -0.821 0 C-N-CA 119.097 -1.041 . . . . 258.06 111.754 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.923 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.7 Cg_exo -61.53 -31.54 87.56 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 N-CA-C 115.37 1.258 . . . . 305.70999999999998 115.37 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.683 -0.858 . . . . 252.69999999999999 108.683 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.65 93.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.785 -1.191 . . . . 149.27000000000001 107.785 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.77 95.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.621 -0.432 . . . . 138.08000000000001 111.485 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.655 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.7 t -66.91 -42.41 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 O-C-N 121.588 -0.695 . . . . 132.88999999999999 110.998 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.69 -44.75 92.74 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.875 -0.787 . . . . 193.61000000000001 108.875 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.46 -37.68 84.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 122.773 0.429 . . . . 63.829999999999998 110.057 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.97 -52.45 59.61 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.092 -0.38 . . . . 76.400000000000006 111.231 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.65 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.203 -1.036 . . . . 171.13 108.203 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.4 m-85 -63.69 -38.68 92.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.845 -0.534 . . . . 78.299999999999997 110.649 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.02 -35.78 80.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.925 -1.11 . . . . 92.359999999999999 109.249 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.967 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.48 -34.3 76.57 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.188 -1.042 . . . . 93.730000000000004 108.188 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.68 84.55 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.194 -1.002 . . . . 132.74000000000001 109.341 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.05 94.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.217 -1.401 . . . . 43.390000000000001 107.217 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.6 t -58.48 -41.97 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.606 -0.887 . . . . 59.340000000000003 108.606 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.08 95.48 Favored 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 121.765 -0.584 . . . . 69.680000000000007 110.553 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.74 91.78 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.339 -0.985 . . . . 106.98 108.339 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.64 81.54 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.69 -0.804 . . . . 147.63 108.956 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.18 -41.49 99.22 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.2 t80 -61.36 -44.03 97.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.298 -1.001 . . . . 118.84999999999999 108.298 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.39 -42.63 98.82 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 110.022 -0.362 . . . . 102.5 110.022 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.64 95.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.808 -0.558 . . . . 89.980000000000004 109.818 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.919 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.76 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 118.201 -1.4 . . . . 106.09 110.985 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.31 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 C-N-CA 117.119 -1.832 . . . . 227.74000000000001 111.81 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.12 50.94 Favored Pre-proline 0 CA--C 1.486 -1.494 0 C-N-CA 116.18 -2.208 . . . . 262.55000000000001 110.057 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.42 28.62 Favored 'Trans proline' 0 C--N 1.289 -2.581 0 C-N-CA 121.616 1.544 . . . . 210.25 111.326 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.95 0.98 Allowed 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.533 -1.655 . . . . 270.57999999999998 106.533 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.878 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.373 -0.831 . . . . 129.84 112.382 -176.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.4 -26.56 81.53 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 N-CA-C 116.27 1.604 . . . . 330.70999999999998 116.27 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.2 7.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.51 -2.876 . . . . 204.50999999999999 107.275 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.71 147.41 0.09 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.419 -1.326 . . . . 387.41000000000003 107.419 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.69 147.07 33.72 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 118.781 -1.168 . . . . 166.22 109.466 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.91 -40.69 87.75 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.851 -1.166 . . . . 44.229999999999997 107.851 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.3 -39.13 85.88 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.195 -1.039 . . . . 28.800000000000001 108.195 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.87 -38.76 92.14 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.079 -0.712 . . . . 30.289999999999999 109.079 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.844 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.63 -42.99 93.95 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.988 -0.745 . . . . 46.109999999999999 108.988 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.18 99.3 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.644 -1.243 . . . . 87.329999999999998 107.644 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.64 -42.09 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.953 -1.129 . . . . 23.690000000000001 107.953 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.17 -44.32 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 109.703 -0.48 . . . . 43.859999999999999 109.703 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.22 -42.59 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.303 -0.999 . . . . 91.129999999999995 108.303 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.486 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.6 -37.94 88.2 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.727 -0.842 . . . . 65.879999999999995 108.727 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.13 -41.84 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 109.521 -0.548 . . . . 33.859999999999999 109.521 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.43 -40.31 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.264 . . . . 146.52000000000001 107.586 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.703 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.28 90.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.469 -0.892 . . . . 75.439999999999998 108.929 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.42 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 O-C-N 121.056 -1.028 . . . . 43.640000000000001 109.726 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.788 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -38.02 89.52 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.042 -0.725 . . . . 102.56999999999999 109.042 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.07 86.76 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.428 -1.323 . . . . 58.159999999999997 107.428 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.8 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.56 73.96 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.999 -0.741 . . . . 121.11 108.999 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.96 -42.32 84.73 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 118.56 -1.256 . . . . 153.15000000000001 109.98 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.08 -43.73 19.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 113.125 -3.43 . . . . 133.66999999999999 113.518 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 120.91 -1.119 . . . . 157.41999999999999 112.187 -171.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.43 -36.06 2.44 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 115.038 1.496 . . . . 250.91 115.038 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.1 Cg_exo -59.58 -25.46 78.92 Favored 'Trans proline' 0 CA--C 1.488 -1.805 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.912 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.2 -34.17 74.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.93 -1.508 . . . . 192.46000000000001 106.93 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.05 98.09 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.959 -2.056 . . . . 261.0 107.959 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.76 159.15 25.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 101.512 -3.514 . . . . 491.39999999999998 101.512 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -60.02 106.86 0.55 Allowed 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 116.25 -2.18 . . . . 386.10000000000002 109.799 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.912 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.2 m -154.02 -166.63 2.42 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 103.563 -2.755 . . . . 289.80000000000001 103.563 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.93 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 117.757 -1.116 . . . . 402.06 109.567 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.22 177.52 7.58 Favored 'General case' 0 CA--C 1.586 2.34 0 C-N-CA 127.302 2.241 . . . . 690.52999999999997 114.922 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.62 0.0 OUTLIER 'General case' 1 C--N 1.429 4.046 1 N-CA-C 123.203 4.52 . . . . 633.62 123.203 162.672 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.69 153.84 22.06 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.354 2.262 . . . . 617.99000000000001 110.917 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.045 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.98 Favored Pre-proline 0 C--N 1.364 1.22 0 C-N-CA 130.291 3.436 . . . . 434.98000000000002 113.381 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.3 Cg_endo -44.25 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 122.428 3.972 . . . . 365.88 122.428 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.96 1.69 Allowed 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 104.774 -2.306 . . . . 635.80999999999995 104.774 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.41 152.24 18.77 Favored 'General case' 1 CA--C 1.419 -4.087 3 N-CA-C 132.002 7.779 . . . . 999.99000000000001 132.002 -135.767 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.84 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.774 1 CA-C-N 103.337 -6.301 . . . . 594.32000000000005 113.615 149.237 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.14 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 1 N-CA-C 98.277 -4.712 . . . . 811.90999999999997 98.277 162.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.48 45.98 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.099 -1.84 . . . . 999.99000000000001 109.424 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.976 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.15 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.003 0.906 . . . . 431.86000000000001 110.05 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.13 148.65 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 124.39 1.076 . . . . 457.18000000000001 108.766 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.48 3.74 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.106 0.962 . . . . 458.76999999999998 113.535 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.975 1.31 . . . . 999.99000000000001 112.401 168.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.1 Cg_exo -65.95 -45.84 5.56 Favored 'Trans proline' 0 N--CA 1.438 -1.794 0 N-CA-C 120.855 3.367 . . . . 999.99000000000001 120.855 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.037 0 C-N-CA 117.2 -1.8 . . . . 81.180000000000007 107.283 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.866 0 CA-C-O 114.908 -2.472 . . . . 999.99000000000001 108.743 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.1 Cg_endo -41.63 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.144 1 C-N-CA 126.045 4.497 . . . . 999.99000000000001 105.692 -170.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.31 -44.01 97.51 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 126.721 2.008 . . . . 967.72000000000003 112.04 -165.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.27 -36.52 78.0 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.75 -1.574 . . . . 934.29999999999995 106.75 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.61 -30.21 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 129.18 2.992 . . . . 565.14999999999998 113.92 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.52 55.43 2.8 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 118.451 0.568 . . . . 755.61000000000001 109.846 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.29 66.99 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.554 1.142 . . . . 325.88999999999999 113.254 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.98 78.31 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 123.582 0.753 . . . . 250.21000000000001 111.602 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.77 -43.28 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.575 0.702 . . . . 142.46000000000001 110.399 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.04 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.6 t80 -61.09 -41.55 96.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.953 0.901 . . . . 247.69 108.83 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.826 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.51 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.429 1.491 . . . . 199.61000000000001 113.122 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.37 -44.52 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 107.673 -1.232 . . . . 106.73 107.673 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.12 -48.57 81.14 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 115.875 -0.602 . . . . 115.01000000000001 110.217 -173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.21 -49.1 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 119.393 -0.923 . . . . 129.41999999999999 111.875 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.797 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.88 -53.18 59.28 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 118.209 -1.396 . . . . 172.47999999999999 109.919 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.2 t -63.82 -54.3 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 120.53 -0.468 . . . . 55.859999999999999 110.942 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.56 58.97 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 118.546 -1.262 . . . . 184.68000000000001 111.525 -174.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 116.641 -2.023 . . . . 291.81 114.74 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.02 -55.02 4.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 115.172 1.545 . . . . 130.66 115.172 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.797 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.92 -48.48 68.52 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.459 1.281 . . . . 80.159999999999997 114.459 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.9 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.53 -45.49 83.33 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 119.996 -0.682 . . . . 136.02000000000001 109.503 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.83 -27.12 59.46 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.627 -0.566 . . . . 92.170000000000002 110.627 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.35 -41.37 76.67 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.475 -1.305 . . . . 135.59999999999999 107.475 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.15 -44.73 91.22 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.563 -0.532 . . . . 52.100000000000001 109.563 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.67 -43.46 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.147 -0.686 . . . . 95.890000000000001 109.147 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.683 -1.599 . . . . 43.409999999999997 106.683 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.29 99.11 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.363 -1.495 . . . . 27.690000000000001 109.363 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.65 -47.4 75.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 122.177 -0.602 . . . . 54.409999999999997 110.47 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.8 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.984 -1.488 . . . . 53.880000000000003 106.984 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.8 -40.81 94.02 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.466 -0.938 . . . . 68.290000000000006 108.466 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.02 92.91 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 119.679 -0.808 . . . . 107.59 110.625 -175.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 119.64 -0.824 . . . . 111.61 109.549 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.919 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.29 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.393 -0.965 . . . . 85.260000000000005 108.393 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.42 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.072 -0.811 . . . . 40.710000000000001 111.072 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.73 -44.11 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.384 -0.969 . . . . 95.859999999999999 108.384 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.91 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.907 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.34 132.13 47.31 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.589 -1.263 . . . . 326.72000000000003 107.589 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.457 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.02 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.991 -1.855 . . . . 158.38 105.991 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.457 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.91 98.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.662 -0.496 . . . . 36.780000000000001 109.662 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.09 125.87 25.29 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.148 -1.021 . . . . 85.459999999999994 109.816 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.696 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.56 8.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.498 -2.038 . . . . 127.78 105.498 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.91 34.81 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.8 Cg_exo -56.78 -39.92 87.94 Favored 'Trans proline' 0 N--CA 1.431 -2.174 0 N-CA-C 113.977 0.722 . . . . 222.34999999999999 113.977 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.14 167.0 44.92 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.92 -45.76 93.37 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.057 -1.831 . . . . 107.56999999999999 106.057 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.729 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.84 58.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 118.842 -1.143 . . . . 167.96000000000001 109.177 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.47 106.75 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 126.754 2.022 . . . . 280.68000000000001 109.732 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 56.02 11.24 0.7 Allowed 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.503 1.121 . . . . 218.25 110.695 174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.61 54.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.251 -2.129 . . . . 343.56999999999999 105.251 177.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.476 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.95 81.88 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.844 -1.539 . . . . 263.29000000000002 106.844 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.33 147.01 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 126.503 1.921 . . . . 261.92000000000002 108.475 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.15 90.04 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.887 -1.153 . . . . 106.81 107.887 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.735 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.44 -39.95 95.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.392 -1.323 . . . . 112.2 107.526 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.24 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.288 -0.634 . . . . 45.409999999999997 109.288 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.814 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.3 p -70.92 -32.01 68.8 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 110.289 -0.263 . . . . 97.620000000000005 110.289 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.57 81.52 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.634 0.774 . . . . 59.289999999999999 111.014 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.735 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.649 1.18 . . . . 106.48999999999999 110.673 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.61 69.18 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.331 -0.989 . . . . 106.62 108.331 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.02 91.27 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.848 -0.532 . . . . 75.969999999999999 110.058 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.481 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.88 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 C-N-CA 122.89 0.476 . . . . 65.269999999999996 109.817 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 120.357 -0.537 . . . . 107.94 110.147 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.51 -40.82 98.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.652 -0.655 . . . . 87.980000000000004 110.293 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.33 96.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 118.834 -1.147 . . . . 65.5 108.382 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.72 -36.35 80.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.173 -1.047 . . . . 85.049999999999997 108.173 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.54 -45.68 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.067 -0.716 . . . . 42.25 109.067 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.33 -38.32 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 119.544 -0.862 . . . . 91.010000000000005 109.344 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.58 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.978 -1.119 . . . . 66.090000000000003 107.978 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.1 -43.12 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 120.731 -0.388 . . . . 52.390000000000001 110.312 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.2 m -61.81 -46.73 88.23 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 121.869 -0.52 . . . . 46.420000000000002 109.834 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.36 -38.17 88.51 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.286 -1.005 . . . . 116.51000000000001 108.286 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.485 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.19 -48.22 82.64 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.437 -0.579 . . . . 65.180000000000007 109.437 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.93 -42.73 97.27 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 122.13 -0.356 . . . . 51.329999999999998 110.437 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.39 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 118.898 -1.121 . . . . 126.3 109.013 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.513 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.508 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.822 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.7 -33.36 35.44 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.8 tp -58.44 -41.64 90.35 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.686 -0.633 . . . . 72.230000000000004 111.618 -167.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.61 -36.02 87.27 Favored 'Trans proline' 0 N--CA 1.429 -2.272 0 CA-C-N 119.88 0.993 . . . . 106.13 111.343 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.68 82.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.723 -0.791 . . . . 128.34999999999999 110.021 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.83 88.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 110.207 -0.294 . . . . 100.73 110.207 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.35 -44.43 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 C-N-CA 119.268 -0.973 . . . . 172.72 109.144 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.192 -1.04 . . . . 249.22999999999999 108.192 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.61 -55.05 36.62 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.615 -1.624 . . . . 259.77999999999997 106.615 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.24 -44.13 72.62 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 113.611 0.967 . . . . 233.11000000000001 113.611 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.38 -48.28 91.45 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 119.153 -1.019 . . . . 169.53999999999999 110.592 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.5 Cg_exo -61.18 -24.52 79.28 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 116.72 -1.72 . . . . 255.47 114.629 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.826 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.21 94.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 119.255 0.934 . . . . 279.02999999999997 108.886 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.79 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.078 -0.342 . . . . 162.21000000000001 110.078 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.87 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.39 84.9 59.25 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.75 -1.18 . . . . 128.13 108.083 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.29 164.03 11.2 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 N-CA-C 107.395 -1.81 . . . . 278.35000000000002 107.395 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.873 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.01 9.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.813 0.695 . . . . 312.91000000000003 109.335 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.873 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.69 -170.7 2.49 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.56 -1.645 . . . . 353.54000000000002 106.56 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.019 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 43.0 p90 -115.66 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.4 -1.333 . . . . 251.25999999999999 107.4 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.95 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 102.092 -3.299 . . . . 175.25999999999999 102.092 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.53 -44.97 96.09 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 100.88 -3.748 . . . . 99.069999999999993 100.88 172.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.41 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.52 -2.77 . . . . 243.21000000000001 103.52 171.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.019 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.93 112.91 25.04 Favored 'General case' 0 CA--C 1.473 -1.995 0 C-N-CA 116.109 -2.237 . . . . 201.03999999999999 105.293 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 C-N-CA 116.033 -2.267 . . . . 201.36000000000001 108.831 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.02 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.278 -1.783 . . . . 203.81999999999999 107.85 174.481 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.927 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.33 -45.69 86.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.196 -1.401 . . . . 215.06 112.56 -171.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.548 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.4 t -65.7 -46.37 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 C-N-CA 118.567 -1.253 . . . . 125.28 112.937 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.954 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.8 -36.99 86.12 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.177 -1.416 . . . . 268.89999999999998 107.177 -171.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.801 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.21 -45.02 74.49 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 125.65 1.58 . . . . 280.88 108.815 -172.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.54 85.79 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 118.957 -1.097 . . . . 184.47 108.971 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.07 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 119.27 -0.972 . . . . 167.91999999999999 112.772 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.77 89.91 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 117.796 -1.562 . . . . 367.18000000000001 110.77 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.74 74.05 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.877 -0.514 . . . . 173.97 110.439 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.44 -36.79 85.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.495 0.718 . . . . 119.66 109.788 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.822 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.19 -34.0 74.36 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.725 -1.213 . . . . 112.3 107.725 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.239 -0.437 . . . . 174.16999999999999 110.246 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 124.685 1.194 . . . . 145.27000000000001 110.616 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.764 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.58 -35.36 70.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.113 -1.069 . . . . 170.15000000000001 108.113 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.819 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.17 63.97 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.3 -0.409 . . . . 214.56999999999999 110.621 -171.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.19 56.51 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.063 1.745 . . . . 168.28999999999999 115.562 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.764 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.88 79.22 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.008 1.114 . . . . 167.15000000000001 114.008 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.2 -38.28 33.18 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 115.521 -2.472 . . . . 165.13 113.942 -171.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.53 -31.88 80.08 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.751 2.018 . . . . 123.92 111.21 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.74 -42.57 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 118.879 -1.128 . . . . 110.55 109.802 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.07 -40.08 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 108.846 -0.798 . . . . 145.31 108.846 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.05 -48.85 78.85 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.408 -0.917 . . . . 246.68000000000001 109.84 -177.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.22 -47.52 84.09 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 119.557 -0.857 . . . . 64.430000000000007 109.555 -173.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.75 -45.13 79.53 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.04 -1.064 . . . . 80.719999999999999 110.204 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 115.989 1.848 . . . . 140.44 115.989 -173.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.089 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.36 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.35 -1.295 . . . . 110.22 110.094 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.54 72.9 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.731 -0.606 . . . . 174.78 109.739 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.95 -41.71 95.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.248 -1.019 . . . . 161.84 108.248 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.521 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.24 -50.27 73.42 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.029 -0.668 . . . . 117.2 109.25 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.13 75.46 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.374 -0.53 . . . . 112.59999999999999 111.063 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.01 -37.43 94.59 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.626 -0.99 . . . . 101.45999999999999 110.626 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.026 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.15 -46.01 90.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 118.458 1.129 . . . . 151.49000000000001 109.52 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.08 -36.31 77.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.962 -1.496 . . . . 142.31999999999999 106.962 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.8 -41.8 92.0 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.41 85.67 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 122.358 -0.213 . . . . 76.109999999999999 111.02 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.49 30.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.879 -0.728 . . . . 120.23999999999999 109.318 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.575 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.54 41.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 102.912 -2.996 . . . . 192.72999999999999 102.912 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.22 -44.17 92.31 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 118.994 -1.082 . . . . 176.28999999999999 109.163 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.758 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.0 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.46 0 N-CA-C 106.303 -1.739 . . . . 69.680000000000007 106.303 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.97 -75.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 118.364 -0.624 . . . . 191.05000000000001 112.605 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.758 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.47 43.88 16.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 O-C-N 123.578 0.549 . . . . 287.02999999999997 109.778 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.945 0 C-N-CA 112.956 -3.498 . . . . 292.29000000000002 109.818 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.213 -2.514 . . . . 184.56999999999999 104.213 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.71 4.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.026 0.75 . . . . 274.56 113.026 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.24 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.748 -2.167 . . . . 268.24000000000001 113.453 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.6 m-20 51.56 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 118.685 1.242 . . . . 200.06 110.764 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.98 74.7 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.885 -1.154 . . . . 114.44 107.885 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.29 46.04 21.87 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.611 -1.255 . . . . 263.81 107.611 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.195 1 N-CA-C 102.563 -4.215 . . . . 103.79000000000001 102.563 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.3 95.6 10.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 114.943 -2.703 . . . . 117.3 106.016 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.76 90.77 Favored 'General case' 0 CA--C 1.468 -2.187 1 N-CA-C 98.041 -4.8 . . . . 231.58000000000001 98.041 167.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.04 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.97 163.44 29.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 102.063 -3.31 . . . . 303.24000000000001 102.063 168.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.55 78.9 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.024 -2.271 . . . . 112.72 108.424 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.8 t -61.06 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.072 -0.714 . . . . 83.219999999999999 109.072 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.3 m -156.28 -126.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.829 -2.656 . . . . 174.36000000000001 103.829 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.81 160.94 8.71 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 105.768 -1.938 . . . . 202.72999999999999 105.768 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.051 -1.463 . . . . 180.62 107.051 176.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.937 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.51 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.937 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.13 -43.11 88.06 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.136 -1.802 . . . . 66.049999999999997 106.136 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.492 -2.781 . . . . 266.49000000000001 103.492 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.93 0.28 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 117.055 -1.858 . . . . 219.19999999999999 107.753 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.08 -37.36 94.08 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 114.542 -1.208 . . . . 94.780000000000001 112.881 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.21 100.41 9.1 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.34 -3.744 . . . . 121.41 109.452 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.08 145.54 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.517 -0.765 . . . . 85.340000000000003 108.949 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.8 143.45 42.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.832 -1.174 . . . . 267.56999999999999 107.832 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.52 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.63 0.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.502 -0.555 . . . . 226.09999999999999 109.502 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.989 -1.485 . . . . 154.84 106.989 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.93 8.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.622 0.725 . . . . 180.00999999999999 110.696 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.888 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.91 23.63 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.971 -1.492 . . . . 333.77999999999997 106.971 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.5 48.77 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.399 -1.334 . . . . 335.19999999999999 107.399 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.729 -0.841 . . . . 266.47000000000003 108.729 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.63 -46.81 88.87 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.698 -1.964 . . . . 59.340000000000003 105.698 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.62 173.81 11.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.422 -2.436 . . . . 201.25999999999999 104.422 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.89 106.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.525 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.4 5.37 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.337 -0.616 . . . . 87.579999999999998 109.337 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.878 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.52 153.71 22.26 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.847 -1.168 . . . . 219.94999999999999 107.847 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 C-N-CA 116.348 -2.141 . . . . 121.79000000000001 105.434 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.9 t -154.14 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.816 -1.92 . . . . 53.850000000000001 105.816 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.26 16.56 77.11 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.886 -1.153 . . . . 35.880000000000003 107.886 -178.896 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 365' ' ' ARG . 1.7 tpp180 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.02 68.13 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.665 1.577 . . . . 1.0 111.877 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' B' ' 367' ' ' LYS . 1.2 mtpt -70.5 127.38 92.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.267 -0.424 . . . . 1.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.821 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -69.01 -19.97 38.99 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.397 2.065 . . . . 1.0 114.601 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -38.63 77.72 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.71 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -71.29 -10.53 59.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.355 . . . . 1.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.821 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.61 -46.34 87.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.332 -178.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -61.51 -49.11 78.05 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.587 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.08 78.31 0.31 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.714 HD23 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.174 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.442 ' H ' HD12 ' B' ' 374' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.518 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 108.361 -0.977 . . . . 97.079999999999998 108.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.59 155.46 22.32 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.161 0.981 . . . . 123.41 110.745 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.879 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.63 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.469 1 N-CA-C 100.106 -4.035 . . . . 151.30000000000001 100.106 173.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.993 HD21 ' HG3' ' B' ' 366' ' ' PRO . 5.2 mp -60.66 -38.61 58.5 Favored Pre-proline 0 N--CA 1.439 -1.01 0 C-N-CA 115.98 -2.288 . . . . 169.25 106.101 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_exo -81.29 168.54 16.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 122.265 0.613 . . . . 185.75999999999999 110.508 171.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.2 t -64.51 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.051 2.141 . . . . 145.47 110.324 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.35 157.42 21.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.064 -1.023 . . . . 102.76000000000001 109.446 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.61 154.18 25.07 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.994 -1.114 . . . . 106.25 107.994 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.92 51.91 0.74 Allowed 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 117.757 -1.577 . . . . 157.81 107.658 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.19 -45.9 91.56 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.541 -2.763 . . . . 150.19999999999999 103.541 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.01 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.874 0 N-CA-C 103.68 -2.711 . . . . 183.52000000000001 103.68 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -76.77 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 N-CA-C 109.995 -0.81 . . . . 235.61000000000001 109.995 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.99 -41.22 82.56 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.847 1.259 . . . . 113.77 113.354 -170.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.24 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 119.616 1.098 . . . . 150.84999999999999 110.965 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.52 156.29 46.37 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 107.594 -1.262 . . . . 100.42 107.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.63 58.33 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.955 0.883 . . . . 129.36000000000001 110.436 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.07 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.288 1.835 . . . . 112.34 106.693 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.7 m -74.11 -40.16 62.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.553 -0.749 . . . . 131.72999999999999 111.777 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.4 -42.9 15.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 117.018 2.229 . . . . 80.489999999999995 117.018 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.53 3.35 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.196 -1.402 . . . . 98.980000000000004 111.252 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.84 -10.7 18.09 Favored 'Trans proline' 0 C--N 1.32 -0.921 1 N-CA-C 128.937 6.476 . . . . 246.94999999999999 128.937 -170.061 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.62 17.55 8.71 Favored 'General case' 0 C--N 1.325 -0.484 1 CA-C-N 126.12 4.055 . . . . 269.62 114.236 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.15 -27.3 67.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.793 -1.188 . . . . 86.799999999999997 107.793 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.83 -29.28 69.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.088 -1.007 . . . . 85.909999999999997 110.498 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 123.65 0.78 . . . . 82.0 111.364 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.76 12.43 Favored Pre-proline 0 CA--C 1.488 -1.417 0 N-CA-C 108.555 -0.906 . . . . 120.73 108.555 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 C-N-CA 120.659 0.906 . . . . 87.859999999999999 109.935 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.814 -0.81 . . . . 36.460000000000001 108.814 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.1 p-90 -63.8 -33.89 76.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.797 -1.186 . . . . 150.59999999999999 107.797 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.18 -32.7 73.37 Favored 'General case' 0 CA--C 1.491 -1.322 0 O-C-N 121.301 -0.874 . . . . 123.26000000000001 108.685 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.14 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 109.196 -0.668 . . . . 120.14 109.196 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.43 -31.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.91 -47.21 84.24 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 119.917 -0.713 . . . . 60.869999999999997 109.633 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.65 81.16 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 119.977 -0.689 . . . . 157.56999999999999 110.362 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.58 -40.9 98.36 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.682 -0.858 . . . . 47.060000000000002 108.682 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.02 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 121.751 -0.593 . . . . 43.939999999999998 109.569 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.29 99.15 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.705 -0.85 . . . . 42.609999999999999 108.705 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.35 -41.26 94.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.653 -0.249 . . . . 140.66 111.064 -178.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.79 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 118.613 -1.235 . . . . 116.04000000000001 110.221 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.44 -38.76 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.745 -0.835 . . . . 97.159999999999997 108.745 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.4 mt -61.32 -39.95 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 108.969 -0.752 . . . . 54.850000000000001 108.969 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.962 HG22 HG21 ' A' ' 86' ' ' THR . 93.1 t -57.7 -42.34 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 108.891 -0.781 . . . . 45.390000000000001 108.891 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.56 -50.97 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.837 -1.145 . . . . 48.640000000000001 110.156 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.21 -47.11 78.02 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.137 -0.625 . . . . 116.65000000000001 111.71 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.93 -43.93 97.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.695 -0.483 . . . . 51.159999999999997 109.695 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.96 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 119.864 -0.734 . . . . 44.299999999999997 110.828 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.1 t -64.71 -46.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 120.349 -0.54 . . . . 48.82 111.039 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.12 95.2 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.492 -0.861 . . . . 58.700000000000003 112.006 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.68 -34.13 66.99 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 117.452 0.626 . . . . 101.40000000000001 111.006 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.77 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.727 -1.212 . . . . 103.56999999999999 107.727 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.41 -43.02 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.996 -0.742 . . . . 61.890000000000001 108.996 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.5 t -63.5 -50.94 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.45 -0.574 . . . . 70.010000000000005 109.45 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.91 -43.45 98.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.118 -0.697 . . . . 132.09999999999999 109.118 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.19 -46.63 83.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.652 -0.249 . . . . 104.5 110.458 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.64 -49.89 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.237 -0.585 . . . . 142.96000000000001 111.241 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.0 pt -64.75 -41.76 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 C-N-CA 116.936 -1.906 . . . . 158.31999999999999 110.897 -175.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 117.692 -1.603 . . . . 137.11000000000001 109.516 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.155 -0.341 . . . . 54.659999999999997 111.02 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.39 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 121.615 0.721 . . . . 127.18000000000001 109.591 -174.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.78 -36.89 80.12 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.884 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.041 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.618 -0.676 . . . . 131.12 111.526 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.023 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.46 7.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.25 -2.58 . . . . 246.56 109.613 -175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.949 0 N-CA-C 105.489 -2.041 . . . . 339.35000000000002 105.489 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.12 165.23 17.89 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.033 -2.951 . . . . 114.66 103.033 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.42 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.799 -1.556 . . . . 143.28 106.799 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.5 m -59.66 -38.1 80.51 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.687 -0.857 . . . . 160.22 108.687 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.4 m-20 -62.3 -31.78 72.43 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.908 -0.775 . . . . 120.54000000000001 108.908 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.56 -43.8 96.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.508 -0.553 . . . . 67.219999999999999 109.508 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.54 -39.75 88.72 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.494 -0.754 . . . . 138.59999999999999 109.71 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.94 82.15 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.451 0.301 . . . . 151.46000000000001 110.614 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.97 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 117.426 -1.71 . . . . 117.93000000000001 106.686 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.03 -46.01 90.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.891 -1.152 . . . . 56.82 107.891 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.016 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.41 -43.92 98.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.885 -0.783 . . . . 145.30000000000001 108.885 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.39 95.54 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.494 -0.928 . . . . 45.710000000000001 108.494 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.41 -42.03 99.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.357 -0.609 . . . . 105.61 109.357 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.617 -0.883 . . . . 47.890000000000001 108.617 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.35 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.935 -0.395 . . . . 124.53 109.935 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 121.966 -0.459 . . . . 35.890000000000001 109.831 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -37.29 84.83 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.999 -1.482 . . . . 88.969999999999999 106.999 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.18 76.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 119.859 -0.737 . . . . 239.91 109.075 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.45 -43.39 90.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.529 -0.732 . . . . 146.09999999999999 110.565 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.2 3.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 117.358 -1.737 . . . . 91.739999999999995 113.874 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.6 -61.33 2.0 Allowed 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 115.745 1.757 . . . . 197.44999999999999 115.745 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.26 -42.31 55.34 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.896 -1.521 . . . . 242.59999999999999 114.026 -170.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.962 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.61 84.55 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 118.957 -1.097 . . . . 215.61000000000001 109.831 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.0 t -60.26 -46.96 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.803 -0.561 . . . . 87.189999999999998 110.489 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 64.0 t -65.95 -41.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.754 -0.462 . . . . 231.81999999999999 109.754 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.9 m-20 -62.33 -34.14 76.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.295 -1.002 . . . . 364.98000000000002 108.295 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.543 -0.723 . . . . 181.63 111.242 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.5 m -60.83 -45.83 92.91 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.423 -1.325 . . . . 269.01999999999998 107.423 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.67 -45.13 92.98 Favored 'General case' 0 CA--C 1.469 -2.15 0 C-N-CA 118.677 -1.209 . . . . 562.65999999999997 110.013 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.21 95.67 Favored 'General case' 0 CA--C 1.479 -1.777 0 C-N-CA 118.713 -1.195 . . . . 446.75 108.108 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.0 m -70.52 -26.31 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 115.826 -2.35 . . . . 370.05000000000001 112.202 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.5 -26.48 60.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.598 -0.689 . . . . 354.91000000000003 112.53 175.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.83 4.55 0.98 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 125.057 1.343 . . . . 462.44 111.87 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.8 mm-40 -172.39 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.067 0.936 . . . . 652.37 111.085 171.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 128.508 2.723 . . . . 905.99000000000001 107.931 -174.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.88 -36.42 80.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.223 -1.028 . . . . 570.42999999999995 108.223 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.52 -36.37 82.35 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 125.31 1.444 . . . . 453.22000000000003 111.191 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.67 33.88 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 118.781 -1.676 . . . . 445.63 109.897 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' CD1' ' HB2' ' B' ' 368' ' ' PRO . 89.1 mt -56.39 -41.23 75.91 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.249 1.419 . . . . 457.72000000000003 112.378 -170.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.64 -46.93 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.688 -1.205 . . . . 340.57999999999998 109.299 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.74 -32.13 71.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.769 -1.172 . . . . 453.60000000000002 111.585 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.04 -40.33 73.32 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.993 -1.855 . . . . 541.48000000000002 105.993 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.9 -47.08 76.0 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 124.025 0.828 . . . . 466.68000000000001 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.06 86.86 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.491 -1.684 . . . . 427.33999999999997 107.263 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.12 -36.77 82.61 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 112.423 0.527 . . . . 537.87 112.423 -174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.66 74.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 116.86 -1.936 . . . . 422.12 111.617 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.05 -50.11 75.32 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.339 -0.85 . . . . 340.17000000000002 111.853 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.35 -46.5 70.74 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.089 -1.045 . . . . 258.06 111.695 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.3 Cg_exo -61.47 -31.58 87.97 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.54 93.78 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.791 -1.188 . . . . 149.27000000000001 107.791 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.96 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.649 -0.42 . . . . 138.08000000000001 111.5 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.96 -42.41 88.72 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 O-C-N 121.556 -0.715 . . . . 132.88999999999999 110.936 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.75 -44.72 92.63 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.849 -0.797 . . . . 193.61000000000001 108.849 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.66 84.31 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 122.842 0.457 . . . . 63.829999999999998 110.128 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.4 59.68 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.75 -0.38 . . . . 76.400000000000006 111.214 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.64 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.163 -1.051 . . . . 171.13 108.163 -174.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.84 -38.53 91.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.866 -0.521 . . . . 78.299999999999997 110.639 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.06 -35.78 80.59 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 118.9 -1.12 . . . . 92.359999999999999 109.236 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . 1.016 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.28 76.49 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.184 -1.043 . . . . 93.730000000000004 108.184 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.49 -41.59 84.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 119.205 -0.998 . . . . 132.74000000000001 109.323 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.13 94.72 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.188 -1.412 . . . . 43.390000000000001 107.188 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.47 -41.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 108.639 -0.875 . . . . 59.340000000000003 108.639 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.06 95.27 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.796 -0.565 . . . . 69.680000000000007 110.5 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.71 91.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.334 -0.987 . . . . 106.98 108.334 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.64 81.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.648 -0.821 . . . . 147.63 108.933 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.54 99.38 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.557 -0.905 . . . . 190.06 108.557 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.13 97.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.273 -1.01 . . . . 118.84999999999999 108.273 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.809 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.65 98.97 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 110.008 -0.367 . . . . 102.5 110.008 -177.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.61 95.23 Favored 'General case' 0 CA--C 1.489 -1.375 0 O-C-N 121.866 -0.521 . . . . 89.980000000000004 109.812 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 C-N-CA 118.104 -1.438 . . . . 106.09 111.012 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.11 -48.26 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 C-N-CA 117.087 -1.845 . . . . 227.74000000000001 111.798 -174.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.08 50.94 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.238 -2.185 . . . . 262.55000000000001 110.052 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.47 28.81 Favored 'Trans proline' 0 C--N 1.289 -2.56 0 C-N-CA 121.685 1.59 . . . . 210.25 111.35 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.23 112.0 0.99 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 106.537 -1.653 . . . . 270.57999999999998 106.537 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.53 24.04 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-N 115.37 -0.832 . . . . 129.84 112.316 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 83.0 Cg_exo -61.36 -26.58 81.75 Favored 'Trans proline' 0 N--CA 1.432 -2.142 0 N-CA-C 116.321 1.623 . . . . 330.70999999999998 116.321 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.04 77.21 7.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 114.452 -2.899 . . . . 204.50999999999999 107.286 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.44 0.09 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.425 -1.324 . . . . 387.41000000000003 107.425 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.04 33.66 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 118.753 -1.179 . . . . 166.22 109.435 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.79 88.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.804 -1.184 . . . . 44.229999999999997 107.804 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.76 -38.83 92.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.085 -0.709 . . . . 30.289999999999999 109.085 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.04 93.88 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.962 -0.755 . . . . 46.109999999999999 108.962 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.12 99.26 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.699 -1.223 . . . . 87.329999999999998 107.699 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.63 -42.13 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.954 -1.128 . . . . 23.690000000000001 107.954 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.22 -44.26 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.676 -0.49 . . . . 43.859999999999999 109.676 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.3 -42.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 108.351 -0.981 . . . . 91.129999999999995 108.351 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.4 t -62.56 -38.0 88.37 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.743 -0.836 . . . . 65.879999999999995 108.743 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.11 -41.81 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 109.58 -0.526 . . . . 33.859999999999999 109.58 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.41 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.173 0 N-CA-C 107.577 -1.268 . . . . 146.52000000000001 107.577 -176.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.84 -38.36 90.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.499 -0.88 . . . . 75.439999999999998 108.936 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.53 -48.39 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 O-C-N 121.04 -1.038 . . . . 43.640000000000001 109.733 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.48 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 109.045 -0.724 . . . . 102.56999999999999 109.045 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.1 86.87 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.398 -1.334 . . . . 58.159999999999997 107.398 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.5 73.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.993 -0.743 . . . . 121.11 108.993 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.3 84.93 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.565 -1.254 . . . . 153.15000000000001 109.938 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.11 -43.76 18.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 113.084 -3.446 . . . . 133.66999999999999 113.477 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.92 -39.93 96.07 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 120.918 -1.114 . . . . 157.41999999999999 112.193 -171.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 114.993 1.479 . . . . 250.91 114.993 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.3 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.488 -1.786 0 N-CA-C 117.984 2.263 . . . . 207.34 117.984 -174.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.914 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.2 -34.22 74.73 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.94 -1.504 . . . . 192.46000000000001 106.94 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.06 98.16 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.01 -2.036 . . . . 261.0 108.01 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.71 159.11 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 101.519 -3.512 . . . . 491.39999999999998 101.519 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.437 0 C-N-CA 116.257 -2.177 . . . . 386.10000000000002 109.87 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.03 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 103.552 -2.758 . . . . 289.80000000000001 103.552 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 117.771 -1.109 . . . . 402.06 109.576 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.29 177.46 7.57 Favored 'General case' 0 CA--C 1.586 2.357 0 C-N-CA 127.32 2.248 . . . . 690.52999999999997 114.9 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.59 0.0 OUTLIER 'General case' 1 C--N 1.43 4.09 1 N-CA-C 123.178 4.511 . . . . 633.62 123.178 162.696 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.67 153.85 22.07 Favored 'General case' 0 C--N 1.389 2.305 0 C-N-CA 127.362 2.265 . . . . 617.99000000000001 110.889 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.42 5.96 Favored Pre-proline 0 C--N 1.364 1.227 0 C-N-CA 130.289 3.435 . . . . 434.98000000000002 113.382 -175.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.1 Cg_endo -44.21 -65.7 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 122.409 3.965 . . . . 365.88 122.409 -168.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.3 m -84.91 20.98 1.69 Allowed 'General case' 0 CA--C 1.467 -2.247 0 N-CA-C 104.832 -2.284 . . . . 635.80999999999995 104.832 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.35 152.19 18.83 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.959 7.762 . . . . 999.99000000000001 131.959 -135.764 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.913 37.2 t -131.79 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.773 1 CA-C-N 103.314 -6.312 . . . . 594.32000000000005 113.613 149.206 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.1 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.307 -4.701 . . . . 811.90999999999997 98.307 162.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.47 144.58 45.89 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 117.063 -1.855 . . . . 999.99000000000001 109.411 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.23 -175.63 4.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.036 0.922 . . . . 431.86000000000001 110.042 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.06 148.63 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 124.384 1.074 . . . . 457.18000000000001 108.823 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.45 3.72 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.134 0.973 . . . . 458.76999999999998 113.523 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.41 -31.56 0.97 Allowed Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.983 1.313 . . . . 999.99000000000001 112.38 168.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.953 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.73 5.68 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 N-CA-C 120.916 3.391 . . . . 999.99000000000001 120.916 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.57 171.76 8.13 Favored 'General case' 0 CA--C 1.472 -2.041 0 C-N-CA 117.133 -1.827 . . . . 81.180000000000007 107.235 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.831 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.12 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.881 0 C-N-CA 115.537 -2.465 . . . . 999.99000000000001 108.798 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.8 Cg_endo -41.61 101.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.126 1 C-N-CA 126.045 4.496 . . . . 999.99000000000001 105.677 -170.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.99 97.55 Favored 'General case' 0 CA--C 1.483 -1.621 0 C-N-CA 126.717 2.007 . . . . 967.72000000000003 112.043 -165.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.31 -36.55 78.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.72 -1.585 . . . . 934.29999999999995 106.72 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.5 -30.29 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 129.188 2.995 . . . . 565.14999999999998 113.951 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.59 55.36 2.78 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 118.468 0.577 . . . . 755.61000000000001 109.854 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.25 67.21 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.559 1.144 . . . . 325.88999999999999 113.259 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -45.02 78.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.582 0.753 . . . . 250.21000000000001 111.639 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.66 -43.38 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-O 121.592 0.711 . . . . 142.46000000000001 110.379 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.953 0.901 . . . . 247.69 108.855 -173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.49 -51.32 69.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 125.444 1.498 . . . . 199.61000000000001 113.111 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.37 -44.49 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.701 -1.222 . . . . 106.73 107.701 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.59 81.03 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.853 -0.612 . . . . 115.01000000000001 110.232 -173.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.19 -49.13 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 119.411 -0.916 . . . . 129.41999999999999 111.857 -174.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.6 m -61.94 -53.09 60.5 Favored 'General case' 0 CA--C 1.482 -1.646 0 C-N-CA 118.178 -1.409 . . . . 172.47999999999999 109.943 -172.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.84 -54.32 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 120.51 -0.476 . . . . 55.859999999999999 110.973 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.5 -51.55 59.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.504 -1.278 . . . . 184.68000000000001 111.524 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.42 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.618 -2.033 . . . . 291.81 114.749 -174.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.98 4.86 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.181 1.548 . . . . 130.66 115.181 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.499 1.296 . . . . 80.159999999999997 114.499 -170.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.44 83.1 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.906 -0.717 . . . . 136.02000000000001 109.509 -174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.2 Cg_exo -64.83 -27.11 59.49 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.596 -0.579 . . . . 92.170000000000002 110.596 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.33 -41.44 76.68 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.441 -1.318 . . . . 135.59999999999999 107.441 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.11 -44.7 91.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.604 -0.517 . . . . 52.100000000000001 109.604 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.49 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 109.079 -0.711 . . . . 95.890000000000001 109.079 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.33 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.714 -1.587 . . . . 43.409999999999997 106.714 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.28 99.12 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.382 -1.487 . . . . 27.690000000000001 109.382 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.71 -47.38 75.57 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 117.32 0.56 . . . . 54.409999999999997 110.45 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.36 -34.19 74.88 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.957 -1.497 . . . . 53.880000000000003 106.957 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.84 93.85 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.503 -0.925 . . . . 68.290000000000006 108.503 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.04 92.96 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.682 -0.807 . . . . 107.59 110.626 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -63.0 -38.38 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.609 -0.837 . . . . 111.61 109.525 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.23 -22.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.45 -0.944 . . . . 85.260000000000005 108.45 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.92 99.42 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.074 -0.81 . . . . 40.710000000000001 111.074 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.71 -44.09 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.382 -0.97 . . . . 95.859999999999999 108.382 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.9 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.416 -0.957 . . . . 144.37 108.416 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.8 mt -55.34 132.12 47.29 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 107.606 -1.257 . . . . 326.72000000000003 107.606 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.1 1.52 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.015 -1.846 . . . . 158.38 106.015 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.28 -41.94 99.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.688 -0.486 . . . . 36.780000000000001 109.688 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.7 m -61.13 125.88 25.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.168 -1.013 . . . . 85.459999999999994 109.77 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.57 8.83 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 105.534 -2.024 . . . . 127.78 105.534 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.78 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 105.938 -1.875 . . . . 164.84 105.938 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.0 Cg_exo -56.77 -39.95 87.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 113.958 0.714 . . . . 222.34999999999999 113.958 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 106.403 -2.679 . . . . 45.219999999999999 106.403 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.77 93.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.017 -1.846 . . . . 107.56999999999999 106.017 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.83 141.82 58.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.897 -1.121 . . . . 167.96000000000001 109.142 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.71 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.686 1.994 . . . . 280.68000000000001 109.715 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.33 0.71 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.493 1.117 . . . . 218.25 110.686 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.212 -2.144 . . . . 343.56999999999999 105.212 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -112.04 81.93 1.54 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.875 -1.528 . . . . 263.29000000000002 106.875 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.4 m80 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 126.57 1.948 . . . . 261.92000000000002 108.471 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.08 89.78 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 107.903 -1.147 . . . . 106.81 107.903 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.88 94.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 118.374 -1.33 . . . . 112.2 107.576 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.3 t -64.31 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.294 -0.632 . . . . 45.409999999999997 109.294 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.06 68.89 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.287 -0.264 . . . . 97.620000000000005 110.287 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.62 81.7 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.735 0.814 . . . . 59.289999999999999 111.025 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.27 -36.48 83.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.615 1.166 . . . . 106.48999999999999 110.687 -174.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.7 69.24 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.28 -1.007 . . . . 106.62 108.28 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.01 -41.03 91.53 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 121.836 -0.54 . . . . 75.969999999999999 110.028 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.7 t -65.56 -40.83 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 122.94 0.496 . . . . 65.269999999999996 109.754 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.6 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 C-N-CA 120.419 -0.512 . . . . 107.94 110.135 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.56 -40.78 97.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 121.68 -0.637 . . . . 87.980000000000004 110.275 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.63 -40.45 96.92 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.847 -1.141 . . . . 65.5 108.389 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.65 -36.37 80.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.157 -1.053 . . . . 85.049999999999997 108.157 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.5 -45.75 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 109.028 -0.73 . . . . 42.25 109.028 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.39 -38.17 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 C-N-CA 119.535 -0.866 . . . . 91.010000000000005 109.377 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.93 -41.55 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 107.973 -1.121 . . . . 66.090000000000003 107.973 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 120.726 -0.39 . . . . 52.390000000000001 110.331 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.3 m -61.75 -46.77 88.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.899 -0.501 . . . . 46.420000000000002 109.858 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.37 -38.05 88.09 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.337 -0.986 . . . . 116.51000000000001 108.337 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.35 -48.17 82.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.392 -0.595 . . . . 65.180000000000007 109.392 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.7 97.33 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 120.827 0.346 . . . . 51.329999999999998 110.472 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.61 -43.41 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 118.936 -1.106 . . . . 126.3 108.982 -176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.4 35.34 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 116.842 2.164 . . . . 134.84 116.842 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.787 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.36 -41.62 90.37 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.692 -0.63 . . . . 72.230000000000004 111.66 -167.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.5 Cg_exo -60.69 -35.98 86.94 Favored 'Trans proline' 0 N--CA 1.429 -2.286 0 CA-C-N 119.851 0.983 . . . . 106.13 111.341 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.69 82.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 119.754 -0.779 . . . . 128.34999999999999 110.068 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.87 89.04 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 110.218 -0.29 . . . . 100.73 110.218 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.27 -44.51 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.279 -0.969 . . . . 172.72 109.185 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.4 m-85 -66.62 -28.09 68.21 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.216 -1.031 . . . . 249.22999999999999 108.216 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.49 -55.17 34.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.701 -1.592 . . . . 259.77999999999997 106.701 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.16 -44.15 72.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.593 0.96 . . . . 233.11000000000001 113.593 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.38 -48.33 91.31 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 119.22 -0.992 . . . . 169.53999999999999 110.544 -170.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.9 Favored 'Trans proline' 0 N--CA 1.429 -2.282 0 C-N-CA 116.784 -1.677 . . . . 255.47 114.66 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.19 94.8 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 119.238 0.926 . . . . 279.02999999999997 108.893 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.055 -0.35 . . . . 162.21000000000001 110.055 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.869 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.4 84.9 59.27 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 118.779 -1.168 . . . . 128.13 108.052 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.25 164.0 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.289 0 N-CA-C 107.499 -1.769 . . . . 278.35000000000002 107.499 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.17 15.0 9.93 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 123.778 0.674 . . . . 312.91000000000003 109.325 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.73 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.54 -1.652 . . . . 353.54000000000002 106.54 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.26 46.97 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.426 -1.324 . . . . 251.25999999999999 107.426 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 102.06 -3.311 . . . . 175.25999999999999 102.06 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.97 96.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 100.857 -3.757 . . . . 99.069999999999993 100.857 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.14 9.16 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.496 -2.779 . . . . 243.21000000000001 103.496 171.2 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.97 112.93 25.07 Favored 'General case' 0 CA--C 1.474 -1.948 0 C-N-CA 116.047 -2.261 . . . . 201.03999999999999 105.293 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 C-N-CA 115.992 -2.283 . . . . 201.36000000000001 108.789 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.44 -41.48 89.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.256 -1.793 . . . . 203.81999999999999 107.872 174.441 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.27 -45.69 86.94 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 118.181 -1.408 . . . . 215.06 112.552 -171.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.39 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.934 -171.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.84 -37.01 86.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.181 -1.414 . . . . 268.89999999999998 107.181 -171.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.19 -45.01 74.57 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 125.658 1.583 . . . . 280.88 108.809 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.52 85.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 118.981 -1.088 . . . . 184.47 108.982 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.91 -42.13 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 119.262 -0.975 . . . . 167.91999999999999 112.769 -175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.498 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.69 -38.87 90.44 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 117.787 -1.565 . . . . 367.18000000000001 110.783 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.73 74.06 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.819 -0.551 . . . . 173.97 110.471 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 123.541 0.736 . . . . 119.66 109.764 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.99 74.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.675 -1.231 . . . . 112.3 107.675 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.02 73.3 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.24 -0.436 . . . . 174.16999999999999 110.244 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 m -64.74 -22.74 67.05 Favored 'General case' 0 CA--C 1.485 -1.542 0 C-N-CA 124.656 1.182 . . . . 145.27000000000001 110.627 -175.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.762 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.36 70.42 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.066 -1.086 . . . . 170.15000000000001 108.066 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.37 -34.05 63.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 122.702 0.401 . . . . 214.56999999999999 110.639 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.27 -33.18 55.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.056 1.742 . . . . 168.28999999999999 115.514 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.762 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.91 79.29 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 114.024 1.12 . . . . 167.15000000000001 114.024 -168.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.72 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.8 p-10 -64.24 -38.23 32.49 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.472 -2.491 . . . . 165.13 113.932 -171.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.72 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.54 -31.82 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 122.846 2.052 . . . . 123.92 111.241 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.79 -42.53 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.769 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.22 -39.99 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.803 -0.814 . . . . 145.31 108.803 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.11 -48.83 78.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 119.386 -0.926 . . . . 246.68000000000001 109.854 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.1 m -62.16 -47.51 84.19 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.608 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.1 79.52 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.005 -1.078 . . . . 80.719999999999999 110.222 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 115.98 1.844 . . . . 140.44 115.98 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.77 132.22 34.46 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 112.753 -3.579 . . . . 178.87 113.061 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -64.98 -37.12 86.61 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.4 -1.273 . . . . 110.22 110.125 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.62 72.62 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 121.772 -0.58 . . . . 174.78 109.708 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.67 95.52 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.274 -1.009 . . . . 161.84 108.274 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.35 -50.17 73.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 120.01 -0.676 . . . . 117.2 109.232 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.06 75.47 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.328 -0.549 . . . . 112.59999999999999 111.114 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.36 94.47 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.671 -0.972 . . . . 101.45999999999999 110.671 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.21 -46.02 90.76 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 118.47 1.135 . . . . 151.49000000000001 109.511 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.0 -36.34 76.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.984 -1.487 . . . . 142.31999999999999 106.984 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.829 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.85 92.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.41 85.93 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 122.287 -0.258 . . . . 76.109999999999999 111.047 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -61.48 -55.46 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.829 -0.748 . . . . 120.23999999999999 109.301 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.31 131.57 41.28 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 102.944 -2.984 . . . . 192.72999999999999 102.944 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.15 -44.22 92.07 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.017 -1.073 . . . . 176.28999999999999 109.22 -172.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.3 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.488 -1.431 0 N-CA-C 106.277 -1.749 . . . . 69.680000000000007 106.277 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.02 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.431 0 C-N-CA 118.381 -0.612 . . . . 191.05000000000001 112.595 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.48 43.92 16.23 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 123.504 0.502 . . . . 287.02999999999997 109.772 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.829 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.56 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.916 0 C-N-CA 112.948 -3.501 . . . . 292.29000000000002 109.795 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.51 -152.8 0.05 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.206 -2.516 . . . . 184.56999999999999 104.206 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.62 8.75 5.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.061 0.763 . . . . 274.56 113.061 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.85 57.28 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 117.72 -2.181 . . . . 268.24000000000001 113.451 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.58 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 118.694 1.247 . . . . 200.06 110.722 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.76 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.868 -1.16 . . . . 114.44 107.868 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.24 46.07 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.635 -1.246 . . . . 263.81 107.635 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.218 1 N-CA-C 102.475 -4.25 . . . . 103.79000000000001 102.475 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.27 95.66 10.26 Favored 'General case' 0 N--CA 1.419 -2.014 0 C-N-CA 114.933 -2.707 . . . . 117.3 106.0 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.03 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.82 90.81 Favored 'General case' 0 CA--C 1.468 -2.178 1 N-CA-C 97.986 -4.82 . . . . 231.58000000000001 97.986 167.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.041 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.061 -3.311 . . . . 303.24000000000001 102.061 169.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.62 78.61 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.051 -2.26 . . . . 112.72 108.402 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.0 t -61.07 -63.6 1.24 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.1 -0.704 . . . . 83.219999999999999 109.1 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.885 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.28 -126.23 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.81 -2.663 . . . . 174.36000000000001 103.81 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.03 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.85 160.96 8.73 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.746 -1.946 . . . . 202.72999999999999 105.746 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.023 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.91 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.085 -1.45 . . . . 180.62 107.085 176.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.406 -2.072 . . . . 145.25 105.406 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.12 -43.12 88.05 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.155 -1.795 . . . . 66.049999999999997 106.155 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.509 -2.775 . . . . 266.49000000000001 103.509 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.29 -124.9 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.029 -1.868 . . . . 219.19999999999999 107.788 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.904 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.14 -37.32 93.98 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 114.546 -1.207 . . . . 94.780000000000001 112.853 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.2 100.42 9.09 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 112.285 -3.766 . . . . 121.41 109.489 -171.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -73.02 145.5 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.947 -0.76 . . . . 85.340000000000003 108.947 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.39 42.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.843 -1.169 . . . . 267.56999999999999 107.843 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.11 69.6 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.472 -0.566 . . . . 226.09999999999999 109.472 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 107.02 -1.474 . . . . 154.84 107.02 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.585 0.707 . . . . 180.00999999999999 110.728 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.47 156.94 23.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.945 -1.502 . . . . 333.77999999999997 106.945 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.5 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.355 -1.35 . . . . 335.19999999999999 107.355 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.768 -0.827 . . . . 266.47000000000003 108.768 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.59 -46.93 88.41 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.633 -1.988 . . . . 59.340000000000003 105.633 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.59 173.85 11.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.428 -2.434 . . . . 201.25999999999999 104.428 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.91 106.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 116.298 -2.161 . . . . 56.229999999999997 105.509 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.26 -59.45 5.28 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.24 -0.652 . . . . 87.579999999999998 109.24 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.5 153.77 22.23 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.842 -1.17 . . . . 219.94999999999999 107.842 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 116.335 -2.146 . . . . 121.79000000000001 105.476 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.13 159.75 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 N-CA-C 105.797 -1.927 . . . . 53.850000000000001 105.797 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 106.021 -2.832 . . . . 196.55000000000001 106.021 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.661 0 N-CA-C 107.843 -1.169 . . . . 35.880000000000003 107.843 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 1.039 ' HD2' ' HB3' ' A' ' 188' ' ' PRO . 32.6 ttt180 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.841 -0.799 . . . . 1.0 108.841 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.993 ' HG3' HD21 ' A' ' 5' ' ' LEU . 50.1 Cg_endo -67.07 143.95 67.58 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.771 1.647 . . . . 1.0 111.815 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -70.33 127.28 92.28 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.941 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 368' ' ' PRO . . . . . 0.77 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -68.98 -20.02 39.08 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 122.386 2.057 . . . . 1.0 114.567 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -38.58 77.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.711 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 367' ' ' LYS . 2.4 pt20 -71.33 -10.63 60.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.354 . . . . 1.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.77 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 3.1 m-85 -58.56 -46.34 87.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.277 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.66 -48.98 78.39 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.555 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.09 78.27 0.31 Allowed Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 109.878 -1.289 . . . . 1.0 109.878 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -41.72 97.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.333 . . . . 1.0 110.176 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 10.3 mtm . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.477 179.889 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.783 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.893 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.525 ' N ' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.07 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.703 1.602 . . . . 1.0 111.856 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 127.36 92.1 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.276 -0.42 . . . . 1.0 109.876 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.664 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.5 Cg_endo -69.01 -20.03 38.89 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.458 2.106 . . . . 1.0 114.543 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.3 -38.67 77.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.702 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -10.55 59.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 1.0 110.55 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.664 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 4.2 m-30 -58.57 -46.36 87.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.307 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.56 -49.06 78.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.55 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.098 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.368 -0.975 . . . . 97.08 108.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.63 155.41 22.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.072 0.939 . . . . 123.41 110.739 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.52 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.51 1 N-CA-C 100.136 -4.024 . . . . 151.3 100.136 173.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.903 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.65 -38.6 58.39 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 115.981 -2.288 . . . . 169.25 106.145 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.903 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.27 168.51 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 122.273 0.617 . . . . 185.76 110.585 171.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.4 t -64.48 -25.9 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 C-N-CA 126.984 2.114 . . . . 145.47 110.336 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.4 21.51 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.088 -1.007 . . . . 102.76 109.453 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.58 154.17 25.13 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.014 -1.106 . . . . 106.25 108.014 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.87 51.87 0.74 Allowed 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.645 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.15 -45.9 91.5 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 103.619 -2.734 . . . . 150.2 103.619 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -86.98 164.7 35.38 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 103.711 -2.699 . . . . 183.52 103.711 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.79 6.87 3.85 Favored 'Trans proline' 0 C--N 1.281 -3.012 0 N-CA-C 109.948 -0.828 . . . . 235.61 109.948 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -57.97 -41.19 82.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.813 1.245 . . . . 113.77 113.375 -170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.19 136.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 119.555 1.071 . . . . 150.85 110.947 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.48 156.24 46.4 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.624 -1.25 . . . . 100.42 107.624 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.04 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.974 0.892 . . . . 129.36 110.445 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.11 -25.45 68.36 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.278 1.831 . . . . 112.34 106.67 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.19 -40.11 62.73 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.565 -0.743 . . . . 131.73 111.75 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.48 -42.86 15.15 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.95 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.825 0 C-N-CA 118.155 -1.418 . . . . 98.98 111.21 -169.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.5 Cg_exo -61.82 -10.8 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.917 1 N-CA-C 128.862 6.447 . . . . 246.95 128.862 -170.05 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.624 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.67 17.56 8.77 Favored 'General case' 0 C--N 1.324 -0.523 1 CA-C-N 126.19 4.086 . . . . 269.62 114.183 175.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.25 67.12 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.785 -1.191 . . . . 86.8 107.785 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.87 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.126 -0.984 . . . . 85.91 110.517 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 123.663 0.785 . . . . 82.0 111.388 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.7 12.55 Favored Pre-proline 0 CA--C 1.489 -1.378 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.9 149.75 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.881 . . . . 87.86 109.913 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.99 89.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.851 -0.796 . . . . 36.46 108.851 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.8 -33.83 76.54 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.4 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.296 -0.877 . . . . 123.26 108.645 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.53 -47.16 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.42 -31.01 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 107.845 -1.169 . . . . 112.19 107.845 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.12 84.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.899 -0.72 . . . . 60.87 109.622 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -65.99 -35.65 81.14 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 119.953 -0.699 . . . . 157.57 110.388 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.614 -0.884 . . . . 47.06 108.614 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.74 -41.32 98.05 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.743 -0.598 . . . . 43.94 109.573 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.35 99.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.717 -0.846 . . . . 42.61 108.717 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.9 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.34 -41.28 94.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.616 -0.266 . . . . 140.66 111.002 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.76 -43.97 97.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 118.596 -1.241 . . . . 116.04 110.236 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.75 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 N-CA-C 108.728 -0.842 . . . . 97.16 108.728 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -39.97 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 108.952 -0.759 . . . . 54.85 108.952 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.74 -42.36 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.835 -0.802 . . . . 45.39 108.835 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.1 t -63.54 -50.94 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 118.826 -1.15 . . . . 48.64 110.166 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.25 -47.07 78.04 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.14 -0.624 . . . . 116.65 111.703 -174.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.96 -43.92 97.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.683 -0.488 . . . . 51.16 109.683 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.58 -48.92 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 C-N-CA 119.85 -0.74 . . . . 44.3 110.834 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.78 -46.91 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 120.239 -0.585 . . . . 48.82 111.034 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.76 -44.14 95.23 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.474 -0.87 . . . . 58.7 112.016 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.64 -34.18 67.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 122.136 -0.626 . . . . 101.4 111.056 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.97 -38.64 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.45 -43.06 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.972 -0.751 . . . . 61.89 108.972 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.98 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 109.463 -0.569 . . . . 70.01 109.463 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.37 98.97 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.128 -0.693 . . . . 132.1 109.128 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.65 82.95 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.706 -0.225 . . . . 104.5 110.435 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.61 -49.91 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 120.233 -0.587 . . . . 142.96 111.303 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.946 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.68 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.926 -1.91 . . . . 158.32 110.893 -175.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.73 -41.39 98.05 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 117.71 -1.596 . . . . 137.11 109.496 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.55 91.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 122.089 -0.382 . . . . 54.66 110.997 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.44 117.17 29.45 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.646 0.736 . . . . 127.18 109.559 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.89 -36.74 80.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 124.039 0.935 . . . . 87.93 110.859 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.045 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.43 -34.62 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.65 -0.656 . . . . 131.12 111.482 -175.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.027 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.67 69.47 7.19 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 115.271 -2.571 . . . . 246.56 109.6 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.24 91.49 3.49 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 105.453 -2.055 . . . . 339.35 105.453 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.24 17.93 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 102.97 -2.974 . . . . 114.66 102.97 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.11 -39.5 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 106.754 -1.573 . . . . 143.28 106.754 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.7 m -59.67 -38.03 80.38 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.697 -0.853 . . . . 160.22 108.697 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.3 m-20 -62.35 -31.75 72.44 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.893 -0.78 . . . . 120.54 108.893 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.66 -43.74 95.85 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.482 -0.562 . . . . 67.22 109.482 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.54 -39.77 88.75 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.537 -0.727 . . . . 138.6 109.683 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.59 -35.9 82.03 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.449 0.3 . . . . 151.46 110.644 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.946 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.51 -38.02 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.719 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.1 -45.97 91.16 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.889 -1.152 . . . . 56.82 107.889 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.94 98.01 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.917 -0.771 . . . . 145.3 108.917 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.34 95.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.574 -0.898 . . . . 45.71 108.574 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.36 -42.04 99.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.387 -0.597 . . . . 105.61 109.387 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.47 92.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.668 -0.864 . . . . 47.89 108.668 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.34 84.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.976 -0.379 . . . . 124.53 109.976 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.19 99.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.944 -0.473 . . . . 35.89 109.807 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.26 -37.3 84.95 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.966 -1.494 . . . . 88.97 106.966 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.21 -49.11 77.06 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.809 -0.756 . . . . 239.91 109.064 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.36 90.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.522 -0.736 . . . . 146.1 110.611 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.4 1.97 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.764 1.765 . . . . 197.45 115.764 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.927 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.26 55.63 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 117.891 -1.524 . . . . 242.6 114.039 -170.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.37 -36.57 84.39 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.862 -1.135 . . . . 215.61 109.886 -172.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.25 -46.92 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 120.361 -0.536 . . . . 87.19 110.493 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.88 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 109.754 -0.461 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.9 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.1 75.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.349 -0.982 . . . . 364.98 108.349 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.23 -44.69 75.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.559 -0.713 . . . . 181.63 111.236 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 58.1 m -60.91 -45.76 93.33 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 107.409 -1.33 . . . . 269.02 107.409 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.78 -45.01 93.62 Favored 'General case' 0 CA--C 1.469 -2.146 0 C-N-CA 118.625 -1.23 . . . . 562.66 109.983 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.28 95.34 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.685 -1.206 . . . . 446.75 108.066 -167.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.48 -26.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.859 -2.336 . . . . 370.05 112.195 -178.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.49 60.04 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.552 -0.717 . . . . 354.91 112.478 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.3 m-20 82.76 4.45 1.01 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 125.048 1.339 . . . . 462.44 111.934 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.3 178.06 2.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.971 0.891 . . . . 652.37 111.168 171.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.7 86.35 2.16 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 128.473 2.709 . . . . 905.99 107.947 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -67.97 -36.36 79.93 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.203 -1.036 . . . . 570.43 108.203 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.37 82.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.345 1.458 . . . . 453.22 111.146 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.57 178.68 33.86 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.716 -1.707 . . . . 445.63 109.875 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.754 HD21 ' CE1' ' B' ' 371' ' ' PHE . 89.1 mt -56.45 -41.23 76.13 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.208 1.403 . . . . 457.72 112.374 -170.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.57 -47.02 85.66 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.69 -1.204 . . . . 340.58 109.266 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.68 -32.14 71.76 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.802 -1.159 . . . . 453.6 111.59 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.36 73.37 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 75.99 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.949 0.781 . . . . 466.68 110.873 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.75 -47.09 86.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.296 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.16 -36.76 82.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 112.365 0.506 . . . . 537.87 112.365 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.39 -42.68 74.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 116.882 -1.927 . . . . 422.12 111.604 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.8 t80 -59.04 -50.09 75.4 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 121.34 -0.85 . . . . 340.17 111.84 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -65.34 -46.48 70.82 Favored Pre-proline 0 N--CA 1.443 -0.776 0 C-N-CA 119.085 -1.046 . . . . 258.06 111.705 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.55 -31.57 87.43 Favored 'Trans proline' 0 N--CA 1.435 -1.954 0 N-CA-C 115.324 1.24 . . . . 305.71 115.324 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.702 -0.851 . . . . 252.7 108.702 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.66 93.93 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.776 -1.194 . . . . 149.27 107.776 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.85 95.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.661 -0.416 . . . . 138.08 111.509 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.92 -42.35 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 121.587 -0.696 . . . . 132.89 110.996 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.81 -44.66 92.63 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.84 -0.8 . . . . 193.61 108.84 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.69 84.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.846 0.458 . . . . 63.83 110.063 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -64.04 -52.41 59.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 122.068 -0.395 . . . . 76.4 111.228 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.63 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.188 -1.041 . . . . 171.13 108.188 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.58 91.63 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.82 -0.55 . . . . 78.3 110.599 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.74 80.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 118.886 -1.126 . . . . 92.36 109.217 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.26 76.45 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.199 -1.037 . . . . 93.73 108.199 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.48 -41.61 84.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.193 -1.003 . . . . 132.74 109.34 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.05 94.65 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.194 -1.41 . . . . 43.39 107.194 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.5 -41.97 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.593 -0.891 . . . . 59.34 108.593 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.43 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 121.781 -0.574 . . . . 69.68 110.491 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.48 -42.79 91.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.287 -1.005 . . . . 106.98 108.287 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.659 -0.817 . . . . 147.63 108.917 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.707 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.17 -41.54 99.25 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.549 -0.908 . . . . 190.06 108.549 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.08 97.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.306 -0.998 . . . . 118.85 108.306 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.3 -42.76 99.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.99 -0.374 . . . . 102.5 109.99 -177.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.61 95.34 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 121.875 -0.516 . . . . 89.98 109.853 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.52 -50.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 C-N-CA 118.151 -1.419 . . . . 106.09 111.003 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.746 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.32 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.847 -174.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.83 100.09 51.01 Favored Pre-proline 0 CA--C 1.486 -1.511 0 C-N-CA 116.261 -2.176 . . . . 262.55 110.047 -175.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.1 Cg_endo -69.65 -10.33 28.38 Favored 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 121.606 1.537 . . . . 210.25 111.332 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.521 -1.659 . . . . 270.58 106.521 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.8 -39.52 24.18 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-N 115.377 -0.829 . . . . 129.84 112.312 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.862 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.5 Cg_exo -61.36 -26.65 81.85 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 116.296 1.614 . . . . 330.71 116.296 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -80.99 77.16 7.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 114.502 -2.879 . . . . 204.51 107.3 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.35 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.431 -1.322 . . . . 387.41 107.431 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.65 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 118.761 -1.176 . . . . 166.22 109.461 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.821 -1.177 . . . . 44.23 107.821 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.28 -39.13 85.77 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.206 -1.035 . . . . 28.8 108.206 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.83 92.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.074 -0.714 . . . . 30.29 109.074 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.4 m -59.56 -43.06 93.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.016 -0.735 . . . . 46.11 109.016 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.1 99.25 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.683 -1.229 . . . . 87.33 107.683 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.68 -42.1 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.883 -1.155 . . . . 23.69 107.883 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.23 -44.31 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 109.649 -0.5 . . . . 43.86 109.649 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.59 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.352 -0.981 . . . . 91.13 108.352 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.53 -37.97 88.15 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.768 -0.827 . . . . 65.88 108.768 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.07 -41.96 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.536 -0.542 . . . . 33.86 109.536 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.34 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.595 -1.261 . . . . 146.52 107.595 -176.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.33 90.5 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.512 -0.875 . . . . 75.44 108.849 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.58 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 O-C-N 121.031 -1.043 . . . . 43.64 109.725 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.73 -37.95 89.26 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 109.027 -0.731 . . . . 102.57 109.027 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.09 87.01 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.383 -1.34 . . . . 58.16 107.383 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.03 -32.52 73.91 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.043 -0.725 . . . . 121.11 109.043 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.99 -42.37 84.97 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 118.586 -1.245 . . . . 153.15 109.895 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.1 -43.73 19.02 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 113.051 -3.46 . . . . 133.67 113.488 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.9 96.07 Favored 'General case' 0 CA--C 1.489 -1.402 0 O-C-N 120.893 -1.13 . . . . 157.42 112.226 -171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.521 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.09 2.44 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 115.037 1.495 . . . . 250.91 115.037 -173.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.6 Cg_exo -59.51 -25.47 78.82 Favored 'Trans proline' 0 CA--C 1.488 -1.816 0 N-CA-C 118.018 2.276 . . . . 207.34 118.018 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.012 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.15 -34.21 74.65 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.978 -1.49 . . . . 192.46 106.978 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.99 98.07 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 107.938 -2.065 . . . . 261.0 107.938 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.83 159.09 26.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 101.554 -3.499 . . . . 491.4 101.554 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 116.287 -2.165 . . . . 386.1 109.797 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 103.54 -2.763 . . . . 289.8 103.54 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.41 0.86 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.725 -1.131 . . . . 402.06 109.556 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 71.9 p -165.29 177.48 7.56 Favored 'General case' 0 CA--C 1.587 2.373 0 C-N-CA 127.323 2.249 . . . . 690.53 114.902 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.35 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.698 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.84 22.09 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 127.399 2.28 . . . . 617.99 110.916 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.99 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.246 3.419 . . . . 434.98 113.455 -175.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 122.397 3.96 . . . . 365.88 122.397 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.89 1.7 Allowed 'General case' 0 CA--C 1.467 -2.235 0 N-CA-C 104.83 -2.285 . . . . 635.81 104.83 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.21 18.83 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.975 7.768 . . . . 999.99 131.975 -135.735 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.909 36.9 t -131.85 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.73 1 CA-C-N 103.311 -6.313 . . . . 594.32 113.588 149.175 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.18 144.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.55 45.91 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.05 -1.86 . . . . 999.99 109.374 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.22 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.009 0.909 . . . . 431.86 110.038 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.039 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.14 148.64 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 124.351 1.06 . . . . 457.18 108.8 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.51 3.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.109 0.963 . . . . 458.77 113.486 -174.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.4 -31.54 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.928 1.291 . . . . 999.99 112.479 168.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.76 5.65 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 N-CA-C 120.865 3.371 . . . . 999.99 120.865 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.59 171.69 8.19 Favored 'General case' 0 CA--C 1.472 -2.032 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.274 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.518 -2.473 . . . . 999.99 108.767 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.55 101.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.167 1 C-N-CA 126.015 4.477 . . . . 999.99 105.716 -170.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.18 -44.02 97.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 126.786 2.034 . . . . 967.72 112.092 -165.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.57 78.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.711 -1.589 . . . . 934.3 106.711 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.26 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.212 3.005 . . . . 565.15 113.898 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.51 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 118.468 0.576 . . . . 755.61 109.863 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.28 67.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.557 1.143 . . . . 325.89 113.274 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.98 78.37 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 123.55 0.74 . . . . 250.21 111.64 -169.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.544 0.688 . . . . 142.46 110.38 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.039 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.14 -41.5 96.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.942 0.897 . . . . 247.69 108.832 -173.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.48 -51.35 69.85 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.467 1.507 . . . . 199.61 113.103 -175.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.36 -44.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 107.694 -1.225 . . . . 106.73 107.694 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.725 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.13 -48.48 81.46 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.88 -0.6 . . . . 115.01 110.251 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.28 -49.17 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 C-N-CA 119.433 -0.907 . . . . 129.42 111.801 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.9 -53.16 59.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 118.23 -1.388 . . . . 172.48 109.933 -172.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.83 -54.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 123.471 0.482 . . . . 55.86 110.982 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.95 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 118.551 -1.259 . . . . 184.68 111.509 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.04 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.41 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 116.67 -2.012 . . . . 291.81 114.715 -174.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -55.05 4.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.54 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.485 1.291 . . . . 80.16 114.485 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.897 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.48 83.22 Favored Pre-proline 0 N--CA 1.435 -1.198 0 C-N-CA 119.963 -0.695 . . . . 136.02 109.48 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.8 -27.11 59.7 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.707 0.574 . . . . 92.17 110.62 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.35 76.63 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.486 -1.302 . . . . 135.6 107.486 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.14 -44.72 91.33 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.603 -0.517 . . . . 52.1 109.603 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.68 -43.51 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.111 -0.7 . . . . 95.89 109.111 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.906 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.33 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.725 -1.583 . . . . 43.41 106.725 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.33 99.14 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.37 75.71 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 122.195 -0.591 . . . . 54.41 110.476 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.1 74.82 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.976 -1.49 . . . . 53.88 106.976 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.85 93.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.469 -0.937 . . . . 68.29 108.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.84 -39.01 92.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.672 -0.811 . . . . 107.59 110.604 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -62.95 -38.41 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.553 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.5 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.87 99.43 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.088 -0.805 . . . . 40.71 111.088 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.08 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.399 -0.963 . . . . 95.86 108.399 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.93 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.401 -0.962 . . . . 144.37 108.401 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.57 -1.27 . . . . 326.72 107.57 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.29 -168.03 1.5 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.072 -1.825 . . . . 158.38 106.072 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.458 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.96 98.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.659 -0.496 . . . . 36.78 109.659 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.12 125.84 25.2 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.17 -1.012 . . . . 85.46 109.808 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.47 8.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.53 -2.026 . . . . 127.78 105.53 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.96 139.87 34.96 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 106.023 -1.843 . . . . 164.84 106.023 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.6 Cg_exo -56.77 -39.97 87.57 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.935 0.706 . . . . 222.35 113.935 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.97 44.94 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 106.445 -2.662 . . . . 45.22 106.445 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.73 93.49 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.035 -1.839 . . . . 107.57 106.035 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.78 141.83 58.18 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.9 -1.12 . . . . 167.96 109.168 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.52 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 126.734 2.014 . . . . 280.68 109.706 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.04 11.23 0.7 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.443 1.097 . . . . 218.25 110.698 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.36 137.64 54.79 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.241 -2.133 . . . . 343.57 105.241 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.557 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.93 1.54 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.839 -1.541 . . . . 263.29 106.839 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.26 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 126.568 1.947 . . . . 261.92 108.522 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.19 -38.1 89.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.893 -1.151 . . . . 106.81 107.893 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.35 -1.34 . . . . 112.2 107.594 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.24 -39.87 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 N-CA-C 109.259 -0.645 . . . . 45.41 109.259 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.81 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.9 p -70.88 -32.05 68.91 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.313 -0.255 . . . . 97.62 110.313 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.62 81.66 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.684 0.794 . . . . 59.29 110.992 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.55 84.01 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.656 1.182 . . . . 106.49 110.683 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.63 69.2 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.32 -0.993 . . . . 106.62 108.32 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.02 -41.02 91.51 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.809 -0.557 . . . . 75.97 110.079 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.446 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.6 t -65.57 -40.8 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 122.908 0.483 . . . . 65.27 109.788 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.06 -41.56 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.154 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.58 -40.76 97.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 121.712 -0.618 . . . . 87.98 110.27 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.4 96.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 118.815 -1.154 . . . . 65.5 108.367 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.774 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.66 -36.41 80.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.162 -1.051 . . . . 85.05 108.162 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.6 mt -63.47 -45.77 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 109.053 -0.721 . . . . 42.25 109.053 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.26 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 119.542 -0.863 . . . . 91.01 109.419 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.86 -41.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.99 -1.115 . . . . 66.09 107.99 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.6 t -66.07 -43.15 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 120.758 -0.377 . . . . 52.39 110.293 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.7 m -61.8 -46.73 88.28 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.907 -0.496 . . . . 46.42 109.866 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.13 88.29 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.486 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.26 -48.23 82.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.402 -0.592 . . . . 65.18 109.402 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.7 97.2 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 120.824 0.345 . . . . 51.33 110.407 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.34 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 C-N-CA 118.941 -1.103 . . . . 126.3 109.015 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.64 -49.31 69.12 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.539 -0.864 . . . . 133.94 112.456 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.821 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.74 -33.32 35.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 116.826 2.158 . . . . 134.84 116.826 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.43 -41.64 90.37 Favored Pre-proline 0 CA--C 1.493 -1.237 0 CA-C-N 118.632 0.651 . . . . 72.23 111.644 -167.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.67 -35.98 87.07 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 CA-C-N 119.83 0.975 . . . . 106.13 111.375 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.35 -44.73 82.45 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 119.752 -0.779 . . . . 128.35 110.051 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.43 -37.85 88.98 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.174 -0.306 . . . . 100.73 110.174 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.3 -44.55 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 C-N-CA 119.274 -0.971 . . . . 172.72 109.123 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.57 -28.06 68.22 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.273 -1.01 . . . . 249.23 108.273 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.6 -55.11 35.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.644 -1.613 . . . . 259.78 106.644 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.11 -44.23 72.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.574 0.953 . . . . 233.11 113.574 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.9 mt -61.38 -48.29 91.41 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 119.162 -1.015 . . . . 169.54 110.596 -171.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.4 Cg_exo -61.12 -24.56 79.51 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 C-N-CA 116.771 -1.686 . . . . 255.47 114.655 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.54 -44.23 94.8 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.213 0.915 . . . . 279.03 108.929 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.79 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.073 -0.343 . . . . 162.21 110.073 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.83 59.38 Favored Pre-proline 0 N--CA 1.431 -1.399 0 C-N-CA 118.802 -1.159 . . . . 128.13 108.09 -178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.02 11.28 Favored 'Trans proline' 0 C--N 1.295 -2.264 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.07 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 123.829 0.705 . . . . 312.91 109.37 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.75 -170.64 2.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.534 -1.654 . . . . 353.54 106.534 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.7 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.01 -118.69 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.5 -45.0 96.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.837 -3.764 . . . . 99.07 100.837 172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.17 9.17 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.463 -2.791 . . . . 243.21 103.463 171.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.94 25.08 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 116.051 -2.259 . . . . 201.04 105.262 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.91 173.76 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 C-N-CA 115.954 -2.298 . . . . 201.36 108.781 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.281 0.6 OUTLIER -59.49 -41.45 89.84 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.248 -1.796 . . . . 203.82 107.905 174.44 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.21 -1.396 . . . . 215.06 112.562 -171.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.5 t -65.7 -46.4 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 118.529 -1.268 . . . . 125.28 112.928 -171.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.74 -37.07 86.36 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.191 -1.411 . . . . 268.9 107.191 -171.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.8 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.18 -45.0 74.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 125.6 1.56 . . . . 280.88 108.817 -172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.49 86.0 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.91 -1.116 . . . . 184.47 109.043 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.88 -42.13 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 119.284 -0.966 . . . . 167.92 112.785 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.86 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 117.772 -1.571 . . . . 367.18 110.765 -175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.17 -32.74 74.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 121.844 -0.535 . . . . 173.97 110.468 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.72 85.09 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.505 0.722 . . . . 119.66 109.78 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.821 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.95 74.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.686 -1.228 . . . . 112.3 107.686 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.08 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.263 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.75 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 124.7 1.2 . . . . 145.27 110.586 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.761 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.64 -35.36 70.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.095 -1.076 . . . . 170.15 108.095 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.32 -34.15 63.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 116.295 -0.411 . . . . 214.57 110.609 -171.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.19 -33.18 56.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.084 1.754 . . . . 168.29 115.566 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.49 -34.82 79.11 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.007 1.114 . . . . 167.15 114.007 -168.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.22 -38.26 32.86 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 115.512 -2.475 . . . . 165.13 113.937 -171.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.7 Cg_exo -62.55 -31.86 79.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.771 2.025 . . . . 123.92 111.236 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.75 -42.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 118.874 -1.131 . . . . 110.55 109.823 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.15 -40.04 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.86 -0.793 . . . . 145.31 108.86 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.2 m-85 -58.16 -48.82 79.1 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.371 -0.932 . . . . 246.68 109.81 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.18 -47.45 84.43 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.542 -0.863 . . . . 64.43 109.621 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.84 -45.07 79.36 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 118.968 -1.093 . . . . 80.72 110.223 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.02 1.859 . . . . 140.44 116.02 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.25 34.37 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 112.699 -3.6 . . . . 178.87 113.03 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.1 86.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.394 -1.275 . . . . 110.22 110.09 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.71 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.268 0 O-C-N 121.744 -0.598 . . . . 174.78 109.757 -174.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.84 -41.69 95.52 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.273 -1.01 . . . . 161.84 108.273 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.34 -50.23 73.61 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.179 -0.675 . . . . 117.2 109.179 -173.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.53 -44.08 75.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.384 -0.527 . . . . 112.6 111.056 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.41 94.54 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.647 -0.981 . . . . 101.46 110.647 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.023 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 91.0 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 118.54 1.17 . . . . 151.49 109.505 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.15 -36.28 77.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.94 -1.504 . . . . 142.32 106.94 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.81 -41.81 92.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.885 -1.524 . . . . 109.09 106.885 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.4 85.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.35 -0.219 . . . . 76.11 111.066 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.44 -55.48 30.78 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.888 -0.725 . . . . 120.24 109.305 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.52 41.22 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 102.942 -2.984 . . . . 192.73 102.942 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.22 92.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.048 -1.061 . . . . 176.29 109.185 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.13 0.82 Allowed Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 106.296 -1.742 . . . . 69.68 106.296 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.97 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-O 118.711 -0.62 . . . . 191.05 112.604 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.51 43.89 16.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.62 0.575 . . . . 287.03 109.753 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.54 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.94 0 C-N-CA 112.964 -3.494 . . . . 292.29 109.847 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.78 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.21 -2.515 . . . . 184.57 104.21 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.7 4.98 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.042 0.756 . . . . 274.56 113.042 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.83 57.25 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 117.737 -2.173 . . . . 268.24 113.47 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.68 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.68 1.24 . . . . 200.06 110.778 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.92 -33.0 74.72 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.858 -1.164 . . . . 114.44 107.858 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.0 21.97 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.65 -1.241 . . . . 263.81 107.65 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.37 -137.28 3.56 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.55 10.24 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 114.942 -2.703 . . . . 117.3 106.014 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.92 Favored 'General case' 0 CA--C 1.468 -2.19 1 N-CA-C 98.016 -4.809 . . . . 231.58 98.016 167.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.045 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.66 -48.57 78.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 116.047 -2.261 . . . . 112.72 108.39 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.61 1.24 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.124 -0.695 . . . . 83.22 109.124 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.5 m -156.29 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.791 -2.67 . . . . 174.36 103.791 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.88 160.98 8.75 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.027 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.93 149.02 52.56 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.1 -1.445 . . . . 180.62 107.1 176.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.5 -171.87 0.27 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 105.362 -2.088 . . . . 145.25 105.362 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.07 -43.11 88.36 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.192 -1.781 . . . . 66.05 106.192 174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.74 -152.17 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.482 -2.785 . . . . 266.49 103.482 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.697 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.36 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.024 -1.87 . . . . 219.2 107.757 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.98 -37.43 94.25 Favored Glycine 0 N--CA 1.426 -2.018 0 CA-C-N 114.52 -1.218 . . . . 94.78 112.885 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.2 100.45 9.11 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 112.321 -3.752 . . . . 121.41 109.41 -171.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.7 t -73.08 145.5 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.957 -0.757 . . . . 85.34 108.957 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.819 -1.178 . . . . 267.57 107.819 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.06 69.56 0.6 Allowed 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.524 -0.547 . . . . 226.1 109.524 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.98 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.31 161.93 8.42 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.626 0.727 . . . . 180.01 110.681 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.97 23.51 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.97 -1.492 . . . . 333.78 106.97 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.972 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.08 142.54 48.79 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.347 -1.353 . . . . 335.2 107.347 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.972 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.8 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.744 -0.836 . . . . 266.47 108.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.3 m -60.62 -46.94 88.38 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.64 -1.985 . . . . 59.34 105.64 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.84 12.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 104.442 -2.429 . . . . 201.26 104.442 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.93 106.71 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 C-N-CA 116.347 -2.141 . . . . 56.23 105.505 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 71.0 m -61.14 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.316 -0.624 . . . . 87.58 109.316 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.75 22.28 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.813 -1.18 . . . . 219.95 107.813 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 C-N-CA 116.372 -2.131 . . . . 121.79 105.423 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.4 t -154.13 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 105.835 -1.913 . . . . 53.85 105.835 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.034 -2.826 . . . . 196.55 106.034 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.677 0 N-CA-C 107.832 -1.173 . . . . 35.88 107.832 -178.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.61 ' NH2' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -67.09 144.06 67.92 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.663 1.575 . . . . 1.0 111.833 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' B' ' 367' ' ' LYS . 0.1 OUTLIER -70.4 127.36 92.18 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.22 -0.446 . . . . 1.0 109.905 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.8 Cg_endo -69.04 -20.02 38.77 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.428 2.085 . . . . 1.0 114.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.28 -38.68 77.48 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.725 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -71.36 -10.44 59.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 1.0 110.604 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.754 ' CE1' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -58.63 -46.28 87.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 1.0 110.323 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -61.65 -49.03 78.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.551 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.07 0 N-CA-C 109.819 -1.313 . . . . 1.0 109.819 179.821 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.38 -0.97 . . . . 97.08 108.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.6 155.4 22.41 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.085 0.945 . . . . 123.41 110.774 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.88 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.57 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.461 1 N-CA-C 100.064 -4.051 . . . . 151.3 100.064 173.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.58 58.35 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 115.952 -2.299 . . . . 169.25 106.148 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.29 168.52 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 122.301 0.632 . . . . 185.76 110.568 171.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.5 t -64.44 -25.96 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 127.042 2.137 . . . . 145.47 110.342 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.44 21.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.058 -1.027 . . . . 102.76 109.445 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.68 154.16 25.0 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.937 -1.134 . . . . 106.25 107.937 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.83 51.84 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.754 -1.578 . . . . 157.81 107.663 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.15 -45.9 91.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.553 -2.758 . . . . 150.2 103.553 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.67 35.33 Favored Pre-proline 0 N--CA 1.422 -1.852 0 N-CA-C 103.669 -2.715 . . . . 183.52 103.669 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.71 6.87 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 N-CA-C 110.014 -0.802 . . . . 235.61 110.014 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.99 -41.16 82.44 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 124.749 1.22 . . . . 113.77 113.409 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.21 136.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 119.564 1.075 . . . . 150.85 110.973 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.487 ' HA ' HH12 ' B' ' 365' ' ' ARG . 47.7 t -140.5 156.28 46.38 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.59 -1.263 . . . . 100.42 107.59 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.93 0.871 . . . . 129.36 110.444 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.326 1.85 . . . . 112.34 106.663 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.2 m -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.618 -0.719 . . . . 131.73 111.739 177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.0 m -84.48 -42.85 15.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 116.984 2.216 . . . . 80.49 116.984 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -146.01 174.54 3.35 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 118.154 -1.418 . . . . 98.98 111.21 -169.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.8 Cg_exo -61.8 -10.74 18.09 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.953 6.482 . . . . 246.95 128.953 -170.103 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.624 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.66 17.49 8.7 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.112 4.051 . . . . 269.62 114.229 175.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.27 67.2 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.797 -1.186 . . . . 86.8 107.797 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.79 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.113 -0.992 . . . . 85.91 110.502 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.2 t -68.5 -40.23 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.718 0.807 . . . . 82.0 111.371 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.385 0 N-CA-C 108.522 -0.918 . . . . 120.73 108.522 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.905 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.03 149.75 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.882 . . . . 87.86 109.861 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.96 89.27 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.812 -0.81 . . . . 36.46 108.812 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.76 -33.87 76.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.87 -1.159 . . . . 150.6 107.87 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.2 -32.75 73.44 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 121.255 -0.903 . . . . 123.26 108.661 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.39 -47.21 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.95 -47.12 84.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.951 -0.7 . . . . 60.87 109.608 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.06 -35.63 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 120.004 -0.678 . . . . 157.57 110.361 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.67 -40.85 98.37 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.633 -0.877 . . . . 47.06 108.633 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.25 97.94 Favored 'General case' 0 CA--C 1.496 -1.12 0 O-C-N 121.721 -0.612 . . . . 43.94 109.544 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.29 99.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.29 93.91 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 122.25 -0.281 . . . . 140.66 110.996 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.75 -44.02 97.72 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.605 -1.238 . . . . 116.04 110.22 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.38 -38.81 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.759 -0.83 . . . . 97.16 108.759 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -40.03 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.978 -0.749 . . . . 54.85 108.978 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 93.2 t -57.65 -42.37 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.91 -0.774 . . . . 45.39 108.91 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.4 t -63.48 -50.99 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 C-N-CA 118.819 -1.152 . . . . 48.64 110.203 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.25 -47.03 78.17 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.167 -0.613 . . . . 116.65 111.73 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.95 -43.96 97.74 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.701 -0.481 . . . . 51.16 109.701 -174.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.58 -48.9 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 119.829 -0.748 . . . . 44.3 110.854 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.74 -46.97 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 120.299 -0.561 . . . . 48.82 111.027 -174.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.2 95.18 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.561 -0.828 . . . . 58.7 111.994 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.61 -34.26 67.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.018 -0.695 . . . . 101.4 111.039 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.89 -38.72 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 107.757 -1.201 . . . . 103.57 107.757 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.45 -43.01 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.977 -0.749 . . . . 61.89 108.977 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.43 -50.93 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.303 -0.559 . . . . 70.01 109.525 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.809 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.43 98.81 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.108 -0.701 . . . . 132.1 109.108 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.62 83.08 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.649 -0.251 . . . . 104.5 110.443 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.022 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 C-N-CA 120.213 -0.595 . . . . 142.96 111.253 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.7 pt -64.82 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.957 -1.897 . . . . 158.32 110.838 -175.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.809 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.71 -41.4 98.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 117.698 -1.601 . . . . 137.11 109.5 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.52 91.14 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.156 -0.34 . . . . 54.66 111.015 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.612 0.72 . . . . 127.18 109.577 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.79 -36.86 80.08 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.102 0.961 . . . . 87.93 110.859 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.042 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.69 78.75 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.69 -0.631 . . . . 131.12 111.514 -175.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.52 7.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.294 -2.562 . . . . 246.56 109.598 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 105.475 -2.046 . . . . 339.35 105.475 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.14 165.3 17.79 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.19 -39.4 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.766 -1.568 . . . . 143.28 106.766 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.72 -38.04 80.56 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.67 -0.863 . . . . 160.22 108.67 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.2 m-20 -62.4 -31.78 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.823 -0.806 . . . . 120.54 108.823 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.57 -43.8 95.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.466 -0.568 . . . . 67.22 109.466 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.59 -39.78 88.59 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.505 -0.747 . . . . 138.6 109.623 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.918 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.53 -35.89 81.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.468 0.307 . . . . 151.46 110.679 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.6 -37.89 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.724 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.448 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.96 91.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.855 -1.165 . . . . 56.82 107.855 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.017 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.937 -0.764 . . . . 145.3 108.937 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.38 95.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.495 -0.928 . . . . 45.71 108.495 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.37 -42.04 99.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.364 -0.606 . . . . 105.61 109.364 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 -39.54 92.78 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.611 -0.885 . . . . 47.89 108.611 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.37 84.84 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.953 -0.388 . . . . 124.53 109.953 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.24 99.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.968 -0.458 . . . . 35.89 109.838 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.29 -37.28 84.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.022 -1.473 . . . . 88.97 107.022 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.822 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.16 76.96 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.086 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.4 -43.41 90.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.511 -0.743 . . . . 146.1 110.591 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 117.423 -1.711 . . . . 91.74 113.829 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.47 1.95 Allowed 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 115.719 1.748 . . . . 197.45 115.719 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.932 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.23 -42.2 55.88 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 117.866 -1.534 . . . . 242.6 114.073 -170.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.48 -36.5 84.04 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.919 -1.113 . . . . 215.61 109.797 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 73.0 t -60.36 -46.95 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 O-C-N 121.782 -0.574 . . . . 87.19 110.399 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.89 -41.84 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 O-C-N 121.942 -0.474 . . . . 231.82 109.776 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.39 -34.12 76.09 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.306 -0.998 . . . . 364.98 108.306 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.2 -44.74 75.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.533 -0.729 . . . . 181.63 111.228 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.3 m -60.8 -45.81 92.95 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 107.468 -1.308 . . . . 269.02 107.468 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.07 93.25 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 118.679 -1.209 . . . . 562.66 110.004 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.22 95.59 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 118.634 -1.226 . . . . 446.75 108.103 -167.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.46 -26.35 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.875 -2.33 . . . . 370.05 112.197 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.814 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.51 60.06 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.565 -0.71 . . . . 354.91 112.491 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.49 0.98 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.047 1.339 . . . . 462.44 111.868 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.9 mm-40 -172.35 178.09 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.009 0.909 . . . . 652.37 111.129 171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.78 86.31 2.2 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 128.492 2.717 . . . . 905.99 107.906 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.83 -36.45 80.38 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.261 -1.014 . . . . 570.43 108.261 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.34 82.36 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 125.331 1.453 . . . . 453.22 111.129 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.48 178.65 33.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.939 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.91 HD21 ' NZ ' ' B' ' 367' ' ' LYS . 89.0 mt -56.4 -41.21 75.92 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 125.274 1.43 . . . . 457.72 112.38 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.02 Favored 'General case' 0 CA--C 1.484 -1.569 0 C-N-CA 118.678 -1.209 . . . . 340.58 109.335 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.66 -32.23 71.92 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 118.819 -1.152 . . . . 453.6 111.544 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.3 73.26 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.013 -1.847 . . . . 541.48 106.013 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.21 75.83 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 123.972 0.795 . . . . 466.68 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.72 -47.09 86.85 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 117.527 -1.669 . . . . 427.34 107.306 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.82 82.77 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 112.402 0.519 . . . . 537.87 112.402 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.33 -42.73 74.93 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 116.845 -1.942 . . . . 422.12 111.576 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.15 75.18 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.314 -0.866 . . . . 340.17 111.84 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.27 -46.49 71.52 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.084 -1.047 . . . . 258.06 111.75 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.53 -31.56 87.52 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 N-CA-C 115.323 1.24 . . . . 305.71 115.323 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.712 -0.848 . . . . 252.7 108.712 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.56 93.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.8 -1.185 . . . . 149.27 107.8 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.05 -44.78 95.95 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 120.632 -0.427 . . . . 138.08 111.506 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.93 -42.42 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.523 -0.735 . . . . 132.89 110.966 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.71 -44.68 92.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.749 -0.78 . . . . 193.61 108.925 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.7 84.55 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 122.838 0.455 . . . . 63.83 110.079 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.98 -52.4 59.81 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.057 -0.402 . . . . 76.4 111.233 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.68 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.166 -1.05 . . . . 171.13 108.166 -174.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.82 -38.52 91.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 121.889 -0.507 . . . . 78.3 110.612 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.13 -35.71 80.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.897 -1.121 . . . . 92.36 109.231 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 1.017 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.51 -34.31 76.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.131 -1.062 . . . . 93.73 108.131 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.908 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.39 -41.65 84.63 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.248 -0.981 . . . . 132.74 109.346 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.1 94.86 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.17 -1.419 . . . . 43.39 107.17 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.826 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.9 t -58.43 -42.03 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.59 -0.893 . . . . 59.34 108.59 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.04 95.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 121.838 -0.539 . . . . 69.68 110.523 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.46 -42.77 91.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.333 -0.988 . . . . 106.98 108.333 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.826 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.58 81.36 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 119.712 -0.795 . . . . 147.63 108.928 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.56 99.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.514 -0.921 . . . . 190.06 108.514 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.32 -44.04 97.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.313 -0.995 . . . . 118.85 108.313 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.808 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.68 98.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.64 95.28 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 121.827 -0.546 . . . . 89.98 109.86 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.72 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 C-N-CA 118.098 -1.441 . . . . 106.09 111.035 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.29 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.062 -1.855 . . . . 227.74 111.799 -174.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.89 100.06 50.94 Favored Pre-proline 0 CA--C 1.486 -1.515 0 C-N-CA 116.237 -2.185 . . . . 262.55 110.05 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.57 -10.42 28.66 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.678 1.586 . . . . 210.25 111.341 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.03 1.0 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 106.556 -1.646 . . . . 270.58 106.556 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.893 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.49 23.54 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 115.382 -0.826 . . . . 129.84 112.325 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.38 -26.59 81.68 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 N-CA-C 116.31 1.619 . . . . 330.71 116.31 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 114.467 -2.893 . . . . 204.51 107.289 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.415 -1.328 . . . . 387.41 107.415 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.73 147.04 33.64 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 118.729 -1.188 . . . . 166.22 109.446 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.73 87.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.841 -1.17 . . . . 44.23 107.841 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.0 m -60.29 -39.11 85.76 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.2 -1.037 . . . . 28.8 108.2 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.73 92.0 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.103 -0.702 . . . . 30.29 109.103 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.65 -42.99 94.03 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.981 -0.748 . . . . 46.11 108.981 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -42.11 99.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.671 -1.233 . . . . 87.33 107.671 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.67 -42.07 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.916 -1.142 . . . . 23.69 107.916 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.21 -44.31 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.625 -0.509 . . . . 43.86 109.625 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.55 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.263 -1.014 . . . . 91.13 108.263 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.58 -37.98 88.32 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.72 -0.844 . . . . 65.88 108.72 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.86 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.52 -0.548 . . . . 33.86 109.52 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.35 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.556 -1.275 . . . . 146.52 107.556 -176.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.84 -38.35 90.41 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.475 -0.89 . . . . 75.44 108.878 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.4 t -60.58 -48.4 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.063 -1.023 . . . . 43.64 109.72 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.795 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -37.95 89.29 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.096 -0.705 . . . . 102.57 109.096 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.08 86.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.403 -1.332 . . . . 58.16 107.403 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.53 73.93 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.989 -0.745 . . . . 121.11 108.989 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.03 -42.26 84.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 C-N-CA 118.55 -1.26 . . . . 153.15 109.948 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.05 -43.76 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 113.09 -3.444 . . . . 133.67 113.533 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.899 -1.126 . . . . 157.42 112.167 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.12 2.45 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 115.011 1.485 . . . . 250.91 115.011 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.5 Cg_exo -59.54 -25.42 78.7 Favored 'Trans proline' 0 CA--C 1.488 -1.81 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.01 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.19 -34.21 74.71 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.915 -1.513 . . . . 192.46 106.915 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.02 98.1 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 108.033 -2.027 . . . . 261.0 108.033 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.77 159.13 25.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.529 -3.508 . . . . 491.4 101.529 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 116.278 -2.169 . . . . 386.1 109.819 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.08 -166.61 2.41 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 103.511 -2.774 . . . . 289.8 103.511 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.137 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 117.745 -1.121 . . . . 402.06 109.534 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.5 p -165.3 177.54 7.51 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.314 2.246 . . . . 690.53 114.94 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.181 4.511 . . . . 633.62 123.181 162.742 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.58 153.79 22.17 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.415 2.286 . . . . 617.99 110.918 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.67 174.39 6.01 Favored Pre-proline 0 C--N 1.364 1.222 0 C-N-CA 130.255 3.422 . . . . 434.98 113.417 -175.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 N-CA-C 122.408 3.965 . . . . 365.88 122.408 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.7 m -84.88 20.92 1.7 Allowed 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.791 -2.3 . . . . 635.81 104.791 178.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.36 152.27 18.77 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.934 7.753 . . . . 999.99 131.934 -135.746 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.85 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.747 1 CA-C-N 103.264 -6.335 . . . . 594.32 113.573 149.195 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.21 144.07 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 1 N-CA-C 98.337 -4.69 . . . . 811.91 98.337 162.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.47 144.55 45.92 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.074 -1.851 . . . . 999.99 109.419 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.972 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.24 -175.65 4.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.007 0.908 . . . . 431.86 110.018 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.12 148.68 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 124.384 1.074 . . . . 457.18 108.758 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.49 3.77 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 124.071 0.948 . . . . 458.77 113.506 -174.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.38 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.9 1.28 . . . . 999.99 112.424 168.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.78 5.63 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 120.84 3.362 . . . . 999.99 120.84 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.164 -1.814 . . . . 81.18 107.248 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.12 45.12 0.19 Allowed Pre-proline 0 N--CA 1.423 -1.817 0 CA-C-O 114.866 -2.492 . . . . 999.99 108.748 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.52 101.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.141 1 C-N-CA 126.051 4.501 . . . . 999.99 105.7 -170.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.03 97.47 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 126.748 2.019 . . . . 967.72 112.045 -165.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.5 77.99 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.779 -1.563 . . . . 934.3 106.779 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.27 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 129.196 2.998 . . . . 565.15 113.938 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.55 55.4 2.79 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 118.423 0.556 . . . . 755.61 109.849 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.137 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.48 -49.35 66.9 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.59 1.156 . . . . 325.89 113.203 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.94 78.32 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 123.557 0.743 . . . . 250.21 111.61 -169.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.81 -43.28 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.552 0.691 . . . . 142.46 110.375 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.1 -41.56 96.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 123.983 0.913 . . . . 247.69 108.806 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.5 -51.34 69.85 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.453 1.501 . . . . 199.61 113.086 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.35 -44.45 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.754 -1.202 . . . . 106.73 107.754 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.14 -48.53 81.28 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.832 -0.622 . . . . 115.01 110.241 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.25 -49.2 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.431 -0.908 . . . . 129.42 111.811 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.3 m -61.79 -53.18 59.38 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.223 -1.391 . . . . 172.48 109.969 -172.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.6 t -63.9 -54.19 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 120.489 -0.484 . . . . 55.86 110.987 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.62 -51.52 58.98 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.513 -1.275 . . . . 184.68 111.501 -174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.64 -52.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.635 -2.026 . . . . 291.81 114.695 -174.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 115.153 1.538 . . . . 130.66 115.153 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.9 -48.46 68.66 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.493 1.294 . . . . 80.16 114.493 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.53 83.3 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.483 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.4 Cg_exo -64.79 -27.11 59.75 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.617 -0.57 . . . . 92.17 110.617 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.36 76.62 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.478 -1.304 . . . . 135.6 107.478 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.63 91.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.61 -0.515 . . . . 52.1 109.61 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.72 -43.51 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.056 -0.72 . . . . 95.89 109.056 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.908 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.31 -42.33 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.655 -1.609 . . . . 43.41 106.655 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.22 99.06 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.338 -1.505 . . . . 27.69 109.338 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.888 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.76 -47.35 75.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 117.411 0.605 . . . . 54.41 110.423 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 107.005 -1.479 . . . . 53.88 107.005 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.71 -40.83 93.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.517 -0.92 . . . . 68.29 108.517 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -39.04 92.94 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 119.71 -0.796 . . . . 107.59 110.634 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.41 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.514 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.3 -22.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.414 -0.958 . . . . 85.26 108.414 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.91 99.43 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.089 -0.804 . . . . 40.71 111.089 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.7 -44.12 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 108.386 -0.968 . . . . 95.86 108.386 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.89 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.445 -0.946 . . . . 144.37 108.445 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.38 132.15 47.48 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.025 -1.843 . . . . 158.38 106.025 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.85 98.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.676 -0.49 . . . . 36.78 109.676 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.14 125.8 25.05 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.15 -1.02 . . . . 85.46 109.812 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.539 -2.023 . . . . 127.78 105.539 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.89 34.77 Favored Pre-proline 0 CA--C 1.493 -1.233 0 N-CA-C 105.929 -1.878 . . . . 164.84 105.929 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.7 Cg_exo -56.82 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.189 0 N-CA-C 113.926 0.702 . . . . 222.35 113.926 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.1 166.95 44.94 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 106.435 -2.666 . . . . 45.22 106.435 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.9 -45.81 93.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.058 -1.83 . . . . 107.57 106.058 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.4 m -65.73 141.77 58.23 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 118.924 -1.11 . . . . 167.96 109.151 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.56 106.71 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.67 1.988 . . . . 280.68 109.71 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.98 11.31 0.7 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.455 1.102 . . . . 218.25 110.694 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.58 54.78 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.234 -2.135 . . . . 343.57 105.234 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.89 1.53 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.868 -1.53 . . . . 263.29 106.868 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.35 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 126.565 1.946 . . . . 261.92 108.484 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.1 89.83 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.891 -1.151 . . . . 106.81 107.891 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.391 -1.324 . . . . 112.2 107.531 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.735 HG12 ' NH1' ' A' ' 244' ' ' ARG . 76.0 t -64.36 -39.77 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 109.247 -0.649 . . . . 45.41 109.247 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.07 68.91 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.28 -0.267 . . . . 97.62 110.28 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.6 81.71 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.691 0.796 . . . . 59.29 110.976 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.26 -36.49 83.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.624 1.17 . . . . 106.49 110.668 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.68 69.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.302 -0.999 . . . . 106.62 108.302 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.08 91.62 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 121.87 -0.518 . . . . 75.97 110.039 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.52 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 C-N-CA 122.909 0.484 . . . . 65.27 109.802 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.95 -41.64 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 C-N-CA 120.391 -0.524 . . . . 107.94 110.174 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.49 -40.82 98.09 Favored 'General case' 0 N--CA 1.434 -1.235 0 O-C-N 121.649 -0.657 . . . . 87.98 110.3 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.62 -40.4 96.81 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.794 -1.162 . . . . 65.5 108.378 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.127 -1.064 . . . . 85.05 108.127 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.5 -45.72 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 109.076 -0.712 . . . . 42.25 109.076 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.31 -38.3 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.55 -0.86 . . . . 91.01 109.378 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.003 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.0 t -58.89 -41.54 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.96 -1.126 . . . . 66.09 107.96 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.23 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 O-C-N 122.108 -0.37 . . . . 52.39 110.324 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.77 88.2 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 121.883 -0.511 . . . . 46.42 109.856 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.742 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.35 -38.12 88.28 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.311 -0.996 . . . . 116.51 108.311 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.26 -48.22 82.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.384 -0.599 . . . . 65.18 109.384 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.67 97.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 122.118 -0.364 . . . . 51.33 110.432 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.32 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 C-N-CA 118.91 -1.116 . . . . 126.3 109.016 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.31 69.25 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.476 -0.889 . . . . 133.94 112.491 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.67 -33.43 35.54 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.853 2.168 . . . . 134.84 116.853 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.41 -41.61 90.22 Favored Pre-proline 0 CA--C 1.493 -1.236 0 O-C-N 121.671 -0.643 . . . . 72.23 111.647 -167.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.2 Cg_exo -60.66 -35.98 87.15 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 CA-C-N 119.887 0.995 . . . . 106.13 111.334 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.7 82.21 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.728 -0.789 . . . . 128.35 110.027 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.639 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.8 88.79 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.24 -0.281 . . . . 100.73 110.24 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.55 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 119.285 -0.966 . . . . 172.72 109.137 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.59 -28.07 68.22 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.195 -1.039 . . . . 249.23 108.195 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.58 -55.1 35.96 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.667 -1.605 . . . . 259.78 106.667 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.2 -44.15 72.7 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.568 0.951 . . . . 233.11 113.568 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.839 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.29 91.35 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 119.182 -1.007 . . . . 169.54 110.588 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.07 -24.59 79.72 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.707 -1.728 . . . . 255.47 114.708 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.57 -44.22 94.72 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 119.189 0.904 . . . . 279.03 108.899 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.29 -44.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.782 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.87 59.36 Favored Pre-proline 0 N--CA 1.431 -1.394 0 C-N-CA 118.712 -1.195 . . . . 128.13 108.028 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.28 164.04 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.274 0 N-CA-C 107.443 -1.791 . . . . 278.35 107.443 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.12 15.03 9.93 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 123.756 0.66 . . . . 312.91 109.343 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.7 -170.65 2.48 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.506 -1.664 . . . . 353.54 106.506 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.28 46.95 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.069 -3.308 . . . . 175.26 102.069 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.96 96.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 100.894 -3.743 . . . . 99.07 100.894 172.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.46 124.16 9.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.455 -2.794 . . . . 243.21 103.455 171.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.99 112.97 25.11 Favored 'General case' 0 CA--C 1.473 -2.0 0 C-N-CA 115.992 -2.283 . . . . 201.04 105.316 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 C-N-CA 116.02 -2.272 . . . . 201.36 108.82 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.52 -41.44 89.98 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.834 174.516 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.92 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.77 86.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 118.213 -1.395 . . . . 215.06 112.538 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.61 -46.47 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.607 -1.237 . . . . 125.28 112.917 -171.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -36.94 85.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.229 -1.397 . . . . 268.9 107.229 -171.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.29 -44.97 74.32 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.617 1.567 . . . . 280.88 108.792 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.48 86.06 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.004 -1.078 . . . . 184.47 108.958 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.99 -42.09 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 119.285 -0.966 . . . . 167.92 112.709 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.81 90.18 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 117.792 -1.563 . . . . 367.18 110.734 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.2 -32.7 73.95 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.824 -0.547 . . . . 173.97 110.402 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.52 -36.73 85.14 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.559 0.744 . . . . 119.66 109.797 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.21 -34.0 74.39 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.703 -1.221 . . . . 112.3 107.703 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.08 73.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.228 -0.442 . . . . 174.17 110.235 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.6 m -64.7 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 124.685 1.194 . . . . 145.27 110.627 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.62 -35.4 70.41 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.093 -1.077 . . . . 170.15 108.093 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.822 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.26 -34.17 63.81 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 122.721 0.408 . . . . 214.57 110.63 -171.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.21 -33.2 56.29 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.022 1.729 . . . . 168.29 115.548 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.35 -34.9 79.22 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 114.096 1.147 . . . . 167.15 114.096 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.18 -38.32 33.67 Favored Pre-proline 0 N--CA 1.434 -1.234 0 C-N-CA 115.485 -2.486 . . . . 165.13 113.931 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.57 -31.81 79.82 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 CA-C-N 122.809 2.039 . . . . 123.92 111.231 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.77 -42.54 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.845 -1.142 . . . . 110.55 109.807 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.003 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.16 -39.99 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.849 -0.797 . . . . 145.31 108.849 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.918 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.08 -48.88 78.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.447 -0.901 . . . . 246.68 109.789 -177.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.18 -47.48 84.29 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.524 -0.87 . . . . 64.43 109.565 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.06 79.34 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.2 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.72 75.91 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 116.022 1.86 . . . . 140.44 116.022 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.79 132.24 34.45 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 112.71 -3.596 . . . . 178.87 113.031 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.35 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.358 -1.292 . . . . 110.22 110.112 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.71 -50.61 72.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 121.74 -0.6 . . . . 174.78 109.756 -174.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.95 -41.63 95.32 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.31 -50.23 73.59 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.011 -0.676 . . . . 117.2 109.214 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.08 75.54 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.375 -0.53 . . . . 112.6 111.113 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.11 -37.44 94.57 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.596 -1.002 . . . . 101.46 110.596 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.022 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.13 -45.98 91.05 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 118.485 1.143 . . . . 151.49 109.541 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.13 -36.31 77.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.931 -1.507 . . . . 142.32 106.931 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.72 -41.9 91.9 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.46 85.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 122.309 -0.244 . . . . 76.11 111.019 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -55.51 30.77 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.374 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.29 131.5 41.23 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.94 -2.985 . . . . 192.73 102.94 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.18 92.14 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.192 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.8 m -79.4 -177.1 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.464 0 N-CA-C 106.332 -1.729 . . . . 69.68 106.332 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -58.97 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 118.368 -0.621 . . . . 191.05 112.583 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.54 43.87 16.43 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 123.562 0.539 . . . . 287.03 109.756 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.5 78.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 112.977 -3.489 . . . . 292.29 109.847 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.41 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 104.195 -2.52 . . . . 184.57 104.195 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.69 4.94 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 113.038 0.755 . . . . 274.56 113.038 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.92 57.3 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 117.69 -2.195 . . . . 268.24 113.487 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.5 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.641 1.221 . . . . 200.06 110.788 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.1 21.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.593 -1.262 . . . . 263.81 107.593 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.37 3.61 Favored Glycine 0 CA--C 1.479 -2.206 1 N-CA-C 102.518 -4.233 . . . . 103.79 102.518 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.054 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.29 95.64 10.26 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 114.914 -2.715 . . . . 117.3 106.016 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.93 -39.82 90.84 Favored 'General case' 0 CA--C 1.468 -2.179 1 N-CA-C 97.989 -4.819 . . . . 231.58 97.989 167.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.042 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.45 29.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.097 -3.297 . . . . 303.24 102.097 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.054 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.62 78.64 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 116.022 -2.271 . . . . 112.72 108.391 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.71 1.2 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.095 -0.706 . . . . 83.22 109.095 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.7 m -156.24 -126.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.86 -2.644 . . . . 174.36 103.86 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.9 160.97 8.81 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.787 -1.931 . . . . 202.73 105.787 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.093 -1.447 . . . . 180.62 107.093 176.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.52 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 105.356 -2.09 . . . . 145.25 105.356 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.05 -43.17 88.27 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.171 -1.789 . . . . 66.05 106.171 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.69 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.536 -2.764 . . . . 266.49 103.536 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.31 -124.96 0.28 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.793 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.38 94.15 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.552 -1.204 . . . . 94.78 112.877 -176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.19 100.41 9.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.324 -3.751 . . . . 121.41 109.469 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.01 145.49 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 108.948 -0.76 . . . . 85.34 108.948 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.47 41.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.518 -0.549 . . . . 226.1 109.518 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.6 p -50.93 156.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.997 -1.483 . . . . 154.84 106.997 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.58 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.36 161.94 8.53 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.627 0.727 . . . . 180.01 110.679 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.898 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.44 156.91 23.66 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.964 -1.495 . . . . 333.78 106.964 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.48 48.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.4 mm-40 82.85 158.84 0.13 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.739 -0.838 . . . . 266.47 108.739 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.53 -46.93 88.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.674 -1.972 . . . . 59.34 105.674 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.6 173.83 11.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.415 -2.439 . . . . 201.26 104.415 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.0 mt -95.87 106.68 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 116.322 -2.151 . . . . 56.23 105.562 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.11 -59.46 5.3 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.309 -0.626 . . . . 87.58 109.309 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.893 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.53 153.74 22.24 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 107.841 -1.17 . . . . 219.95 107.841 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.04 83.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.435 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 105.86 -1.904 . . . . 53.85 105.86 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.58 77.09 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 106.067 -2.813 . . . . 196.55 106.067 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.683 0 N-CA-C 107.848 -1.167 . . . . 35.88 107.848 -178.866 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.487 HH12 ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.04 144.09 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.67 1.58 . . . . 1.0 111.831 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.91 ' NZ ' HD21 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -70.52 127.39 92.07 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.248 -0.433 . . . . 1.0 109.864 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.4 Cg_endo -69.09 -19.96 38.61 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.496 2.13 . . . . 1.0 114.504 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.512 ' HB3' ' HD2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -58.31 -38.66 77.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.789 -178.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -71.28 -10.48 59.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.812 0.339 . . . . 1.0 110.578 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.811 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.66 -46.34 87.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.28 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -49.03 78.29 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.596 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.113 0 N-CA-C 109.764 -1.334 . . . . 1.0 109.764 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.365 -0.976 . . . . 97.08 108.365 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.088 0.946 . . . . 123.41 110.766 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.888 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.62 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.513 1 N-CA-C 100.056 -4.053 . . . . 151.3 100.056 173.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.904 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.57 58.05 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.939 -2.305 . . . . 169.25 106.139 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.27 0.616 . . . . 185.76 110.53 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.5 -25.86 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.988 2.115 . . . . 145.47 110.383 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.77 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.38 21.48 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.099 -1.0 . . . . 102.76 109.427 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.58 154.2 25.1 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.994 -1.113 . . . . 106.25 107.994 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.914 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.9 51.9 0.74 Allowed 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 117.807 -1.557 . . . . 157.81 107.616 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.24 -45.87 91.75 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.585 -2.746 . . . . 150.2 103.585 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.01 164.71 35.26 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 103.652 -2.721 . . . . 183.52 103.652 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -76.82 6.92 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.982 0 N-CA-C 109.973 -0.818 . . . . 235.61 109.973 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.95 -41.24 82.44 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 124.781 1.233 . . . . 113.77 113.377 -170.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.21 136.2 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 119.605 1.093 . . . . 150.85 110.989 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.595 -1.261 . . . . 100.42 107.595 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.077 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.967 0.889 . . . . 129.36 110.389 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.43 68.36 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 126.241 1.816 . . . . 112.34 106.702 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.4 m -74.1 -40.2 62.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.545 -0.752 . . . . 131.73 111.766 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.077 ' H ' HG23 ' A' ' 17' ' ' THR . 71.6 m -84.42 -42.85 15.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 117.036 2.236 . . . . 80.49 117.036 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -146.0 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 118.151 -1.42 . . . . 98.98 111.198 -169.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.0 Cg_exo -61.81 -10.8 18.29 Favored 'Trans proline' 0 C--N 1.321 -0.898 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.09 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.58 8.75 Favored 'General case' 0 C--N 1.324 -0.542 1 CA-C-N 126.152 4.069 . . . . 269.62 114.209 175.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.12 -27.33 67.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.816 -1.179 . . . . 86.8 107.816 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.119 -0.988 . . . . 85.91 110.493 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.869 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.57 -40.18 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.728 0.811 . . . . 82.0 111.339 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.894 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.73 12.49 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.518 -0.919 . . . . 120.73 108.518 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.97 149.76 89.85 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 120.578 0.852 . . . . 87.86 109.937 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.05 -37.92 89.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.884 -0.784 . . . . 36.46 108.884 -176.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.91 76.73 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.16 -32.74 73.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 121.301 -0.874 . . . . 123.26 108.645 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.15 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.4 -31.02 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.918 -1.141 . . . . 112.19 107.918 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.4 tp -63.02 -47.09 84.55 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.924 -0.71 . . . . 60.87 109.576 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.6 80.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.933 -0.707 . . . . 157.57 110.392 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.92 98.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.622 -0.881 . . . . 47.06 108.622 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.19 97.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.745 -0.597 . . . . 43.94 109.526 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.735 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.88 -43.29 99.14 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.688 -0.856 . . . . 42.61 108.688 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.22 93.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.625 -0.261 . . . . 140.66 111.024 -178.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.81 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.566 -1.254 . . . . 116.04 110.211 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.43 -38.72 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.747 -0.835 . . . . 97.16 108.747 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.34 -39.94 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.99 -0.744 . . . . 54.85 108.99 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.72 -42.39 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 108.877 -0.786 . . . . 45.39 108.877 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.6 t -63.49 -50.94 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.217 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.26 -47.07 78.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.196 -0.601 . . . . 116.65 111.693 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -62.0 -43.93 97.81 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.705 -0.48 . . . . 51.16 109.705 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.7 t -65.5 -48.93 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.878 -0.729 . . . . 44.3 110.878 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.8 -46.94 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 120.308 -0.557 . . . . 48.82 110.995 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.2 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.505 -0.855 . . . . 58.7 111.987 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.66 -34.17 67.07 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 122.118 -0.637 . . . . 101.4 111.032 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 107.748 -1.204 . . . . 103.57 107.748 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.4 -43.06 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 108.965 -0.754 . . . . 61.89 108.965 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.9 t -63.45 -50.93 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 109.453 -0.573 . . . . 70.01 109.453 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.804 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.41 98.87 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.165 -0.68 . . . . 132.1 109.165 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.16 -46.64 83.14 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.623 -0.262 . . . . 104.5 110.472 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.91 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.941 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.9 pt -64.77 -41.67 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 116.96 -1.896 . . . . 158.32 110.859 -175.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.34 98.04 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.459 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.53 90.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.173 -0.329 . . . . 54.66 110.994 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.928 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.17 29.45 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.651 0.739 . . . . 127.18 109.575 -174.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.618 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.88 80.3 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.067 0.947 . . . . 87.93 110.813 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.04 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.63 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.655 -0.653 . . . . 131.12 111.481 -175.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.43 7.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 115.319 -2.553 . . . . 246.56 109.607 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.48 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.471 -2.048 . . . . 339.35 105.471 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.22 165.26 17.92 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 102.989 -2.967 . . . . 114.66 102.989 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.13 -39.46 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.783 -1.562 . . . . 143.28 106.783 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.67 -38.05 80.44 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.673 -0.862 . . . . 160.22 108.673 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.3 m-20 -62.37 -31.75 72.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.88 -0.785 . . . . 120.54 108.88 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.56 -43.86 95.8 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.507 -0.553 . . . . 67.22 109.507 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.49 -39.8 88.92 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.504 -0.747 . . . . 138.6 109.654 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.94 82.14 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 122.529 0.332 . . . . 151.46 110.631 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.941 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 C-N-CA 117.397 -1.721 . . . . 117.93 106.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.0 -46.01 90.88 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.928 -1.138 . . . . 56.82 107.928 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.89 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.4 -43.94 98.01 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.911 -0.774 . . . . 145.3 108.911 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.38 95.47 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.523 -0.917 . . . . 45.71 108.523 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.35 -42.06 99.09 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.384 -0.599 . . . . 105.61 109.384 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.5 92.67 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.608 -0.886 . . . . 47.89 108.608 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.942 -0.392 . . . . 124.53 109.942 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.23 99.28 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 121.979 -0.45 . . . . 35.89 109.851 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.19 -37.31 84.8 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 107.038 -1.467 . . . . 88.97 107.038 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.819 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.23 -49.2 76.69 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.978 -0.749 . . . . 239.91 108.978 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.38 91.02 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.594 -0.691 . . . . 146.1 110.635 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 117.422 -1.711 . . . . 91.74 113.86 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.6 -61.31 2.0 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.74 1.755 . . . . 197.45 115.74 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.923 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.32 -42.2 55.01 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.872 -1.531 . . . . 242.6 114.042 -170.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.959 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.921 -1.112 . . . . 215.61 109.813 -172.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 O-C-N 121.843 -0.535 . . . . 87.19 110.462 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.8 t -65.96 -41.83 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.15 76.07 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.13 -44.8 75.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.568 -0.708 . . . . 181.63 111.29 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.806 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.1 m -60.81 -45.78 93.07 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.471 -1.307 . . . . 269.02 107.471 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.75 -45.0 93.56 Favored 'General case' 0 N--CA 1.415 -2.183 0 C-N-CA 118.646 -1.222 . . . . 562.66 110.03 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.26 95.42 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 118.725 -1.19 . . . . 446.75 108.076 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.47 -26.37 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 C-N-CA 115.842 -2.343 . . . . 370.05 112.22 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.806 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.1 m-70 -74.45 -26.5 60.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.555 -0.716 . . . . 354.91 112.507 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.77 4.59 0.99 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.09 1.356 . . . . 462.44 111.891 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.8 mm-40 -172.36 178.04 2.91 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.989 0.9 . . . . 652.37 111.107 171.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.31 2.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.477 2.711 . . . . 905.99 107.905 -174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.95 -36.37 79.99 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.2 -1.037 . . . . 570.43 108.2 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.34 82.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 125.303 1.441 . . . . 453.22 111.171 -174.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.54 178.67 33.91 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 118.799 -1.667 . . . . 445.63 109.925 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.21 75.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 125.274 1.429 . . . . 457.72 112.358 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.6 -46.99 85.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.701 -1.2 . . . . 340.58 109.262 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 87.8 m-85 -68.71 -32.17 71.78 Favored 'General case' 0 N--CA 1.424 -1.747 0 C-N-CA 118.755 -1.178 . . . . 453.6 111.552 -176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.4 t -56.03 -40.32 73.27 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.86 -47.18 75.8 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 123.976 0.798 . . . . 466.68 110.803 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.07 86.92 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.457 -1.697 . . . . 427.34 107.287 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.12 -36.78 82.64 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.398 0.518 . . . . 537.87 112.398 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.67 74.73 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.852 -1.939 . . . . 422.12 111.585 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.08 -50.09 75.41 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 121.336 -0.853 . . . . 340.17 111.818 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.24 -46.58 71.95 Favored Pre-proline 0 N--CA 1.443 -0.821 0 C-N-CA 119.097 -1.041 . . . . 258.06 111.754 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.923 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.7 Cg_exo -61.53 -31.54 87.56 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 N-CA-C 115.37 1.258 . . . . 305.71 115.37 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.683 -0.858 . . . . 252.7 108.683 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.65 93.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.785 -1.191 . . . . 149.27 107.785 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.77 95.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.621 -0.432 . . . . 138.08 111.485 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.655 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.7 t -66.91 -42.41 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 O-C-N 121.588 -0.695 . . . . 132.89 110.998 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.69 -44.75 92.74 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.875 -0.787 . . . . 193.61 108.875 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.46 -37.68 84.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 122.773 0.429 . . . . 63.83 110.057 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.97 -52.45 59.61 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.092 -0.38 . . . . 76.4 111.231 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.65 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.203 -1.036 . . . . 171.13 108.203 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.4 m-85 -63.69 -38.68 92.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.845 -0.534 . . . . 78.3 110.649 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.02 -35.78 80.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.925 -1.11 . . . . 92.36 109.249 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.967 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.48 -34.3 76.57 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.188 -1.042 . . . . 93.73 108.188 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.68 84.55 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.194 -1.002 . . . . 132.74 109.341 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.05 94.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.217 -1.401 . . . . 43.39 107.217 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.6 t -58.48 -41.97 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.08 95.48 Favored 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 121.765 -0.584 . . . . 69.68 110.553 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.74 91.78 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.339 -0.985 . . . . 106.98 108.339 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.64 81.54 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.69 -0.804 . . . . 147.63 108.956 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.18 -41.49 99.22 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.2 t80 -61.36 -44.03 97.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.298 -1.001 . . . . 118.85 108.298 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.39 -42.63 98.82 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 110.022 -0.362 . . . . 102.5 110.022 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.64 95.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.808 -0.558 . . . . 89.98 109.818 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.919 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.76 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 118.201 -1.4 . . . . 106.09 110.985 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.31 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 C-N-CA 117.119 -1.832 . . . . 227.74 111.81 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.12 50.94 Favored Pre-proline 0 CA--C 1.486 -1.494 0 C-N-CA 116.18 -2.208 . . . . 262.55 110.057 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.42 28.62 Favored 'Trans proline' 0 C--N 1.289 -2.581 0 C-N-CA 121.616 1.544 . . . . 210.25 111.326 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.95 0.98 Allowed 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.533 -1.655 . . . . 270.58 106.533 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.878 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.373 -0.831 . . . . 129.84 112.382 -176.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.4 -26.56 81.53 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 N-CA-C 116.27 1.604 . . . . 330.71 116.27 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.2 7.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.51 -2.876 . . . . 204.51 107.275 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.71 147.41 0.09 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.419 -1.326 . . . . 387.41 107.419 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.69 147.07 33.72 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 118.781 -1.168 . . . . 166.22 109.466 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.91 -40.69 87.75 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.851 -1.166 . . . . 44.23 107.851 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.3 -39.13 85.88 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.195 -1.039 . . . . 28.8 108.195 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.87 -38.76 92.14 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.079 -0.712 . . . . 30.29 109.079 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.844 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.63 -42.99 93.95 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.988 -0.745 . . . . 46.11 108.988 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.18 99.3 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.644 -1.243 . . . . 87.33 107.644 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.64 -42.09 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.953 -1.129 . . . . 23.69 107.953 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.17 -44.32 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 109.703 -0.48 . . . . 43.86 109.703 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.22 -42.59 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.303 -0.999 . . . . 91.13 108.303 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.486 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.6 -37.94 88.2 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.727 -0.842 . . . . 65.88 108.727 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.13 -41.84 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 109.521 -0.548 . . . . 33.86 109.521 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.43 -40.31 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.264 . . . . 146.52 107.586 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.703 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.28 90.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.469 -0.892 . . . . 75.44 108.929 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.42 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 O-C-N 121.056 -1.028 . . . . 43.64 109.726 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.788 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -38.02 89.52 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.042 -0.725 . . . . 102.57 109.042 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.07 86.76 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.428 -1.323 . . . . 58.16 107.428 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.8 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.56 73.96 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.999 -0.741 . . . . 121.11 108.999 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.96 -42.32 84.73 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 118.56 -1.256 . . . . 153.15 109.98 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.08 -43.73 19.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.518 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 120.91 -1.119 . . . . 157.42 112.187 -171.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.43 -36.06 2.44 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 115.038 1.496 . . . . 250.91 115.038 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.1 Cg_exo -59.58 -25.46 78.92 Favored 'Trans proline' 0 CA--C 1.488 -1.805 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.018 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.2 -34.17 74.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.93 -1.508 . . . . 192.46 106.93 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.05 98.09 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.959 -2.056 . . . . 261.0 107.959 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.76 159.15 25.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 101.512 -3.514 . . . . 491.4 101.512 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -60.02 106.86 0.55 Allowed 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 116.25 -2.18 . . . . 386.1 109.799 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.912 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.2 m -154.02 -166.63 2.42 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 103.563 -2.755 . . . . 289.8 103.563 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.93 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 117.757 -1.116 . . . . 402.06 109.567 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.22 177.52 7.58 Favored 'General case' 0 CA--C 1.586 2.34 0 C-N-CA 127.302 2.241 . . . . 690.53 114.922 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.62 0.0 OUTLIER 'General case' 1 C--N 1.429 4.046 1 N-CA-C 123.203 4.52 . . . . 633.62 123.203 162.672 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.69 153.84 22.06 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.354 2.262 . . . . 617.99 110.917 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.045 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.98 Favored Pre-proline 0 C--N 1.364 1.22 0 C-N-CA 130.291 3.436 . . . . 434.98 113.381 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.3 Cg_endo -44.25 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 122.428 3.972 . . . . 365.88 122.428 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.96 1.69 Allowed 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 104.774 -2.306 . . . . 635.81 104.774 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.41 152.24 18.77 Favored 'General case' 1 CA--C 1.419 -4.087 3 N-CA-C 132.002 7.779 . . . . 999.99 132.002 -135.767 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.84 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.774 1 CA-C-N 103.337 -6.301 . . . . 594.32 113.615 149.237 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.14 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 1 N-CA-C 98.277 -4.712 . . . . 811.91 98.277 162.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.48 45.98 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.424 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.976 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.15 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.003 0.906 . . . . 431.86 110.05 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.13 148.65 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 124.39 1.076 . . . . 457.18 108.766 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.48 3.74 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.106 0.962 . . . . 458.77 113.535 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.975 1.31 . . . . 999.99 112.401 168.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.1 Cg_exo -65.95 -45.84 5.56 Favored 'Trans proline' 0 N--CA 1.438 -1.794 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.037 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.283 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.866 0 CA-C-O 114.908 -2.472 . . . . 999.99 108.743 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.1 Cg_endo -41.63 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.144 1 C-N-CA 126.045 4.497 . . . . 999.99 105.692 -170.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.31 -44.01 97.51 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 126.721 2.008 . . . . 967.72 112.04 -165.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.27 -36.52 78.0 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.75 -1.574 . . . . 934.3 106.75 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.61 -30.21 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 129.18 2.992 . . . . 565.15 113.92 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.52 55.43 2.8 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 118.451 0.568 . . . . 755.61 109.846 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.29 66.99 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.554 1.142 . . . . 325.89 113.254 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.98 78.31 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 123.582 0.753 . . . . 250.21 111.602 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.77 -43.28 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.575 0.702 . . . . 142.46 110.399 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.04 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.6 t80 -61.09 -41.55 96.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.953 0.901 . . . . 247.69 108.83 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.826 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.51 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.429 1.491 . . . . 199.61 113.122 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.37 -44.52 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 107.673 -1.232 . . . . 106.73 107.673 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.12 -48.57 81.14 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 115.875 -0.602 . . . . 115.01 110.217 -173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.21 -49.1 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 119.393 -0.923 . . . . 129.42 111.875 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.797 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.88 -53.18 59.28 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 118.209 -1.396 . . . . 172.48 109.919 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.2 t -63.82 -54.3 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 120.53 -0.468 . . . . 55.86 110.942 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.56 58.97 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 118.546 -1.262 . . . . 184.68 111.525 -174.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 116.641 -2.023 . . . . 291.81 114.74 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.02 -55.02 4.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 115.172 1.545 . . . . 130.66 115.172 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.797 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.92 -48.48 68.52 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.459 1.281 . . . . 80.16 114.459 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.9 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.53 -45.49 83.33 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.503 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.83 -27.12 59.46 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.627 -0.566 . . . . 92.17 110.627 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.35 -41.37 76.67 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.475 -1.305 . . . . 135.6 107.475 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.15 -44.73 91.22 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.67 -43.46 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.147 -0.686 . . . . 95.89 109.147 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.683 -1.599 . . . . 43.41 106.683 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.29 99.11 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.363 -1.495 . . . . 27.69 109.363 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.65 -47.4 75.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 122.177 -0.602 . . . . 54.41 110.47 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.8 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.984 -1.488 . . . . 53.88 106.984 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.8 -40.81 94.02 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.466 -0.938 . . . . 68.29 108.466 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.02 92.91 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 119.679 -0.808 . . . . 107.59 110.625 -175.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 119.64 -0.824 . . . . 111.61 109.549 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.919 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.29 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.393 -0.965 . . . . 85.26 108.393 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.42 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.072 -0.811 . . . . 40.71 111.072 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.73 -44.11 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.384 -0.969 . . . . 95.86 108.384 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.91 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.907 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.34 132.13 47.31 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.589 -1.263 . . . . 326.72 107.589 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.457 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.02 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.991 -1.855 . . . . 158.38 105.991 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.457 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.91 98.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.662 -0.496 . . . . 36.78 109.662 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.09 125.87 25.29 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.148 -1.021 . . . . 85.46 109.816 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.696 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.56 8.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.498 -2.038 . . . . 127.78 105.498 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.91 34.81 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.8 Cg_exo -56.78 -39.92 87.94 Favored 'Trans proline' 0 N--CA 1.431 -2.174 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.14 167.0 44.92 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.92 -45.76 93.37 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.057 -1.831 . . . . 107.57 106.057 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.729 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.84 58.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 118.842 -1.143 . . . . 167.96 109.177 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.47 106.75 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 126.754 2.022 . . . . 280.68 109.732 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 56.02 11.24 0.7 Allowed 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.503 1.121 . . . . 218.25 110.695 174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.61 54.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.251 -2.129 . . . . 343.57 105.251 177.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.555 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.88 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.844 -1.539 . . . . 263.29 106.844 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.33 147.01 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 126.503 1.921 . . . . 261.92 108.475 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.15 90.04 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.887 -1.153 . . . . 106.81 107.887 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.735 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.44 -39.95 95.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.392 -1.323 . . . . 112.2 107.526 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.24 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.288 -0.634 . . . . 45.41 109.288 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.814 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.3 p -70.92 -32.01 68.8 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.57 81.52 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.634 0.774 . . . . 59.29 111.014 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.735 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.649 1.18 . . . . 106.49 110.673 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.61 69.18 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.331 -0.989 . . . . 106.62 108.331 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.02 91.27 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.848 -0.532 . . . . 75.97 110.058 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.481 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.88 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 C-N-CA 122.89 0.476 . . . . 65.27 109.817 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 120.357 -0.537 . . . . 107.94 110.147 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.51 -40.82 98.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.652 -0.655 . . . . 87.98 110.293 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.33 96.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 118.834 -1.147 . . . . 65.5 108.382 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.72 -36.35 80.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.173 -1.047 . . . . 85.05 108.173 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.54 -45.68 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.067 -0.716 . . . . 42.25 109.067 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.33 -38.32 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 119.544 -0.862 . . . . 91.01 109.344 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.58 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.978 -1.119 . . . . 66.09 107.978 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.1 -43.12 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 120.731 -0.388 . . . . 52.39 110.312 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.2 m -61.81 -46.73 88.23 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 121.869 -0.52 . . . . 46.42 109.834 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.36 -38.17 88.51 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.286 -1.005 . . . . 116.51 108.286 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.485 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.19 -48.22 82.64 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.437 -0.579 . . . . 65.18 109.437 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.93 -42.73 97.27 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 122.13 -0.356 . . . . 51.33 110.437 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.39 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 118.898 -1.121 . . . . 126.3 109.013 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.513 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.508 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.822 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.7 -33.36 35.44 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.8 tp -58.44 -41.64 90.35 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.686 -0.633 . . . . 72.23 111.618 -167.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.61 -36.02 87.27 Favored 'Trans proline' 0 N--CA 1.429 -2.272 0 CA-C-N 119.88 0.993 . . . . 106.13 111.343 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.68 82.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.723 -0.791 . . . . 128.35 110.021 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.83 88.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 110.207 -0.294 . . . . 100.73 110.207 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.35 -44.43 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 C-N-CA 119.268 -0.973 . . . . 172.72 109.144 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.192 -1.04 . . . . 249.23 108.192 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.61 -55.05 36.62 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.615 -1.624 . . . . 259.78 106.615 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.24 -44.13 72.62 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.38 -48.28 91.45 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 119.153 -1.019 . . . . 169.54 110.592 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.5 Cg_exo -61.18 -24.52 79.28 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 116.72 -1.72 . . . . 255.47 114.629 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.826 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.21 94.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 119.255 0.934 . . . . 279.03 108.886 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.79 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.078 -0.342 . . . . 162.21 110.078 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.787 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.9 59.25 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.75 -1.18 . . . . 128.13 108.083 -178.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.29 164.03 11.2 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 N-CA-C 107.395 -1.81 . . . . 278.35 107.395 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.873 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.01 9.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.813 0.695 . . . . 312.91 109.335 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.873 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.69 -170.7 2.49 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.56 -1.645 . . . . 353.54 106.56 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.019 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 43.0 p90 -115.66 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.95 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 102.092 -3.299 . . . . 175.26 102.092 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.53 -44.97 96.09 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 100.88 -3.748 . . . . 99.07 100.88 172.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.41 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.52 -2.77 . . . . 243.21 103.52 171.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.019 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.93 112.91 25.04 Favored 'General case' 0 CA--C 1.473 -1.995 0 C-N-CA 116.109 -2.237 . . . . 201.04 105.293 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 C-N-CA 116.033 -2.267 . . . . 201.36 108.831 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.02 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.278 -1.783 . . . . 203.82 107.85 174.481 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.927 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.196 -1.401 . . . . 215.06 112.56 -171.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.548 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.4 t -65.7 -46.37 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 C-N-CA 118.567 -1.253 . . . . 125.28 112.937 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.954 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.8 -36.99 86.12 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.177 -1.416 . . . . 268.9 107.177 -171.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.801 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.21 -45.02 74.49 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 125.65 1.58 . . . . 280.88 108.815 -172.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.54 85.79 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 118.957 -1.097 . . . . 184.47 108.971 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.07 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 119.27 -0.972 . . . . 167.92 112.772 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.77 89.91 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 117.796 -1.562 . . . . 367.18 110.77 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.74 74.05 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.877 -0.514 . . . . 173.97 110.439 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.44 -36.79 85.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.495 0.718 . . . . 119.66 109.788 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.822 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.19 -34.0 74.36 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.725 -1.213 . . . . 112.3 107.725 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.239 -0.437 . . . . 174.17 110.246 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 124.685 1.194 . . . . 145.27 110.616 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.764 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.58 -35.36 70.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.113 -1.069 . . . . 170.15 108.113 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.819 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.17 63.97 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.3 -0.409 . . . . 214.57 110.621 -171.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.19 56.51 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.063 1.745 . . . . 168.29 115.562 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.764 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.88 79.22 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.008 1.114 . . . . 167.15 114.008 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.2 -38.28 33.18 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 115.521 -2.472 . . . . 165.13 113.942 -171.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.53 -31.88 80.08 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.751 2.018 . . . . 123.92 111.21 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.74 -42.57 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 118.879 -1.128 . . . . 110.55 109.802 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.07 -40.08 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 108.846 -0.798 . . . . 145.31 108.846 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.05 -48.85 78.85 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.408 -0.917 . . . . 246.68 109.84 -177.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.22 -47.52 84.09 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 119.557 -0.857 . . . . 64.43 109.555 -173.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.75 -45.13 79.53 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.04 -1.064 . . . . 80.72 110.204 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 115.989 1.848 . . . . 140.44 115.989 -173.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.089 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.36 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.35 -1.295 . . . . 110.22 110.094 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.54 72.9 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.731 -0.606 . . . . 174.78 109.739 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.95 -41.71 95.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.248 -1.019 . . . . 161.84 108.248 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.521 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.24 -50.27 73.42 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.029 -0.668 . . . . 117.2 109.25 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.13 75.46 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.374 -0.53 . . . . 112.6 111.063 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.01 -37.43 94.59 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.626 -0.99 . . . . 101.46 110.626 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.026 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.15 -46.01 90.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 118.458 1.129 . . . . 151.49 109.52 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.08 -36.31 77.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.962 -1.496 . . . . 142.32 106.962 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.8 -41.8 92.0 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.41 85.67 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 122.358 -0.213 . . . . 76.11 111.02 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.49 30.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.879 -0.728 . . . . 120.24 109.318 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.575 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.54 41.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 102.912 -2.996 . . . . 192.73 102.912 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.22 -44.17 92.31 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 118.994 -1.082 . . . . 176.29 109.163 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.758 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.0 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.46 0 N-CA-C 106.303 -1.739 . . . . 69.68 106.303 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.97 -75.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 118.364 -0.624 . . . . 191.05 112.605 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.758 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.47 43.88 16.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 O-C-N 123.578 0.549 . . . . 287.03 109.778 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.945 0 C-N-CA 112.956 -3.498 . . . . 292.29 109.818 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.213 -2.514 . . . . 184.57 104.213 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.71 4.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.026 0.75 . . . . 274.56 113.026 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.24 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.748 -2.167 . . . . 268.24 113.453 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.6 m-20 51.56 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 118.685 1.242 . . . . 200.06 110.764 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.98 74.7 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.885 -1.154 . . . . 114.44 107.885 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.29 46.04 21.87 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.611 -1.255 . . . . 263.81 107.611 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.195 1 N-CA-C 102.563 -4.215 . . . . 103.79 102.563 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.3 95.6 10.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 114.943 -2.703 . . . . 117.3 106.016 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.76 90.77 Favored 'General case' 0 CA--C 1.468 -2.187 1 N-CA-C 98.041 -4.8 . . . . 231.58 98.041 167.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.04 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.97 163.44 29.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 102.063 -3.31 . . . . 303.24 102.063 168.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.55 78.9 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.024 -2.271 . . . . 112.72 108.424 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.8 t -61.06 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.072 -0.714 . . . . 83.22 109.072 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.3 m -156.28 -126.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.829 -2.656 . . . . 174.36 103.829 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.81 160.94 8.71 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 105.768 -1.938 . . . . 202.73 105.768 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.051 -1.463 . . . . 180.62 107.051 176.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.937 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.51 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.937 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.13 -43.11 88.06 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.492 -2.781 . . . . 266.49 103.492 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.93 0.28 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 117.055 -1.858 . . . . 219.2 107.753 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.08 -37.36 94.08 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 114.542 -1.208 . . . . 94.78 112.881 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.21 100.41 9.1 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.34 -3.744 . . . . 121.41 109.452 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.08 145.54 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.517 -0.765 . . . . 85.34 108.949 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.8 143.45 42.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.832 -1.174 . . . . 267.57 107.832 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.52 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.63 0.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.502 -0.555 . . . . 226.1 109.502 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.989 -1.485 . . . . 154.84 106.989 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.93 8.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.622 0.725 . . . . 180.01 110.696 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.888 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.91 23.63 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.5 48.77 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.399 -1.334 . . . . 335.2 107.399 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.63 -46.81 88.87 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.698 -1.964 . . . . 59.34 105.698 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.62 173.81 11.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.422 -2.436 . . . . 201.26 104.422 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.89 106.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.525 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.4 5.37 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.337 -0.616 . . . . 87.58 109.337 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.878 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.52 153.71 22.26 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.847 -1.168 . . . . 219.95 107.847 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 C-N-CA 116.348 -2.141 . . . . 121.79 105.434 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.9 t -154.14 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.816 -1.92 . . . . 53.85 105.816 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.26 16.56 77.11 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.886 -1.153 . . . . 35.88 107.886 -178.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 365' ' ' ARG . 1.7 tpp180 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.02 68.13 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.665 1.577 . . . . 1.0 111.877 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' B' ' 367' ' ' LYS . 1.2 mtpt -70.5 127.38 92.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.267 -0.424 . . . . 1.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.821 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -69.01 -19.97 38.99 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.397 2.065 . . . . 1.0 114.601 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.524 HE21 ' HB3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -58.39 -38.63 77.72 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.71 -178.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -71.29 -10.53 59.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.355 . . . . 1.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.821 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.61 -46.34 87.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.332 -178.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -61.51 -49.11 78.05 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.587 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 -0.068 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 108.361 -0.977 . . . . 97.08 108.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.59 155.46 22.32 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.161 0.981 . . . . 123.41 110.745 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.879 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.63 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.469 1 N-CA-C 100.106 -4.035 . . . . 151.3 100.106 173.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.993 HD21 ' HG3' ' B' ' 366' ' ' PRO . 5.2 mp -60.66 -38.61 58.5 Favored Pre-proline 0 N--CA 1.439 -1.01 0 C-N-CA 115.98 -2.288 . . . . 169.25 106.101 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_exo -81.29 168.54 16.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 122.265 0.613 . . . . 185.76 110.508 171.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.2 t -64.51 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.051 2.141 . . . . 145.47 110.324 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.35 157.42 21.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.064 -1.023 . . . . 102.76 109.446 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.61 154.18 25.07 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.994 -1.114 . . . . 106.25 107.994 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.92 51.91 0.74 Allowed 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 117.757 -1.577 . . . . 157.81 107.658 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.19 -45.9 91.56 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.541 -2.763 . . . . 150.2 103.541 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.01 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.874 0 N-CA-C 103.68 -2.711 . . . . 183.52 103.68 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -76.77 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 N-CA-C 109.995 -0.81 . . . . 235.61 109.995 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.99 -41.22 82.56 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.847 1.259 . . . . 113.77 113.354 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.24 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 119.616 1.098 . . . . 150.85 110.965 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.52 156.29 46.37 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 107.594 -1.262 . . . . 100.42 107.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.63 58.33 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.955 0.883 . . . . 129.36 110.436 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.288 1.835 . . . . 112.34 106.693 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.7 m -74.11 -40.16 62.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.553 -0.749 . . . . 131.73 111.777 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.4 -42.9 15.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 117.018 2.229 . . . . 80.49 117.018 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.53 3.35 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.196 -1.402 . . . . 98.98 111.252 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.84 -10.7 18.09 Favored 'Trans proline' 0 C--N 1.32 -0.921 1 N-CA-C 128.937 6.476 . . . . 246.95 128.937 -170.061 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.624 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.62 17.55 8.71 Favored 'General case' 0 C--N 1.325 -0.484 1 CA-C-N 126.12 4.055 . . . . 269.62 114.236 175.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.15 -27.3 67.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.793 -1.188 . . . . 86.8 107.793 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.83 -29.28 69.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.088 -1.007 . . . . 85.91 110.498 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 123.65 0.78 . . . . 82.0 111.364 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.76 12.43 Favored Pre-proline 0 CA--C 1.488 -1.417 0 N-CA-C 108.555 -0.906 . . . . 120.73 108.555 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 C-N-CA 120.659 0.906 . . . . 87.86 109.935 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.814 -0.81 . . . . 36.46 108.814 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.1 p-90 -63.8 -33.89 76.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.18 -32.7 73.37 Favored 'General case' 0 CA--C 1.491 -1.322 0 O-C-N 121.301 -0.874 . . . . 123.26 108.685 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.14 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 109.196 -0.668 . . . . 120.14 109.196 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.43 -31.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.91 -47.21 84.24 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.633 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.65 81.16 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 119.977 -0.689 . . . . 157.57 110.362 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.58 -40.9 98.36 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.682 -0.858 . . . . 47.06 108.682 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.02 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 121.751 -0.593 . . . . 43.94 109.569 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.29 99.15 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.705 -0.85 . . . . 42.61 108.705 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.35 -41.26 94.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.653 -0.249 . . . . 140.66 111.064 -178.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.79 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 118.613 -1.235 . . . . 116.04 110.221 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.44 -38.76 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.745 -0.835 . . . . 97.16 108.745 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.4 mt -61.32 -39.95 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.962 HG22 HG21 ' A' ' 86' ' ' THR . 93.1 t -57.7 -42.34 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 108.891 -0.781 . . . . 45.39 108.891 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.56 -50.97 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.837 -1.145 . . . . 48.64 110.156 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.21 -47.11 78.02 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.137 -0.625 . . . . 116.65 111.71 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.93 -43.93 97.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.695 -0.483 . . . . 51.16 109.695 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.96 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 119.864 -0.734 . . . . 44.3 110.828 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.1 t -64.71 -46.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 120.349 -0.54 . . . . 48.82 111.039 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.12 95.2 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.492 -0.861 . . . . 58.7 112.006 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.13 66.99 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 117.452 0.626 . . . . 101.4 111.006 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.77 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.727 -1.212 . . . . 103.57 107.727 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.41 -43.02 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.996 -0.742 . . . . 61.89 108.996 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.5 t -63.5 -50.94 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.45 -0.574 . . . . 70.01 109.45 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.91 -43.45 98.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.118 -0.697 . . . . 132.1 109.118 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.19 -46.63 83.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.652 -0.249 . . . . 104.5 110.458 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.64 -49.89 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.0 pt -64.75 -41.76 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 C-N-CA 116.936 -1.906 . . . . 158.32 110.897 -175.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 117.692 -1.603 . . . . 137.11 109.516 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.155 -0.341 . . . . 54.66 111.02 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.39 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 121.615 0.721 . . . . 127.18 109.591 -174.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.78 -36.89 80.12 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.099 0.96 . . . . 87.93 110.884 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.041 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.618 -0.676 . . . . 131.12 111.526 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.023 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.46 7.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.25 -2.58 . . . . 246.56 109.613 -175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.949 0 N-CA-C 105.489 -2.041 . . . . 339.35 105.489 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.12 165.23 17.89 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.033 -2.951 . . . . 114.66 103.033 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.42 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.799 -1.556 . . . . 143.28 106.799 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.5 m -59.66 -38.1 80.51 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.687 -0.857 . . . . 160.22 108.687 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.4 m-20 -62.3 -31.78 72.43 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.908 -0.775 . . . . 120.54 108.908 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.56 -43.8 96.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.508 -0.553 . . . . 67.22 109.508 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.54 -39.75 88.72 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.494 -0.754 . . . . 138.6 109.71 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.94 82.15 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.451 0.301 . . . . 151.46 110.614 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.97 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 117.426 -1.71 . . . . 117.93 106.686 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.03 -46.01 90.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.891 -1.152 . . . . 56.82 107.891 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.016 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.41 -43.92 98.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.885 -0.783 . . . . 145.3 108.885 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.39 95.54 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.494 -0.928 . . . . 45.71 108.494 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.41 -42.03 99.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.357 -0.609 . . . . 105.61 109.357 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.617 -0.883 . . . . 47.89 108.617 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.35 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.935 -0.395 . . . . 124.53 109.935 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 121.966 -0.459 . . . . 35.89 109.831 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -37.29 84.83 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.999 -1.482 . . . . 88.97 106.999 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.18 76.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 119.859 -0.737 . . . . 239.91 109.075 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.45 -43.39 90.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.529 -0.732 . . . . 146.1 110.565 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.2 3.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 117.358 -1.737 . . . . 91.74 113.874 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.6 -61.33 2.0 Allowed 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.26 -42.31 55.34 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.896 -1.521 . . . . 242.6 114.026 -170.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.962 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.61 84.55 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 118.957 -1.097 . . . . 215.61 109.831 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.0 t -60.26 -46.96 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.803 -0.561 . . . . 87.19 110.489 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 64.0 t -65.95 -41.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.754 -0.462 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.295 -1.002 . . . . 364.98 108.295 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.543 -0.723 . . . . 181.63 111.242 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.5 m -60.83 -45.83 92.91 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.423 -1.325 . . . . 269.02 107.423 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.67 -45.13 92.98 Favored 'General case' 0 CA--C 1.469 -2.15 0 C-N-CA 118.677 -1.209 . . . . 562.66 110.013 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.21 95.67 Favored 'General case' 0 CA--C 1.479 -1.777 0 C-N-CA 118.713 -1.195 . . . . 446.75 108.108 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.0 m -70.52 -26.31 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 115.826 -2.35 . . . . 370.05 112.202 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.814 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.5 -26.48 60.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.598 -0.689 . . . . 354.91 112.53 175.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.83 4.55 0.98 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 125.057 1.343 . . . . 462.44 111.87 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.8 mm-40 -172.39 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.067 0.936 . . . . 652.37 111.085 171.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 128.508 2.723 . . . . 905.99 107.931 -174.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.88 -36.42 80.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.223 -1.028 . . . . 570.43 108.223 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.52 -36.37 82.35 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 125.31 1.444 . . . . 453.22 111.191 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.67 33.88 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 118.781 -1.676 . . . . 445.63 109.897 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' CD1' ' HB2' ' B' ' 368' ' ' PRO . 89.1 mt -56.39 -41.23 75.91 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.249 1.419 . . . . 457.72 112.378 -170.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.64 -46.93 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.688 -1.205 . . . . 340.58 109.299 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.74 -32.13 71.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.769 -1.172 . . . . 453.6 111.585 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.04 -40.33 73.32 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.9 -47.08 76.0 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 124.025 0.828 . . . . 466.68 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.06 86.86 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.491 -1.684 . . . . 427.34 107.263 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.12 -36.77 82.61 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 112.423 0.527 . . . . 537.87 112.423 -174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.66 74.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 116.86 -1.936 . . . . 422.12 111.617 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.05 -50.11 75.32 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.339 -0.85 . . . . 340.17 111.853 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.35 -46.5 70.74 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.089 -1.045 . . . . 258.06 111.695 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.3 Cg_exo -61.47 -31.58 87.97 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.54 93.78 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.791 -1.188 . . . . 149.27 107.791 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.96 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.649 -0.42 . . . . 138.08 111.5 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.96 -42.41 88.72 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 O-C-N 121.556 -0.715 . . . . 132.89 110.936 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.75 -44.72 92.63 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.849 -0.797 . . . . 193.61 108.849 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.66 84.31 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 122.842 0.457 . . . . 63.83 110.128 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.4 59.68 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.75 -0.38 . . . . 76.4 111.214 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.64 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.163 -1.051 . . . . 171.13 108.163 -174.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.84 -38.53 91.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.866 -0.521 . . . . 78.3 110.639 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.06 -35.78 80.59 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 118.9 -1.12 . . . . 92.36 109.236 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 1.016 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.28 76.49 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.184 -1.043 . . . . 93.73 108.184 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.49 -41.59 84.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 119.205 -0.998 . . . . 132.74 109.323 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.13 94.72 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.188 -1.412 . . . . 43.39 107.188 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.47 -41.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 108.639 -0.875 . . . . 59.34 108.639 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.06 95.27 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.796 -0.565 . . . . 69.68 110.5 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.71 91.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.334 -0.987 . . . . 106.98 108.334 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.64 81.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.648 -0.821 . . . . 147.63 108.933 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.54 99.38 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.557 -0.905 . . . . 190.06 108.557 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.13 97.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.273 -1.01 . . . . 118.85 108.273 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.809 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.65 98.97 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 110.008 -0.367 . . . . 102.5 110.008 -177.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.61 95.23 Favored 'General case' 0 CA--C 1.489 -1.375 0 O-C-N 121.866 -0.521 . . . . 89.98 109.812 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 C-N-CA 118.104 -1.438 . . . . 106.09 111.012 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.11 -48.26 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 C-N-CA 117.087 -1.845 . . . . 227.74 111.798 -174.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.08 50.94 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.238 -2.185 . . . . 262.55 110.052 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.47 28.81 Favored 'Trans proline' 0 C--N 1.289 -2.56 0 C-N-CA 121.685 1.59 . . . . 210.25 111.35 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.23 112.0 0.99 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 106.537 -1.653 . . . . 270.58 106.537 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.53 24.04 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-N 115.37 -0.832 . . . . 129.84 112.316 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 83.0 Cg_exo -61.36 -26.58 81.75 Favored 'Trans proline' 0 N--CA 1.432 -2.142 0 N-CA-C 116.321 1.623 . . . . 330.71 116.321 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.04 77.21 7.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 114.452 -2.899 . . . . 204.51 107.286 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.44 0.09 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.425 -1.324 . . . . 387.41 107.425 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.04 33.66 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 118.753 -1.179 . . . . 166.22 109.435 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.79 88.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.804 -1.184 . . . . 44.23 107.804 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.76 -38.83 92.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.085 -0.709 . . . . 30.29 109.085 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.04 93.88 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.962 -0.755 . . . . 46.11 108.962 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.12 99.26 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.699 -1.223 . . . . 87.33 107.699 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.63 -42.13 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.954 -1.128 . . . . 23.69 107.954 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.22 -44.26 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.676 -0.49 . . . . 43.86 109.676 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.3 -42.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 108.351 -0.981 . . . . 91.13 108.351 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.4 t -62.56 -38.0 88.37 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.743 -0.836 . . . . 65.88 108.743 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.11 -41.81 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 109.58 -0.526 . . . . 33.86 109.58 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.41 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.173 0 N-CA-C 107.577 -1.268 . . . . 146.52 107.577 -176.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.84 -38.36 90.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.499 -0.88 . . . . 75.44 108.936 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.53 -48.39 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 O-C-N 121.04 -1.038 . . . . 43.64 109.733 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.48 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 109.045 -0.724 . . . . 102.57 109.045 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.1 86.87 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.398 -1.334 . . . . 58.16 107.398 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.5 73.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.993 -0.743 . . . . 121.11 108.993 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.3 84.93 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.565 -1.254 . . . . 153.15 109.938 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.11 -43.76 18.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 113.084 -3.446 . . . . 133.67 113.477 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.92 -39.93 96.07 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 120.918 -1.114 . . . . 157.42 112.193 -171.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 114.993 1.479 . . . . 250.91 114.993 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.3 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.488 -1.786 0 N-CA-C 117.984 2.263 . . . . 207.34 117.984 -174.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.012 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.2 -34.22 74.73 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.94 -1.504 . . . . 192.46 106.94 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.06 98.16 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.01 -2.036 . . . . 261.0 108.01 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.71 159.11 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 101.519 -3.512 . . . . 491.4 101.519 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.437 0 C-N-CA 116.257 -2.177 . . . . 386.1 109.87 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.03 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 103.552 -2.758 . . . . 289.8 103.552 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 117.771 -1.109 . . . . 402.06 109.576 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.29 177.46 7.57 Favored 'General case' 0 CA--C 1.586 2.357 0 C-N-CA 127.32 2.248 . . . . 690.53 114.9 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.59 0.0 OUTLIER 'General case' 1 C--N 1.43 4.09 1 N-CA-C 123.178 4.511 . . . . 633.62 123.178 162.696 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.67 153.85 22.07 Favored 'General case' 0 C--N 1.389 2.305 0 C-N-CA 127.362 2.265 . . . . 617.99 110.889 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.42 5.96 Favored Pre-proline 0 C--N 1.364 1.227 0 C-N-CA 130.289 3.435 . . . . 434.98 113.382 -175.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.1 Cg_endo -44.21 -65.7 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 122.409 3.965 . . . . 365.88 122.409 -168.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.3 m -84.91 20.98 1.69 Allowed 'General case' 0 CA--C 1.467 -2.247 0 N-CA-C 104.832 -2.284 . . . . 635.81 104.832 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.35 152.19 18.83 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.959 7.762 . . . . 999.99 131.959 -135.764 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.913 37.2 t -131.79 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.773 1 CA-C-N 103.314 -6.312 . . . . 594.32 113.613 149.206 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.1 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.307 -4.701 . . . . 811.91 98.307 162.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.47 144.58 45.89 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 117.063 -1.855 . . . . 999.99 109.411 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.23 -175.63 4.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.036 0.922 . . . . 431.86 110.042 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.06 148.63 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 124.384 1.074 . . . . 457.18 108.823 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.45 3.72 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.134 0.973 . . . . 458.77 113.523 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.41 -31.56 0.97 Allowed Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.983 1.313 . . . . 999.99 112.38 168.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.953 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.73 5.68 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 N-CA-C 120.916 3.391 . . . . 999.99 120.916 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.57 171.76 8.13 Favored 'General case' 0 CA--C 1.472 -2.041 0 C-N-CA 117.133 -1.827 . . . . 81.18 107.235 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.831 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.14 45.12 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.881 0 C-N-CA 115.537 -2.465 . . . . 999.99 108.798 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.8 Cg_endo -41.61 101.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.126 1 C-N-CA 126.045 4.496 . . . . 999.99 105.677 -170.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.99 97.55 Favored 'General case' 0 CA--C 1.483 -1.621 0 C-N-CA 126.717 2.007 . . . . 967.72 112.043 -165.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.31 -36.55 78.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.72 -1.585 . . . . 934.3 106.72 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.5 -30.29 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 129.188 2.995 . . . . 565.15 113.951 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.59 55.36 2.78 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 118.468 0.577 . . . . 755.61 109.854 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.25 67.21 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.559 1.144 . . . . 325.89 113.259 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -45.02 78.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.582 0.753 . . . . 250.21 111.639 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.66 -43.38 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-O 121.592 0.711 . . . . 142.46 110.379 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.953 0.901 . . . . 247.69 108.855 -173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.49 -51.32 69.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 125.444 1.498 . . . . 199.61 113.111 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.37 -44.49 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.701 -1.222 . . . . 106.73 107.701 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.59 81.03 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.853 -0.612 . . . . 115.01 110.232 -173.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.19 -49.13 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 119.411 -0.916 . . . . 129.42 111.857 -174.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.6 m -61.94 -53.09 60.5 Favored 'General case' 0 CA--C 1.482 -1.646 0 C-N-CA 118.178 -1.409 . . . . 172.48 109.943 -172.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.84 -54.32 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 120.51 -0.476 . . . . 55.86 110.973 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.5 -51.55 59.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.504 -1.278 . . . . 184.68 111.524 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.42 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.618 -2.033 . . . . 291.81 114.749 -174.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.98 4.86 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.181 1.548 . . . . 130.66 115.181 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.499 1.296 . . . . 80.16 114.499 -170.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.44 83.1 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.906 -0.717 . . . . 136.02 109.509 -174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.2 Cg_exo -64.83 -27.11 59.49 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.596 -0.579 . . . . 92.17 110.596 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.33 -41.44 76.68 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.441 -1.318 . . . . 135.6 107.441 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.11 -44.7 91.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.604 -0.517 . . . . 52.1 109.604 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.49 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 109.079 -0.711 . . . . 95.89 109.079 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.33 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.714 -1.587 . . . . 43.41 106.714 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.28 99.12 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.382 -1.487 . . . . 27.69 109.382 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.71 -47.38 75.57 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 117.32 0.56 . . . . 54.41 110.45 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.36 -34.19 74.88 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.957 -1.497 . . . . 53.88 106.957 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.84 93.85 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.503 -0.925 . . . . 68.29 108.503 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.04 92.96 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.682 -0.807 . . . . 107.59 110.626 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -63.0 -38.38 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.609 -0.837 . . . . 111.61 109.525 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.23 -22.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.45 -0.944 . . . . 85.26 108.45 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.92 99.42 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.074 -0.81 . . . . 40.71 111.074 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.71 -44.09 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.382 -0.97 . . . . 95.86 108.382 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.9 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.416 -0.957 . . . . 144.37 108.416 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.8 mt -55.34 132.12 47.29 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 107.606 -1.257 . . . . 326.72 107.606 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.1 1.52 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.015 -1.846 . . . . 158.38 106.015 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.28 -41.94 99.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.688 -0.486 . . . . 36.78 109.688 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.7 m -61.13 125.88 25.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.168 -1.013 . . . . 85.46 109.77 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.57 8.83 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 105.534 -2.024 . . . . 127.78 105.534 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.78 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 105.938 -1.875 . . . . 164.84 105.938 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.0 Cg_exo -56.77 -39.95 87.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 113.958 0.714 . . . . 222.35 113.958 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 106.403 -2.679 . . . . 45.22 106.403 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.77 93.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.017 -1.846 . . . . 107.57 106.017 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.83 141.82 58.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.897 -1.121 . . . . 167.96 109.142 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.71 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.686 1.994 . . . . 280.68 109.715 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.33 0.71 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.493 1.117 . . . . 218.25 110.686 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.212 -2.144 . . . . 343.57 105.212 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.04 81.93 1.54 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.875 -1.528 . . . . 263.29 106.875 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 126.57 1.948 . . . . 261.92 108.471 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.08 89.78 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 107.903 -1.147 . . . . 106.81 107.903 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.88 94.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 118.374 -1.33 . . . . 112.2 107.576 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.3 t -64.31 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.294 -0.632 . . . . 45.41 109.294 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.06 68.89 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.287 -0.264 . . . . 97.62 110.287 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.62 81.7 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.735 0.814 . . . . 59.29 111.025 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.27 -36.48 83.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.615 1.166 . . . . 106.49 110.687 -174.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.7 69.24 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.28 -1.007 . . . . 106.62 108.28 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.01 -41.03 91.53 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 121.836 -0.54 . . . . 75.97 110.028 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.7 t -65.56 -40.83 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 122.94 0.496 . . . . 65.27 109.754 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.6 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 C-N-CA 120.419 -0.512 . . . . 107.94 110.135 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.56 -40.78 97.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 121.68 -0.637 . . . . 87.98 110.275 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.63 -40.45 96.92 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.847 -1.141 . . . . 65.5 108.389 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.65 -36.37 80.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.157 -1.053 . . . . 85.05 108.157 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.5 -45.75 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 109.028 -0.73 . . . . 42.25 109.028 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.39 -38.17 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 C-N-CA 119.535 -0.866 . . . . 91.01 109.377 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.93 -41.55 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 107.973 -1.121 . . . . 66.09 107.973 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 120.726 -0.39 . . . . 52.39 110.331 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.3 m -61.75 -46.77 88.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.899 -0.501 . . . . 46.42 109.858 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.37 -38.05 88.09 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.337 -0.986 . . . . 116.51 108.337 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.35 -48.17 82.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.392 -0.595 . . . . 65.18 109.392 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.7 97.33 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 120.827 0.346 . . . . 51.33 110.472 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.61 -43.41 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 118.936 -1.106 . . . . 126.3 108.982 -176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.4 35.34 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 116.842 2.164 . . . . 134.84 116.842 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.787 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.36 -41.62 90.37 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.692 -0.63 . . . . 72.23 111.66 -167.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.5 Cg_exo -60.69 -35.98 86.94 Favored 'Trans proline' 0 N--CA 1.429 -2.286 0 CA-C-N 119.851 0.983 . . . . 106.13 111.341 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.69 82.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 119.754 -0.779 . . . . 128.35 110.068 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.87 89.04 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 110.218 -0.29 . . . . 100.73 110.218 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.27 -44.51 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.279 -0.969 . . . . 172.72 109.185 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.4 m-85 -66.62 -28.09 68.21 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.216 -1.031 . . . . 249.23 108.216 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.49 -55.17 34.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.701 -1.592 . . . . 259.78 106.701 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.16 -44.15 72.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.593 0.96 . . . . 233.11 113.593 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.38 -48.33 91.31 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 119.22 -0.992 . . . . 169.54 110.544 -170.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.9 Favored 'Trans proline' 0 N--CA 1.429 -2.282 0 C-N-CA 116.784 -1.677 . . . . 255.47 114.66 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.19 94.8 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 119.238 0.926 . . . . 279.03 108.893 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.055 -0.35 . . . . 162.21 110.055 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.781 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.4 84.9 59.27 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 118.779 -1.168 . . . . 128.13 108.052 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.25 164.0 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.289 0 N-CA-C 107.499 -1.769 . . . . 278.35 107.499 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.17 15.0 9.93 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 123.778 0.674 . . . . 312.91 109.325 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.73 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.54 -1.652 . . . . 353.54 106.54 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.26 46.97 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 102.06 -3.311 . . . . 175.26 102.06 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.97 96.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 100.857 -3.757 . . . . 99.07 100.857 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.14 9.16 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.496 -2.779 . . . . 243.21 103.496 171.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.97 112.93 25.07 Favored 'General case' 0 CA--C 1.474 -1.948 0 C-N-CA 116.047 -2.261 . . . . 201.04 105.293 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.789 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.44 -41.48 89.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.256 -1.793 . . . . 203.82 107.872 174.441 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.27 -45.69 86.94 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 118.181 -1.408 . . . . 215.06 112.552 -171.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.39 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.934 -171.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.84 -37.01 86.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.181 -1.414 . . . . 268.9 107.181 -171.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.19 -45.01 74.57 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 125.658 1.583 . . . . 280.88 108.809 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.52 85.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 118.981 -1.088 . . . . 184.47 108.982 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.91 -42.13 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 119.262 -0.975 . . . . 167.92 112.769 -175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.498 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.69 -38.87 90.44 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 117.787 -1.565 . . . . 367.18 110.783 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.73 74.06 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.819 -0.551 . . . . 173.97 110.471 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 123.541 0.736 . . . . 119.66 109.764 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.99 74.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.675 -1.231 . . . . 112.3 107.675 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.02 73.3 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.244 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 m -64.74 -22.74 67.05 Favored 'General case' 0 CA--C 1.485 -1.542 0 C-N-CA 124.656 1.182 . . . . 145.27 110.627 -175.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.762 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.36 70.42 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.066 -1.086 . . . . 170.15 108.066 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.37 -34.05 63.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 122.702 0.401 . . . . 214.57 110.639 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.27 -33.18 55.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.056 1.742 . . . . 168.29 115.514 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.762 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.91 79.29 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 114.024 1.12 . . . . 167.15 114.024 -168.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.72 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.8 p-10 -64.24 -38.23 32.49 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.472 -2.491 . . . . 165.13 113.932 -171.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.72 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.54 -31.82 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 122.846 2.052 . . . . 123.92 111.241 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.79 -42.53 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.769 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.22 -39.99 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.803 -0.814 . . . . 145.31 108.803 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.11 -48.83 78.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 119.386 -0.926 . . . . 246.68 109.854 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.1 m -62.16 -47.51 84.19 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.608 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.1 79.52 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.005 -1.078 . . . . 80.72 110.222 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 115.98 1.844 . . . . 140.44 115.98 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.77 132.22 34.46 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 112.753 -3.579 . . . . 178.87 113.061 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -64.98 -37.12 86.61 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.4 -1.273 . . . . 110.22 110.125 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.62 72.62 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 121.772 -0.58 . . . . 174.78 109.708 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.67 95.52 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.274 -1.009 . . . . 161.84 108.274 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.35 -50.17 73.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 120.01 -0.676 . . . . 117.2 109.232 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.06 75.47 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.328 -0.549 . . . . 112.6 111.114 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.36 94.47 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.671 -0.972 . . . . 101.46 110.671 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.21 -46.02 90.76 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 118.47 1.135 . . . . 151.49 109.511 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.0 -36.34 76.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.984 -1.487 . . . . 142.32 106.984 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.829 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.85 92.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.41 85.93 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 122.287 -0.258 . . . . 76.11 111.047 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -61.48 -55.46 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.829 -0.748 . . . . 120.24 109.301 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.31 131.57 41.28 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 102.944 -2.984 . . . . 192.73 102.944 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.15 -44.22 92.07 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.017 -1.073 . . . . 176.29 109.22 -172.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.3 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.488 -1.431 0 N-CA-C 106.277 -1.749 . . . . 69.68 106.277 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.02 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.431 0 C-N-CA 118.381 -0.612 . . . . 191.05 112.595 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.48 43.92 16.23 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 123.504 0.502 . . . . 287.03 109.772 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.829 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.56 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.916 0 C-N-CA 112.948 -3.501 . . . . 292.29 109.795 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.51 -152.8 0.05 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.206 -2.516 . . . . 184.57 104.206 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.62 8.75 5.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.061 0.763 . . . . 274.56 113.061 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.85 57.28 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 117.72 -2.181 . . . . 268.24 113.451 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.58 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 118.694 1.247 . . . . 200.06 110.722 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.76 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.868 -1.16 . . . . 114.44 107.868 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.24 46.07 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.635 -1.246 . . . . 263.81 107.635 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.218 1 N-CA-C 102.475 -4.25 . . . . 103.79 102.475 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.27 95.66 10.26 Favored 'General case' 0 N--CA 1.419 -2.014 0 C-N-CA 114.933 -2.707 . . . . 117.3 106.0 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.03 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.82 90.81 Favored 'General case' 0 CA--C 1.468 -2.178 1 N-CA-C 97.986 -4.82 . . . . 231.58 97.986 167.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.041 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.061 -3.311 . . . . 303.24 102.061 169.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.62 78.61 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.051 -2.26 . . . . 112.72 108.402 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.0 t -61.07 -63.6 1.24 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.1 -0.704 . . . . 83.22 109.1 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.885 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.28 -126.23 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.81 -2.663 . . . . 174.36 103.81 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.03 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.85 160.96 8.73 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.023 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.91 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.085 -1.45 . . . . 180.62 107.085 176.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.406 -2.072 . . . . 145.25 105.406 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.12 -43.12 88.05 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.155 -1.795 . . . . 66.05 106.155 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.509 -2.775 . . . . 266.49 103.509 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.29 -124.9 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.029 -1.868 . . . . 219.2 107.788 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.904 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.14 -37.32 93.98 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 114.546 -1.207 . . . . 94.78 112.853 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.2 100.42 9.09 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 112.285 -3.766 . . . . 121.41 109.489 -171.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -73.02 145.5 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.947 -0.76 . . . . 85.34 108.947 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.39 42.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.843 -1.169 . . . . 267.57 107.843 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.11 69.6 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.472 -0.566 . . . . 226.1 109.472 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 107.02 -1.474 . . . . 154.84 107.02 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.585 0.707 . . . . 180.01 110.728 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.47 156.94 23.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.945 -1.502 . . . . 333.78 106.945 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.5 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.768 -0.827 . . . . 266.47 108.768 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.59 -46.93 88.41 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.633 -1.988 . . . . 59.34 105.633 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.59 173.85 11.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.428 -2.434 . . . . 201.26 104.428 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.91 106.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 116.298 -2.161 . . . . 56.23 105.509 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.26 -59.45 5.28 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.24 -0.652 . . . . 87.58 109.24 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.5 153.77 22.23 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.842 -1.17 . . . . 219.95 107.842 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 116.335 -2.146 . . . . 121.79 105.476 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.13 159.75 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 N-CA-C 105.797 -1.927 . . . . 53.85 105.797 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 106.021 -2.832 . . . . 196.55 106.021 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.661 0 N-CA-C 107.843 -1.169 . . . . 35.88 107.843 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 1.039 ' HD2' ' HB3' ' A' ' 188' ' ' PRO . 32.6 ttt180 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.841 -0.799 . . . . 1.0 108.841 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.993 ' HG3' HD21 ' A' ' 5' ' ' LEU . 50.1 Cg_endo -67.07 143.95 67.58 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.771 1.647 . . . . 1.0 111.815 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -70.33 127.28 92.28 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.941 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . 0.77 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -68.98 -20.02 39.08 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 122.386 2.057 . . . . 1.0 114.567 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -38.58 77.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.711 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 367' ' ' LYS . 2.4 pt20 -71.33 -10.63 60.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.354 . . . . 1.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.77 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 3.1 m-85 -58.56 -46.34 87.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.277 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.66 -48.98 78.39 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.555 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.086 0 N-CA-C 109.878 -1.289 . . . . 1.0 109.878 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.783 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.893 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.525 ' N ' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.07 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.703 1.602 . . . . 1.0 111.856 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 127.36 92.1 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.276 -0.42 . . . . 1.0 109.876 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.664 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.5 Cg_endo -69.01 -20.03 38.89 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.458 2.106 . . . . 1.0 114.543 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.3 -38.67 77.5 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.702 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -10.55 59.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 1.0 110.55 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.664 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 4.2 m-30 -58.57 -46.36 87.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.307 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.56 -49.06 78.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.55 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.12 78.31 0.31 Allowed Glycine 0 CA--C 1.516 0.098 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -41.75 97.21 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.139 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.485 ' HA ' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.532 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.368 -0.975 . . . . 97.08 108.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.63 155.41 22.43 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.072 0.939 . . . . 123.41 110.739 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.52 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.51 1 N-CA-C 100.136 -4.024 . . . . 151.3 100.136 173.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.903 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.65 -38.6 58.39 Favored Pre-proline 0 N--CA 1.439 -0.992 0 C-N-CA 115.981 -2.288 . . . . 169.25 106.145 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.903 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.7 Cg_exo -81.27 168.51 16.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 122.273 0.617 . . . . 185.76 110.585 171.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.4 t -64.48 -25.9 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 C-N-CA 126.984 2.114 . . . . 145.47 110.336 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.773 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.4 21.51 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.088 -1.007 . . . . 102.76 109.453 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.58 154.17 25.13 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.014 -1.106 . . . . 106.25 108.014 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.87 51.87 0.74 Allowed 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.645 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.15 -45.9 91.5 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 103.619 -2.734 . . . . 150.2 103.619 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -86.98 164.7 35.38 Favored Pre-proline 0 N--CA 1.422 -1.846 0 N-CA-C 103.711 -2.699 . . . . 183.52 103.711 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -76.79 6.87 3.85 Favored 'Trans proline' 0 C--N 1.281 -3.012 0 N-CA-C 109.948 -0.828 . . . . 235.61 109.948 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -57.97 -41.19 82.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.813 1.245 . . . . 113.77 113.375 -170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.19 136.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 119.555 1.071 . . . . 150.85 110.947 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.48 156.24 46.4 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.624 -1.25 . . . . 100.42 107.624 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -65.04 142.62 58.35 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.974 0.892 . . . . 129.36 110.445 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.11 -25.45 68.36 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.278 1.831 . . . . 112.34 106.67 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.19 -40.11 62.73 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.565 -0.743 . . . . 131.73 111.75 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.48 -42.86 15.15 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.95 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.825 0 C-N-CA 118.155 -1.418 . . . . 98.98 111.21 -169.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.5 Cg_exo -61.82 -10.8 18.33 Favored 'Trans proline' 0 C--N 1.321 -0.917 1 N-CA-C 128.862 6.447 . . . . 246.95 128.862 -170.05 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.624 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.67 17.56 8.77 Favored 'General case' 0 C--N 1.324 -0.523 1 CA-C-N 126.19 4.086 . . . . 269.62 114.183 175.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.17 -27.25 67.12 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.785 -1.191 . . . . 86.8 107.785 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.87 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.126 -0.984 . . . . 85.91 110.517 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.19 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 123.663 0.785 . . . . 82.0 111.388 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.7 12.55 Favored Pre-proline 0 CA--C 1.489 -1.378 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.9 149.75 89.93 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.881 . . . . 87.86 109.913 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.99 89.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.851 -0.796 . . . . 36.46 108.851 -176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.8 -33.83 76.54 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.4 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 121.296 -0.877 . . . . 123.26 108.645 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.53 -47.16 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.42 -31.01 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 107.845 -1.169 . . . . 112.19 107.845 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -63.0 -47.12 84.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.899 -0.72 . . . . 60.87 109.622 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -65.99 -35.65 81.14 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 119.953 -0.699 . . . . 157.57 110.388 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.87 98.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.614 -0.884 . . . . 47.06 108.614 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.74 -41.32 98.05 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.743 -0.598 . . . . 43.94 109.573 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.35 99.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.717 -0.846 . . . . 42.61 108.717 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.9 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.34 -41.28 94.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 116.616 -0.266 . . . . 140.66 111.002 -178.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.76 -43.97 97.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 118.596 -1.241 . . . . 116.04 110.236 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.75 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 N-CA-C 108.728 -0.842 . . . . 97.16 108.728 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.851 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -39.97 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 108.952 -0.759 . . . . 54.85 108.952 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 92.8 t -57.74 -42.36 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 108.835 -0.802 . . . . 45.39 108.835 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.1 t -63.54 -50.94 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 118.826 -1.15 . . . . 48.64 110.166 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.25 -47.07 78.04 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 120.14 -0.624 . . . . 116.65 111.703 -174.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.96 -43.92 97.84 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.683 -0.488 . . . . 51.16 109.683 -174.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.58 -48.92 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 C-N-CA 119.85 -0.74 . . . . 44.3 110.834 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.78 -46.91 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 120.239 -0.585 . . . . 48.82 111.034 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.76 -44.14 95.23 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.474 -0.87 . . . . 58.7 112.016 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.64 -34.18 67.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 O-C-N 122.136 -0.626 . . . . 101.4 111.056 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.97 -38.64 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.742 -1.207 . . . . 103.57 107.742 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.45 -43.06 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 108.972 -0.751 . . . . 61.89 108.972 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.98 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 109.463 -0.569 . . . . 70.01 109.463 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.37 98.97 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.128 -0.693 . . . . 132.1 109.128 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.22 -46.65 82.95 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.706 -0.225 . . . . 104.5 110.435 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.61 -49.91 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 120.233 -0.587 . . . . 142.96 111.303 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.946 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.68 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.926 -1.91 . . . . 158.32 110.893 -175.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.73 -41.39 98.05 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 117.71 -1.596 . . . . 137.11 109.496 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.55 91.05 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 122.089 -0.382 . . . . 54.66 110.997 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.7 m-70 -91.44 117.17 29.45 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.646 0.736 . . . . 127.18 109.559 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.89 -36.74 80.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 124.039 0.935 . . . . 87.93 110.859 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.045 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.43 -34.62 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.65 -0.656 . . . . 131.12 111.482 -175.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.027 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.8 mtp -80.67 69.47 7.19 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 115.271 -2.571 . . . . 246.56 109.6 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.24 91.49 3.49 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 105.453 -2.055 . . . . 339.35 105.453 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.24 17.93 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 102.97 -2.974 . . . . 114.66 102.97 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.11 -39.5 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 N-CA-C 106.754 -1.573 . . . . 143.28 106.754 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.7 m -59.67 -38.03 80.38 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.697 -0.853 . . . . 160.22 108.697 -176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.3 m-20 -62.35 -31.75 72.44 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.893 -0.78 . . . . 120.54 108.893 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.66 -43.74 95.85 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.482 -0.562 . . . . 67.22 109.482 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.54 -39.77 88.75 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.537 -0.727 . . . . 138.6 109.683 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.59 -35.9 82.03 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.449 0.3 . . . . 151.46 110.644 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.946 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.51 -38.02 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.719 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.1 -45.97 91.16 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.889 -1.152 . . . . 56.82 107.889 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.94 98.01 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.917 -0.771 . . . . 145.3 108.917 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.34 95.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.574 -0.898 . . . . 45.71 108.574 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.36 -42.04 99.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.387 -0.597 . . . . 105.61 109.387 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.47 92.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 108.668 -0.864 . . . . 47.89 108.668 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.34 84.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.976 -0.379 . . . . 124.53 109.976 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.19 99.31 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.944 -0.473 . . . . 35.89 109.807 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.26 -37.3 84.95 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.966 -1.494 . . . . 88.97 106.966 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.821 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.21 -49.11 77.06 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 119.809 -0.756 . . . . 239.91 109.064 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.42 -43.36 90.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.522 -0.736 . . . . 146.1 110.611 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.872 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.53 -61.4 1.97 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.764 1.765 . . . . 197.45 115.764 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.927 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.26 55.63 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 117.891 -1.524 . . . . 242.6 114.039 -170.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.37 -36.57 84.39 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.862 -1.135 . . . . 215.61 109.886 -172.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.1 t -60.25 -46.92 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 120.361 -0.536 . . . . 87.19 110.493 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.88 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 109.754 -0.461 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.9 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.32 -34.1 75.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.349 -0.982 . . . . 364.98 108.349 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.23 -44.69 75.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 121.559 -0.713 . . . . 181.63 111.236 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 58.1 m -60.91 -45.76 93.33 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 107.409 -1.33 . . . . 269.02 107.409 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.78 -45.01 93.62 Favored 'General case' 0 CA--C 1.469 -2.146 0 C-N-CA 118.625 -1.23 . . . . 562.66 109.983 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.28 95.34 Favored 'General case' 0 CA--C 1.478 -1.8 0 C-N-CA 118.685 -1.206 . . . . 446.75 108.066 -167.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.48 -26.3 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 115.859 -2.336 . . . . 370.05 112.195 -178.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.49 60.04 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.552 -0.717 . . . . 354.91 112.478 175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.3 m-20 82.76 4.45 1.01 Allowed 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 125.048 1.339 . . . . 462.44 111.934 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.3 178.06 2.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.971 0.891 . . . . 652.37 111.168 171.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.7 86.35 2.16 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 128.473 2.709 . . . . 905.99 107.947 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -67.97 -36.36 79.93 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.203 -1.036 . . . . 570.43 108.203 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.37 82.42 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.345 1.458 . . . . 453.22 111.146 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.57 178.68 33.86 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.716 -1.707 . . . . 445.63 109.875 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.754 HD21 ' CE1' ' B' ' 371' ' ' PHE . 89.1 mt -56.45 -41.23 76.13 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 125.208 1.403 . . . . 457.72 112.374 -170.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.57 -47.02 85.66 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.69 -1.204 . . . . 340.58 109.266 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.68 -32.14 71.76 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.802 -1.159 . . . . 453.6 111.59 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.36 73.37 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 75.99 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.949 0.781 . . . . 466.68 110.873 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -61.75 -47.09 86.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.296 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.16 -36.76 82.5 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 112.365 0.506 . . . . 537.87 112.365 -174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.39 -42.68 74.82 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 116.882 -1.927 . . . . 422.12 111.604 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.8 t80 -59.04 -50.09 75.4 Favored 'General case' 0 CA--C 1.501 -0.904 0 O-C-N 121.34 -0.85 . . . . 340.17 111.84 -173.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -65.34 -46.48 70.82 Favored Pre-proline 0 N--CA 1.443 -0.776 0 C-N-CA 119.085 -1.046 . . . . 258.06 111.705 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.927 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.55 -31.57 87.43 Favored 'Trans proline' 0 N--CA 1.435 -1.954 0 N-CA-C 115.324 1.24 . . . . 305.71 115.324 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.702 -0.851 . . . . 252.7 108.702 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.66 93.93 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.776 -1.194 . . . . 149.27 107.776 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.85 95.9 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.661 -0.416 . . . . 138.08 111.509 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.92 -42.35 88.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 O-C-N 121.587 -0.696 . . . . 132.89 110.996 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.81 -44.66 92.63 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.84 -0.8 . . . . 193.61 108.84 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.69 84.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.846 0.458 . . . . 63.83 110.063 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -64.04 -52.41 59.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 122.068 -0.395 . . . . 76.4 111.228 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.63 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.188 -1.041 . . . . 171.13 108.188 -175.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.83 -38.58 91.63 Favored 'General case' 0 N--CA 1.433 -1.281 0 O-C-N 121.82 -0.55 . . . . 78.3 110.599 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.74 80.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 118.886 -1.126 . . . . 92.36 109.217 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 1.014 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.26 76.45 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.199 -1.037 . . . . 93.73 108.199 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.48 -41.61 84.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.193 -1.003 . . . . 132.74 109.34 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.05 94.65 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.194 -1.41 . . . . 43.39 107.194 -177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.5 -41.97 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.593 -0.891 . . . . 59.34 108.593 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.43 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 121.781 -0.574 . . . . 69.68 110.491 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.48 -42.79 91.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.287 -1.005 . . . . 106.98 108.287 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.659 -0.817 . . . . 147.63 108.917 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.707 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.17 -41.54 99.25 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.549 -0.908 . . . . 190.06 108.549 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.08 97.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.306 -0.998 . . . . 118.85 108.306 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.3 -42.76 99.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.99 -0.374 . . . . 102.5 109.99 -177.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.61 95.34 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 121.875 -0.516 . . . . 89.98 109.853 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.921 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.52 -50.71 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 C-N-CA 118.151 -1.419 . . . . 106.09 111.003 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.746 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.32 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.847 -174.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.83 100.09 51.01 Favored Pre-proline 0 CA--C 1.486 -1.511 0 C-N-CA 116.261 -2.176 . . . . 262.55 110.047 -175.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.1 Cg_endo -69.65 -10.33 28.38 Favored 'Trans proline' 0 C--N 1.29 -2.531 0 C-N-CA 121.606 1.537 . . . . 210.25 111.332 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.521 -1.659 . . . . 270.58 106.521 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.8 -39.52 24.18 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-N 115.377 -0.829 . . . . 129.84 112.312 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.862 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.5 Cg_exo -61.36 -26.65 81.85 Favored 'Trans proline' 0 N--CA 1.432 -2.134 0 N-CA-C 116.296 1.614 . . . . 330.71 116.296 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -80.99 77.16 7.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 114.502 -2.879 . . . . 204.51 107.3 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.35 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.431 -1.322 . . . . 387.41 107.431 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.65 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 118.761 -1.176 . . . . 166.22 109.461 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.78 88.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.821 -1.177 . . . . 44.23 107.821 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.28 -39.13 85.77 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.206 -1.035 . . . . 28.8 108.206 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.83 92.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.074 -0.714 . . . . 30.29 109.074 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.845 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.4 m -59.56 -43.06 93.67 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.016 -0.735 . . . . 46.11 109.016 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.1 99.25 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.683 -1.229 . . . . 87.33 107.683 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.68 -42.1 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.883 -1.155 . . . . 23.69 107.883 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.23 -44.31 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 109.649 -0.5 . . . . 43.86 109.649 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.22 -42.59 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.352 -0.981 . . . . 91.13 108.352 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.53 -37.97 88.15 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.768 -0.827 . . . . 65.88 108.768 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.07 -41.96 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.536 -0.542 . . . . 33.86 109.536 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.33 -40.34 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.173 0 N-CA-C 107.595 -1.261 . . . . 146.52 107.595 -176.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.33 90.5 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 119.512 -0.875 . . . . 75.44 108.849 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.5 t -60.58 -48.37 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 O-C-N 121.031 -1.043 . . . . 43.64 109.725 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.73 -37.95 89.26 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 109.027 -0.731 . . . . 102.57 109.027 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.09 87.01 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.383 -1.34 . . . . 58.16 107.383 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.03 -32.52 73.91 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.043 -0.725 . . . . 121.11 109.043 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.99 -42.37 84.97 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 118.586 -1.245 . . . . 153.15 109.895 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.1 -43.73 19.02 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 113.051 -3.46 . . . . 133.67 113.488 173.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.9 96.07 Favored 'General case' 0 CA--C 1.489 -1.402 0 O-C-N 120.893 -1.13 . . . . 157.42 112.226 -171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.521 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.09 2.44 Favored Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 115.037 1.495 . . . . 250.91 115.037 -173.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.6 Cg_exo -59.51 -25.47 78.82 Favored 'Trans proline' 0 CA--C 1.488 -1.816 0 N-CA-C 118.018 2.276 . . . . 207.34 118.018 -174.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.012 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.15 -34.21 74.65 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.978 -1.49 . . . . 192.46 106.978 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.99 98.07 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 107.938 -2.065 . . . . 261.0 107.938 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.83 159.09 26.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 101.554 -3.499 . . . . 491.4 101.554 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.93 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 116.287 -2.165 . . . . 386.1 109.797 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 103.54 -2.763 . . . . 289.8 103.54 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.41 0.86 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 117.725 -1.131 . . . . 402.06 109.556 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 71.9 p -165.29 177.48 7.56 Favored 'General case' 0 CA--C 1.587 2.373 0 C-N-CA 127.323 2.249 . . . . 690.53 114.902 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.35 160.57 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.174 4.509 . . . . 633.62 123.174 162.698 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.65 153.84 22.09 Favored 'General case' 0 C--N 1.389 2.294 0 C-N-CA 127.399 2.28 . . . . 617.99 110.916 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.042 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.99 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.246 3.419 . . . . 434.98 113.455 -175.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.4 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 122.397 3.96 . . . . 365.88 122.397 -168.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.89 1.7 Allowed 'General case' 0 CA--C 1.467 -2.235 0 N-CA-C 104.83 -2.285 . . . . 635.81 104.83 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.21 18.83 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.975 7.768 . . . . 999.99 131.975 -135.735 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.909 36.9 t -131.85 73.22 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.73 1 CA-C-N 103.311 -6.313 . . . . 594.32 113.588 149.175 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.18 144.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.289 -4.708 . . . . 811.91 98.289 162.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.55 45.91 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 117.05 -1.86 . . . . 999.99 109.374 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.22 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.009 0.909 . . . . 431.86 110.038 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.039 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.14 148.64 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 124.351 1.06 . . . . 457.18 108.8 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.51 3.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 124.109 0.963 . . . . 458.77 113.486 -174.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.4 -31.54 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.928 1.291 . . . . 999.99 112.479 168.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.76 5.65 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 N-CA-C 120.865 3.371 . . . . 999.99 120.865 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.59 171.69 8.19 Favored 'General case' 0 CA--C 1.472 -2.032 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.274 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.15 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.518 -2.473 . . . . 999.99 108.767 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.55 101.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.167 1 C-N-CA 126.015 4.477 . . . . 999.99 105.716 -170.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.18 -44.02 97.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 126.786 2.034 . . . . 967.72 112.092 -165.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.3 -36.57 78.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.711 -1.589 . . . . 934.3 106.711 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.26 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.212 3.005 . . . . 565.15 113.898 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.51 55.41 2.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 118.468 0.576 . . . . 755.61 109.863 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.46 -49.28 67.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.557 1.143 . . . . 325.89 113.274 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.98 78.37 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 123.55 0.74 . . . . 250.21 111.64 -169.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.544 0.688 . . . . 142.46 110.38 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.039 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.14 -41.5 96.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.942 0.897 . . . . 247.69 108.832 -173.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.48 -51.35 69.85 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 125.467 1.507 . . . . 199.61 113.103 -175.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.36 -44.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 107.694 -1.225 . . . . 106.73 107.694 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.725 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.13 -48.48 81.46 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.88 -0.6 . . . . 115.01 110.251 -173.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.28 -49.17 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 C-N-CA 119.433 -0.907 . . . . 129.42 111.801 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.9 -53.16 59.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 118.23 -1.388 . . . . 172.48 109.933 -172.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.83 -54.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 123.471 0.482 . . . . 55.86 110.982 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.55 58.95 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 118.551 -1.259 . . . . 184.68 111.509 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.04 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.41 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 116.67 -2.012 . . . . 291.81 114.715 -174.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -55.05 4.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.126 1.528 . . . . 130.66 115.126 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.795 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.54 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.485 1.291 . . . . 80.16 114.485 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.897 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.48 83.22 Favored Pre-proline 0 N--CA 1.435 -1.198 0 C-N-CA 119.963 -0.695 . . . . 136.02 109.48 -174.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.8 -27.11 59.7 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 CA-C-N 118.707 0.574 . . . . 92.17 110.62 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.35 76.63 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.486 -1.302 . . . . 135.6 107.486 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.14 -44.72 91.33 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.603 -0.517 . . . . 52.1 109.603 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.68 -43.51 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 109.111 -0.7 . . . . 95.89 109.111 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.906 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.33 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.725 -1.583 . . . . 43.41 106.725 -178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.33 99.14 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.67 -47.37 75.71 Favored 'General case' 0 CA--C 1.496 -1.102 0 O-C-N 122.195 -0.591 . . . . 54.41 110.476 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.1 74.82 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.976 -1.49 . . . . 53.88 106.976 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.85 93.89 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.469 -0.937 . . . . 68.29 108.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.84 -39.01 92.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.672 -0.811 . . . . 107.59 110.604 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -62.95 -38.41 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.553 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.921 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.5 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.358 -0.979 . . . . 85.26 108.358 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.87 99.43 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.088 -0.805 . . . . 40.71 111.088 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.74 -44.08 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.399 -0.963 . . . . 95.86 108.399 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.93 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.401 -0.962 . . . . 144.37 108.401 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.5 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 107.57 -1.27 . . . . 326.72 107.57 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.458 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.29 -168.03 1.5 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.072 -1.825 . . . . 158.38 106.072 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.458 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.33 -41.96 98.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.659 -0.496 . . . . 36.78 109.659 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.12 125.84 25.2 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.17 -1.012 . . . . 85.46 109.808 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.47 8.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.53 -2.026 . . . . 127.78 105.53 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.96 139.87 34.96 Favored Pre-proline 0 CA--C 1.492 -1.264 0 N-CA-C 106.023 -1.843 . . . . 164.84 106.023 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.6 Cg_exo -56.77 -39.97 87.57 Favored 'Trans proline' 0 N--CA 1.431 -2.159 0 N-CA-C 113.935 0.706 . . . . 222.35 113.935 -176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.97 44.94 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 106.445 -2.662 . . . . 45.22 106.445 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.93 -45.73 93.49 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 106.035 -1.839 . . . . 107.57 106.035 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.78 141.83 58.18 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 118.9 -1.12 . . . . 167.96 109.168 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.52 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 126.734 2.014 . . . . 280.68 109.706 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.04 11.23 0.7 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.443 1.097 . . . . 218.25 110.698 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.36 137.64 54.79 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.241 -2.133 . . . . 343.57 105.241 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.557 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.93 1.54 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.839 -1.541 . . . . 263.29 106.839 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.624 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.26 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 126.568 1.947 . . . . 261.92 108.522 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.19 -38.1 89.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.893 -1.151 . . . . 106.81 107.893 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.39 -39.98 94.99 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.35 -1.34 . . . . 112.2 107.594 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.737 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.24 -39.87 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 N-CA-C 109.259 -0.645 . . . . 45.41 109.259 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.81 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 94.9 p -70.88 -32.05 68.91 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.313 -0.255 . . . . 97.62 110.313 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.62 81.66 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 123.684 0.794 . . . . 59.29 110.992 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.21 -36.55 84.01 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.656 1.182 . . . . 106.49 110.683 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.63 69.2 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.32 -0.993 . . . . 106.62 108.32 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -66.02 -41.02 91.51 Favored 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 121.809 -0.557 . . . . 75.97 110.079 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.446 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.6 t -65.57 -40.8 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 C-N-CA 122.908 0.483 . . . . 65.27 109.788 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.06 -41.56 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 120.382 -0.527 . . . . 107.94 110.154 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.58 -40.76 97.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 O-C-N 121.712 -0.618 . . . . 87.98 110.27 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.66 -40.4 96.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 118.815 -1.154 . . . . 65.5 108.367 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.774 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.66 -36.41 80.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.162 -1.051 . . . . 85.05 108.162 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.6 mt -63.47 -45.77 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 109.053 -0.721 . . . . 42.25 109.053 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.26 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 C-N-CA 119.542 -0.863 . . . . 91.01 109.419 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.6 t -58.86 -41.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 107.99 -1.115 . . . . 66.09 107.99 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.6 t -66.07 -43.15 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 C-N-CA 120.758 -0.377 . . . . 52.39 110.293 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.7 m -61.8 -46.73 88.28 Favored 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 121.907 -0.496 . . . . 46.42 109.866 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.13 88.29 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.323 -0.991 . . . . 116.51 108.323 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.486 ' N ' HG23 ' A' ' 256' ' ' THR . 85.9 t80 -60.26 -48.23 82.61 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.402 -0.592 . . . . 65.18 109.402 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.7 97.2 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 120.824 0.345 . . . . 51.33 110.407 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.34 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 C-N-CA 118.941 -1.103 . . . . 126.3 109.015 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.64 -49.31 69.12 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.539 -0.864 . . . . 133.94 112.456 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.821 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.74 -33.32 35.25 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 116.826 2.158 . . . . 134.84 116.826 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.7 tp -58.43 -41.64 90.37 Favored Pre-proline 0 CA--C 1.493 -1.237 0 CA-C-N 118.632 0.651 . . . . 72.23 111.644 -167.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.67 -35.98 87.07 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 CA-C-N 119.83 0.975 . . . . 106.13 111.375 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.35 -44.73 82.45 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 119.752 -0.779 . . . . 128.35 110.051 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.2 m-70 -64.43 -37.85 88.98 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.174 -0.306 . . . . 100.73 110.174 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.3 -44.55 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 C-N-CA 119.274 -0.971 . . . . 172.72 109.123 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.8 m-85 -66.57 -28.06 68.22 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.273 -1.01 . . . . 249.23 108.273 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.6 -55.11 35.86 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.644 -1.613 . . . . 259.78 106.644 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.11 -44.23 72.85 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.574 0.953 . . . . 233.11 113.574 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.9 mt -61.38 -48.29 91.41 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 119.162 -1.015 . . . . 169.54 110.596 -171.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.4 Cg_exo -61.12 -24.56 79.51 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 C-N-CA 116.771 -1.686 . . . . 255.47 114.655 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.7 t80 -63.54 -44.23 94.8 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.213 0.915 . . . . 279.03 108.929 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.79 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.073 -0.343 . . . . 162.21 110.073 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.83 59.38 Favored Pre-proline 0 N--CA 1.431 -1.399 0 C-N-CA 118.802 -1.159 . . . . 128.13 108.09 -178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.24 164.02 11.28 Favored 'Trans proline' 0 C--N 1.295 -2.264 0 N-CA-C 107.445 -1.79 . . . . 278.35 107.445 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.07 15.1 9.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 123.829 0.705 . . . . 312.91 109.37 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.75 -170.64 2.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.534 -1.654 . . . . 353.54 106.534 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.012 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.9 p90 -115.7 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.01 -118.69 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.5 -45.0 96.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.837 -3.764 . . . . 99.07 100.837 172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.17 9.17 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.463 -2.791 . . . . 243.21 103.463 171.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.012 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.94 25.08 Favored 'General case' 0 CA--C 1.474 -1.953 0 C-N-CA 116.051 -2.259 . . . . 201.04 105.262 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.91 173.76 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 C-N-CA 115.954 -2.298 . . . . 201.36 108.781 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.281 0.6 OUTLIER -59.49 -41.45 89.84 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.248 -1.796 . . . . 203.82 107.905 174.44 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.21 -1.396 . . . . 215.06 112.562 -171.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.5 t -65.7 -46.4 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.481 0 C-N-CA 118.529 -1.268 . . . . 125.28 112.928 -171.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.74 -37.07 86.36 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.191 -1.411 . . . . 268.9 107.191 -171.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.8 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.18 -45.0 74.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 C-N-CA 125.6 1.56 . . . . 280.88 108.817 -172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.49 86.0 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.91 -1.116 . . . . 184.47 109.043 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.88 -42.13 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 119.284 -0.966 . . . . 167.92 112.785 -175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.77 -38.73 89.86 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 117.772 -1.571 . . . . 367.18 110.765 -175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.17 -32.74 74.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 121.844 -0.535 . . . . 173.97 110.468 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.72 85.09 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.505 0.722 . . . . 119.66 109.78 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.821 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.95 74.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.686 -1.228 . . . . 112.3 107.686 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.771 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.08 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.263 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.75 -22.76 67.06 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 124.7 1.2 . . . . 145.27 110.586 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.761 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.64 -35.36 70.39 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.095 -1.076 . . . . 170.15 108.095 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.821 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.32 -34.15 63.95 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 116.295 -0.411 . . . . 214.57 110.609 -171.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.19 -33.18 56.39 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.084 1.754 . . . . 168.29 115.566 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.761 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.49 -34.82 79.11 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.007 1.114 . . . . 167.15 114.007 -168.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.22 -38.26 32.86 Favored Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 115.512 -2.475 . . . . 165.13 113.937 -171.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.7 Cg_exo -62.55 -31.86 79.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.771 2.025 . . . . 123.92 111.236 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.75 -42.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 118.874 -1.131 . . . . 110.55 109.823 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.15 -40.04 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.86 -0.793 . . . . 145.31 108.86 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.2 m-85 -58.16 -48.82 79.1 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.371 -0.932 . . . . 246.68 109.81 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.18 -47.45 84.43 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.542 -0.863 . . . . 64.43 109.621 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.84 -45.07 79.36 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 118.968 -1.093 . . . . 80.72 110.223 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.85 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.02 1.859 . . . . 140.44 116.02 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.84 132.25 34.37 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 112.699 -3.6 . . . . 178.87 113.03 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.1 86.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.394 -1.275 . . . . 110.22 110.09 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.71 -50.6 72.65 Favored 'General case' 0 CA--C 1.492 -1.268 0 O-C-N 121.744 -0.598 . . . . 174.78 109.757 -174.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.84 -41.69 95.52 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 108.273 -1.01 . . . . 161.84 108.273 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.34 -50.23 73.61 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.179 -0.675 . . . . 117.2 109.179 -173.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.53 -44.08 75.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 120.384 -0.527 . . . . 112.6 111.056 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.06 -37.41 94.54 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.647 -0.981 . . . . 101.46 110.647 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.023 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 91.0 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 118.54 1.17 . . . . 151.49 109.505 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.15 -36.28 77.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.94 -1.504 . . . . 142.32 106.94 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.81 -41.81 92.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.885 -1.524 . . . . 109.09 106.885 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.4 85.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 122.35 -0.219 . . . . 76.11 111.066 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.44 -55.48 30.78 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 119.888 -0.725 . . . . 120.24 109.305 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.574 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.52 41.22 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 102.942 -2.984 . . . . 192.73 102.942 177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.22 92.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 119.048 -1.061 . . . . 176.29 109.185 -172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.13 0.82 Allowed Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 106.296 -1.742 . . . . 69.68 106.296 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.97 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-O 118.711 -0.62 . . . . 191.05 112.604 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.51 43.89 16.31 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 123.62 0.575 . . . . 287.03 109.753 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.48 78.54 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.94 0 C-N-CA 112.964 -3.494 . . . . 292.29 109.847 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.78 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.21 -2.515 . . . . 184.57 104.21 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.7 4.98 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.042 0.756 . . . . 274.56 113.042 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.99 0.83 57.25 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 117.737 -2.173 . . . . 268.24 113.47 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.68 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.68 1.24 . . . . 200.06 110.778 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.92 -33.0 74.72 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.858 -1.164 . . . . 114.44 107.858 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.0 21.97 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.65 -1.241 . . . . 263.81 107.65 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.37 -137.28 3.56 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.55 10.24 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 114.942 -2.703 . . . . 117.3 106.014 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.92 Favored 'General case' 0 CA--C 1.468 -2.19 1 N-CA-C 98.016 -4.809 . . . . 231.58 98.016 167.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.045 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.48 29.07 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.066 -3.309 . . . . 303.24 102.066 168.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.66 -48.57 78.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 116.047 -2.261 . . . . 112.72 108.39 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.07 -63.61 1.24 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.124 -0.695 . . . . 83.22 109.124 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.5 m -156.29 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.791 -2.67 . . . . 174.36 103.791 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.88 160.98 8.75 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 105.762 -1.94 . . . . 202.73 105.762 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.027 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.93 149.02 52.56 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.1 -1.445 . . . . 180.62 107.1 176.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.5 -171.87 0.27 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 105.362 -2.088 . . . . 145.25 105.362 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.07 -43.11 88.36 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.192 -1.781 . . . . 66.05 106.192 174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.74 -152.17 0.48 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.482 -2.785 . . . . 266.49 103.482 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.697 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.36 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.024 -1.87 . . . . 219.2 107.757 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.98 -37.43 94.25 Favored Glycine 0 N--CA 1.426 -2.018 0 CA-C-N 114.52 -1.218 . . . . 94.78 112.885 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.2 100.45 9.11 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 112.321 -3.752 . . . . 121.41 109.41 -171.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.7 t -73.08 145.5 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 108.957 -0.757 . . . . 85.34 108.957 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.819 -1.178 . . . . 267.57 107.819 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.06 69.56 0.6 Allowed 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.524 -0.547 . . . . 226.1 109.524 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.98 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.6 m -61.31 161.93 8.42 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.626 0.727 . . . . 180.01 110.681 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.97 23.51 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.97 -1.492 . . . . 333.78 106.97 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.972 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.08 142.54 48.79 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.347 -1.353 . . . . 335.2 107.347 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.972 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.8 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 108.744 -0.836 . . . . 266.47 108.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.3 m -60.62 -46.94 88.38 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 105.64 -1.985 . . . . 59.34 105.64 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.84 12.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 104.442 -2.429 . . . . 201.26 104.442 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.93 106.71 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 C-N-CA 116.347 -2.141 . . . . 56.23 105.505 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 71.0 m -61.14 -59.5 5.23 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 109.316 -0.624 . . . . 87.58 109.316 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.45 153.75 22.28 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.813 -1.18 . . . . 219.95 107.813 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 C-N-CA 116.372 -2.131 . . . . 121.79 105.423 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.4 t -154.13 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 N-CA-C 105.835 -1.913 . . . . 53.85 105.835 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.034 -2.826 . . . . 196.55 106.034 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.677 0 N-CA-C 107.832 -1.173 . . . . 35.88 107.832 -178.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.61 ' NH2' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -67.09 144.06 67.92 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.663 1.575 . . . . 1.0 111.833 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' B' ' 367' ' ' LYS . 0.1 OUTLIER -70.4 127.36 92.18 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.22 -0.446 . . . . 1.0 109.905 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.8 Cg_endo -69.04 -20.02 38.77 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.428 2.085 . . . . 1.0 114.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.28 -38.68 77.48 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.573 -0.451 . . . . 1.0 111.725 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -71.36 -10.44 59.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.825 0.345 . . . . 1.0 110.604 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.754 ' CE1' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -58.63 -46.28 87.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.106 0.479 . . . . 1.0 110.323 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -61.65 -49.03 78.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.551 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.12 78.32 0.31 Allowed Glycine 0 N--CA 1.455 -0.07 0 N-CA-C 109.819 -1.313 . . . . 1.0 109.819 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' B' ' 374' ' ' LEU . 0.3 OUTLIER -61.02 -41.73 97.12 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.221 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.505 ' H ' ' HG3' ' B' ' 375' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 108.38 -0.97 . . . . 97.08 108.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.6 155.4 22.41 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.085 0.945 . . . . 123.41 110.774 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.88 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.57 -162.42 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.461 1 N-CA-C 100.064 -4.051 . . . . 151.3 100.064 173.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.61 -38.58 58.35 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 115.952 -2.299 . . . . 169.25 106.148 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.29 168.52 16.64 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 122.301 0.632 . . . . 185.76 110.568 171.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.902 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.5 t -64.44 -25.96 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 127.042 2.137 . . . . 145.47 110.342 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.44 21.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 121.058 -1.027 . . . . 102.76 109.445 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.7 p -82.68 154.16 25.0 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 107.937 -1.134 . . . . 106.25 107.937 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.83 51.84 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.754 -1.578 . . . . 157.81 107.663 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.15 -45.9 91.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.553 -2.758 . . . . 150.2 103.553 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.67 35.33 Favored Pre-proline 0 N--CA 1.422 -1.852 0 N-CA-C 103.669 -2.715 . . . . 183.52 103.669 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.71 6.87 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 N-CA-C 110.014 -0.802 . . . . 235.61 110.014 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.99 -41.16 82.44 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 124.749 1.22 . . . . 113.77 113.409 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.21 136.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 119.564 1.075 . . . . 150.85 110.973 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.487 ' HA ' HH12 ' B' ' 365' ' ' ARG . 47.7 t -140.5 156.28 46.38 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.59 -1.263 . . . . 100.42 107.59 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.04 142.6 58.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.93 0.871 . . . . 129.36 110.444 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.48 68.39 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.326 1.85 . . . . 112.34 106.663 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.2 m -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.618 -0.719 . . . . 131.73 111.739 177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.0 m -84.48 -42.85 15.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 116.984 2.216 . . . . 80.49 116.984 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -146.01 174.54 3.35 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 118.154 -1.418 . . . . 98.98 111.21 -169.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.8 Cg_exo -61.8 -10.74 18.09 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.953 6.482 . . . . 246.95 128.953 -170.103 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.624 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.66 17.49 8.7 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.112 4.051 . . . . 269.62 114.229 175.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.12 -27.27 67.2 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.797 -1.186 . . . . 86.8 107.797 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.2 p90 -66.79 -29.36 69.29 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.113 -0.992 . . . . 85.91 110.502 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.2 t -68.5 -40.23 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 123.718 0.807 . . . . 82.0 111.371 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.77 12.4 Favored Pre-proline 0 CA--C 1.489 -1.385 0 N-CA-C 108.522 -0.918 . . . . 120.73 108.522 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.905 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.03 149.75 89.8 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 120.622 0.882 . . . . 87.86 109.861 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.06 -37.96 89.27 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.812 -0.81 . . . . 36.46 108.812 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.7 p-90 -63.76 -33.87 76.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.87 -1.159 . . . . 150.6 107.87 -176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.2 -32.75 73.44 Favored 'General case' 0 CA--C 1.491 -1.319 0 O-C-N 121.255 -0.903 . . . . 123.26 108.661 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.39 -47.21 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.41 -31.04 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.95 -47.12 84.57 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.951 -0.7 . . . . 60.87 109.608 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.06 -35.63 81.06 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 120.004 -0.678 . . . . 157.57 110.361 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.67 -40.85 98.37 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.633 -0.877 . . . . 47.06 108.633 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.25 97.94 Favored 'General case' 0 CA--C 1.496 -1.12 0 O-C-N 121.721 -0.612 . . . . 43.94 109.544 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.85 -43.29 99.15 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.744 -0.836 . . . . 42.61 108.744 -176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.903 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.29 93.91 Favored 'General case' 0 N--CA 1.427 -1.606 0 O-C-N 122.25 -0.281 . . . . 140.66 110.996 -178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.804 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.75 -44.02 97.72 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.605 -1.238 . . . . 116.04 110.22 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.38 -38.81 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 108.759 -0.83 . . . . 97.16 108.759 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.25 -40.03 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.978 -0.749 . . . . 54.85 108.978 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.963 HG22 HG21 ' A' ' 86' ' ' THR . 93.2 t -57.65 -42.37 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.91 -0.774 . . . . 45.39 108.91 -175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.4 t -63.48 -50.99 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 C-N-CA 118.819 -1.152 . . . . 48.64 110.203 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.25 -47.03 78.17 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.167 -0.613 . . . . 116.65 111.73 -174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.95 -43.96 97.74 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.701 -0.481 . . . . 51.16 109.701 -174.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.58 -48.9 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 119.829 -0.748 . . . . 44.3 110.854 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.74 -46.97 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 C-N-CA 120.299 -0.561 . . . . 48.82 111.027 -174.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.2 95.18 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.561 -0.828 . . . . 58.7 111.994 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.61 -34.26 67.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.018 -0.695 . . . . 101.4 111.039 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.89 -38.72 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 107.757 -1.201 . . . . 103.57 107.757 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.45 -43.01 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 108.977 -0.749 . . . . 61.89 108.977 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.7 t -63.43 -50.93 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 120.303 -0.559 . . . . 70.01 109.525 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.809 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.93 -43.43 98.81 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.108 -0.701 . . . . 132.1 109.108 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.21 -46.62 83.08 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.649 -0.251 . . . . 104.5 110.443 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.022 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 C-N-CA 120.213 -0.595 . . . . 142.96 111.253 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.7 pt -64.82 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.957 -1.897 . . . . 158.32 110.838 -175.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.809 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.71 -41.4 98.09 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 117.698 -1.601 . . . . 137.11 109.5 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.37 -44.52 91.14 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 122.156 -0.34 . . . . 54.66 111.015 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 121.612 0.72 . . . . 127.18 109.577 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.79 -36.86 80.08 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 124.102 0.961 . . . . 87.93 110.859 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.042 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.69 78.75 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.69 -0.631 . . . . 131.12 111.514 -175.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.52 7.14 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.294 -2.562 . . . . 246.56 109.598 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.965 0 N-CA-C 105.475 -2.046 . . . . 339.35 105.475 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.14 165.3 17.79 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.19 -39.4 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.766 -1.568 . . . . 143.28 106.766 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.72 -38.04 80.56 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.67 -0.863 . . . . 160.22 108.67 -176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.2 m-20 -62.4 -31.78 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.823 -0.806 . . . . 120.54 108.823 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.57 -43.8 95.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.466 -0.568 . . . . 67.22 109.466 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.59 -39.78 88.59 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 121.505 -0.747 . . . . 138.6 109.623 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.918 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.53 -35.89 81.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.468 0.307 . . . . 151.46 110.679 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.6 -37.89 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 C-N-CA 117.406 -1.718 . . . . 117.93 106.724 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.448 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.96 91.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.855 -1.165 . . . . 56.82 107.855 -177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.017 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.92 98.06 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.937 -0.764 . . . . 145.3 108.937 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.38 95.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.495 -0.928 . . . . 45.71 108.495 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.37 -42.04 99.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.364 -0.606 . . . . 105.61 109.364 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 -39.54 92.78 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.611 -0.885 . . . . 47.89 108.611 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.37 84.84 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.953 -0.388 . . . . 124.53 109.953 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.24 99.26 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.968 -0.458 . . . . 35.89 109.838 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.29 -37.28 84.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.022 -1.473 . . . . 88.97 107.022 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.822 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.16 -49.16 76.96 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.817 -0.753 . . . . 239.91 109.086 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.4 -43.41 90.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.511 -0.743 . . . . 146.1 110.591 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 117.423 -1.711 . . . . 91.74 113.829 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.47 1.95 Allowed 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 115.719 1.748 . . . . 197.45 115.719 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.932 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -75.23 -42.2 55.88 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 117.866 -1.534 . . . . 242.6 114.073 -170.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.963 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.48 -36.5 84.04 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.919 -1.113 . . . . 215.61 109.797 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' CG2' ' A' ' 86' ' ' THR . 73.0 t -60.36 -46.95 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 O-C-N 121.782 -0.574 . . . . 87.19 110.399 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.89 -41.84 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 O-C-N 121.942 -0.474 . . . . 231.82 109.776 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.903 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 10.9 m120 -62.39 -34.12 76.09 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.306 -0.998 . . . . 364.98 108.306 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.2 -44.74 75.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 121.533 -0.729 . . . . 181.63 111.228 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.3 m -60.8 -45.81 92.95 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 107.468 -1.308 . . . . 269.02 107.468 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.062 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.7 -45.07 93.25 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 118.679 -1.209 . . . . 562.66 110.004 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.22 95.59 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 118.634 -1.226 . . . . 446.75 108.103 -167.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.46 -26.35 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.875 -2.33 . . . . 370.05 112.197 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.814 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.49 -26.51 60.06 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.565 -0.71 . . . . 354.91 112.491 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.49 0.98 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.047 1.339 . . . . 462.44 111.868 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.265 11.9 mm-40 -172.35 178.09 2.9 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-O 122.009 0.909 . . . . 652.37 111.129 171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.78 86.31 2.2 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 128.492 2.717 . . . . 905.99 107.906 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.83 -36.45 80.38 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.261 -1.014 . . . . 570.43 108.261 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.34 82.36 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 125.331 1.453 . . . . 453.22 111.129 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.48 178.65 33.98 Favored Glycine 0 C--N 1.348 1.237 0 C-N-CA 118.754 -1.689 . . . . 445.63 109.939 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.91 HD21 ' NZ ' ' B' ' 367' ' ' LYS . 89.0 mt -56.4 -41.21 75.92 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 125.274 1.43 . . . . 457.72 112.38 -170.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.02 Favored 'General case' 0 CA--C 1.484 -1.569 0 C-N-CA 118.678 -1.209 . . . . 340.58 109.335 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.66 -32.23 71.92 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 118.819 -1.152 . . . . 453.6 111.544 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.03 -40.3 73.26 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.013 -1.847 . . . . 541.48 106.013 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.21 75.83 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 123.972 0.795 . . . . 466.68 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.72 -47.09 86.85 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 117.527 -1.669 . . . . 427.34 107.306 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.82 82.77 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 112.402 0.519 . . . . 537.87 112.402 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.33 -42.73 74.93 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 116.845 -1.942 . . . . 422.12 111.576 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.02 -50.15 75.18 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 121.314 -0.866 . . . . 340.17 111.84 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.27 -46.49 71.52 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.084 -1.047 . . . . 258.06 111.75 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.5 Cg_exo -61.53 -31.56 87.52 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 N-CA-C 115.323 1.24 . . . . 305.71 115.323 176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.712 -0.848 . . . . 252.7 108.712 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.56 93.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.8 -1.185 . . . . 149.27 107.8 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.05 -44.78 95.95 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 120.632 -0.427 . . . . 138.08 111.506 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.93 -42.42 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.523 -0.735 . . . . 132.89 110.966 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.71 -44.68 92.89 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 119.749 -0.78 . . . . 193.61 108.925 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.47 -37.7 84.55 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 122.838 0.455 . . . . 63.83 110.079 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.98 -52.4 59.81 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 122.057 -0.402 . . . . 76.4 111.233 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.68 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.166 -1.05 . . . . 171.13 108.166 -174.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.82 -38.52 91.4 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 121.889 -0.507 . . . . 78.3 110.612 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.13 -35.71 80.33 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.897 -1.121 . . . . 92.36 109.231 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 1.017 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.51 -34.31 76.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.131 -1.062 . . . . 93.73 108.131 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.908 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.39 -41.65 84.63 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.248 -0.981 . . . . 132.74 109.346 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.1 94.86 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.17 -1.419 . . . . 43.39 107.17 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.826 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.9 t -58.43 -42.03 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.59 -0.893 . . . . 59.34 108.59 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.04 95.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 121.838 -0.539 . . . . 69.68 110.523 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.46 -42.77 91.95 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.333 -0.988 . . . . 106.98 108.333 -177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.826 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.58 81.36 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 119.712 -0.795 . . . . 147.63 108.928 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.56 99.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.514 -0.921 . . . . 190.06 108.514 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.32 -44.04 97.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.313 -0.995 . . . . 118.85 108.313 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.808 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.39 -42.68 98.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.64 95.28 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 121.827 -0.546 . . . . 89.98 109.86 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.72 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 C-N-CA 118.098 -1.441 . . . . 106.09 111.035 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.29 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 C-N-CA 117.062 -1.855 . . . . 227.74 111.799 -174.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.89 100.06 50.94 Favored Pre-proline 0 CA--C 1.486 -1.515 0 C-N-CA 116.237 -2.185 . . . . 262.55 110.05 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.57 -10.42 28.66 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.678 1.586 . . . . 210.25 111.341 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.03 1.0 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 106.556 -1.646 . . . . 270.58 106.556 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.893 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.85 -39.49 23.54 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 115.382 -0.826 . . . . 129.84 112.325 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.38 -26.59 81.68 Favored 'Trans proline' 0 N--CA 1.431 -2.155 0 N-CA-C 116.31 1.619 . . . . 330.71 116.31 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.01 77.23 7.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 114.467 -2.893 . . . . 204.51 107.289 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.415 -1.328 . . . . 387.41 107.415 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.874 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.73 147.04 33.64 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 118.729 -1.188 . . . . 166.22 109.446 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.73 87.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.841 -1.17 . . . . 44.23 107.841 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.0 m -60.29 -39.11 85.76 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.2 -1.037 . . . . 28.8 108.2 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.73 92.0 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.103 -0.702 . . . . 30.29 109.103 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.65 -42.99 94.03 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.981 -0.748 . . . . 46.11 108.981 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -42.11 99.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.671 -1.233 . . . . 87.33 107.671 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.67 -42.07 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 107.916 -1.142 . . . . 23.69 107.916 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.21 -44.31 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.625 -0.509 . . . . 43.86 109.625 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.55 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.263 -1.014 . . . . 91.13 108.263 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.58 -37.98 88.32 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.72 -0.844 . . . . 65.88 108.72 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.86 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.52 -0.548 . . . . 33.86 109.52 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.35 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.556 -1.275 . . . . 146.52 107.556 -176.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.84 -38.35 90.41 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.475 -0.89 . . . . 75.44 108.878 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.4 t -60.58 -48.4 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 O-C-N 121.063 -1.023 . . . . 43.64 109.72 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.795 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -37.95 89.29 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.096 -0.705 . . . . 102.57 109.096 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.08 86.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.403 -1.332 . . . . 58.16 107.403 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.797 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.53 73.93 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.989 -0.745 . . . . 121.11 108.989 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.03 -42.26 84.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 C-N-CA 118.55 -1.26 . . . . 153.15 109.948 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.05 -43.76 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 113.09 -3.444 . . . . 133.67 113.533 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.899 -1.126 . . . . 157.42 112.167 -171.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.12 2.45 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 115.011 1.485 . . . . 250.91 115.011 -173.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.5 Cg_exo -59.54 -25.42 78.7 Favored 'Trans proline' 0 CA--C 1.488 -1.81 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.01 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.19 -34.21 74.71 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.915 -1.513 . . . . 192.46 106.915 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.02 98.1 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 108.033 -2.027 . . . . 261.0 108.033 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.77 159.13 25.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.529 -3.508 . . . . 491.4 101.529 172.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 116.278 -2.169 . . . . 386.1 109.819 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.913 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.08 -166.61 2.41 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 103.511 -2.774 . . . . 289.8 103.511 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.137 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 117.745 -1.121 . . . . 402.06 109.534 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.5 p -165.3 177.54 7.51 Favored 'General case' 0 CA--C 1.586 2.348 0 C-N-CA 127.314 2.246 . . . . 690.53 114.94 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.31 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.058 1 N-CA-C 123.181 4.511 . . . . 633.62 123.181 162.742 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.763 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.58 153.79 22.17 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.415 2.286 . . . . 617.99 110.918 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.67 174.39 6.01 Favored Pre-proline 0 C--N 1.364 1.222 0 C-N-CA 130.255 3.422 . . . . 434.98 113.417 -175.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.093 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.22 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 N-CA-C 122.408 3.965 . . . . 365.88 122.408 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.7 m -84.88 20.92 1.7 Allowed 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 104.791 -2.3 . . . . 635.81 104.791 178.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.751 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.36 152.27 18.77 Favored 'General case' 1 CA--C 1.419 -4.075 3 N-CA-C 131.934 7.753 . . . . 999.99 131.934 -135.746 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.062 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.85 73.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.747 1 CA-C-N 103.264 -6.335 . . . . 594.32 113.573 149.195 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.21 144.07 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.646 1 N-CA-C 98.337 -4.69 . . . . 811.91 98.337 162.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.763 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.47 144.55 45.92 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.074 -1.851 . . . . 999.99 109.419 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.972 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.24 -175.65 4.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.007 0.908 . . . . 431.86 110.018 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.12 148.68 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 124.384 1.074 . . . . 457.18 108.758 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.35 85.49 3.77 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 124.071 0.948 . . . . 458.77 113.506 -174.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.954 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.38 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.043 0 C-N-CA 124.9 1.28 . . . . 999.99 112.424 168.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.954 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.78 5.63 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 120.84 3.362 . . . . 999.99 120.84 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.029 0 C-N-CA 117.164 -1.814 . . . . 81.18 107.248 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.832 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.12 45.12 0.19 Allowed Pre-proline 0 N--CA 1.423 -1.817 0 CA-C-O 114.866 -2.492 . . . . 999.99 108.748 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.9 Cg_endo -41.52 101.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.141 1 C-N-CA 126.051 4.501 . . . . 999.99 105.7 -170.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.03 97.47 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 126.748 2.019 . . . . 967.72 112.045 -165.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.5 77.99 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.779 -1.563 . . . . 934.3 106.779 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.55 -30.27 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 129.196 2.998 . . . . 565.15 113.938 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.55 55.4 2.79 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 118.423 0.556 . . . . 755.61 109.849 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.137 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.48 -49.35 66.9 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 124.59 1.156 . . . . 325.89 113.203 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.81 -44.94 78.32 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 123.557 0.743 . . . . 250.21 111.61 -169.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.81 -43.28 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.552 0.691 . . . . 142.46 110.375 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.1 -41.56 96.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 123.983 0.913 . . . . 247.69 108.806 -173.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.5 -51.34 69.85 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 125.453 1.501 . . . . 199.61 113.086 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.35 -44.45 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.754 -1.202 . . . . 106.73 107.754 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.14 -48.53 81.28 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.832 -0.622 . . . . 115.01 110.241 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 85.8 t -65.25 -49.2 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.431 -0.908 . . . . 129.42 111.811 -174.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 67.3 m -61.79 -53.18 59.38 Favored 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.223 -1.391 . . . . 172.48 109.969 -172.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.6 t -63.9 -54.19 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 120.489 -0.484 . . . . 55.86 110.987 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.62 -51.52 58.98 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 118.513 -1.275 . . . . 184.68 111.501 -174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.64 -52.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.635 -2.026 . . . . 291.81 114.695 -174.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.06 -54.99 4.85 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 115.153 1.538 . . . . 130.66 115.153 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.9 -48.46 68.66 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.493 1.294 . . . . 80.16 114.493 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.53 83.3 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.483 -174.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.4 Cg_exo -64.79 -27.11 59.75 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.617 -0.57 . . . . 92.17 110.617 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.37 -41.36 76.62 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.478 -1.304 . . . . 135.6 107.478 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.63 91.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.61 -0.515 . . . . 52.1 109.61 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.72 -43.51 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.056 -0.72 . . . . 95.89 109.056 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.908 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.31 -42.33 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.655 -1.609 . . . . 43.41 106.655 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.22 99.06 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.338 -1.505 . . . . 27.69 109.338 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.888 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.76 -47.35 75.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 117.411 0.605 . . . . 54.41 110.423 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.829 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 107.005 -1.479 . . . . 53.88 107.005 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.71 -40.83 93.76 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.517 -0.92 . . . . 68.29 108.517 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -39.04 92.94 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 119.71 -0.796 . . . . 107.59 110.634 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -62.99 -38.41 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 C-N-CA 119.628 -0.829 . . . . 111.61 109.514 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.3 -22.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 108.414 -0.958 . . . . 85.26 108.414 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.91 99.43 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.089 -0.804 . . . . 40.71 111.089 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.7 -44.12 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 108.386 -0.968 . . . . 95.86 108.386 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.89 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.445 -0.946 . . . . 144.37 108.445 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.38 132.15 47.48 Favored 'General case' 0 CA--C 1.488 -1.412 0 N-CA-C 107.61 -1.255 . . . . 326.72 107.61 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.025 -1.843 . . . . 158.38 106.025 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.85 98.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.676 -0.49 . . . . 36.78 109.676 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.14 125.8 25.05 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.15 -1.02 . . . . 85.46 109.812 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.84 126.57 8.88 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.539 -2.023 . . . . 127.78 105.539 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.89 34.77 Favored Pre-proline 0 CA--C 1.493 -1.233 0 N-CA-C 105.929 -1.878 . . . . 164.84 105.929 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.7 Cg_exo -56.82 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.189 0 N-CA-C 113.926 0.702 . . . . 222.35 113.926 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.1 166.95 44.94 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 106.435 -2.666 . . . . 45.22 106.435 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.9 -45.81 93.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.058 -1.83 . . . . 107.57 106.058 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.4 m -65.73 141.77 58.23 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 118.924 -1.11 . . . . 167.96 109.151 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.4 m 99.56 106.71 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 126.67 1.988 . . . . 280.68 109.71 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.98 11.31 0.7 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.455 1.102 . . . . 218.25 110.694 174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.58 54.78 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.234 -2.135 . . . . 343.57 105.234 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.89 1.53 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.868 -1.53 . . . . 263.29 106.868 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.35 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 126.565 1.946 . . . . 261.92 108.484 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.2 -38.1 89.83 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.891 -1.151 . . . . 106.81 107.891 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.391 -1.324 . . . . 112.2 107.531 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.735 HG12 ' NH1' ' A' ' 244' ' ' ARG . 76.0 t -64.36 -39.77 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 109.247 -0.649 . . . . 45.41 109.247 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.07 68.91 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.28 -0.267 . . . . 97.62 110.28 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.6 81.71 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.691 0.796 . . . . 59.29 110.976 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.26 -36.49 83.84 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.624 1.17 . . . . 106.49 110.668 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.68 69.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.302 -0.999 . . . . 106.62 108.302 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.08 91.62 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 121.87 -0.518 . . . . 75.97 110.039 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.52 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 C-N-CA 122.909 0.484 . . . . 65.27 109.802 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.95 -41.64 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 C-N-CA 120.391 -0.524 . . . . 107.94 110.174 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.49 -40.82 98.09 Favored 'General case' 0 N--CA 1.434 -1.235 0 O-C-N 121.649 -0.657 . . . . 87.98 110.3 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.62 -40.4 96.81 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.794 -1.162 . . . . 65.5 108.378 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.127 -1.064 . . . . 85.05 108.127 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.5 -45.72 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 109.076 -0.712 . . . . 42.25 109.076 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.31 -38.3 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.55 -0.86 . . . . 91.01 109.378 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.003 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.0 t -58.89 -41.54 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.96 -1.126 . . . . 66.09 107.96 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 95.0 t -66.04 -43.23 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 O-C-N 122.108 -0.37 . . . . 52.39 110.324 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.77 88.2 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 121.883 -0.511 . . . . 46.42 109.856 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.742 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.4 t -62.35 -38.12 88.28 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.311 -0.996 . . . . 116.51 108.311 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.26 -48.22 82.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.384 -0.599 . . . . 65.18 109.384 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.67 97.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 122.118 -0.364 . . . . 51.33 110.432 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.63 -43.32 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 C-N-CA 118.91 -1.116 . . . . 126.3 109.016 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.6 -49.31 69.25 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.476 -0.889 . . . . 133.94 112.491 -176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.67 -33.43 35.54 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.853 2.168 . . . . 134.84 116.853 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.41 -41.61 90.22 Favored Pre-proline 0 CA--C 1.493 -1.236 0 O-C-N 121.671 -0.643 . . . . 72.23 111.647 -167.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.2 Cg_exo -60.66 -35.98 87.15 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 CA-C-N 119.887 0.995 . . . . 106.13 111.334 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.7 82.21 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 119.728 -0.789 . . . . 128.35 110.027 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.639 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.8 88.79 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 110.24 -0.281 . . . . 100.73 110.24 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.55 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 C-N-CA 119.285 -0.966 . . . . 172.72 109.137 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.59 -28.07 68.22 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 108.195 -1.039 . . . . 249.23 108.195 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.5 t80 -55.58 -55.1 35.96 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.667 -1.605 . . . . 259.78 106.667 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.2 -44.15 72.7 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 113.568 0.951 . . . . 233.11 113.568 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.839 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.29 91.35 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 119.182 -1.007 . . . . 169.54 110.588 -171.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.07 -24.59 79.72 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.707 -1.728 . . . . 255.47 114.708 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.57 -44.22 94.72 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 119.189 0.904 . . . . 279.03 108.899 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.839 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.29 -44.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 110.091 -0.337 . . . . 162.21 110.091 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.782 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.43 84.87 59.36 Favored Pre-proline 0 N--CA 1.431 -1.394 0 C-N-CA 118.712 -1.195 . . . . 128.13 108.028 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.28 164.04 11.22 Favored 'Trans proline' 0 C--N 1.295 -2.274 0 N-CA-C 107.443 -1.791 . . . . 278.35 107.443 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.871 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.12 15.03 9.93 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 123.756 0.66 . . . . 312.91 109.343 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.7 -170.65 2.48 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.506 -1.664 . . . . 353.54 106.506 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.28 46.95 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.389 -1.337 . . . . 251.26 107.389 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 102.069 -3.308 . . . . 175.26 102.069 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.96 96.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 100.894 -3.743 . . . . 99.07 100.894 172.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.46 124.16 9.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.455 -2.794 . . . . 243.21 103.455 171.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.99 112.97 25.11 Favored 'General case' 0 CA--C 1.473 -2.0 0 C-N-CA 115.992 -2.283 . . . . 201.04 105.316 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 C-N-CA 116.02 -2.272 . . . . 201.36 108.82 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.093 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.52 -41.44 89.98 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.834 174.516 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.92 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.77 86.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 118.213 -1.395 . . . . 215.06 112.538 -171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.61 -46.47 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.607 -1.237 . . . . 125.28 112.917 -171.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.953 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -36.94 85.93 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.229 -1.397 . . . . 268.9 107.229 -171.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.29 -44.97 74.32 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 125.617 1.567 . . . . 280.88 108.792 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.48 86.06 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.004 -1.078 . . . . 184.47 108.958 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.99 -42.09 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 119.285 -0.966 . . . . 167.92 112.709 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.73 -38.81 90.18 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 117.792 -1.563 . . . . 367.18 110.734 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.3 m95 -67.2 -32.7 73.95 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.824 -0.547 . . . . 173.97 110.402 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.52 -36.73 85.14 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.559 0.744 . . . . 119.66 109.797 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.21 -34.0 74.39 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.703 -1.221 . . . . 112.3 107.703 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.1 -32.08 73.37 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.228 -0.442 . . . . 174.17 110.235 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.6 m -64.7 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 124.685 1.194 . . . . 145.27 110.627 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.62 -35.4 70.41 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.093 -1.077 . . . . 170.15 108.093 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.822 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.26 -34.17 63.81 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 122.721 0.408 . . . . 214.57 110.63 -171.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.21 -33.2 56.29 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.022 1.729 . . . . 168.29 115.548 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.35 -34.9 79.22 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 114.096 1.147 . . . . 167.15 114.096 -168.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.18 -38.32 33.67 Favored Pre-proline 0 N--CA 1.434 -1.234 0 C-N-CA 115.485 -2.486 . . . . 165.13 113.931 -171.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.57 -31.81 79.82 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 CA-C-N 122.809 2.039 . . . . 123.92 111.231 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.77 -42.54 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 118.845 -1.142 . . . . 110.55 109.807 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.003 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.16 -39.99 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.849 -0.797 . . . . 145.31 108.849 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.918 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.08 -48.88 78.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.447 -0.901 . . . . 246.68 109.789 -177.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.4 m -62.18 -47.48 84.29 Favored 'General case' 0 CA--C 1.485 -1.555 0 C-N-CA 119.524 -0.87 . . . . 64.43 109.565 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.85 -45.06 79.34 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 118.985 -1.086 . . . . 80.72 110.2 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.72 75.91 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 116.022 1.86 . . . . 140.44 116.022 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.79 132.24 34.45 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 112.71 -3.596 . . . . 178.87 113.031 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.615 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.35 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 114.358 -1.292 . . . . 110.22 110.112 -177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.85 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.71 -50.61 72.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 121.74 -0.6 . . . . 174.78 109.756 -174.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.95 -41.63 95.32 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.31 -50.23 73.59 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 120.011 -0.676 . . . . 117.2 109.214 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.08 75.54 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.375 -0.53 . . . . 112.6 111.113 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.11 -37.44 94.57 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.596 -1.002 . . . . 101.46 110.596 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.022 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.13 -45.98 91.05 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 118.485 1.143 . . . . 151.49 109.541 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.13 -36.31 77.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.931 -1.507 . . . . 142.32 106.931 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.72 -41.9 91.9 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.46 85.87 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 122.309 -0.244 . . . . 76.11 111.019 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -55.51 30.77 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.374 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.29 131.5 41.23 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.94 -2.985 . . . . 192.73 102.94 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.17 -44.18 92.14 Favored 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.192 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.8 m -79.4 -177.1 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.464 0 N-CA-C 106.332 -1.729 . . . . 69.68 106.332 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -58.97 -75.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 118.368 -0.621 . . . . 191.05 112.583 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.54 43.87 16.43 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 123.562 0.539 . . . . 287.03 109.756 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.5 78.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.922 0 C-N-CA 112.977 -3.489 . . . . 292.29 109.847 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.41 -152.84 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 104.195 -2.52 . . . . 184.57 104.195 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.69 4.94 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 113.038 0.755 . . . . 274.56 113.038 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.92 57.3 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 117.69 -2.195 . . . . 268.24 113.487 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 58.0 m-20 51.5 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.641 1.221 . . . . 200.06 110.788 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.85 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.897 -1.149 . . . . 114.44 107.897 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.1 21.79 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.593 -1.262 . . . . 263.81 107.593 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.37 3.61 Favored Glycine 0 CA--C 1.479 -2.206 1 N-CA-C 102.518 -4.233 . . . . 103.79 102.518 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.054 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.29 95.64 10.26 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 114.914 -2.715 . . . . 117.3 106.016 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.029 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.93 -39.82 90.84 Favored 'General case' 0 CA--C 1.468 -2.179 1 N-CA-C 97.989 -4.819 . . . . 231.58 97.989 167.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.042 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.45 29.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.097 -3.297 . . . . 303.24 102.097 169.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.054 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.6 -48.62 78.64 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 116.022 -2.271 . . . . 112.72 108.391 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -60.99 -63.71 1.2 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.095 -0.706 . . . . 83.22 109.095 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.7 m -156.24 -126.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.86 -2.644 . . . . 174.36 103.86 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.029 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.2 mtt180 -60.9 160.97 8.81 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.787 -1.931 . . . . 202.73 105.787 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.92 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.093 -1.447 . . . . 180.62 107.093 176.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.52 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 105.356 -2.09 . . . . 145.25 105.356 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 66.9 tt0 -66.05 -43.17 88.27 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 106.171 -1.789 . . . . 66.05 106.171 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.69 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.536 -2.764 . . . . 266.49 103.536 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.698 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.31 -124.96 0.28 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.023 -1.871 . . . . 219.2 107.793 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.903 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.03 -37.38 94.15 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.552 -1.204 . . . . 94.78 112.877 -176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.827 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.19 100.41 9.08 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.324 -3.751 . . . . 121.41 109.469 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.01 145.49 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 108.948 -0.76 . . . . 85.34 108.948 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.75 143.47 41.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.865 -1.161 . . . . 267.57 107.865 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.524 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 49.97 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 109.518 -0.549 . . . . 226.1 109.518 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.6 p -50.93 156.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 106.997 -1.483 . . . . 154.84 106.997 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.58 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.36 161.94 8.53 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 121.627 0.727 . . . . 180.01 110.679 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.898 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.44 156.91 23.66 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.964 -1.495 . . . . 333.78 106.964 -178.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.48 48.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.4 mm-40 82.85 158.84 0.13 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.739 -0.838 . . . . 266.47 108.739 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.53 -46.93 88.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.674 -1.972 . . . . 59.34 105.674 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.6 173.83 11.99 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.415 -2.439 . . . . 201.26 104.415 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.0 mt -95.87 106.68 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 116.322 -2.151 . . . . 56.23 105.562 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.11 -59.46 5.3 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 109.309 -0.626 . . . . 87.58 109.309 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.893 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.53 153.74 22.24 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 107.841 -1.17 . . . . 219.95 107.841 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.04 83.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.435 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 105.86 -1.904 . . . . 53.85 105.86 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.24 16.58 77.09 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 106.067 -2.813 . . . . 196.55 106.067 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.683 0 N-CA-C 107.848 -1.167 . . . . 35.88 107.848 -178.866 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.487 HH12 ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.04 144.09 68.34 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.67 1.58 . . . . 1.0 111.831 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.91 ' NZ ' HD21 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -70.52 127.39 92.07 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.248 -0.433 . . . . 1.0 109.864 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.4 Cg_endo -69.09 -19.96 38.61 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.496 2.13 . . . . 1.0 114.504 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.512 ' HB3' ' HD2' ' B' ' 367' ' ' LYS . 0.7 OUTLIER -58.31 -38.66 77.51 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.789 -178.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.486 ' O ' HD22 ' B' ' 374' ' ' LEU . 17.2 tt0 -71.28 -10.48 59.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.812 0.339 . . . . 1.0 110.578 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.811 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.66 -46.34 87.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.28 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.57 -49.03 78.29 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.596 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.06 78.35 0.31 Allowed Glycine 0 CA--C 1.516 0.113 0 N-CA-C 109.764 -1.334 . . . . 1.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.486 HD22 ' O ' ' B' ' 370' ' ' GLN . 0.1 OUTLIER -61.01 -41.89 97.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.759 0.314 . . . . 1.0 110.191 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.07 -0.967 . . . . 1.0 110.522 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.365 -0.976 . . . . 97.08 108.365 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.55 155.39 22.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.088 0.946 . . . . 123.41 110.766 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.888 HG11 HD13 ' A' ' 15' ' ' ILE . 28.9 m -134.62 -162.39 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.513 1 N-CA-C 100.056 -4.053 . . . . 151.3 100.056 173.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.904 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.65 -38.57 58.05 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.939 -2.305 . . . . 169.25 106.139 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.904 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.27 0.616 . . . . 185.76 110.53 171.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.905 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.8 t -64.5 -25.86 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.988 2.115 . . . . 145.47 110.383 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.77 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.36 157.38 21.48 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.099 -1.0 . . . . 102.76 109.427 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.58 154.2 25.1 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 107.994 -1.113 . . . . 106.25 107.994 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.914 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.9 51.9 0.74 Allowed 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 117.807 -1.557 . . . . 157.81 107.616 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.24 -45.87 91.75 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.585 -2.746 . . . . 150.2 103.585 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.01 164.71 35.26 Favored Pre-proline 0 N--CA 1.423 -1.819 0 N-CA-C 103.652 -2.721 . . . . 183.52 103.652 172.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -76.82 6.92 3.82 Favored 'Trans proline' 0 C--N 1.281 -2.982 0 N-CA-C 109.973 -0.818 . . . . 235.61 109.973 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.95 -41.24 82.44 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 124.781 1.233 . . . . 113.77 113.377 -170.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.21 136.2 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 119.605 1.093 . . . . 150.85 110.989 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.47 156.29 46.4 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.595 -1.261 . . . . 100.42 107.595 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.077 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.59 58.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.967 0.889 . . . . 129.36 110.389 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.43 68.36 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 126.241 1.816 . . . . 112.34 106.702 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.946 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.4 m -74.1 -40.2 62.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.545 -0.752 . . . . 131.73 111.766 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.077 ' H ' HG23 ' A' ' 17' ' ' THR . 71.6 m -84.42 -42.85 15.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 117.036 2.236 . . . . 80.49 117.036 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -146.0 174.55 3.34 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 118.151 -1.42 . . . . 98.98 111.198 -169.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 86.0 Cg_exo -61.81 -10.8 18.29 Favored 'Trans proline' 0 C--N 1.321 -0.898 1 N-CA-C 128.919 6.469 . . . . 246.95 128.919 -170.09 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.63 17.58 8.75 Favored 'General case' 0 C--N 1.324 -0.542 1 CA-C-N 126.152 4.069 . . . . 269.62 114.209 175.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.12 -27.33 67.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.816 -1.179 . . . . 86.8 107.816 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.77 -29.33 69.26 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.119 -0.988 . . . . 85.91 110.493 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.869 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.57 -40.18 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.728 0.811 . . . . 82.0 111.339 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.894 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.44 167.73 12.49 Favored Pre-proline 0 CA--C 1.489 -1.376 0 N-CA-C 108.518 -0.919 . . . . 120.73 108.518 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.9 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.8 Cg_endo -63.97 149.76 89.85 Favored 'Trans proline' 0 N--CA 1.433 -2.082 0 C-N-CA 120.578 0.852 . . . . 87.86 109.937 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.05 -37.92 89.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.884 -0.784 . . . . 36.46 108.884 -176.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.815 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.77 -33.91 76.73 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.812 -1.181 . . . . 150.6 107.812 -176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.9 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.16 -32.74 73.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 121.301 -0.874 . . . . 123.26 108.645 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.15 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.16 -0.681 . . . . 120.14 109.16 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.4 -31.02 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.918 -1.141 . . . . 112.19 107.918 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.4 tp -63.02 -47.09 84.55 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.924 -0.71 . . . . 60.87 109.576 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.07 -35.6 80.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.933 -0.707 . . . . 157.57 110.392 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.92 98.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.622 -0.881 . . . . 47.06 108.622 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.19 97.93 Favored 'General case' 0 CA--C 1.496 -1.128 0 O-C-N 121.745 -0.597 . . . . 43.94 109.526 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.735 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.88 -43.29 99.14 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.688 -0.856 . . . . 42.61 108.688 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.22 93.86 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.625 -0.261 . . . . 140.66 111.024 -178.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.81 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.566 -1.254 . . . . 116.04 110.211 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.43 -38.72 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.747 -0.835 . . . . 97.16 108.747 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.849 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.0 mt -61.34 -39.94 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 108.99 -0.744 . . . . 54.85 108.99 -176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.959 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.72 -42.39 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 108.877 -0.786 . . . . 45.39 108.877 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.6 t -63.49 -50.94 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.217 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.26 -47.07 78.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.196 -0.601 . . . . 116.65 111.693 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.591 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -62.0 -43.93 97.81 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.705 -0.48 . . . . 51.16 109.705 -174.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.7 t -65.5 -48.93 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.878 -0.729 . . . . 44.3 110.878 -177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.5 t -64.8 -46.94 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 120.308 -0.557 . . . . 48.82 110.995 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.2 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.505 -0.855 . . . . 58.7 111.987 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.66 -34.17 67.07 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 122.118 -0.637 . . . . 101.4 111.032 -175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 107.748 -1.204 . . . . 103.57 107.748 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.9 t -61.4 -43.06 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 108.965 -0.754 . . . . 61.89 108.965 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.532 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.9 t -63.45 -50.93 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 109.453 -0.573 . . . . 70.01 109.453 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.804 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.96 -43.41 98.87 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 109.165 -0.68 . . . . 132.1 109.165 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.641 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.16 -46.64 83.14 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 116.623 -0.262 . . . . 104.5 110.472 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.026 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.71 -49.91 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.941 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.9 pt -64.77 -41.67 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 116.96 -1.896 . . . . 158.32 110.859 -175.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.74 -41.34 98.04 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.459 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.53 90.95 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.173 -0.329 . . . . 54.66 110.994 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.928 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.4 117.17 29.45 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-O 121.651 0.739 . . . . 127.18 109.575 -174.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.618 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.88 80.3 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.067 0.947 . . . . 87.93 110.813 -176.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.04 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.63 78.61 Favored 'General case' 0 CA--C 1.491 -1.309 0 O-C-N 121.655 -0.653 . . . . 131.12 111.481 -175.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.026 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.43 7.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 115.319 -2.553 . . . . 246.56 109.607 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.48 3.49 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 105.471 -2.048 . . . . 339.35 105.471 177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.22 165.26 17.92 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 102.989 -2.967 . . . . 114.66 102.989 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.13 -39.46 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.783 -1.562 . . . . 143.28 106.783 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.837 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.67 -38.05 80.44 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.673 -0.862 . . . . 160.22 108.673 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.3 m-20 -62.37 -31.75 72.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.88 -0.785 . . . . 120.54 108.88 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.899 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.56 -43.86 95.8 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.507 -0.553 . . . . 67.22 109.507 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.49 -39.8 88.92 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.504 -0.747 . . . . 138.6 109.654 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.926 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.94 82.14 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 122.529 0.332 . . . . 151.46 110.631 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.941 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.54 -37.98 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 C-N-CA 117.397 -1.721 . . . . 117.93 106.75 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.0 -46.01 90.88 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.928 -1.138 . . . . 56.82 107.928 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.89 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.4 -43.94 98.01 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.911 -0.774 . . . . 145.3 108.911 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.38 95.47 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.523 -0.917 . . . . 45.71 108.523 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.35 -42.06 99.09 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.384 -0.599 . . . . 105.61 109.384 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.5 92.67 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.608 -0.886 . . . . 47.89 108.608 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.58 -37.35 84.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 109.942 -0.392 . . . . 124.53 109.942 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.23 99.28 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 121.979 -0.45 . . . . 35.89 109.851 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.19 -37.31 84.8 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 107.038 -1.467 . . . . 88.97 107.038 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.819 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.23 -49.2 76.69 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.978 -0.749 . . . . 239.91 108.978 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.38 91.02 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.594 -0.691 . . . . 146.1 110.635 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.14 -58.24 3.4 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 117.422 -1.711 . . . . 91.74 113.86 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.6 -61.31 2.0 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.74 1.755 . . . . 197.45 115.74 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.923 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.32 -42.2 55.01 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.872 -1.531 . . . . 242.6 114.042 -170.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.959 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.56 84.33 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 118.921 -1.112 . . . . 215.61 109.813 -172.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 O-C-N 121.843 -0.535 . . . . 87.19 110.462 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.8 t -65.96 -41.83 90.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 109.72 -0.474 . . . . 231.82 109.72 -178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.15 76.07 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.326 -0.99 . . . . 364.98 108.326 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.1 t80 -68.13 -44.8 75.27 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.568 -0.708 . . . . 181.63 111.29 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.806 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.1 m -60.81 -45.78 93.07 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.471 -1.307 . . . . 269.02 107.471 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.75 -45.0 93.56 Favored 'General case' 0 N--CA 1.415 -2.183 0 C-N-CA 118.646 -1.222 . . . . 562.66 110.03 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.26 95.42 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 118.725 -1.19 . . . . 446.75 108.076 -167.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.47 -26.37 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 C-N-CA 115.842 -2.343 . . . . 370.05 112.22 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.806 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.1 m-70 -74.45 -26.5 60.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.555 -0.716 . . . . 354.91 112.507 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.77 4.59 0.99 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.09 1.356 . . . . 462.44 111.891 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.8 mm-40 -172.36 178.04 2.91 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.989 0.9 . . . . 652.37 111.107 171.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.794 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.31 2.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.477 2.711 . . . . 905.99 107.905 -174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.95 -36.37 79.99 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.2 -1.037 . . . . 570.43 108.2 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.55 -36.34 82.32 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 125.303 1.441 . . . . 453.22 111.171 -174.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.54 178.67 33.91 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 118.799 -1.667 . . . . 445.63 109.925 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.21 75.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 125.274 1.429 . . . . 457.72 112.358 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.6 -46.99 85.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.701 -1.2 . . . . 340.58 109.262 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 87.8 m-85 -68.71 -32.17 71.78 Favored 'General case' 0 N--CA 1.424 -1.747 0 C-N-CA 118.755 -1.178 . . . . 453.6 111.552 -176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.4 t -56.03 -40.32 73.27 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.86 -47.18 75.8 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 123.976 0.798 . . . . 466.68 110.803 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.07 86.92 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.457 -1.697 . . . . 427.34 107.287 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.12 -36.78 82.64 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.398 0.518 . . . . 537.87 112.398 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.42 -42.67 74.73 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.852 -1.939 . . . . 422.12 111.585 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.86 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.08 -50.09 75.41 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 121.336 -0.853 . . . . 340.17 111.818 -173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -65.24 -46.58 71.95 Favored Pre-proline 0 N--CA 1.443 -0.821 0 C-N-CA 119.097 -1.041 . . . . 258.06 111.754 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.923 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 22.7 Cg_exo -61.53 -31.54 87.56 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 N-CA-C 115.37 1.258 . . . . 305.71 115.37 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.683 -0.858 . . . . 252.7 108.683 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.89 -40.65 93.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.785 -1.191 . . . . 149.27 107.785 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.77 95.99 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.621 -0.432 . . . . 138.08 111.485 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.655 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.7 t -66.91 -42.41 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 O-C-N 121.588 -0.695 . . . . 132.89 110.998 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.926 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.69 -44.75 92.74 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.875 -0.787 . . . . 193.61 108.875 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.46 -37.68 84.46 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 122.773 0.429 . . . . 63.83 110.057 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.1 m -63.97 -52.45 59.61 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.092 -0.38 . . . . 76.4 111.231 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.65 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 108.203 -1.036 . . . . 171.13 108.203 -174.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.091 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.4 m-85 -63.69 -38.68 92.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.845 -0.534 . . . . 78.3 110.649 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.56 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.3 t -67.02 -35.78 80.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 118.925 -1.11 . . . . 92.36 109.249 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.967 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.48 -34.3 76.57 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.188 -1.042 . . . . 93.73 108.188 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.1 p -67.39 -41.68 84.55 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.194 -1.002 . . . . 132.74 109.341 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.05 94.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.217 -1.401 . . . . 43.39 107.217 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.6 t -58.48 -41.97 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.08 95.48 Favored 'General case' 0 CA--C 1.497 -1.061 0 O-C-N 121.765 -0.584 . . . . 69.68 110.553 -177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.5 -42.74 91.78 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.339 -0.985 . . . . 106.98 108.339 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.32 -35.64 81.54 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.69 -0.804 . . . . 147.63 108.956 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.708 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.18 -41.49 99.22 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.602 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.2 t80 -61.36 -44.03 97.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.298 -1.001 . . . . 118.85 108.298 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.39 -42.63 98.82 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 110.022 -0.362 . . . . 102.5 110.022 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.64 95.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.808 -0.558 . . . . 89.98 109.818 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.919 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.47 -50.76 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 118.201 -1.4 . . . . 106.09 110.985 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.08 -48.31 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 C-N-CA 117.119 -1.832 . . . . 227.74 111.81 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.757 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.12 50.94 Favored Pre-proline 0 CA--C 1.486 -1.494 0 C-N-CA 116.18 -2.208 . . . . 262.55 110.057 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.42 28.62 Favored 'Trans proline' 0 C--N 1.289 -2.581 0 C-N-CA 121.616 1.544 . . . . 210.25 111.326 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 111.95 0.98 Allowed 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.533 -1.655 . . . . 270.58 106.533 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.878 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.74 -39.53 24.67 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.373 -0.831 . . . . 129.84 112.382 -176.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.9 Cg_exo -61.4 -26.56 81.53 Favored 'Trans proline' 0 N--CA 1.431 -2.161 0 N-CA-C 116.27 1.604 . . . . 330.71 116.27 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.2 7.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.51 -2.876 . . . . 204.51 107.275 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.71 147.41 0.09 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.419 -1.326 . . . . 387.41 107.419 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.69 147.07 33.72 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 118.781 -1.168 . . . . 166.22 109.466 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.91 -40.69 87.75 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.851 -1.166 . . . . 44.23 107.851 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.3 -39.13 85.88 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 108.195 -1.039 . . . . 28.8 108.195 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.87 -38.76 92.14 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.079 -0.712 . . . . 30.29 109.079 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.844 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.7 m -59.63 -42.99 93.95 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.988 -0.745 . . . . 46.11 108.988 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.18 99.3 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.644 -1.243 . . . . 87.33 107.644 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.773 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.64 -42.09 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.953 -1.129 . . . . 23.69 107.953 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.17 -44.32 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 109.703 -0.48 . . . . 43.86 109.703 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.916 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.22 -42.59 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.303 -0.999 . . . . 91.13 108.303 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.486 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.6 -37.94 88.2 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.727 -0.842 . . . . 65.88 108.727 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.13 -41.84 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 109.521 -0.548 . . . . 33.86 109.521 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.091 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.43 -40.31 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 107.586 -1.264 . . . . 146.52 107.586 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.703 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.0 m95 -62.89 -38.28 90.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.469 -0.892 . . . . 75.44 108.929 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.55 -48.42 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 O-C-N 121.056 -1.028 . . . . 43.64 109.726 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.788 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.68 -38.02 89.52 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.042 -0.725 . . . . 102.57 109.042 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.07 86.76 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.428 -1.323 . . . . 58.16 107.428 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.8 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.56 73.96 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.999 -0.741 . . . . 121.11 108.999 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -57.96 -42.32 84.73 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 118.56 -1.256 . . . . 153.15 109.98 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.055 HD13 HG13 ' A' ' 200' ' ' VAL . 11.6 mt -81.08 -43.73 19.04 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 113.125 -3.43 . . . . 133.67 113.518 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.96 -39.93 96.14 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 120.91 -1.119 . . . . 157.42 112.187 -171.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.43 -36.06 2.44 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 115.038 1.496 . . . . 250.91 115.038 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.1 Cg_exo -59.58 -25.46 78.92 Favored 'Trans proline' 0 CA--C 1.488 -1.805 0 N-CA-C 117.989 2.265 . . . . 207.34 117.989 -174.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.018 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.2 -34.17 74.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.93 -1.508 . . . . 192.46 106.93 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.05 98.09 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.959 -2.056 . . . . 261.0 107.959 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.76 159.15 25.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 101.512 -3.514 . . . . 491.4 101.512 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -60.02 106.86 0.55 Allowed 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 116.25 -2.18 . . . . 386.1 109.799 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.912 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.2 m -154.02 -166.63 2.42 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 103.563 -2.755 . . . . 289.8 103.563 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.131 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.93 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 117.757 -1.116 . . . . 402.06 109.567 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.22 177.52 7.58 Favored 'General case' 0 CA--C 1.586 2.34 0 C-N-CA 127.302 2.241 . . . . 690.53 114.922 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.32 160.62 0.0 OUTLIER 'General case' 1 C--N 1.429 4.046 1 N-CA-C 123.203 4.52 . . . . 633.62 123.203 162.672 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.69 153.84 22.06 Favored 'General case' 0 C--N 1.389 2.321 0 C-N-CA 127.354 2.262 . . . . 617.99 110.917 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.045 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.41 5.98 Favored Pre-proline 0 C--N 1.364 1.22 0 C-N-CA 130.291 3.436 . . . . 434.98 113.381 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.09 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.3 Cg_endo -44.25 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 122.428 3.972 . . . . 365.88 122.428 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.96 1.69 Allowed 'General case' 0 CA--C 1.467 -2.229 0 N-CA-C 104.774 -2.306 . . . . 635.81 104.774 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.41 152.24 18.77 Favored 'General case' 1 CA--C 1.419 -4.087 3 N-CA-C 132.002 7.779 . . . . 999.99 132.002 -135.767 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.2 t -131.84 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.774 1 CA-C-N 103.337 -6.301 . . . . 594.32 113.615 149.237 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.14 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 1 N-CA-C 98.277 -4.712 . . . . 811.91 98.277 162.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.48 144.48 45.98 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.424 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.976 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.15 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.003 0.906 . . . . 431.86 110.05 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.13 148.65 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 124.39 1.076 . . . . 457.18 108.766 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.48 3.74 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 124.106 0.962 . . . . 458.77 113.535 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CD1' ' HD3' ' A' ' 185' ' ' PRO . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.975 1.31 . . . . 999.99 112.401 168.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.1 Cg_exo -65.95 -45.84 5.56 Favored 'Trans proline' 0 N--CA 1.438 -1.794 0 N-CA-C 120.855 3.367 . . . . 999.99 120.855 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.509 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.55 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.037 0 C-N-CA 117.2 -1.8 . . . . 81.18 107.283 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.835 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.866 0 CA-C-O 114.908 -2.472 . . . . 999.99 108.743 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.066 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.1 Cg_endo -41.63 101.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.144 1 C-N-CA 126.045 4.497 . . . . 999.99 105.692 -170.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -62.31 -44.01 97.51 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 126.721 2.008 . . . . 967.72 112.04 -165.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.27 -36.52 78.0 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.75 -1.574 . . . . 934.3 106.75 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.61 -30.21 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 129.18 2.992 . . . . 565.15 113.92 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.52 55.43 2.8 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 118.451 0.568 . . . . 755.61 109.846 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.131 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.53 -49.29 66.99 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.554 1.142 . . . . 325.89 113.254 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 272' ' ' TYR . 79.0 tttt -55.79 -44.98 78.31 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 123.582 0.753 . . . . 250.21 111.602 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.77 -43.28 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 121.575 0.702 . . . . 142.46 110.399 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.04 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.6 t80 -61.09 -41.55 96.87 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.953 0.901 . . . . 247.69 108.83 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.826 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.51 -51.29 70.07 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 125.429 1.491 . . . . 199.61 113.122 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.37 -44.52 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 107.673 -1.232 . . . . 106.73 107.673 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.12 -48.57 81.14 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 115.875 -0.602 . . . . 115.01 110.217 -173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.055 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.21 -49.1 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 119.393 -0.923 . . . . 129.42 111.875 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.797 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.0 m -61.88 -53.18 59.28 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 118.209 -1.396 . . . . 172.48 109.919 -172.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.2 t -63.82 -54.3 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 120.53 -0.468 . . . . 55.86 110.942 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.56 58.97 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 118.546 -1.262 . . . . 184.68 111.525 -174.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 116.641 -2.023 . . . . 291.81 114.74 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.7 t80 -82.02 -55.02 4.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 115.172 1.545 . . . . 130.66 115.172 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.797 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.92 -48.48 68.52 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.459 1.281 . . . . 80.16 114.459 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.9 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.53 -45.49 83.33 Favored Pre-proline 0 N--CA 1.435 -1.19 0 C-N-CA 119.996 -0.682 . . . . 136.02 109.503 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.83 -27.12 59.46 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 N-CA-C 110.627 -0.566 . . . . 92.17 110.627 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.35 -41.37 76.67 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.475 -1.305 . . . . 135.6 107.475 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.15 -44.73 91.22 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.67 -43.46 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.147 -0.686 . . . . 95.89 109.147 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.29 -42.39 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.683 -1.599 . . . . 43.41 106.683 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.42 -42.29 99.11 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.363 -1.495 . . . . 27.69 109.363 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.65 -47.4 75.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 O-C-N 122.177 -0.602 . . . . 54.41 110.47 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.39 -34.12 74.8 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.984 -1.488 . . . . 53.88 106.984 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.8 -40.81 94.02 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.466 -0.938 . . . . 68.29 108.466 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.8 -39.02 92.91 Favored 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 119.679 -0.808 . . . . 107.59 110.625 -175.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.33 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 119.64 -0.824 . . . . 111.61 109.549 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.919 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.29 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.393 -0.965 . . . . 85.26 108.393 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.88 -41.89 99.42 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.072 -0.811 . . . . 40.71 111.072 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.73 -44.11 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 108.384 -0.969 . . . . 95.86 108.384 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.825 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.91 -137.53 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.907 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.34 132.13 47.31 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.589 -1.263 . . . . 326.72 107.589 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.457 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.02 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 105.991 -1.855 . . . . 158.38 105.991 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.457 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.91 98.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.662 -0.496 . . . . 36.78 109.662 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.4 m -61.09 125.87 25.29 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.148 -1.021 . . . . 85.46 109.816 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.696 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.9 126.56 8.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.498 -2.038 . . . . 127.78 105.498 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.91 34.81 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.8 Cg_exo -56.78 -39.92 87.94 Favored 'Trans proline' 0 N--CA 1.431 -2.174 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.14 167.0 44.92 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.92 -45.76 93.37 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 106.057 -1.831 . . . . 107.57 106.057 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.729 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.8 141.84 58.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 118.842 -1.143 . . . . 167.96 109.177 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.47 106.75 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 126.754 2.022 . . . . 280.68 109.732 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.8 m-20 56.02 11.24 0.7 Allowed 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.503 1.121 . . . . 218.25 110.695 174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.61 54.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.251 -2.129 . . . . 343.57 105.251 177.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.555 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.95 81.88 1.53 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.844 -1.539 . . . . 263.29 106.844 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.33 147.01 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 126.503 1.921 . . . . 261.92 108.475 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.15 -38.15 90.04 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.887 -1.153 . . . . 106.81 107.887 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.735 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.44 -39.95 95.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 118.392 -1.323 . . . . 112.2 107.526 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.1 t -64.24 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.288 -0.634 . . . . 45.41 109.288 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.814 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.3 p -70.92 -32.01 68.8 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 110.289 -0.263 . . . . 97.62 110.289 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.57 81.52 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.634 0.774 . . . . 59.29 111.014 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.735 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.649 1.18 . . . . 106.49 110.673 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.94 -30.61 69.18 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.331 -0.989 . . . . 106.62 108.331 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.532 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.08 -41.02 91.27 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.848 -0.532 . . . . 75.97 110.058 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.481 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.49 -40.88 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 C-N-CA 122.89 0.476 . . . . 65.27 109.817 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 120.357 -0.537 . . . . 107.94 110.147 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.51 -40.82 98.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.652 -0.655 . . . . 87.98 110.293 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.33 96.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 118.834 -1.147 . . . . 65.5 108.382 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.6 mtt -61.72 -36.35 80.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.173 -1.047 . . . . 85.05 108.173 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.54 -45.68 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 109.067 -0.716 . . . . 42.25 109.067 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.33 -38.32 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 C-N-CA 119.544 -0.862 . . . . 91.01 109.344 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.84 -41.58 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 107.978 -1.119 . . . . 66.09 107.978 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.1 -43.12 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 C-N-CA 120.731 -0.388 . . . . 52.39 110.312 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.2 m -61.81 -46.73 88.23 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 121.869 -0.52 . . . . 46.42 109.834 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.36 -38.17 88.51 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.286 -1.005 . . . . 116.51 108.286 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.485 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.19 -48.22 82.64 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.437 -0.579 . . . . 65.18 109.437 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.93 -42.73 97.27 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 122.13 -0.356 . . . . 51.33 110.437 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.39 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 C-N-CA 118.898 -1.121 . . . . 126.3 109.013 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.513 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.508 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.822 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.7 -33.36 35.44 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 116.878 2.177 . . . . 134.84 116.878 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.788 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.8 tp -58.44 -41.64 90.35 Favored Pre-proline 0 CA--C 1.493 -1.23 0 O-C-N 121.686 -0.633 . . . . 72.23 111.618 -167.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.4 Cg_exo -60.61 -36.02 87.27 Favored 'Trans proline' 0 N--CA 1.429 -2.272 0 CA-C-N 119.88 0.993 . . . . 106.13 111.343 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.853 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.68 82.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.723 -0.791 . . . . 128.35 110.021 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.41 -37.83 88.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 110.207 -0.294 . . . . 100.73 110.207 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.35 -44.43 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 C-N-CA 119.268 -0.973 . . . . 172.72 109.144 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.192 -1.04 . . . . 249.23 108.192 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.895 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.61 -55.05 36.62 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.615 -1.624 . . . . 259.78 106.615 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.24 -44.13 72.62 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.38 -48.28 91.45 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 119.153 -1.019 . . . . 169.54 110.592 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.5 Cg_exo -61.18 -24.52 79.28 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 116.72 -1.72 . . . . 255.47 114.629 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.826 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.21 94.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 119.255 0.934 . . . . 279.03 108.886 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.79 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 110.078 -0.342 . . . . 162.21 110.078 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.787 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.39 84.9 59.25 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 118.75 -1.18 . . . . 128.13 108.083 -178.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.29 164.03 11.2 Favored 'Trans proline' 0 C--N 1.294 -2.297 0 N-CA-C 107.395 -1.81 . . . . 278.35 107.395 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.873 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.13 15.01 9.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.813 0.695 . . . . 312.91 109.335 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.873 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.69 -170.7 2.49 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.56 -1.645 . . . . 353.54 106.56 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.019 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 43.0 p90 -115.66 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.4 -1.333 . . . . 251.26 107.4 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.95 -118.72 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 102.092 -3.299 . . . . 175.26 102.092 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.53 -44.97 96.09 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 100.88 -3.748 . . . . 99.07 100.88 172.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.41 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 103.52 -2.77 . . . . 243.21 103.52 171.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.019 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.93 112.91 25.04 Favored 'General case' 0 CA--C 1.473 -1.995 0 C-N-CA 116.109 -2.237 . . . . 201.04 105.293 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.775 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.9 173.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 C-N-CA 116.033 -2.267 . . . . 201.36 108.831 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.09 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.02 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.278 -1.783 . . . . 203.82 107.85 174.481 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.927 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.33 -45.69 86.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.196 -1.401 . . . . 215.06 112.56 -171.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.548 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.4 t -65.7 -46.37 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 C-N-CA 118.567 -1.253 . . . . 125.28 112.937 -171.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.954 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.8 -36.99 86.12 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.177 -1.416 . . . . 268.9 107.177 -171.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.801 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.21 -45.02 74.49 Favored 'General case' 0 CA--C 1.484 -1.588 0 C-N-CA 125.65 1.58 . . . . 280.88 108.815 -172.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.63 -47.54 85.79 Favored 'General case' 0 CA--C 1.485 -1.535 0 C-N-CA 118.957 -1.097 . . . . 184.47 108.971 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.853 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.07 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 119.27 -0.972 . . . . 167.92 112.772 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.77 89.91 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 117.796 -1.562 . . . . 367.18 110.77 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.15 -32.74 74.05 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.877 -0.514 . . . . 173.97 110.439 177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.44 -36.79 85.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 123.495 0.718 . . . . 119.66 109.788 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.822 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.19 -34.0 74.36 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.725 -1.213 . . . . 112.3 107.725 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 116.239 -0.437 . . . . 174.17 110.246 -177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.0 m -64.74 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 124.685 1.194 . . . . 145.27 110.616 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.764 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.58 -35.36 70.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.113 -1.069 . . . . 170.15 108.113 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.819 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.17 63.97 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 116.3 -0.409 . . . . 214.57 110.621 -171.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.19 56.51 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.063 1.745 . . . . 168.29 115.562 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.764 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.88 79.22 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 114.008 1.114 . . . . 167.15 114.008 -168.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.721 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.7 p-10 -64.2 -38.28 33.18 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 115.521 -2.472 . . . . 165.13 113.942 -171.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.721 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.53 -31.88 80.08 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.751 2.018 . . . . 123.92 111.21 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.74 -42.57 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 118.879 -1.128 . . . . 110.55 109.802 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.2 pt -61.07 -40.08 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 108.846 -0.798 . . . . 145.31 108.846 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.926 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.3 m-85 -58.05 -48.85 78.85 Favored 'General case' 0 CA--C 1.494 -1.195 0 C-N-CA 119.408 -0.917 . . . . 246.68 109.84 -177.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.8 m -62.22 -47.52 84.09 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 119.557 -0.857 . . . . 64.43 109.555 -173.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.75 -45.13 79.53 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 119.04 -1.064 . . . . 80.72 110.204 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.47 -35.69 75.83 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 115.989 1.848 . . . . 140.44 115.989 -173.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 112.711 -3.595 . . . . 178.87 113.089 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.06 86.36 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.35 -1.295 . . . . 110.22 110.094 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.851 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.54 72.9 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 121.731 -0.606 . . . . 174.78 109.739 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.961 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.4 m-85 -64.95 -41.71 95.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.248 -1.019 . . . . 161.84 108.248 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.521 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.24 -50.27 73.42 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 120.029 -0.668 . . . . 117.2 109.25 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.13 75.46 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.374 -0.53 . . . . 112.6 111.063 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.01 -37.43 94.59 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.626 -0.99 . . . . 101.46 110.626 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.026 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.15 -46.01 90.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 118.458 1.129 . . . . 151.49 109.52 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.08 -36.31 77.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.962 -1.496 . . . . 142.32 106.962 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.828 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.8 m80 -59.8 -41.8 92.0 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.887 -1.523 . . . . 109.09 106.887 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.87 -42.41 85.67 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 122.358 -0.213 . . . . 76.11 111.02 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.49 30.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.879 -0.728 . . . . 120.24 109.318 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.575 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.32 131.54 41.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 102.912 -2.996 . . . . 192.73 102.912 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.22 -44.17 92.31 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 118.994 -1.082 . . . . 176.29 109.163 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.758 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.0 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.46 0 N-CA-C 106.303 -1.739 . . . . 69.68 106.303 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -58.97 -75.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 118.364 -0.624 . . . . 191.05 112.605 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.758 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.47 43.88 16.15 Favored 'General case' 0 CA--C 1.494 -1.21 0 O-C-N 123.578 0.549 . . . . 287.03 109.778 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.828 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.945 0 C-N-CA 112.956 -3.498 . . . . 292.29 109.818 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 104.213 -2.514 . . . . 184.57 104.213 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.71 8.71 4.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.026 0.75 . . . . 274.56 113.026 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.24 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.748 -2.167 . . . . 268.24 113.453 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.6 m-20 51.56 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 118.685 1.242 . . . . 200.06 110.764 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.851 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -32.98 74.7 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 107.885 -1.154 . . . . 114.44 107.885 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.29 46.04 21.87 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.611 -1.255 . . . . 263.81 107.611 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.29 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.195 1 N-CA-C 102.563 -4.215 . . . . 103.79 102.563 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.058 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.3 mt -88.3 95.6 10.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 114.943 -2.703 . . . . 117.3 106.016 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.034 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.76 90.77 Favored 'General case' 0 CA--C 1.468 -2.187 1 N-CA-C 98.041 -4.8 . . . . 231.58 98.041 167.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.04 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.97 163.44 29.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 102.063 -3.31 . . . . 303.24 102.063 168.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.058 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.55 78.9 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.024 -2.271 . . . . 112.72 108.424 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.8 t -61.06 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.072 -0.714 . . . . 83.22 109.072 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.882 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.3 m -156.28 -126.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.829 -2.656 . . . . 174.36 103.829 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.034 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.81 160.94 8.71 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 105.768 -1.938 . . . . 202.73 105.768 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.026 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.051 -1.463 . . . . 180.62 107.051 176.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.937 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.51 -171.87 0.27 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.937 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.13 -43.11 88.06 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.136 -1.802 . . . . 66.05 106.136 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.77 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.16 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.492 -2.781 . . . . 266.49 103.492 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.93 0.28 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 117.055 -1.858 . . . . 219.2 107.753 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.08 -37.36 94.08 Favored Glycine 0 N--CA 1.425 -2.038 0 CA-C-N 114.542 -1.208 . . . . 94.78 112.881 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.21 100.41 9.1 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 112.34 -3.744 . . . . 121.41 109.452 -171.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.4 t -73.08 145.54 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.517 -0.765 . . . . 85.34 108.949 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.8 143.45 42.15 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.832 -1.174 . . . . 267.57 107.832 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.52 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.02 69.63 0.59 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.502 -0.555 . . . . 226.1 109.502 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.989 -1.485 . . . . 154.84 106.989 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.583 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.93 8.52 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.622 0.725 . . . . 180.01 110.696 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.888 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.91 23.63 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.02 142.5 48.77 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.399 -1.334 . . . . 335.2 107.399 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.4 m -60.63 -46.81 88.87 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.698 -1.964 . . . . 59.34 105.698 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.62 173.81 11.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.422 -2.436 . . . . 201.26 104.422 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.89 106.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.525 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.4 5.37 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.337 -0.616 . . . . 87.58 109.337 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.878 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.52 153.71 22.26 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.847 -1.168 . . . . 219.95 107.847 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.8 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 C-N-CA 116.348 -2.141 . . . . 121.79 105.434 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.9 t -154.14 159.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 105.816 -1.92 . . . . 53.85 105.816 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.26 16.56 77.11 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.684 0 N-CA-C 107.886 -1.153 . . . . 35.88 107.886 -178.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 365' ' ' ARG . 1.7 tpp180 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -67.03 144.02 68.13 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.665 1.577 . . . . 1.0 111.877 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' B' ' 367' ' ' LYS . 1.2 mtpt -70.5 127.38 92.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.267 -0.424 . . . . 1.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.821 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -69.01 -19.97 38.99 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 122.397 2.065 . . . . 1.0 114.601 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.524 HE21 ' HB3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -58.39 -38.63 77.72 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.71 -178.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -71.29 -10.53 59.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.355 . . . . 1.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.821 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 0.3 OUTLIER -58.61 -46.34 87.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.332 -178.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -61.51 -49.11 78.05 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.587 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.08 78.31 0.31 Allowed Glycine 0 C--O 1.231 -0.068 0 N-CA-C 109.827 -1.309 . . . . 1.0 109.827 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.714 HD23 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.174 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.442 ' H ' HD12 ' B' ' 374' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.976 -1.012 . . . . 1.0 110.518 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 108.361 -0.977 . . . . 97.08 108.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -110.59 155.46 22.32 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.161 0.981 . . . . 123.41 110.745 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.879 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.63 -162.37 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.469 1 N-CA-C 100.106 -4.035 . . . . 151.3 100.106 173.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.993 HD21 ' HG3' ' B' ' 366' ' ' PRO . 5.2 mp -60.66 -38.61 58.5 Favored Pre-proline 0 N--CA 1.439 -1.01 0 C-N-CA 115.98 -2.288 . . . . 169.25 106.101 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.905 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_exo -81.29 168.54 16.62 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 122.265 0.613 . . . . 185.76 110.508 171.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.903 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.2 t -64.51 -25.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.051 2.141 . . . . 145.47 110.324 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.35 157.42 21.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.064 -1.023 . . . . 102.76 109.446 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.4 p -82.61 154.18 25.07 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.994 -1.114 . . . . 106.25 107.994 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.92 51.91 0.74 Allowed 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 117.757 -1.577 . . . . 157.81 107.658 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.19 -45.9 91.56 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.541 -2.763 . . . . 150.2 103.541 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.7 m -87.01 164.69 35.34 Favored Pre-proline 0 N--CA 1.422 -1.874 0 N-CA-C 103.68 -2.711 . . . . 183.52 103.68 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -76.77 6.88 3.83 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 N-CA-C 109.995 -0.81 . . . . 235.61 109.995 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.99 -41.22 82.56 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.847 1.259 . . . . 113.77 113.354 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.92 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.5 pt -52.17 136.24 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 119.616 1.098 . . . . 150.85 110.965 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.52 156.29 46.37 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 107.594 -1.262 . . . . 100.42 107.594 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.07 142.63 58.33 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.955 0.883 . . . . 129.36 110.436 -174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.07 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.288 1.835 . . . . 112.34 106.693 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.7 m -74.11 -40.16 62.88 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.553 -0.749 . . . . 131.73 111.777 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.4 -42.9 15.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 117.018 2.229 . . . . 80.49 117.018 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.53 3.35 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 118.196 -1.402 . . . . 98.98 111.252 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.84 -10.7 18.09 Favored 'Trans proline' 0 C--N 1.32 -0.921 1 N-CA-C 128.937 6.476 . . . . 246.95 128.937 -170.061 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.624 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.62 17.55 8.71 Favored 'General case' 0 C--N 1.325 -0.484 1 CA-C-N 126.12 4.055 . . . . 269.62 114.236 175.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.15 -27.3 67.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.793 -1.188 . . . . 86.8 107.793 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.83 -29.28 69.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.088 -1.007 . . . . 85.91 110.498 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 123.65 0.78 . . . . 82.0 111.364 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.76 12.43 Favored Pre-proline 0 CA--C 1.488 -1.417 0 N-CA-C 108.555 -0.906 . . . . 120.73 108.555 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.02 149.76 89.8 Favored 'Trans proline' 0 N--CA 1.431 -2.18 0 C-N-CA 120.659 0.906 . . . . 87.86 109.935 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.742 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.814 -0.81 . . . . 36.46 108.814 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.1 p-90 -63.8 -33.89 76.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.18 -32.7 73.37 Favored 'General case' 0 CA--C 1.491 -1.322 0 O-C-N 121.301 -0.874 . . . . 123.26 108.685 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.14 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 109.196 -0.668 . . . . 120.14 109.196 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.43 -31.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.859 -1.164 . . . . 112.19 107.859 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.91 -47.21 84.24 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.633 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.65 81.16 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 119.977 -0.689 . . . . 157.57 110.362 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.749 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.58 -40.9 98.36 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.682 -0.858 . . . . 47.06 108.682 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.02 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 121.751 -0.593 . . . . 43.94 109.569 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.29 99.15 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.705 -0.85 . . . . 42.61 108.705 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.35 -41.26 94.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.653 -0.249 . . . . 140.66 111.064 -178.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.79 -43.97 97.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 118.613 -1.235 . . . . 116.04 110.221 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 34.9 m -65.44 -38.76 83.26 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 108.745 -0.835 . . . . 97.16 108.745 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.853 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.4 mt -61.32 -39.95 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.962 HG22 HG21 ' A' ' 86' ' ' THR . 93.1 t -57.7 -42.34 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 108.891 -0.781 . . . . 45.39 108.891 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 48' ' ' VAL . 96.9 t -63.56 -50.97 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.837 -1.145 . . . . 48.64 110.156 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.7 t -65.21 -47.11 78.02 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.137 -0.625 . . . . 116.65 111.71 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.93 -43.93 97.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 109.695 -0.483 . . . . 51.16 109.695 -174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.57 -48.96 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 C-N-CA 119.864 -0.734 . . . . 44.3 110.828 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.865 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.1 t -64.71 -46.95 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 120.349 -0.54 . . . . 48.82 111.039 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.8 -44.12 95.2 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.492 -0.861 . . . . 58.7 112.006 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.68 -34.13 66.99 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 117.452 0.626 . . . . 101.4 111.006 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.93 -38.77 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.727 -1.212 . . . . 103.57 107.727 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.41 -43.02 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.996 -0.742 . . . . 61.89 108.996 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.5 t -63.5 -50.94 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 109.45 -0.574 . . . . 70.01 109.45 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.808 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.91 -43.45 98.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.118 -0.697 . . . . 132.1 109.118 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.19 -46.63 83.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.652 -0.249 . . . . 104.5 110.458 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.02 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.64 -49.89 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 C-N-CA 120.237 -0.585 . . . . 142.96 111.241 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL 0.28 25.0 pt -64.75 -41.76 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 C-N-CA 116.936 -1.906 . . . . 158.32 110.897 -175.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 54' ' ' MET . 8.5 mp -63.68 -41.4 98.16 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 117.692 -1.603 . . . . 137.11 109.516 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.57 91.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.155 -0.341 . . . . 54.66 111.02 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.924 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.39 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 121.615 0.721 . . . . 127.18 109.591 -174.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.78 -36.89 80.12 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 124.099 0.96 . . . . 87.93 110.884 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.041 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.36 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 121.618 -0.676 . . . . 131.12 111.526 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.023 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.64 69.46 7.15 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 115.25 -2.58 . . . . 246.56 109.613 -175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.949 0 N-CA-C 105.489 -2.041 . . . . 339.35 105.489 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.442 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.4 p -124.12 165.23 17.89 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.033 -2.951 . . . . 114.66 103.033 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.42 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 N-CA-C 106.799 -1.556 . . . . 143.28 106.799 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.5 m -59.66 -38.1 80.51 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.687 -0.857 . . . . 160.22 108.687 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 72' ' ' VAL . 86.4 m-20 -62.3 -31.78 72.43 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.908 -0.775 . . . . 120.54 108.908 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 72' ' ' VAL . 90.0 m-85 -63.56 -43.8 96.01 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.508 -0.553 . . . . 67.22 109.508 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.54 -39.75 88.72 Favored 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 121.494 -0.754 . . . . 138.6 109.71 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.57 -35.94 82.15 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.451 0.301 . . . . 151.46 110.614 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.97 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 C-N-CA 117.426 -1.71 . . . . 117.93 106.686 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.03 -46.01 90.92 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.891 -1.152 . . . . 56.82 107.891 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.016 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.41 -43.92 98.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.885 -0.783 . . . . 145.3 108.885 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.39 95.54 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 108.494 -0.928 . . . . 45.71 108.494 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.41 -42.03 99.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.357 -0.609 . . . . 105.61 109.357 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.617 -0.883 . . . . 47.89 108.617 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.59 -37.35 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.935 -0.395 . . . . 124.53 109.935 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.27 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 121.966 -0.459 . . . . 35.89 109.831 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -37.29 84.83 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.999 -1.482 . . . . 88.97 106.999 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.18 76.91 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 119.859 -0.737 . . . . 239.91 109.075 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.45 -43.39 90.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.529 -0.732 . . . . 146.1 110.565 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.2 3.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 117.358 -1.737 . . . . 91.74 113.874 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -76.6 -61.33 2.0 Allowed 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 115.745 1.757 . . . . 197.45 115.745 -173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.26 -42.31 55.34 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.896 -1.521 . . . . 242.6 114.026 -170.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.962 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.61 84.55 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 118.957 -1.097 . . . . 215.61 109.831 -172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.0 t -60.26 -46.96 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 O-C-N 121.803 -0.561 . . . . 87.19 110.489 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 108' ' ' HIS . 64.0 t -65.95 -41.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.754 -0.462 . . . . 231.82 109.754 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.14 76.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.295 -1.002 . . . . 364.98 108.295 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.7 75.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.543 -0.723 . . . . 181.63 111.242 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.5 m -60.83 -45.83 92.91 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.423 -1.325 . . . . 269.02 107.423 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.061 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.67 -45.13 92.98 Favored 'General case' 0 CA--C 1.469 -2.15 0 C-N-CA 118.677 -1.209 . . . . 562.66 110.013 -179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.21 95.67 Favored 'General case' 0 CA--C 1.479 -1.777 0 C-N-CA 118.713 -1.195 . . . . 446.75 108.108 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.0 m -70.52 -26.31 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 115.826 -2.35 . . . . 370.05 112.202 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.814 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.5 -26.48 60.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.598 -0.689 . . . . 354.91 112.53 175.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.83 4.55 0.98 Allowed 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 125.057 1.343 . . . . 462.44 111.87 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.8 mm-40 -172.39 178.06 2.89 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.067 0.936 . . . . 652.37 111.085 171.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.79 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 128.508 2.723 . . . . 905.99 107.931 -174.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.88 -36.42 80.21 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.223 -1.028 . . . . 570.43 108.223 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.52 -36.37 82.35 Favored 'General case' 0 N--CA 1.428 -1.554 0 C-N-CA 125.31 1.444 . . . . 453.22 111.191 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.67 33.88 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 118.781 -1.676 . . . . 445.63 109.897 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' CD1' ' HB2' ' B' ' 368' ' ' PRO . 89.1 mt -56.39 -41.23 75.91 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.249 1.419 . . . . 457.72 112.378 -170.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -58.64 -46.93 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.688 -1.205 . . . . 340.58 109.299 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.74 -32.13 71.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.769 -1.172 . . . . 453.6 111.585 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.04 -40.33 73.32 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.993 -1.855 . . . . 541.48 105.993 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.9 -47.08 76.0 Favored 'General case' 0 CA--C 1.486 -1.503 0 O-C-N 124.025 0.828 . . . . 466.68 110.888 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.77 -47.06 86.86 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.491 -1.684 . . . . 427.34 107.263 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.844 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.12 -36.77 82.61 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 112.423 0.527 . . . . 537.87 112.423 -174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.66 74.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 116.86 -1.936 . . . . 422.12 111.617 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.7 t80 -59.05 -50.11 75.32 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 121.339 -0.85 . . . . 340.17 111.853 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.35 -46.5 70.74 Favored Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 119.089 -1.045 . . . . 258.06 111.695 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.3 Cg_exo -61.47 -31.58 87.97 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.874 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.9 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.96 -40.54 93.78 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.791 -1.188 . . . . 149.27 107.791 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.81 95.96 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.649 -0.42 . . . . 138.08 111.5 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.96 -42.41 88.72 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 O-C-N 121.556 -0.715 . . . . 132.89 110.936 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.925 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.75 -44.72 92.63 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.849 -0.797 . . . . 193.61 108.849 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.42 -37.66 84.31 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 122.842 0.457 . . . . 63.83 110.128 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.4 59.68 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.75 -0.38 . . . . 76.4 111.214 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.0 -41.64 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.163 -1.051 . . . . 171.13 108.163 -174.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.094 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.84 -38.53 91.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.866 -0.521 . . . . 78.3 110.639 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.7 t -67.06 -35.78 80.59 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 118.9 -1.12 . . . . 92.36 109.236 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 1.016 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.45 -34.28 76.49 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.184 -1.043 . . . . 93.73 108.184 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.49 -41.59 84.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 119.205 -0.998 . . . . 132.74 109.323 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.13 94.72 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.188 -1.412 . . . . 43.39 107.188 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.828 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.2 t -58.47 -41.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 108.639 -0.875 . . . . 59.34 108.639 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.06 95.27 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.796 -0.565 . . . . 69.68 110.5 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.71 91.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.334 -0.987 . . . . 106.98 108.334 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.828 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.64 81.56 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.648 -0.821 . . . . 147.63 108.933 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.11 -41.54 99.38 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.557 -0.905 . . . . 190.06 108.557 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.32 -44.13 97.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.273 -1.01 . . . . 118.85 108.273 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.809 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.65 98.97 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 110.008 -0.367 . . . . 102.5 110.008 -177.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.61 95.23 Favored 'General case' 0 CA--C 1.489 -1.375 0 O-C-N 121.866 -0.521 . . . . 89.98 109.812 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 C-N-CA 118.104 -1.438 . . . . 106.09 111.012 -177.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.747 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.11 -48.26 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 C-N-CA 117.087 -1.845 . . . . 227.74 111.798 -174.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.753 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.88 100.08 50.94 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.238 -2.185 . . . . 262.55 110.052 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.56 -10.47 28.81 Favored 'Trans proline' 0 C--N 1.289 -2.56 0 C-N-CA 121.685 1.59 . . . . 210.25 111.35 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.23 112.0 0.99 Allowed 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 106.537 -1.653 . . . . 270.58 106.537 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.53 24.04 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-N 115.37 -0.832 . . . . 129.84 112.316 -175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 83.0 Cg_exo -61.36 -26.58 81.75 Favored 'Trans proline' 0 N--CA 1.432 -2.142 0 N-CA-C 116.321 1.623 . . . . 330.71 116.321 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.753 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.04 77.21 7.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 114.452 -2.899 . . . . 204.51 107.286 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.44 0.09 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.425 -1.324 . . . . 387.41 107.425 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.04 33.66 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 118.753 -1.179 . . . . 166.22 109.435 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.79 88.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.804 -1.184 . . . . 44.23 107.804 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.76 -38.83 92.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.085 -0.709 . . . . 30.29 109.085 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.04 93.88 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.962 -0.755 . . . . 46.11 108.962 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -42.12 99.26 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.699 -1.223 . . . . 87.33 107.699 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.8 t -61.63 -42.13 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 107.954 -1.128 . . . . 23.69 107.954 -178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.22 -44.26 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.676 -0.49 . . . . 43.86 109.676 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.3 -42.51 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 108.351 -0.981 . . . . 91.13 108.351 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.4 t -62.56 -38.0 88.37 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.743 -0.836 . . . . 65.88 108.743 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.6 t -62.11 -41.81 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 109.58 -0.526 . . . . 33.86 109.58 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.094 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.41 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.173 0 N-CA-C 107.577 -1.268 . . . . 146.52 107.577 -176.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.2 m95 -62.84 -38.36 90.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 119.499 -0.88 . . . . 75.44 108.936 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.53 -48.39 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 O-C-N 121.04 -1.038 . . . . 43.64 109.733 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.48 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 109.045 -0.724 . . . . 102.57 109.045 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.1 86.87 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.398 -1.334 . . . . 58.16 107.398 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.5 73.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.993 -0.743 . . . . 121.11 108.993 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.3 84.93 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.565 -1.254 . . . . 153.15 109.938 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.11 -43.76 18.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 113.084 -3.446 . . . . 133.67 113.477 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.92 -39.93 96.07 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 120.918 -1.114 . . . . 157.42 112.193 -171.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 114.993 1.479 . . . . 250.91 114.993 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 53.3 Cg_exo -59.54 -25.45 78.81 Favored 'Trans proline' 0 CA--C 1.488 -1.786 0 N-CA-C 117.984 2.263 . . . . 207.34 117.984 -174.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.012 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.2 -34.22 74.73 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.94 -1.504 . . . . 192.46 106.94 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.06 98.16 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 108.01 -2.036 . . . . 261.0 108.01 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.71 159.11 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 101.519 -3.512 . . . . 491.4 101.519 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -59.94 106.81 0.54 Allowed 'General case' 0 CA--C 1.488 -1.437 0 C-N-CA 116.257 -2.177 . . . . 386.1 109.87 -176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.914 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.03 -166.63 2.42 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 103.552 -2.758 . . . . 289.8 103.552 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.136 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 117.771 -1.109 . . . . 402.06 109.576 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.79 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.29 177.46 7.57 Favored 'General case' 0 CA--C 1.586 2.357 0 C-N-CA 127.32 2.248 . . . . 690.53 114.9 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.59 0.0 OUTLIER 'General case' 1 C--N 1.43 4.09 1 N-CA-C 123.178 4.511 . . . . 633.62 123.178 162.696 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.67 153.85 22.07 Favored 'General case' 0 C--N 1.389 2.305 0 C-N-CA 127.362 2.265 . . . . 617.99 110.889 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.42 5.96 Favored Pre-proline 0 C--N 1.364 1.227 0 C-N-CA 130.289 3.435 . . . . 434.98 113.382 -175.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.094 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.1 Cg_endo -44.21 -65.7 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 122.409 3.965 . . . . 365.88 122.409 -168.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.3 m -84.91 20.98 1.69 Allowed 'General case' 0 CA--C 1.467 -2.247 0 N-CA-C 104.832 -2.284 . . . . 635.81 104.832 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.35 152.19 18.83 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.959 7.762 . . . . 999.99 131.959 -135.764 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.061 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.913 37.2 t -131.79 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.773 1 CA-C-N 103.314 -6.312 . . . . 594.32 113.613 149.206 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.728 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.19 144.1 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.64 1 N-CA-C 98.307 -4.701 . . . . 811.91 98.307 162.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.47 144.58 45.89 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 117.063 -1.855 . . . . 999.99 109.411 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.23 -175.63 4.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.036 0.922 . . . . 431.86 110.042 -177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.06 148.63 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 124.384 1.074 . . . . 457.18 108.823 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.79 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.29 85.45 3.72 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 124.134 0.973 . . . . 458.77 113.523 -174.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.955 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.41 -31.56 0.97 Allowed Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.983 1.313 . . . . 999.99 112.38 168.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.953 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.96 -45.73 5.68 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 N-CA-C 120.916 3.391 . . . . 999.99 120.916 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.57 171.76 8.13 Favored 'General case' 0 CA--C 1.472 -2.041 0 C-N-CA 117.133 -1.827 . . . . 81.18 107.235 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.831 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.14 45.12 0.19 Allowed Pre-proline 0 N--CA 1.421 -1.881 0 C-N-CA 115.537 -2.465 . . . . 999.99 108.798 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.071 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.8 Cg_endo -41.61 101.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.126 1 C-N-CA 126.045 4.496 . . . . 999.99 105.677 -170.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.3 -43.99 97.55 Favored 'General case' 0 CA--C 1.483 -1.621 0 C-N-CA 126.717 2.007 . . . . 967.72 112.043 -165.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.31 -36.55 78.16 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.72 -1.585 . . . . 934.3 106.72 -175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.071 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.5 -30.29 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 129.188 2.995 . . . . 565.15 113.951 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.59 55.36 2.78 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 118.468 0.577 . . . . 755.61 109.854 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.136 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.25 67.21 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.559 1.144 . . . . 325.89 113.259 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -45.02 78.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.582 0.753 . . . . 250.21 111.639 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.66 -43.38 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-O 121.592 0.711 . . . . 142.46 110.379 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.953 0.901 . . . . 247.69 108.855 -173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 22.9 t60 -60.49 -51.32 69.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 125.444 1.498 . . . . 199.61 113.111 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.37 -44.49 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.701 -1.222 . . . . 106.73 107.701 -177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.723 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.1 -48.59 81.03 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.853 -0.612 . . . . 115.01 110.232 -173.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.19 -49.13 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 C-N-CA 119.411 -0.916 . . . . 129.42 111.857 -174.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.6 m -61.94 -53.09 60.5 Favored 'General case' 0 CA--C 1.482 -1.646 0 C-N-CA 118.178 -1.409 . . . . 172.48 109.943 -172.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.0 t -63.84 -54.32 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 C-N-CA 120.51 -0.476 . . . . 55.86 110.973 -174.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.5 -51.55 59.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.504 -1.278 . . . . 184.68 111.524 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.58 -52.42 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 C-N-CA 116.618 -2.033 . . . . 291.81 114.749 -174.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.06 -54.98 4.86 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.181 1.548 . . . . 130.66 115.181 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.85 -48.53 68.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 114.499 1.296 . . . . 80.16 114.499 -170.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.895 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.56 -45.44 83.1 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.906 -0.717 . . . . 136.02 109.509 -174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.895 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.2 Cg_exo -64.83 -27.11 59.49 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 110.596 -0.579 . . . . 92.17 110.596 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.33 -41.44 76.68 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.441 -1.318 . . . . 135.6 107.441 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.11 -44.7 91.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.604 -0.517 . . . . 52.1 109.604 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.49 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 109.079 -0.711 . . . . 95.89 109.079 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.33 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.714 -1.587 . . . . 43.41 106.714 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.28 99.12 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.382 -1.487 . . . . 27.69 109.382 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.71 -47.38 75.57 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 117.32 0.56 . . . . 54.41 110.45 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.36 -34.19 74.88 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 106.957 -1.497 . . . . 53.88 106.957 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.73 -40.84 93.85 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.503 -0.925 . . . . 68.29 108.503 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.77 -39.04 92.96 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.682 -0.807 . . . . 107.59 110.626 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.8 p -63.0 -38.38 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 119.609 -0.837 . . . . 111.61 109.525 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 80.4 t -63.23 -22.55 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.45 -0.944 . . . . 85.26 108.45 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.92 99.42 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.074 -0.81 . . . . 40.71 111.074 -176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.71 -44.09 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 108.382 -0.97 . . . . 95.86 108.382 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.2 p -76.9 -137.51 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.416 -0.957 . . . . 144.37 108.416 -176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.903 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.8 mt -55.34 132.12 47.29 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 107.606 -1.257 . . . . 326.72 107.606 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.46 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.38 -168.1 1.52 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.015 -1.846 . . . . 158.38 106.015 -176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.28 -41.94 99.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.688 -0.486 . . . . 36.78 109.688 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.7 m -61.13 125.88 25.35 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.168 -1.013 . . . . 85.46 109.77 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.694 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.91 126.57 8.83 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 105.534 -2.024 . . . . 127.78 105.534 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.05 139.91 34.78 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 105.938 -1.875 . . . . 164.84 105.938 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.0 Cg_exo -56.77 -39.95 87.72 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 113.958 0.714 . . . . 222.35 113.958 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 106.403 -2.679 . . . . 45.22 106.403 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.881 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.77 93.37 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.017 -1.846 . . . . 107.57 106.017 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.83 141.82 58.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.897 -1.121 . . . . 167.96 109.142 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.71 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 126.686 1.994 . . . . 280.68 109.715 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 55.99 11.33 0.71 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.493 1.117 . . . . 218.25 110.686 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.92 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.4 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.212 -2.144 . . . . 343.57 105.212 177.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.04 81.93 1.54 Allowed 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.875 -1.528 . . . . 263.29 106.875 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 126.57 1.948 . . . . 261.92 108.471 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.08 89.78 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 107.903 -1.147 . . . . 106.81 107.903 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.88 94.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 118.374 -1.33 . . . . 112.2 107.576 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.3 t -64.31 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.294 -0.632 . . . . 45.41 109.294 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.9 -32.06 68.89 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.287 -0.264 . . . . 97.62 110.287 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.37 -39.62 81.7 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 123.735 0.814 . . . . 59.29 111.025 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.27 -36.48 83.82 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 124.615 1.166 . . . . 106.49 110.687 -174.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.92 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.93 -30.7 69.24 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.28 -1.007 . . . . 106.62 108.28 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.01 -41.03 91.53 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 121.836 -0.54 . . . . 75.97 110.028 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.7 t -65.56 -40.83 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 C-N-CA 122.94 0.496 . . . . 65.27 109.754 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.6 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 C-N-CA 120.419 -0.512 . . . . 107.94 110.135 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.56 -40.78 97.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 121.68 -0.637 . . . . 87.98 110.275 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.824 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.63 -40.45 96.92 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.847 -1.141 . . . . 65.5 108.389 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.65 -36.37 80.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.157 -1.053 . . . . 85.05 108.157 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 248' ' ' LYS . 87.2 mt -63.5 -45.75 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 109.028 -0.73 . . . . 42.25 109.028 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.39 -38.17 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 C-N-CA 119.535 -0.866 . . . . 91.01 109.377 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.1 t -58.93 -41.55 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 107.973 -1.121 . . . . 66.09 107.973 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.05 -43.17 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 120.726 -0.39 . . . . 52.39 110.331 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.3 m -61.75 -46.77 88.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 O-C-N 121.899 -0.501 . . . . 46.42 109.858 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.37 -38.05 88.09 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.337 -0.986 . . . . 116.51 108.337 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.2 t80 -60.35 -48.17 82.88 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.392 -0.595 . . . . 65.18 109.392 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.7 97.33 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 120.827 0.346 . . . . 51.33 110.472 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.61 -43.41 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 118.936 -1.106 . . . . 126.3 108.982 -176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.511 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.6 m -65.6 -49.28 69.34 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.71 -33.4 35.34 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 116.842 2.164 . . . . 134.84 116.842 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.787 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.36 -41.62 90.37 Favored Pre-proline 0 CA--C 1.493 -1.248 0 O-C-N 121.692 -0.63 . . . . 72.23 111.66 -167.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.5 Cg_exo -60.69 -35.98 86.94 Favored 'Trans proline' 0 N--CA 1.429 -2.286 0 CA-C-N 119.851 0.983 . . . . 106.13 111.341 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.854 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.69 82.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 119.754 -0.779 . . . . 128.35 110.068 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.39 -37.87 89.04 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 110.218 -0.29 . . . . 100.73 110.218 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.27 -44.51 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.279 -0.969 . . . . 172.72 109.185 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.4 m-85 -66.62 -28.09 68.21 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.216 -1.031 . . . . 249.23 108.216 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.896 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.49 -55.17 34.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.701 -1.592 . . . . 259.78 106.701 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.16 -44.15 72.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.593 0.96 . . . . 233.11 113.593 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.38 -48.33 91.31 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 119.22 -0.992 . . . . 169.54 110.544 -170.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.9 Favored 'Trans proline' 0 N--CA 1.429 -2.282 0 C-N-CA 116.784 -1.677 . . . . 255.47 114.66 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.19 94.8 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 119.238 0.926 . . . . 279.03 108.893 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.055 -0.35 . . . . 162.21 110.055 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.781 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.4 84.9 59.27 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 118.779 -1.168 . . . . 128.13 108.052 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.25 164.0 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.289 0 N-CA-C 107.499 -1.769 . . . . 278.35 107.499 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.17 15.0 9.93 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 123.778 0.674 . . . . 312.91 109.325 175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.73 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.54 -1.652 . . . . 353.54 106.54 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.26 46.97 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.426 -1.324 . . . . 251.26 107.426 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -77.0 -118.75 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 102.06 -3.311 . . . . 175.26 102.06 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.49 -44.97 96.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 100.857 -3.757 . . . . 99.07 100.857 172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.44 124.14 9.16 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.496 -2.779 . . . . 243.21 103.496 171.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -92.97 112.93 25.07 Favored 'General case' 0 CA--C 1.474 -1.948 0 C-N-CA 116.047 -2.261 . . . . 201.04 105.293 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.774 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.92 173.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 C-N-CA 115.992 -2.283 . . . . 201.36 108.789 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.094 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.44 -41.48 89.71 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.256 -1.793 . . . . 203.82 107.872 174.441 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.27 -45.69 86.94 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 118.181 -1.408 . . . . 215.06 112.552 -171.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.1 t -65.66 -46.39 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.934 -171.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.84 -37.01 86.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.181 -1.414 . . . . 268.9 107.181 -171.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.799 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.19 -45.01 74.57 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 125.658 1.583 . . . . 280.88 108.809 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.52 85.84 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 118.981 -1.088 . . . . 184.47 108.982 -172.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.854 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.7 mp -67.91 -42.13 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 119.262 -0.975 . . . . 167.92 112.769 -175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.498 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.69 -38.87 90.44 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 117.787 -1.565 . . . . 367.18 110.783 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.549 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.73 74.06 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.819 -0.551 . . . . 173.97 110.471 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 123.541 0.736 . . . . 119.66 109.764 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.22 -33.99 74.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.675 -1.231 . . . . 112.3 107.675 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.02 73.3 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.24 -0.436 . . . . 174.17 110.244 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 m -64.74 -22.74 67.05 Favored 'General case' 0 CA--C 1.485 -1.542 0 C-N-CA 124.656 1.182 . . . . 145.27 110.627 -175.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.762 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.36 70.42 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.066 -1.086 . . . . 170.15 108.066 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.37 -34.05 63.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 122.702 0.401 . . . . 214.57 110.639 -171.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.27 -33.18 55.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.056 1.742 . . . . 168.29 115.514 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.762 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.43 -34.91 79.29 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 114.024 1.12 . . . . 167.15 114.024 -168.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.72 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.28 18.8 p-10 -64.24 -38.23 32.49 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.472 -2.491 . . . . 165.13 113.932 -171.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.72 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.54 -31.82 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 122.846 2.052 . . . . 123.92 111.241 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.79 -42.53 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 118.912 -1.115 . . . . 110.55 109.769 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.22 -39.99 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.803 -0.814 . . . . 145.31 108.803 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.252 63.4 m-85 -58.11 -48.83 78.99 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 119.386 -0.926 . . . . 246.68 109.854 -177.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.1 m -62.16 -47.51 84.19 Favored 'General case' 0 CA--C 1.484 -1.57 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.608 -173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.1 79.52 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.005 -1.078 . . . . 80.72 110.222 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 115.98 1.844 . . . . 140.44 115.98 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.77 132.22 34.46 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 112.753 -3.579 . . . . 178.87 113.061 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -64.98 -37.12 86.61 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.4 -1.273 . . . . 110.22 110.125 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.62 72.62 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 121.772 -0.58 . . . . 174.78 109.708 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.959 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.85 -41.67 95.52 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.274 -1.009 . . . . 161.84 108.274 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.35 -50.17 73.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 120.01 -0.676 . . . . 117.2 109.232 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.796 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.06 75.47 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.328 -0.549 . . . . 112.6 111.114 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.873 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.36 94.47 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.671 -0.972 . . . . 101.46 110.671 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.02 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.21 -46.02 90.76 Favored 'General case' 0 CA--C 1.492 -1.282 0 CA-C-N 118.47 1.135 . . . . 151.49 109.511 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.0 -36.34 76.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.984 -1.487 . . . . 142.32 106.984 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.829 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.1 m80 -59.78 -41.85 92.04 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.888 -1.523 . . . . 109.09 106.888 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.41 85.93 Favored 'General case' 0 N--CA 1.436 -1.136 0 O-C-N 122.287 -0.258 . . . . 76.11 111.047 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -61.48 -55.46 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 119.829 -0.748 . . . . 120.24 109.301 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.577 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.31 131.57 41.28 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 102.944 -2.984 . . . . 192.73 102.944 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.15 -44.22 92.07 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.017 -1.073 . . . . 176.29 109.22 -172.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.3 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.488 -1.431 0 N-CA-C 106.277 -1.749 . . . . 69.68 106.277 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.9 Cg_exo -59.02 -75.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.431 0 C-N-CA 118.381 -0.612 . . . . 191.05 112.595 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.48 43.92 16.23 Favored 'General case' 0 CA--C 1.492 -1.252 0 O-C-N 123.504 0.502 . . . . 287.03 109.772 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.829 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.56 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.916 0 C-N-CA 112.948 -3.501 . . . . 292.29 109.795 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.51 -152.8 0.05 Allowed 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 104.206 -2.516 . . . . 184.57 104.206 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.62 8.75 5.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.061 0.763 . . . . 274.56 113.061 176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.85 57.28 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 117.72 -2.181 . . . . 268.24 113.451 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.58 -172.03 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 118.694 1.247 . . . . 200.06 110.722 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.85 -33.03 74.76 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.868 -1.16 . . . . 114.44 107.868 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.24 46.07 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.635 -1.246 . . . . 263.81 107.635 -177.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.636 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.41 3.63 Favored Glycine 0 CA--C 1.479 -2.218 1 N-CA-C 102.475 -4.25 . . . . 103.79 102.475 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.055 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.27 95.66 10.26 Favored 'General case' 0 N--CA 1.419 -2.014 0 C-N-CA 114.933 -2.707 . . . . 117.3 106.0 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.03 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.94 -39.82 90.81 Favored 'General case' 0 CA--C 1.468 -2.178 1 N-CA-C 97.986 -4.82 . . . . 231.58 97.986 167.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.041 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.061 -3.311 . . . . 303.24 102.061 169.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.055 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.62 78.61 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.051 -2.26 . . . . 112.72 108.402 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 48.0 t -61.07 -63.6 1.24 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.1 -0.704 . . . . 83.22 109.1 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.885 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.2 m -156.28 -126.23 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.81 -2.663 . . . . 174.36 103.81 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.03 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.85 160.96 8.73 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.746 -1.946 . . . . 202.73 105.746 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.023 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.91 149.03 52.56 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.085 -1.45 . . . . 180.62 107.085 176.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.83 0.27 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.406 -2.072 . . . . 145.25 105.406 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.12 -43.12 88.05 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.155 -1.795 . . . . 66.05 106.155 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.13 0.48 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.509 -2.775 . . . . 266.49 103.509 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.29 -124.9 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 117.029 -1.868 . . . . 219.2 107.788 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.904 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.14 -37.32 93.98 Favored Glycine 0 N--CA 1.426 -2.023 0 CA-C-N 114.546 -1.207 . . . . 94.78 112.853 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.2 100.42 9.09 Favored 'General case' 0 CA--C 1.483 -1.608 0 C-N-CA 112.285 -3.766 . . . . 121.41 109.489 -171.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -73.02 145.5 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.947 -0.76 . . . . 85.34 108.947 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.39 42.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.843 -1.169 . . . . 267.57 107.843 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.11 69.6 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.472 -0.566 . . . . 226.1 109.472 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.99 156.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 107.02 -1.474 . . . . 154.84 107.02 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.7 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.585 0.707 . . . . 180.01 110.728 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.47 156.94 23.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.945 -1.502 . . . . 333.78 106.945 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.973 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.5 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.355 -1.35 . . . . 335.2 107.355 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.973 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.81 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.768 -0.827 . . . . 266.47 108.768 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.59 -46.93 88.41 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.633 -1.988 . . . . 59.34 105.633 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.59 173.85 11.96 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.428 -2.434 . . . . 201.26 104.428 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.91 106.76 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 C-N-CA 116.298 -2.161 . . . . 56.23 105.509 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.6 m -61.26 -59.45 5.28 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 109.24 -0.652 . . . . 87.58 109.24 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.5 153.77 22.23 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.842 -1.17 . . . . 219.95 107.842 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.99 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 C-N-CA 116.335 -2.146 . . . . 121.79 105.476 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.13 159.75 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 N-CA-C 105.797 -1.927 . . . . 53.85 105.797 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.66 77.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 106.021 -2.832 . . . . 196.55 106.021 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.661 0 N-CA-C 107.843 -1.169 . . . . 35.88 107.843 -178.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 1.039 ' HD2' ' HB3' ' A' ' 188' ' ' PRO . 32.6 ttt180 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.841 -0.799 . . . . 1.0 108.841 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.993 ' HG3' HD21 ' A' ' 5' ' ' LEU . 50.1 Cg_endo -67.07 143.95 67.58 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.771 1.647 . . . . 1.0 111.815 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.504 ' HB2' ' HE2' ' B' ' 367' ' ' LYS . 0.0 OUTLIER -70.33 127.28 92.28 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.941 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . 0.77 ' O ' ' HB2' ' B' ' 371' ' ' PHE . 57.7 Cg_endo -68.98 -20.02 39.08 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 122.386 2.057 . . . . 1.0 114.567 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -38.58 77.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.711 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 367' ' ' LYS . 2.4 pt20 -71.33 -10.63 60.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.844 0.354 . . . . 1.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.77 ' HB2' ' O ' ' B' ' 368' ' ' PRO . 3.1 m-85 -58.56 -46.34 87.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.277 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.66 -48.98 78.39 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.555 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -119.09 78.27 0.31 Allowed Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 109.878 -1.289 . . . . 1.0 109.878 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -41.72 97.12 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.333 . . . . 1.0 110.176 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 10.3 mtm . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.477 179.889 . . . . . . . . 0 0 . 1 stop_ save_